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Introduction 
Panic disorder (PD) and panic disorder with agoraphobia (PDA) are common 
experiences today and are largely identified in primary and emergency care. A 
delayed diagnosis is often made due to the inexplicable somatic complaints of 
patients. This delay results in high costs, not to mention inadequate treatment, since 
several investigations as to a physical source of the complaints have been carried out 
prior to the diagnosis of PD or PDA (Roy-Byrne et al., 2005a). 
Panic disorder carries a current prevalence rate of 3.7 percent in the population and 
may exist with or without agoraphobia (Kessler et al., 2006). 
Patients often report extreme anxiety and physical symptoms that seemingly come 
out of nowhere (American Psychiatric Association, 2000) thus generating a sense of 
confusion or fear. They do not realize that emotional, not physical, triggers are 
causing these reactions.  
As patients identify certain situations as causing panic, they begin to limit or avoid 
these events thus negatively impacting their personal or even occupational 
environments. Agoraphobic avoidance increases thus creating a need for even more 
intensive clinical treatments, not to mention costs.  
Historically, pharmacotherapy has been the first line treatment for panic disorder 
(American Psychiatric Association, 2007). This has fallen out of mode however due to 
the high relapse rates once the medication is reduced, the side effects that outweigh 
any benefit felt, and the high rate of patients that simply refuse to medicate their 
symptoms (Pollack, Lepöla & Koponen, et al., 2006; Barlow, et al., 2000; Hofmann et 
al., 1998). 
Cognitive behavioral therapy (CBT) has the best documented efficacy for the 
treatment of panic disorder in current psychiatric literature (American Psychiatric 
Association, 2007; Lydiard, Otto, & Milrod, 2001; Barlow & Craske., 2007; Öst et al., 
2004; Kenardy et al., 2003). Unfortunately, barely any empirical research has been 
done regarding the effectiveness of different CBTs on panic disorder specifically. 
Each CBT program has varying factors that affect how treatment is provided, as well 
as what role the therapist plays, how the client is encouraged to share and discuss 
their problems, the interaction between therapist and client, as well as the types of 
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patients accepted into the program. One way to increase the efficiency of a CBT is to 
provide group treatment (Sharp, Power & Swanson, 2004). 
To date, most investigations have employed nonstandard controls such as self help 
or bibliotherapy (Lidren, Watkins, Gould, et al., 1994) or no treatment controls (Otto, 
Pollack, Penava & Zucker, 1999) and are thus not clinically informative. Schwartz & 
Lellouch (1967), recommend using a widely available standard treatment in a 
comparison group to yield useful treatment outcome study designs. In relation to 
group CBT for panic disorder and agoraphobia, the clear comparison group choice 
would be individual CBT (Sharp, Power & Swanson, 2004). 
The goal of this study is to analyze the efficacy of individual cognitive behavioral 
treatment and group cognitive behavioral treatment strategies for panic disorder. 
Due to the change in policy in recent years regarding panic disorder treatments this 
study also aims to provide a prototype intervention for future policy direction. 
Not only does this study aim to provide a model for future group treatment 
interventions in panic disorder, but other anxiety disorders as well, by evaluating the 
effectiveness of Group Cognitive Behavior and Individual Cognitive Behavior 
Therapy in panic disorder. This group treatment format should generate cost savings 
which may then be applied towards other pressing health concerns. 
The present study investigates the relative efficacy of a group treatment CBT and an 
individual treatment CBT in comparison with a waiting list control group in the 
treatment of panic disorder with or without agoraphobia. 
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Chapter I - Theoritical Background 
1.1 Historical Background 
The word “panic” stems from Greek mythology. The god, Pan oversaw nature but 
often fell asleep near country roads. When awakened by travelers he would scream 
to such an extent that the traveler’s hair would stand on end or death could even 
occur (Barlow & Cerny 1988).  
Over the years, panic has been defined by several elements such as sudden onset and 
uncontrollable fear. Panic can be overt, escaping the perceived danger or covert, a 
confused, disorganized state of mind which leads to an inability to take action (Ley, 
1987). 
The psychiatric roots of panic disorder stem from Sigmund Freud’s 1849 paper ,''On 
the Grounds Detaching” a particular syndrome from Neurasthenia under the 
Description of “Anxiety Neurosis” which proposed a diagnostic category of anxiety 
neurosis (Weiner, 2008). Key to this diagnosis was a state of excitation and 
irritability, often displayed as irregular heart beat and respiration rates, coupled with 
dizziness. This condition was termed anxiety attack until Klein’s work in the early 
1960’s (Barker, 1989). 
As explained by Nardi (2006), Klein distinguished panic as a separate disorder from 
generalized anxiety. Using a pharmacologic approach, Klein distinguished three 
types of anxiety: panic, phobic and anticipatory (Nardi, 2006; McNally, 1990). Klein 
(1984) proposed that panic disorder actually occurred as a result of a lowered 
threshold of separation anxiety. Agoraphobia was considered a complication of panic 
disorder (Barker, 1989).  
Panic disorder became an entry in the Diagnostic and Statistical Manual of Mental 
Disorders (DSM) III twenty-five years ago but accounts of this syndrome can be 
found in early publications such as Da Costa’s soldier’s heart, Wheeler's 
neurocirculatory asthenia and Lewis’s effort syndrome (Nixon, 1993) which all 
reported aroused nervous systems and catastrophic thoughts. The defining 
difference in these early accounts is the symptom of extreme fatigue, which is not a 
current DSM diagnostic criteria. These reports were based on military experiences 
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which involved stress and trauma and thereby crossed over to post-traumatic stress 
disorder, which is another anxiety illness listing panic attacks as a diagnostic criteria. 
Of all the anxiety-related syndromes, panic disorder has been the most intensely 
researched anxiety illness during the past 25 years. Studies have contributed to a 
greater understanding of the psychology and neurobiology of anxiety, and have 
helped dispel the notion that anxiety is a trivial problem that does not require 
treatment (Roy-Byrne, Craske & Stein 2006). 
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1.2 Panic Disorder with or without Agoraphobia 
1.2.1 Definition of Panic Disorder 
According to the American Psychiatric Association (APA) Diagnostic and Statistical 
Manual of Mental Disorders (DSM-IV-TR, 2000), panic attacks are a key feature of 
panic disorder (PD). A panic attack is defined as the sudden, unexpected onset of 
fear that is accompanied by the presence of four or more physical and emotional 
symptoms such as palpitations, shortness of breath or smothering sensations, chest 
pain or discomfort, sweating, trembling or shaking, dizziness, nausea or abdominal 
distress, choking, flushes and a fear of dying or losing control. Panic attacks typically 
peak within ten minutes of onset (see Appendix A for DSM-IV-TR criteria for Panic 
Attack).  
A diagnosis of panic disorder is given when a patient suffers from recurrent 
unexpected panic attacks and evidences one of the following symptoms: persistent 
anxiety about the possibility of having more attacks, worry about the ramification of 
the attacks, or a modification of lifestyle in order to avoid having more attacks. These 
symptoms must be present for at least one month to meet criteria for panic disorder.  
 An important issue associated with panic disorder is agoraphobia. There are two 
subtypes of panic disorder: panic disorder with agoraphobia (PDA) and panic 
disorder without agoraphobia (PDWA). Agoraphobia is severe fear or anxiety related 
to a place or situation from which escape may be difficult. Often this anxiety is so 
severe that sufferers will rarely leave the house in an effort to avoid a panic attack. 
This avoidance can be seen as a coping mechanism to help deal with their anxiety. 
Because so many individuals with panic disorder (PD) also have agoraphobia, the 
American Psychiatric Association has given panic disorder with agoraphobia (PDA) 
a diagnostic code separate from panic disorder without agoraphobia (DSM-IV-TR, 
2000). 
1.2.2 Diagnostic Criteria for Agoraphobia 
A) Anxiety about being in places or situations from which escape might be difficult 
(or embarrassing) or in which help may not be available in the event of having 
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an unexpected or situationally predisposed panic attack or panic-like symptoms. 
Agoraphobic fears typically involve characteristic clusters of situations that 
include being outside the home alone; being in a crowd or standing in a line; 
being on a bridge; and traveling in a bus, train, or automobile. 
B) The situations are avoided (e.g., travel is restricted) or else are endured with 
marked distress or with anxiety about having a panic attack or panic-like 
symptoms, or require the presence of a companion. 
C) The anxiety or phobic avoidance is not better accounted for by another mental 
disorder, such as Social Phobia, Specific Phobia. Obsessive-Compulsive 
Disorder, Post Traumatic Stress Disorder, or Separation Anxiety Disorder (DSM-
IV-TR, 2000). 
In addition, to meet the criteria for panic disorder (PD) at least some of these attacks 
must occur spontaneously or "out of the blue" when the patient is not exposed to a 
fear-inducing stimulus or in a situation in which the person is the focal point of other 
people's attention (DSM-IV-TR, 2000). At least four of these anxiety attacks must 
occur within a four week period, or one of the attacks must be followed by a period 
of at least a month of persistent fear of having another attack. 
According to Bennett, (2004) the development of Panic Disorder has been defined 
into three phases: 
Stage One: Initial acute panic attack or series of multiple attacks. The first attack is 
often an extremely frightening experience since it often occurs unexpectedly while 
the person is carrying out their normal everyday tasks, (in other words they are not 
in a high stress trigger situation) thus leading them to believe that there is something 
physically wrong with them. This sudden onset along with one or more of the 
somatic sensations listed above often lead the person to seek medical care 
immediately. Unfortunately their fear is further exacerbated when no medical 
diagnosis can be found. The diagnosis of panic disorder differentiates itself from 
panic attacks a person may experience in reaction to a stressful event in that patients 
experience these attacks on a more frequent, even regular basis (Holrander, 
Liebowitz & Gorman, 1988).  
Stage Two: Patients who have already suffered attacks may then also begin to 
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anticipate anxiety about future attacks, causing a continuous vicious cycle 
(Holrander, Liebowitz & Gorman, 1988). In this stage, attacks begin to increase in 
frequency and phobias, as well as avoidance behavior, begin to develop. The patient 
begins to identify which situations serve as triggers for the attacks and then begins to 
avoid said situations. For example, someone who identifies riding on the subway as 
a trigger will first become anxious about future trips thinking that they might have 
another attack (anticipatory anxiety). This anticipation may trigger somatic 
symptoms thus generating a full panic attack. Later the person may avoid the 
subway completely thus leading to a subway phobia. A study by Katon, (1986) found 
that PD patients reported an average of 4.8 phobias compared to 1.2 phobias 
reported by the control group who did not report experiencing panic. When PD is 
not diagnosed early enough, the phobias tend to multiply to the point that the 
patient becomes more hindered in carrying out daily activities in order to avoid 
trigger situations. In this stage, the PD patient begins aggressively seeking medical 
attention in the hopes of receiving a medical diagnosis for their somatic complaints 
(Bennett, 2004; Katon, 1994). They begin to become hypochondriacs as they obsess 
over every physical sensation their body experiences. When told that the pains may 
stem from anxiety, patients argue that any anxiety is a result of the physical pain 
(Katerndahl, 1988). 
Stage Three: At this point the PD patient has developed avoidant behavior to the 
point of agoraphobia. Agoraphobia stems from Greek and literally means “fear of the 
marketplace”. DSM-IV (2000) uses the term to mean fear of being in places or 
situations from which escape may be difficult or embarrassing, or where help might 
be unavailable in the event of a panic attack. Once agoraphobia develops the person 
may become homebound or at least extremely limited in his/her ability to function 
in the outside world. The patient often relies on the company of a significant other 
for any outing (Shoenberger & Hazlett-Stevens, 2007; Katon, 1994; Franklin & 
Andrews, 1989) which can then lead to interpersonal problems since now another is 
indirectly affected by the condition. 
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1.2.3 Panic Disorder and Comorbidity 
 PD has been associated with increased comorbidity with other mental disorders and 
can occur in conjunction with other anxiety disorders such as posttraumatic stress 
disorder, social phobias, agoraphobia, obsessive disorder as well as depression, 
personality disorders, substance abuse disorder (Bernstein et al., 2006), alcohol abuse 
(Kessler, et al., 2006; Kinley, et al., 2009), suicidal ideation (Goodwin et al., 2006; 
Kinley et al., 2009), negative life events such as illness, bereavement and legal 
problems (Cramer, Torgersen & Kringlen, 2005). 
PD has also been shown to be associated with decreased quality of life (QoL), 
reduced contact with friends and family and reduced social support (Rufer et al., 
2010; Cramer et al., 2005; Rubin et al., 2000). Rubin et al., (2000) in one investigation 
found that patients with panic disorder lost on average 39 quality adjusted days for 
each year that they lived with the disorder based on the Quality of Well-Being Scale 
(QWB) that can be described in terms of quality adjusted life-years. 
Persons with panic attacks also have higher rates of disability and unemployment 
(Kessler et al., 2006; Marshall et al., 2008), lower education (Katon et al., 1995), lower 
income (Katerndahl & Realini, 1997) and increased financial dependency (Klerman, 
et al., 1991). 
Agoraphobia disorder is strongly linked with PD; Klerman et al (1991) found about 
33% of 254 subjects with PD have comorbid agoraphobia. Another study found that 
about one third to one half of those with panic disorder developed agoraphobia 
avoidance (Kessler, et al., 2006). Agoraphobia leads to avoidance of situations from 
which escape might be difficult or help unavailable in the event of a panic attack. 
Typical agoraphobic situations include driving, crowded restaurants, shopping 
malls, being far away from home or being alone (Craske, Miller, Rotunda & Barlow, 
1990). 
Among anxiety disorders comorbid with PD, social phobia may occur in up to one-
third of patients with PD, because one major fear of patients with PD is of having a 
panic attack in social situations. According to DSMIV TR (2000) the most common 
comorbid PD with anxiety disorders are: social phobia and generalized anxiety 
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disorder (15% to 30%) specific phobia (2% to 20%), obsessive compulsive disorder 
(10%) and post-traumatic stress disorder (2% to 10%). 
A study by Barlow, Brown & Antony (1995) examined diagnostic comorbidity in 
panic disorder in 126 patients with PD. Their results showed that of the 64 patients 
with comorbidity the most frequent additional diagnoses were: generalized anxiety 
(32.5%) social phobia (13.5%) and depression (12.7%). 
Major depression is the most frequent comorbid diagnosis (Merikangas et al., 1996) 
and approximately 30-60% of PD patients suffer from a depressive disorder 
(Weissman et al., 1997; Roy-Byrne, Stang, & Wittchen, et al., 2000).  
Kessler et al., (2006) reported that about 50% of patients with PD and 73.3% of 
patients with PDA have a comorbid mood disorder and another report found a 
lifetime prevalence of depression in PD patients of 55.6%. 
 Some studies have shown substantially elevated risks of suicide for patients with PD 
who present with comorbid depressive disorders, borderline personality disorder 
and/or substance use disorders (Barlow, 2002; Goodwin & Roy-Birne, 2006; Kinley et 
al., 2009). Weissman and her colleagues (1990) found that panic attacks and PD are 
strongly associated with suicidal ideation and actual suicide attempts. They reported 
a history of suicide attempts in 20 percent of the persons who met criteria for PD, as 
opposed to 12 percent among persons who experience panic attacks, but who did not 
meet all the criteria for panic disorder. After further calculation of their data, the 
research concluded that persons with PD were 5.4 times more likely to attempt 
suicide than persons who have never qualified for a psychiatric diagnosis. Also 
Özkan & Altindag (2005) in a study found that the rates of suicidal ideation and 
suicide attempts in subjects with panic disorder were 34.8% and 9.8%, consecutively. 
In particular, impaired social, marital functioning and comorbid lifetime with major 
depression, alcohol or substance abuse and brief depressive symptoms can increase 
the risk of possible suicide attempts in patients with PD (Kinley et al., 2009; Pollack, 
Rapaport & Clary, 2000; Uhlenhuth, et al., 2002).  
PD is also associated with negative coping behaviors, including alcohol or substance 
abuse and dependence, particularly alcohol and psychoactive medication (Kinley, et 
al., 2009) and smoking (Cosci, Knuts, et al., 2010). These are about twice as common 
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among those with PD compared to those without (Ramage-Morin, 2004). 
 Epidemiological studies indicate that the prevalence of smoking in patients with PD 
is higher than that of the general population. McCabe et al., (2004) reported that 
smoking prevalence in PD is 40.4%. 
The result of the National Epidemiological Survey on Alcohol and Related 
Conditions (NESARC) showed that PDA or PDWA presented a nearly 8-fold risk for 
drug dependence (Compton et al., 2007). The National Institute of Mental Health 
(NIMH) (2007) reported that about 30% of people with PD use alcohol and 17% use 
other psychoactive drugs such as cocaine and marijuana. Mavissakalian & Guo’s 
study (2002) showed a lifetime prevalence of alcohol abuse in 51 of 306 participants 
(16.7%) with PD. 
As Barlow points out, studies show that there is no consistent pattern concerning the 
onset of alcoholism relative to major depression, dysthymia, or panic disorder-
mental disorders which often co-occur. PD can occur “either as a consequence of 
alcoholism, or subsequent to attempts to self-medicate panic and anxiety” (Barlow, 
2002). 
Physical health problems such as hay fever (Goodwin, 2002), asthma (Goodwin, Pine 
& Hoven, 2003) and the presence of any medical condition (Kinley et al., 2009) occur 
more frequently in people with panic attacks and these individuals have lower 
perceived physical functioning and health (Marshall et al., 2008). The research 
evidence shows that there is a high level of comorbidity between panic disorder and 
somatization (Battaglia et al., 1995) and hypochondriasis (Furer et al., 1997; Hiller et 
al., 2005). One study showed that 48% of somatization disorder patients had also 
been diagnosed with PD (Katon, Lin et al., 1991). Another study provided evidence 
that 90% of people with PD have somatization disorder (Sheehan & Sheehan, 1982). 
Also Hiller et al., (2005) in a study showed that 57.1% patients with PD have 
hypochondriasis and 33.3% comorbid with somatization. The reason for the high 
comorbidity rate between these two disorders is open to speculation, but it is likely 
that the relationship is associated with the overlap of somatic symptoms which occur 
with both diagnoses. In order to receive a diagnosis for both disorders, the patient 
must exhibit somatic symptoms in the absence of a panic attack (American 
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Psychiatric Association, 2000). 
Rates of migraine headache are increased in panic disorder (Jette et al., 2008). 
Yamada et al., (2011) investigated the comorbidity rate of migraine and headache 
with PD in 54 patients with PD. They found forty-three (79.6%) patients were 
diagnosed as having some type of headache; 61.1% migraine, 32 tension-type 
headache. Breslau & Davis (1993) and Stewart, Breslau & Keck (1994) found a lower 
incidence rate of people with both migraine headaches and PD, but they still 
reported that 10.9% of people with migraine headaches have PD. The differences in 
the incidence rates between the studies could be accounted for by the fact that 
Breslau and Davis only used subjects between the ages of 21 to 30.  
Hocaglu et al., (2008) in a study evaluated the comorbidity rate in patients with chest 
pain but without any detectable cardiac etiology. The result showed that PD was 
diagnosed in 47% of the non-cardiac chest pain group. 
PD is therefore disruptive to many people as it occurs not only as a disorder by itself, 
but often overlaps with many other disorders. In people who exhibit comorbid 
disorders, it is difficult to determine if the disorders are reactive to one another or 
exist independently of one another. However, some studies have shown that the 
treatment of one disorder may reduce the symptoms of the other existing disorder 
(Brown et al., 1995).  
The Comorbid disorders with panic disorder are shown below (Table 1.1). 
 
Table 1.1: Comorbid disorders with panic disorder 
Comorbidity Author Prevalence 
Anxiety disorders 
• Agoraphobia Klermann et al., (1991) 33% 
Eaton et al., (1994)   29.5% to 58.2% 
• Generalized anxiety 
Barlow, Brown, Anotony (1995) 
32% 
• Social phobia 13.5% 
• Post-traumatic Stress 
Disorder 
DSM IV TR (2000) 
2% to 10% 
• Obsessive Compulsive 
Disorder 
10% 
Mood Disorder 
• Depression Kessler et al., (1998) 55.6% 
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Hiller, Leibbrand, Rief, Fichter (2005) 71.1% 
Suicidal: 
• Ideation 
Özkan & Altindag (2005) 
34.8% 
• Attempts 9.8% 
Substance abuse 
• Alcohol abuse Mavissakalian & Guo (2002) 16.7% 
National Institute of Mental Health 
(NIMH) (2007) 
30% 
• Psychoactive drug (Cocaine 
and Marijuana) 
National Institute of Mental Health 
(NIMH) (2007) 
17% 
• Smoking McCabe et al., (2004) 40.4% 
Somatization Disorder 
• Somatization Sheehan & Sheehan, (1982)  90% 
Battaglia et al., (1995)  48% 
Hiller, Leibbrand, Rief, Fichter, (2005)  33.3% 
• Hypochondria Furer, Walker, Chartier, Stein (1997) 48% 
Hiller, Leibbrand, Rief, Fichter, (2005) 57.1% 
• Headaches Breslau & Davis (1993) 
Yamada et al., (2011) 
10.9% 
79.6%. 
• Chest pain Hocaglu et al., (2008) 47% 
 
1.2.4 Epidemiology 
1.2.4.1 Epidemiology of panic disorder 
PD occurs frequently in the general population, but there are no certain figures to 
document the prevalence. This is partially due to significant misdiagnosis and the 
failure of many persons with PD to seek treatment. 
The American National Comorbidity Survey Replication (NCS-R), an 
epidemiological study of prevalent psychiatric disorders, reported a life-time 
prevalence of 4.7% for Panic Disorder with or without agoraphobia (Kessler, et al., 
2005a). 
In a study by Kessler, et al., (2006) the life time prevalence for Panic Disorder without 
agoraphobia (PDWA) was 3.7% as opposed to 1.1% for Panic Disorder with 
agoraphobia (PDA).  
Another large epidemiological study by Grant, et al., (2006) reported the following 
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lifetime prevalence: 5.1% for PD (with or without agoraphobia), 4.0% for PD without 
agoraphobia (PDWA) and 1.1% for Panic Disorder with Agoraphobia (PDA). The 
rate of lifetime agoraphobia was substantially lower, at 0.17%. 
For a 12-month prevalence, the NCS-R (Kessler, et al., 2005b) reported a rate of 2.7% 
for PD (with or without agoraphobia), and for agoraphobia (without panic) 0.8%. 
Nevertheless, many studies have reported higher rates for the prevalence of panic 
attacks. For example, Norton, Harrison, Hauch & Rhodes (1985) found that one-third 
of university students experienced a panic attack in a one year period.  
Telch, et al., (1989b) sampled 2,375 college students and found that 12% of the sample 
had at least one unexpected panic attack. However, Brown and Cash (1989) raised 
concerns about whether estimates of panickers may be inflated due to the use of the 
paper and pencil measure, such as the Panic Attack Questionnaire (PAQ). This 
measure provides participants with a two-sentence description of a panic attack, and 
participants are labeled as panickers based solely on their responses to the panic 
frequency items. Although the reliability of the reported percentage was questioned, 
it was evident that more people experience occasional panic attacks than panic 
disorder.  
Warren et al., (1988) found that 32% of a high school sample (ages 12-19) reported 
having at least one panic attack. In addition, 4.7% of the sample met the criteria for 
PD. Despite the early onset of PD, the mean age of initial treatment was 34 years of 
age (Breier et al., 1986). 
According to the National Comorbidity Survey (NCS), women are over two times 
more likely to be affected with PD than men (Sheikh, Leskin & Klein, 2002). Other 
studies have shown that up to 71% of panic disorder with agoraphobia patients are 
women (Yonkers et al., 1998).  
Marital status is a significant risk factor for panic disorder, the highest lifetime 
prevalence rates are found in widowed, separated or divorced subjects (Yates, 2009; 
Wittchen & Essau, 1993). Additionally, panic disorder is associated with low 
education and many studies have reported higher rates of low education in patients 
with PD. For example, Tilli et al., (2012) in a study found that the panic disorder 
patients had significantly less education, so that only about one-third of panic 
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disorder patients had finished high school. Furthermore, 40% of patients with PD 
and over half of patients with PDA had no professional education, and were 
significantly less likely to be employed than controls. 
1.2.4.2 Epidemiological survey of panic disorders in Iran 
The nationwide epidemiological survey of lifetime prevalence of psychiatric 
disorders is not adequately known in Iran. Burden of psychiatric disorders in 
developed countries has been identified by screening questionnaires and standard 
clinical interviews at a high level, but the epidemiological studies of psychiatric 
disorders in Iran are brief and their numbers are few (Yasamy & Shahmohammadi et 
al., 2002). 
Nevertheless the prevalence of lifetime psychiatric disorders was estimated in the 
year 2005 among the population aged 18 and stratified for gender, age group, 
educational level, occupational status, marital status and residential area. The 
subjects were 25,180 individuals selected through a clustered random sampling 
method. The psychiatric disorders were diagnosed on the bases of DSM_IV criteria. It 
was the first study in Iran to have administered a structured psychiatric interview to 
a representative sample, in this case an Iranian population aged 18 and over. The 
prevalence of psychiatric disorders was 10.81%. It was more common among females 
than males (14.34% vs. 7.34%, P < 0.001). The prevalence of anxiety and mood 
disorders was 8.35% and 4.29% respectively. Among mood disorders, major 
depressive disorder (2.98%) and among anxiety disorders, phobic disorder (2.05%) 
and PD (1.51%) had the highest prevalence. An increased prevalence of psychiatric 
disorders was found among divorced and separated 22.31%; residents of urban areas 
11.77%; illiterates 13.80%; householders 15.48% and the unemployed 12.33% 
(Mohammadi, Davidian et al., 2005). 
Ahmadvand et al., (2012) reported the prevalence of mental disorders in Iran during 
2008-2009. They reported anxiety disorders were the most prevalent mental disorder 
(26%) and among anxiety disorder group, GAD and PDA had the highest range. the 
range of PD was 3.5%. 
The result of a study about the prevalence of panic attacks among 347 university 
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students of Iran in 2003, showed 38% percent of participants reported panic attacks 
in the past year, and 21.4% reported panic attacks in the past four weeks, when 
prompted by a broad definition of panic. Men and those with unexpected panic 
reported greater panic severity, whereas women with panic attacks reported greater 
situational fear and avoidance (Nazemi, et al., 2003a). 
1.2.4.3 Epidemiology of psychiatric disorders in the Hormozgan 
province 
The results of a study of the epidemiology of psychiatric disorders in the Hormozgan 
province in 2001 showed a prevalence of 24.31 percent in women and 8.95 percent in 
men. The anxiety and mood disorders with 14.68 and 4.99 percent respectively, had 
the highest prevalence in the province. The prevalence of psychotic disorders in this 
study was 1.94 percent in men. The frequency of psychotic disorders in this study 
was 1.49 percent, neuro-cognitive disorders 2.22 percent and dissociative disorders 
0.78 percent. In the group of mood disorders, major depression with 3.60 percent and 
in the group of anxiety disorders, panic disorder with 5.82 percent had the highest 
frequency (Mohammadi & Rahgozar, et al., 2001).  
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1.2.5 Etiology 
Many different theories have been developed to explain why panic disorder occurs 
and how it is maintained. Five major etiological models of panic are examined here, 
including genetics effects, neurobiological models, carbon dioxide sensitivity, false 
alarm theory, cognitive model, and anxiety sensitivity model. 
1.2.5.1 Heredity 
Genetics and heritable effects are likely to play an important role in the cause of 
anxiety disorders. An at risk group for developing PD is the relatives of PD patients 
(Li, Sundquist & Sundquist, 2011; Gratacòs, et al., 2007). 
A molecular genetic study by Maron, Hettema, & Shlik, (2010) on PD suggests 
involvement of genetic factors in the familial transmission of PD with an estimate of 
nearly 40% heritability.  
Crowe et al., (1983) in a family study of panic disorder found a genetic risk for PD of 
24.7% among first-degree relatives of PD patients, compared with only 2.3% among 
normal controls. They also concluded the risk of PD in female subjects was twice that 
in male subjects. In another study, Crowe (1985) found that 17.3% of PD patient 
relatives met the criteria for PD, with an additional 7.4% reporting infrequent attacks.  
Goldstein et al., (1997) in a study of 152 probands with PD, concluded an early age at 
onset of PD has been associated with increased familial risk. They found that 
relatives of probands who developed panic disorder before age 20 had a 17-fold 
higher risk whereas only a 6-fold risk increase for PD was observed in first-degree 
relatives of probands when the onset age exceeded 20 year. 
Li et al., (2011) examined sibling risk of any type of anxiety disorder in Sweden over 
a 40-year period. The results showed that among a total of 42,602 persons 
hospitalized for anxiety disorders, 2,093 affected siblings were identified. In this 
study, standardized incidence ratios (SIR) were calculated by comparing risk in 
siblings of persons hospitalized for anxiety disorders with risk in persons whose 
siblings had no hospital diagnosis of anxiety disorders. The result showed that, the 
sibling risk was 2.26. Analysis of risk by subtype showed that having a sibling 
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diagnosed with any anxiety disorder resulted in increased risks of a number of 
disorders. 
In another study, Turner et al., (1987) found a significant difference on measures of 
fear and anxiety between offspring of anxious parents and the offspring of non-
anxious parents. In addition, forty-four percent of the anxiety offspring met criteria 
for an anxiety disorder, whereas only 9% of the offspring of non-anxious parents had 
a diagnosable disorder.  
Although these findings suggest a strong heritable component to PD a challenge 
with family studies is that the cause of the association could be either genetic, 
learned, or some combination of the two.  
One step to exploring these issues is to use twin studies. More studies of twins 
separated at birth need to be done to gain more data on whether genetic and 
environmental influences contribute to a disposition for panic issues (McNally, 1990). 
One twin study estimated the heritability of panic disorder to range between 37% 
and 43% (Jang, 2005; Nauert, 2011).  
Torgersen (1983) examined 299 sets of monozygotic or dizygotic adult twins for 
anxiety disorders. Concordance rates for panic disorder with or without agoraphobia 
for monozygotic twins were significantly higher than for dizygotic twins.  
Differences between monozygotic and dizygotic twins in frequency of co-occurring 
panic disorder appear to be due to heredity. In addition, first-degree probands of 
persons with panic disorder are more likely to have panic disorder than probands of 
persons without panic disorder.  
 
The results of family and twin studies of panic disorder are shown below (Table 1.2) 
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Table 1.2: Family, twin studies of panic disorder 
 First-Degree Relatives Morbidity Risk in First-Degree 
Relatives 
Family Studies (Cases) (Controls) Cases Controls 
Crowe et al. (1983) 278 262 17.3% 1.8% 
Noyes et al. (1986) 241 113 17.3% 4.2% 
Hopper et al. (1987) 519 - 11.6% - 
Maier et al. (1993) 174 309 7.9% 2.3% 
Weissman (1993) 141 255 10.6% 0.7% 
Goldstein et al. (1994) 141 225 16.4% 1.8% 
Fyer et al. (1996) 236 380 10% 3% 
Twin Studies n (MZ pairs) n (DZ pairs) MZ concordance DZ concordance 
Torgersen (1983) 13 16 31% 0% 
Skre et al. (1993) 12 18 42% 17% 
Perna et al. (1997) 26 34 73% 0,00% 
 
1.2.5.2 Neurobiological Models 
The biological model defines panic attacks as stemming from an extreme autonomic 
system arousal, hypothesized to be caused by a neurochemical imbalance, most 
likely a dysfunctional noradrenergic neuotransmitter system (Bremner, 2004; 
Garakani et al. 2006; Antony, Brown, & Barlow, 1992; Ninan & Dunlop, 2005; 
Gorman, et al., 2000).  
There are three major neurobiological models of panic disorder although no model is 
definitive or conclusive:  
First is the suffocation alarm model which claims over-reactive fear circuits located in 
the limbic system lead to PD (Klein, 1993). This hyperarousal then stimulates the area 
of the brainstem responsible for respiration, leading to the physical symptoms 
associated with panic disorder (Klein, 1993; Gorman et al., 2000). In this way, 
neurobiological reactivity in emotion centers of the brain perpetuates panic disorder. 
The second model emphasizes the role of the pre-frontal cortex, the brain region 
responsible for the modulation of the fear circuit. In this model, the amygdala (the 
emotion center of the brain), the hippocampus (the memory center of the brain), and 
the pre-frontal cortex (executive functioning), interact in a feedback circuit that either 
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inhibits or escalates the anxiety response. The pre-frontal cortex is responsible for 
inhibiting the amygdala. Interestingly, if the amygdala is over-active, the pre-frontal 
cortex is actually less able to exert control over the amygdala, creating a vicious circle 
(Ninan & Dunlop, 2005; Rauch, Shin, & Wright, 2003). 
The neurobiological diathesis that maintains panic disorder is hypothesized as 
follows: 
If the baseline activity of the amygdala is high (for example, high anticipatory 
anxiety or temperament) the likelihood that another stimulus will trigger a panic 
attack increases. If the hippocampally mediated explicit memory is constantly 
triggered by conscious associations to the panic attack (recounting the details of the 
attack in an effort to “forget” the experience), it also increases the likelihood of 
another panic attack. If there is a history of behavioral inhibition in childhood, there 
may be a temperamental skewing toward avoidance (Ninan & Dunlop, 2005). In this 
way, a synergy is created in which pathways are laid down that become 
strengthened by each experience of anxiety. 
The third model maintains that in patients with panic, anxiety states stimulate the 
activation of the limbic system. However, higher order centers of the brain are not 
recruited to modulate the anxiety reaction. Thus the anxious thought that triggered 
the attack remains outside of conscious awareness (Rauch, Shin, & Wright, 2003; 
Whalen et al., 1998). The third model offers a rationale for panic being experienced as 
“out of the blue.” 
These different models of the pathophysiology of panic disorder suggest that the 
regions responsible for emotion/fear responses are over-reactive, and the regions 
responsible for executive functioning and emotion regulation are under-active.  
Psychotropic medications are thought to remediate the over-reactivity of the limbic 
system by dampening and modulating the responsiveness of this region (Gorman et 
al., 2000). 
As emotional reactivity becomes less intense, patients are able to experience greater 
control over their affective experience, and they are less likely to become 
overwhelmed. 
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1.2.5.3 Carbon dioxide sensitivity 
Some studies have shown that hyperventilation (which releases excess carbon 
dioxide) may lead to panic. When carbon dioxide is inhaled (causing an excess) 
this can cause peripheral acidosis which is an "excess retention of carbon dioxide in 
the body" (W.B. Saunders Company-Dorland's pocket medical dictionary, 2001). This 
in turn leads to increased respiration (hyperventilation) and respiratory alkalosis 
which leads to physical panic symptoms such as dizziness and heart racing 
(Wilhelm, Gevirtz, & Roth, 2001). The body then experiences blood vessel 
constriction which reduces the amount of blood supplied to the brain, heart, and skin 
is reduced as result of blood (Jacob & Rapport, 1984).  
Alkin, Tural et al., (2007) and Gibbs (1992) found that panic disorder patients, when 
compared to controls, had a significant reduction in basal artery flow as a result of 
hyperventilation.  
There have been many studies on patients diagnosed with panic disorder where the 
inhalation of carbon dioxide has been used to induce panic attacks in patients 
diagnosed with panic disorder (Coryell et al., 2006; Perna, et al. 2004; van Beek &, 
Griez, 2000; Griez, et al., 1990a & 1990b; Perna et al., 1995). 
Results of induced hyperventilation have not always led to panic (Gorman et al., 
1984) leading some to believe that acute hyperventilation is not sufficient to trigger 
panic. Stronger evidence indicates a patient’s sensitivity to bodily symptoms along 
with respiratory alkalosis results in the physiological symptoms of panic (Kenardy, 
Oei & Evans, 1990).  
Many of the studies have shown that carbon dioxide inhalation provokes panic in 
panic disorder patients but not in controls (Caldirola et al, 2004; Alkin, Tural et al, 
2007; Fyer, et al., 1987; Lousberg, Griez & van den Hout, 1988; Gorman, Martinez, 
Browne, Coplan & Papp 2001). It has been hypothesized that the patients who panic 
as a result of carbon dioxide inhalation may have a hypersensitivity to carbon 
dioxide (Gorman et al. 1984; Fyer et al., 1987; Nardi et al., 1999). For example, in a 
study of healthy individuals who received sodium lactate and placebo on two 
different days, only those who received the lactate infusion and anxious instruction 
experienced a significant increase in anxiety (van der Molen et al., 1986). 
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Berzak et al., (2004) found that sensitivity to carbon dioxide (CO2) is lower in healthy 
volunteers than in panic disorder patients. In their study participants with a single 
lifetime panic attack and participants with panic disorder received an inhalation of 
35% CO2. The result showed none of the 14 subjects with a single lifetime panic 
attack, compared to 7 of 17 subjects with panic disorder (P=.009), had an attack. 
Nardi et al., (2003) in a study examined the responses to a breath-holding challenge 
test in patients with anxiety disorders. The patients in this study were 29 panic 
disorder (PD) patients, 27 social anxiety disorder (SAD) patients, 21 generalized 
anxiety disorder (GAD) patients. They were induced to hold their breath as long as 
possible four times with two-minute intervals. The result showed panic disorder 
patients were more sensitive than other anxiety disorder patients. 44.8% PD patients, 
14.8% SAD patients, 9.5% GAD patients had a panic attack after the test. 
Gorman et al., (1984) suggested that carbon dioxide triggers locus ceruleus firing in 
sensitive individuals, which results in spontaneous panic. However, Gorman et al., 
(1988) found in tests in which patients hyperventilated room air (versus carbon 
dioxide enriched air), did not cause panic in panic patients. Therefore the conclusion 
was that respiratory alkalosis is not a sufficient cause of panic in patients with panic 
disorder, and some psychological mechanism is also needed. 
Salkovskis and Clark (1990) examined the association between acute 
hyperventilation and panic attacks. In their study the patients underwent two 
minutes of hyperventilation (60 respiratory cycles / min). This resulted in about 60% 
of them experiencing panic attacks similar to a symptomatological actual attack. The 
subjects were less successful at distinguishing between the fear response and the 
bodily sensations as opposed to the control. 
Griez et al., (1990b) in a study revealed that PD patients who had rated at least 50 on 
both the Zung self-rated Anxiety Scale (SAS) and the State-Trait Anxiety Inventory 
(STAI) and other anxiety patients who had rated at least 50 on both the Zung self-
rated Anxiety Scale and the State-Trait Anxiety Inventory but without no history of 
panic attacks, do not significantly differ from each other in initial reporting of high 
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arousal state. However, they do suggest that the carbon dioxide differences between 
PD patients and the non-panic patients may be due to initial physiological 
differences of high arousal that may not be captured through a self-report measure. 
Lousberg et al., (1988) suggest that the increased panic response to carbon dioxide is 
a psychological fear of the somatic sensations, which produces the panic, rather than 
the physiological symptoms themselves being the cause of panic. 
Salkovskis and Clark (1990) and Papp, Klein, Gorman (1993) argued that panic 
disorder may be due to an inherently unstable autonomic nervous system or result of 
a hypersensitive carbon dioxide chemoreceptor system. When this hypersensitive 
system is challenged slightly hyperventilation is the result.  
Papp et al., (1989) found a significant difference in carbon dioxide sensitivity 
between PD patients and normal controls. PD patients demonstrated greater 
sensitivity than the healthy subjects as measured by increased carbon dioxide levels 
in minute volume arterial blood samples for blood gases.  
Woods et al., (1986) in a study demonstrated that the increased carbon dioxide 
sensitivity of panic disorder patients is not an outcome of having carbon dioxide 
chemoreceptor irregularity, but also is due to an increased firing rate of neurons in 
the locus coeruleus-noradrenergic system as an outcome of carbon dioxide. 
It is still not clear what triggers panic in some patients. Is it solely that some are more 
hypersensitive to the physiological effects of carbon dioxide, thus leading them to 
hyperventilation? (Gorman et al., 1994) Or do panic prone individuals simply 
misinterpret the symptoms thus escalating the physiological effect? (Salkovski & 
Clark, 1990; Papp et al., 1993) This uncertainty as to the actual source impedes 
finding an effective treatment for the disease. 
1.2.5.4 False Alarm theory 
Alarm theory (Barlow, 1988, 2002, Bouton, Mineka & Barlow, 2001; Cartner & 
Barlow, 1995; Forsyth & Eifert, 1996) came about in order to distinguish between 
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panic and anxiety. Often unexpected panic attacks occur in the population at large 
(e.g., Norton, Cox, & Malan, 1992; Telch, et al., 1989a; Wittchen & Essau, 1991), but 
seldom result in PD and are referred to as"nonclinical" attacks. This population 
shows little or no concern of experiencing attacks in the future and understands them 
as being an isolated event. Other evidence proposes that panic attacks as a 
nonspecific response to stress, similar to hypertension or headaches that run in 
families (Barlow, et al., 1996). 
In contrast PD patients anticipate the next apprehensively and view it as 
uncontrollable and unpredictable. They are extremely aware of somatic symptoms 
since they consider these a signal of an impending attack (Bouton, Mineka, Barlow, 
2001).  
The false alarm theory defines a panic attack as unconditional fear occurring at 
wrong time. These "false" alarm occure when there is no real danger making the 
panic an even greater surprise to the patients (Bouton, Mineka, Barlow, 2001). 
It has been widely recognized that it is adaptive to learn to associate emotional 
responses very quickly with both discrete and contextual cues. When these alarms, 
true or false, are associated with, or conditioned to, external or internal cues, they 
become "learned alarms".  
In a specific phobia, the fear or anxiety is clearly conditioned to an object or situation. 
In contrast, the source of fear in a PD patient cannot be easily distinguished. Thus 
following Goldstein and Chambless (1978), Barlow proposed that false alarms could 
be conditioned to internal physiological stimuli thus creating interoceptive 
conditioning (Razran, 1961). 
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Figure 1.1: A model of the causes of panic disorder with or without agoraphobia (White & 
Barlow, 2002) 
The occurrence of false alarms and subsequent learned alarms need not be 
pathological if the alarms are infrequent and anxiety towards future alarms does not 
develop. It is anxiety that stimulates vigilance for somatic sensations, increased 
somatic cues, tension and arousal which spirals into anxiety and panic. Anxiety 
focused on a possible future panic attack is now part of the defining DSM-IV criteria 
for PD (American Psychiatric Association, 2000). 
Craske et al., (1990) with interview data from 162 subjects with panic disorder with 
or without agoraphobia found that, extensive avoiders tended subsequently to 
develop additional anxiety disorders more than minimal avoiders. Moreover, most 
individual with panic disorder with or without agoraphobia (approximately 72%) 
report identifiable stressors around the time of their first panic attack. The most 
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frequently reported stressors were somatic in nature. Almost half of the patients 
reported having experienced panicky feelings at some time prior their first full panic 
attack. There were no differences between minimal and extensive avoiders in terms 
of the presence of others, behavioral response, or location of the first panic attack. 
Moreover the groups did not differ with respect to the presence of other anxiety 
disorders prior to the first panic. However, high avoiders were more likely to 
develop anxiety disorders than low avoiders. 
In support of this model, Öst & Hugdahl, (1983) found that 81% of their agoraphobic 
sample could identify a specific conditioning experience to account for their fear. 
They investigated the ways in which 73 phobic patients had acquired their phobia by 
asking subjects to answer a questionnaire concerning: (a) the origin of the phobia, 
items associated with conditioning experiences, vicarious experiences and 
experiences of negative information/instruction; (b) physiological reactions; (c) 
anticipatory anxiety; and (d) catastrophic thoughts while in the phobic situation. The 
reported anxiety reaction was conceptualized in terms of the 3-systems model of 
anxiety (i.e., anxiety as composed of a physiological, cognitive and behavioral 
component). The Results of study indicated that 61% of the participants attributed 
their phobias to a conditional stressor; while 18% recalled vicarious learning 7% 
instruction/information and 14% could not recall any specific onset circumstances at 
all. 
1.2.5.5 Cognitive model  
The cognitive behavioral conceptualization of panic is based on Clark's model (1986, 
1988 & 1996), Beck (l985) and Casey et al., (2004a). 
Clark's theory: This model holds that individuals who have panic attacks make 
catastrophic interpretations about their physical sensations symptoms. This focus on 
internal bodily sensations (whether produced by anxiety or not) leads to catastrophic 
thoughts (e.g., "I am going to have a heart attack"). Such catastrophic thoughts, which 
are anxiety-producing themselves, lead to further bodily sensations, which incites 
more catastrophic thoughts, leading to a vicious cycle that culminates in a panic 
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attack. This vicious cycle is shown in Figure 1.2. 
 
Figure 1.2: The vicious circle of panic proposed by Clark (1986) 
According to Craske (1999) initial panic attacks often occur due to a fear of adverse 
consequences. For example, someone might avoid driving due to a fear of being 
injured; air travel might be avoided due to a fear of entrapment; social events are 
avoided due to a fear of negative social evaluation. Physiological events such as 
illness, occupational stress, medications/drugs (allergic reactions/side effects) or 
environmental conditions (heat, snow) can also trigger fears and are thus avoided.  
Panic disorder distinguishes itself from a panic attack in that the bodily sensations 
are misinterpreted (Barlow) and the person cannot find an explanation for their 
anxiety, thus leading them to believe there must be an internal reason (e.g., they are 
dying, losing control or going crazy). This creates a “fear of fear” (Razran) where the 
physical symptoms lead to uncontrollable frightening thoughts which then snowball 
into increased fear, exacerbate negative physical feelings and lead to panic behaviors 
(avoidance). The fear of something unpredictable and inescapable creates a high 
anxiety about when it will happen again and how to deal with it when it does recur 
(Barlow, 2002). 
There is strong empirical support for the catastrophic misinterpretation hypothesis 
(Austin & Richards, 2001; Khawaja & Oei, 1998; Casey et al., 2004b). Misinterpreting 
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physical or mental sensations as signifying an imminent threat has been consistently 
found in self-report, clinical, and experimental studies and its presence influences the 
intensity of panic symptoms. Although a number of studies have supported the 
catastrophic misinterpretation hypothesis of bodily sensations, most found that the 
interpretation bias is not specific to internal sensations alone and that anxiety 
interpretations (i.e., an expectation of becoming more anxious) are much more 
common than truly harm-related catastrophes (i.e., appraisals of dying from 
suffocation or a heart attack). 
A few studies have investigated the presence of catastrophic misinterpretation in 
panic disorder samples that have been exposed to fear situations. Occurrence of a 
panic attack leads to greater expectation of subsequent fear or a heightening of 
anticipatory anxiety, which increase the likelihood that individuals will consider 
their anxious symptoms highly threatening (i.e., Rachman & Levitt, 1985). Moreover, 
when panic occurs during exposure to a feared situation, panic disorder individuals 
experience more bodily sensations and catastrophic cognitions, although 27% of the 
panic episodes were not associated with any fearful cognition (Rachman, Lopatka, & 
Levitt, 1988). In a further analysis of these data, Rachman et al., (1987) reported that 
patients with PD are four times more likely to have a panic attack when the 
physiological sensation is accompanied by catastrophic misinterpretations. 
Westling and Öst (1993) examined the relation catastrophic cognitions and symptoms 
experienced during panic attacks. In this study, 36 participants were asked to record 
the types of cognitions experienced during panic attacks over a two-week period. 
Out of 285 panic attacks, over 90% contained catastrophic cognitions and specific 
panic symptoms. Catastrophic cognitions were associated with more severe panic 
attacks and an increased number of reported symptoms. 
Kenardy & Taylor (1999) investigate the factors related to prediction of panic attacks. 
In their study, ten women with panic disorder used a computer diary to self-monitor 
onset of panic attacks over a 7-day period. This allowed them to prospective 
assessment of expected versus unexpected panic attacks. Analysis revealed that 
individuals with expected versus unexpected panic attacks do not differ in the 
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experience of the actual attack (in 70% of cases the expectation of an attack never 
materialized). Moreover, sense of helplessness, catastrophic cognitions and somatic 
symptoms were more frequent before expected but not unexpected panic attacks, 
indicating that catastrophic thoughts were associated with prediction or expectation 
of a panic attack rather than its actual occurrence. 
Finally, a small pilot study found that 3.25 hours of belief disconfirmation exposure 
resulted in significantly greater reduction in frequency and belief of agoraphobic 
cognitions as well as symptom measures than the group who received habituation 
exposure training only (Salkovskis et al., 2006). This suggests that reducing 
catastrophic interpretations leads to an improvement in anxious and panic 
symptoms. 
1.2.5.6 Anxiety sensitivity 
Anxiety Sensitivity (AS) has been considered as a cognitive risk factor for the 
development of panic attacks (Kashdan, Zvolensky & McLeish, 2008; McNally, 2002; 
Schmidt, Zvolensky, & Maner, 2006). AS refers to fear of anxiety-related sensations 
and is measured by the Anxiety Sensitivity Index (ASI).  
Some studies (McNally & Foa, 1996; Struzik et al., 2004; Sturges et al., 1998) found 
that Anxiety Sensitivity is a dispositional variable which is especially elevated in 
people with panic disorder. The most important finding was that ASI scores predict 
panic symptoms in response to biological challenges (e.g., carbon dioxide inhalation) 
that provoke feared bodily sensations. 
Ehlers (1993) revealed that individuals with panic attacks and panic disorder, in 
comparison to normal controls and patients with other anxiety disorders reported 
that as children their families experienced more severe illnesses and physical 
symptoms typical of anxiety such as dizziness, shortness of breath, palpitations or 
nausea. Ehlers supposed that childhood and adolescent learning experiences may 
contribute to how panic disorder patients misappraise physical sensations. 
Although misappraisal of physical sensations has been proposed as a factor leading 
to panic disorder, the debate continues regarding the distinction between AS and 
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Trait Anxiety. Trait Anxiety has been defined as a tendency to respond anxiously to 
stress and threat. AS on the other hand has been identified by some researchers as an 
aspect of Trait Anxiety, where bodily sensations are viewed with severe negative 
consequences. Thus Trait Anxiety can be considered a first-order tendency of anxiety 
in general, whereas AS can be considered a second-order tendency for the 
development of panic. According to Lilienfeld (1997) AS is not distinct from Trait 
Anxiety. Taylor (1999) on the other hand, claims that AS is independent and distinct 
from other fears and from trait anxiety, even if the two may be hierarchical. 
Regardless of the debate, there is sufficient evidence that AS is a predictor of panic 
attacks and panic disorder in non-clinical and clinical samples. In his review of AS 
literature, Taylor (1999) reported that people with elevated AS, as measured by the 
Anxiety Sensitivity Index (ASI; Reiss, Peterson, Gursky & McNally, 1986) are more 
likely to have histories of panic attacks than people with low AS. Likewise, people 
with panic disorder are more likely to have higher AS scores than people without 
panic disorder. There is evidence that AS is a predictor of panic attacks and panic 
disorder in non-clinical and clinical samples.  
Ehlers (1995) found in one-year prospective naturalistic study that participants with 
simple phobias or no anxiety disorders, who experienced their first panic attack, had 
higher AS than participants who did not have panic attacks. Furthermore, AS 
showed incremental validity in predicting of panic disorder beyond other factors 
such as the frequency of baseline panic attacks as, patients with simple phobias or 
normal controls who experienced their first panic attack during follow-up had 
shown higher anxiety sensitivity at baseline than nonpanickers. 
Norton, Cox, & Malan (1992) in their review of research on non-clinical panickers, 
concluded that non-clinical panickers (i.e., people who have panic attacks but do not 
have panic disorder) had lower anxiety sensitivity than individuals with panic 
disorder, but higher anxiety sensitivity than those who did not experience panic 
attacks. 
Schmidt, Lerew & Jackson, (1997) indicated that Major stressors, such as military 
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basic training, is a risk factor in the development of anxiety conditions and panic 
attacks. Their study, found that approximately 20% of the participants scoring in the 
upper decile on the ASI, experienced a panic attack during a period of five weeks 
following military training (i.e., a major stressor) in comparission to 6% in the lower 
decile of the sample. 
Anxiety Sensitivity has also been studied in a sample of nonclinical adolescence aged 
14 to 18 years. Lau, Calamari & Waraczynski (1996) found that anxiety sensitivity 
scores were positively associated with the frequency and severity of panic 
symptomatology among 77 high school students. 
Maller & Reiss (1992) examined AS and the relation to panic symptoms in a sample 
of 151 college students. Results indicated that students who reported high AS had a 
greater chance of developing panic attacks over three years compared to those who 
reported low AS.  
Kashdan, Zvolensky & McLeish (2008) found that high AS is more associated with 
panic disorder than any other anxiety disorder. Other researchers have also found 
that panic patients report higher AS than people with other anxiety disorders (e.g., 
Taylor, Koch, & McNally, 1992; Zeitlin & McNally, 1993; Apfeldorf et al., 1994). All 
together, there is evidence of a relationship between Anxiety Sensitivity and panic. 
1.3 Treatment of panic disorder 
1.3.1 Pharmacological interventions 
Treatments for panic disorder vary depending on the presumed etiological cause of 
the disorder. Psychiatrists and other medical researchers who accept the primacy of 
the biological factors associated with panic disorder will most likely endorse 
psychopharmacological treatments. 
Currently, there are five major groups of medications that are used to treat panic 
disorder directly: tricyclic antidepressants, monoamine oxidase inhibitors, minor 
tranquilizers, high-potency benzodiazepines, and beta-blockers (Baldwin, Anderson, 
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Nutt, et al., 2005). 
Although researchers have discovered that antidepressants such as imipramine 
(Tofranil) and amitriptyline (Elavil) are quite effective at relieving anxiety symptoms 
of Panic Attack when accompanied by exposure-based treatments (Barlow, 1988), 
contray evidence has also been found. In one well-controlled study by Marks et al., 
(1983) groups of agoraphobics were treated with imipramine and therapist-assisted 
exposure both separately and in combination. All groups received a manual on 
structured self-exposure homework assignments. The results immediately following 
treatment, as well as at one and two year follow-ups, revealed no differences among 
the four treatments and all groups demonstrated substantial improvement. Thus, 
adding imipramine to exposure provided no advantage over placebo with exposure, 
even after treatment (Marks et al., 1983). 
Mavissakalian and Michelson (1986) also studied the effect of adding imipramine to 
exposure in four groups of agoraphobics receiving systematic instruction on self-
directed exposure between sessions. As in the Marks et al., (1983) study, all four 
groups demonstrated substantial improvement but, in this study the researchers 
found imipramine to be effective on several outcome measures immediately after 
treatment termination. However, one month later, the advantage of imipramine with 
exposure disappeared. Although imipramine may initially potentiate in vivo 
exposure, there is weak evidence that imipramine directly and differently reduces 
panic and avoidance behavior (Barlow, 1988). 
Although imipramine received the most attention among drugs, a number of other 
antidepressant drugs such as Desipramine and Clomipramine proved effective 
(Loughlin & Generali, 2006 & Barlow, 1988). There was a 63% effectiveness of 
experienced symptom relief from antidepressants, which is defined as at least a 50% 
decrease in the frequency of panic disorder (Clum, 1989). 
A disadvantage of tricyclics is that, it usually takes between three and four weeks to 
experience therapeutic effects. Furthermore, antidepressants produce several 
anticholinergic side effects such as blurred vision, rapid heart rate, constipation, and 
jitteriness which patients may view as symptoms of a panic attack and therefore 
discontinue the drug before experiencing any benefits (Marcus, Gorman, & Shear, et 
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al., 2007; Hollander, Liebowits & Gorman, 1988). More than 30% of panic sufferers 
who stop taking these medications experience a relapse that requires additional 
treatment. Clum (1989) believed this estimate to be rather low considering most of 
these individuals were also receiving some form of psychotherapy. 
Results from studies with monoamine oxidase inhibitors (MAOIs), appear to be 
much like the results with imipramine in the sense that phenelzine (Nardil) seems to 
potentiate self-initiated exposure (Sheehan, Ballenger, & Jacobson, 1980). The 
expected effectiveness of phenelzine is approximately 58% and again, this estimate is 
derived from individuals who were simultaneously involved in some form of 
psychotherapy or supportive therapy (Clum, 1989). Complications from this drug 
include extreme dietary restrictions, dangerously high blood pressure, dry mouth, 
difficulty sleeping, and difficulty with orgasmic functioning. There is a high drop-out 
rate (40%) even when a supportive type of therapy is concurrently provided. 
Furthermore, the relapse rate for phenelzine is approximately 55% which is one of 
the highest rates among all medications used for panic sufferers (Clum, 1990). 
Benzodiazepines such as diazepam (Valium) and chlordiazepoxide (Librium) have 
been extensively used in the treatment of anxiety disorders, but the most results 
indicate that they are only effective in preventing panic attacks when administered in 
high dosages and potency (Hollander & simeon 2010; Argyropoulos, Sandford, Nutt, 
2000; Hollander, Liebowitz & Gorman, 1988). Alprazolam (Xanax) is the major 
representative of the high potency benzodiazepine category (Pollack, 2005) and 
appears to have the highest success rate (60%) of all anti-panic medications (Clum, 
1989). 
Low potency benzodiazepines are less effective for treating the primary symptoms of 
panic attacks and anticipatory anxiety (Chouinard, 2004; Barlow, 1988). 
Benzodiazepines under certain conditions tend to hinder rather than facilitate 
exposure-based anxiety reduction procedures in both animals and humans. It is 
assumed that exposure to interoceptive symptoms characteristic of anxiety is a 
necessary condition for the process of long-term anxiety reduction (Barlow, 1988). 
The effectiveness of benzodiazepine has a 45% averages. A reliable estimate of the 
relapse rate after treatment does not exist, but there is presently at least a 20% drop-
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out rate from treatment due to lack of drug effectiveness and side effects such as 
physical and psychological addictiveness (Clum, 1989; 1990). 
Unfortunately, psychological and physiological addictions and other concomitant 
effects with alcohol and medications are often associated with alprazolam. Other side 
effects such as drowsiness, unsteady gait, headaches, and cognitive and motor 
impairment are associated with this drug. Furthermore, relapse rates in current 
studies appear to be extremely high (up to 80%) but the average rate across all 
studies is approximately 40% (Clum, 1989). In addition studies show that chronic use 
of benzodiazepines causes a decrease in overall effectiveness, increase in tolerance, 
and ultimately an increase in psychological and physical dependencies (Stevens & 
Pollack. 2005). 
Beta-blockers such as propranolol (Inderal) target symptoms such as rapid heart rate, 
respiratory distress, sweating, and general tension (Stein, Steckler et al., 2010). 
However the results with beta-blockers are disappointing. Hafner and Milton (1977) 
reported that adding propranolol to an in vivo exposure treatment produced 
significantly worse results than exposure with placebo. Noyes et al., (1984) also 
reported that only 7 out of 21 panic or agoraphobic patients receiving propranolol 
showed even moderate improvement. Propranolol's overall expected effectiveness of 
symptom relief is only approximately 30% for both avoidance and non-avoidance 
behaviors (Clum, 1989). The drop-out rate from propranolol is approximately 20% 
which reflects the minimal side effects of this drug. However, it is contraindicated for 
those individuals who suffer from lung disease, diabetes, or severe depression 
(Sadock & Sadock, 2008). The relapse rate has not been thoroughly studied for this 
medication class. 
Although drug treatments will not solve underlying panic issues, they may provide 
relief of symptoms that could enable an individual to cope more effectively or 
facilitate a psychotherapeutic intervention such as in vivo exposure (Choy, 2008; 
Barlow, 1988). Additionally, drug treatments may help in situations where avoidance 
behaviors are prominent, since they reduce the severity and intensity of anxiety and 
panic attacks. However, a common consequence is that patients may attribute 
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therapeutic gains to medication rather than to their own personal efforts. Thus, when 
drugs are withdrawn the patient may expect therapeutic gains to disappear (Seddon, 
& Nutt, 2007; Barlow, 1988). Although psychopharmacological treatments treat the 
physical symptoms and manifestations of panic attacks, they do not address the 
other elements of the disorder, namely, the cognitive fear, avoidant behavior, and 
phobias. As Baldwin, Anderson, Nutt, et al., (2005) also point out, all 
psychopharmacological treatments have side effects and since a person with panic 
disorder is already hypersensitive and hypervigilant about bodily symptoms, such 
medications may be subject to abuse and overuse leading to dependence with 
prolonged use. These disadvantages coupled with the high cost, lack of long term 
treatment response, and high relapse rates necessitate other forms of treatment 
(Barlow, 1988) that help the client develop coping skills to handel the various aspects 
of panic disorder (Williams, Kinney, & Falbo, 1989).  
1.3.2 Psychological interventions 
Psychotherapy is the principal alternative to pharmacological interventions to treat 
PD. Although different therapy modalities may be used to treat panic disorder, CBT 
demonstrates the greatest effectiveness in empirical studies (e.g. Barlow & Craske, 
2007; Olatunji, Cisler, Deacon, 2010; Hofmann, Smits, 2008; Stewart & Chambless, 
2009; Mitte, 2005; Westen & Morrison, 2001; Barlow, Craske, Cerny, & Klosko, 1989). 
Treatment is generally conducted individually or in groups, and the length of 
treatment ranges from ten to twenty, one and a half hour weekly sessions (Craske, 
1999; Hazlett-Stevens & Craske, 2004). In addition to this time commitment, clients 
are asked to complete homework assignments that assist them in the therapy 
process. 
Forms of CBT vary according to emphasis on the "cognitive" side or the "behavioral" 
side of treatment (Barlow & Craske, 2007). A truly comprehensive cognitive-
behavioral therapy is an amalgam of both approaches which addresses the entire 
scope of panic disorders: 
1) The panic attacks themselves with the cognitive, affective, and somatic symptoms 
2) The anticipatory anxiety (the so-called fear of fear) 
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3) The avoidant behavior that develops subsequent to a panic attack 
4) The low self-esteem and sense of hopelessness that frequently accompanies the 
disorder. 
Barlow & Craske (2007) suggest that the specific components of such a treatment 
approach include: psychoeducation about the nature and course of panic attacks and 
panic disorder, cognitive restructuring, anxiety management skills, breathing 
retraining, relaxation training and in vivo exposure/desensitization to phobic 
stimuli. 
Most forms of panic-focused CBT employ the following treatment components: 
1) Habituation training or exposure to feared bodily sensations (i.e., interoceptive 
exposure) and external fear cues (i.e., agoraphobic situations). 
2) Anxiety management or coping skills for managing bodily symptoms (i.e., 
relaxation and rebreathing training).  
 3) Cognitive interaction, cognitive restructuring and education about the nature and 
physiology of anxiety and panic, or cognitive techniques designed to modify the 
tendency to misinterpret catastrophically bodily sensations. 
1.3.2.1 Habituation Training 
Exposure plays an important role in preventing PD based on learning theory and the 
extinction model (Pérez-Ara et al 2010). Exposure therapies were originally derived 
from a behavior therapy technique called flooding which may expose the individual 
to the fear-evoking stimulus, either in real life (in vivo), in fantasy (imaginal), or in 
some structured artificial situation (in vitro) such as a clinical laboratory 
(Abramowitz et al., 2011). The basic goal of exposure treatment is to decrease a 
person's anxious and fearful reactions (emotions, thoughts, or physical sensations) 
and changes the participant's faulty cognitions regarding their symptoms through 
repeated exposures to anxiety-producing material (Abramowitz et al., 2011; 
Salkovkis et al., 1991). 
This reduction of the patient's anxiety response association with prolonged 
confrontation of fearful stimuli is known as habituation (Rubenstein, 2003).  
The concept of habituation posits that the body is not able to maintain an acute fear 
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state for an indefinite amount of time. In a sense, the body is thought to “tire” of 
producing substantial amounts of sympathetic activity, resulting in a reduced state of 
arousal over time (Ronen, Freeman, 2007). Another related purpose of exposure 
treatment is to eliminate the anxious or fearful response altogether so that the patient 
can face the feared situation repeatedly without experiencing anxiety or fear. This 
elimination of the anxiety response is known as extinction (Wolpe, 1958). 
Interoceptive exposure involves a series of exercises designed to induce the feared 
bodily sensations associated with panic attacks such as dizziness, nausea, sweating, 
or heart palpitations through various exercises designed in order to reduce the fear 
associated with these physical sensations through habituation (Eifert & Forsyth, 2005; 
Forsyth, Acheson & Fuse 2009). With exposure, patients apply new learned coping 
methods by changing the psychophysiological responses during a panic attack 
(Sanderson & Wetzler, 1995) and learn to tolerate fear without the need to avoid, 
escape, or escalate into a panic attack (Cabill & Foa, 2003). 
Studies have reported that patients who are able to discern and control internal 
somatic symptoms of anxiety that trigger panic attacks are successful in reducing 
panic (Beamish et al., 1996). Physical sensations are capable of increasing arousal and 
catastrophizing cognitions and exposure to somatic sensations are able to quench 
anxiety related with bodily symptoms of panic attack (Cabill & Foa, 2003; McCarter, 
1996).  
Interoceptive exposure combines techniques that attempt to gradually expose the 
individual to internal physiological cues and confront the physical sensations of 
panic (Barlow, 1994; Agras, 1993; Sanchez-Meca et al., 2010) by identifying a 
hierarchy of exercises that evoke the most anxiety and result in sensations similar to 
those which the client experiences during a natural panic attack. The patient 
practices each identified exercise, working towards the most difficult on the 
hierarchy. Through repeated exposure to the feared bodily sensations, clients will 
become less fearful of the sensations they associate with panic attacks and thereby 
decrease their vulnerability to the attacks themselves (Tompking, 2002). 
 Barlow, Craske, Cerny & Klosko (1989) compared Bernstein and Borkovec's (1973) 
relaxation to cognitive therapy with exposure therapy, and a combined condition of 
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cognitive therapy, relaxation, and exposure. All three techniques were shown to be 
superior to a waitlist control in the reduction of panic attacks. But the combined 
condition and the cognitive therapy plus exposure, were both superior to relaxation 
therapy, in eliminating panic attacks in 85% or more of patients who were panic free 
at post treatment. However, relaxation therapy positively affected the score on the 
psychosomatic checklist more than the other treatments. 
The same group of patients was assessed 6 months and 24 months following 
treatment completion (Craske, Brown, Barlow, 1991). They found that 81% of clients 
in the exposure plus cognitive therapy group maintained their status over the 2 year 
follow up. 
Arntz, (2002) evaluated treatment effects of Cognitive Therapy (CT) and 
interoceptive exposure (IE) as treatments of panic disorder without agoraphobia. The 
sample of 69 patients was randomly allocated to conditions. There were no 
significant differences between treatments in reducing panic frequency, daily anxiety 
levels and a composite questionnaire score at post-test after the 12-session treatment, 
and at both follow-ups (4 weeks, 6 months). In both conditions, high percentages of 
patients were panic free at post and follow-up tests (range 75-92%). Although the 
reduction in idiosyncratic beliefs about the catastrophic nature of bodily sensations 
was equally strong in both conditions, post-treatment beliefs correlated strongly with 
symptoms at post and follow-up tests in the CT condition, but not in the IE 
condition. Reduction of beliefs may be essential in CT, but not in IE. This suggests 
that the two treatments utilize different change mechanisms. 
Most, if not all, PD patients exhibit some degree of agoraphobia. Indeed the most 
profound consequences of PD may arise from the professional and personal 
limitations caused by attempts to avoid or escape panic. For this reason, situational 
exposure is an important component in the treatment of anxiety and panic 
(Tompking, 2002; Fava et al. 2001). 
Situational exposure involves the repeated approach (rather than avoidance) to the 
feared object or situation. Simply put, the fearful situation is broken down into small 
manageable steps which the patient works through one at a time until the most 
difficult level is mastered (Nutt, & Ballenger, 2003; Barlow, 1988). Typical situations 
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feared by panickers include crowded places (malls, theaters, public transportation), 
performance situations (public speaking, business meetings), driving situations 
(freeways, tunnels, bridges, overpasses), or any situation from which escape might 
be difficult in case of a panic attack. Situational exposure treatment takes three forms. 
During in vivo exposure the client approaches the fear-evoking stimulus in real life, 
such as driving on a specified stretch of freeway.  
During imgaginal exposure the client approaches the fear evoking stimulus by 
imagining interacting with the stimulus such as sitting in a business meeting when a 
colleague notices that he is blushing and laughs at him.  
During in vitro exposure the client approaches the fear evoking-stimulus in a 
structured, controlled, and artificial setting such as the therapist’s office (Tompking, 
2002). 
By repeatedly engaging in a structured process of incremental exposure and retreat 
from phobic stimuli the patient learns to tolerate the initial anxiety and develop 
appropriate coping mechanisms (Nutt, & Ballenger, 2003). 
Some investigators have demonstrated very clearly that direct in vivo exposure is the 
central ingredient in the behavioral treatment of agoraphobia, and that this 
procedure is more effective (60%-70%) than any number of credible alternative 
psychotherapeutic procedures (Lazarus, 2006; Botella, et al., 2007; McNally, 1990). 
Follow-up studies reveal that these effects have been maintained, on the average, for 
periods of four years or more (Burns, Thorpe & Cavallaro, 1986; Jansson, Jerrem-alm 
& Öst, 1986). 
Swinson, Soulios et al., (1992) examined the effectiveness exposure therapy in 
treatment for 33 patients with panic attacks who were seen in the emergency room. 
The patients were randomly assigned to groups receiving reassurance (N = 16) or 
exposure instruction (N = 17). The results showed that the subjects who received 
exposure instruction significantly improved over the 6-month period on depression, 
avoidance, and panic frequency. The reassurance subjects did not improve on any 
measure and eventually reported more agoraphobic avoidance. 
 
Beck et al. (1994) in a study indicated the importance of exposure in treatment of PD. 
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They compared a treatment package consisting of (a) relaxation training (b) cognitive 
therapy and exposure therapy for the treatment of PD. In this study 64 subjects with 
PD were assigned randomly to one of two treatment conditions or to a minimal 
contact control condition. The results showed both treatments to be equally effective, 
and they were unable to note any differences in the specific mechanism (i.e., 
cognitive or physiological) that these treatments may affect. The significant 
percentage of patients after treatments were CT (82%) and REL (68%), compared 
with the control group (36%). Moreover the participants in cognitive therapy showed 
better outcomes in agoraphobic fear measure, than relaxation group. These results 
indicated the importance of exposure in its treatment. 
Kiliç, Noshirvani, Başoğlu & Marks (1997), examined 69 patients with PD with 
agoraphobia who had been in an 8-week controlled study of alprazolam and/or 
exposure. 31 were followed up at a mean of 3.5 years later (4 years after trial entry). 
These follow-up patients had more cases of relapse at week 43 than did the group 
which did not attend the 3.5-year follow-up. The results further showed as a group, 
followed-up cases maintained their gains over the 3.5 years. Ex-alprazolam and ex-
exposure patients did not differ significantly on any variable at the 3.5-year follow-
up. 
Ito, de Araujo et al., (2001) in a study compared the effectiveness of self-exposure 
therapy for PD with agoraphobia. In their study eighty PD patients were randomized 
to a control group or to one of three forms of self-exposure treatment (external, 
interoceptive, or combined). Each treatment included seven sessions over 10 weeks 
and daily self-exposure homework. Assessments were at pre- and post-treatment 
and up to 1 year post-entry. Assessors remained blind during treatment. The results 
showed that the three methods of self-exposure were equally effective in reducing 
panic and agoraphobic symptoms in the short- and long-term. Rates of improvement 
on main outcome measures averaged 60% at post-treatment and 77% at follow-up. 
Craske et al., (2003) studied efficacy of CBT for panic control alone versus this 
treatment containing an additional in vivo exposure component. The sample in this 
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study was 68 individuals with diagnosis of PD with agoraphobia. Participants were 
randomly assigned to one of two 16-week treatment conditions, panic control only 
and panic control with in vivo exposure. Assessments were repeated at baseline, 
mid-treatment, post-treatment, and a 6-month follow-up using diagnostic and 
behavioral measures. Results indicated that the two treatment conditions were 
equally efficacious for both PD and agoraphobia. 
Öst, Thulin & Ramnerö (2004) investigated cognitive behavior therapy vs exposure in 
vivo in the treatment of panic disorder with agoraphobia. Seventy-three psychiatric 
patients with DSM-IV diagnosis of PD with agoraphobia were assessed with a 
battery of independent assessor, self-observation, self-report and behavioral 
measures before and after therapy, and at a 1-year follow-up. They were randomly 
assigned to exposure, CBT, or a wait-list control and received 12-16 individual 
therapy sessions, once a week. The treatments yielded significant improvements, 
both on panic/agoraphobia measures and on measures of general anxiety, 
depression, social adjustment and quality of life, which were maintained at follow-
up. The result showed cognitive therapy did not yield significantly better results 
than exposure. The three criteria of clinically significant improvement were achieved 
by 67% of the Exposure-patients and 79% of the CBT-patients at post-treatment, and 
74% and 76%, respectively, at follow-up. 
Uhle (2006) examined the effectiveness up to 7 years post-treatment of exposure for 
PD with agoraphobia. The participants in her study were 379 inpatients with PD plus 
agoraphobia that received a 3-4 week long treatment program with "high density" 
cognitive behavioral in vivo exposure that was symptom-focused. Each patient is 
treated with one therapist, up to 8 hours a day. The results at the 6 week, 1 year and 7 
year follow-up showed a high significant reduction in anxiety cognition, anxiety 
sensation, agoraphobia avoidance and depressive symptoms. 
Marchand, et al., (2008) compared four psychosocial treatments: cognitive and 
graded in vivo exposure treatments, graded in vivo exposure, cognitive treatment, 
and supportive therapy, to evaluate the benefits of combining cognitive therapy with 
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exposure in vivo. These treatments were combined with imipramine or placebo for a 
total of eight experimental conditions. Participants presented moderate to severe 
agoraphobia. The method involved a randomized, double-blind, placebo-controlled 
trial with 137 participants who completed a 14-session protocol involving the 
treatments just mentioned. Measures were taken at baseline and post-treatment and 
at 3-, 6-, and 12-month follow-ups. The study found that all treatment modalities 
proved statistically and clinically effective in reducing panic and agoraphobia 
symptoms over the 1-year follow-up period. 
Peter et al., (2008) in a study compared treatment outcome of female agoraphobics 3–
9 years after exposure in vivo with healthy controls. The results showed a stable 
treatment outcome among two thirds of the patients during follow-up. A total of 17 
(40%) of the patients had no further agoraphobic symptoms at all. A total of 15 (36%) 
patients still had mild-to-moderate agoraphobic symptoms at follow-up. A total of 10 
(24%) were non-responders and suffered from severe agoraphobia at follow up. 
An extensive review on exposure treatment in panic disorder is presented below 
(Table 1.3). 
 
Table 1.3: Overview of exposure treatment studies in panic disorder 
Barlow, 
Craske, 
Cerny, 
Klosko 
(1989) 
Participants  Fifty-six patients with PD or PDA. 
Condition A long term clinical outcome study testing variations of 
behavioral treatments for PD. Patients were randomly 
assigned to (a) relaxation (REL), b) exposure+cognitive 
restructuring (EXP + CR), (c) combined relaxation with 
exposure and cognitive restructuring (REL+EXP+CR) 
and (d) waiting list (WL). 
F/Up 3 months, 6 months, 12 months and 24 months 
Outcome (REL)+(EXP+CR), (REL+CR+EXP) > WL  
(EXP+CR), (REL+CR+EXP)>( REL) 
Craske, 
Barlow, 
Brown 
(1991)  
Participants Forty-one patients with PD or PDA  
Condition A long-term study for efficacy of behavioral treatment in 
PD. Participants were randomly assigned one of three 
CBT conditions: (a) relaxation (REL) (b) exposure plus 
cognitive restructuring (EXP+CR), (c) combination of 
relaxation and exposure plus cognitive restructuring 
(REL+EXP+CR). 
F/Up Six months, Two years  
Outcome (EXP+ CR)>(REL+CR+EXP), (REL)  
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Swinson, 
Soulios, 
Cox, Kuch, 
(1992) 
Participants Thirty-three patients with PD and panic attack 
Condition A pre-post design to examine the efficacy of exposure 
instruction in PD. The subjects were randomly assigned 
one of two conditions: (a) exposure instruction (b) 
receiving reassurance 
F/Up 3 months, and 6 months. 
Outcome EXP > reassurance group  
Marks, 
Swinson, 
Başoğlu, 
Kuch, 
Noshirvani, 
et al., (1993) 
 
Participants One hundred fifty-seven PDA patients  
Condition A pre-post design to examine the efficacy of Alprazolam 
and exposure alone and combined in PDA. The patients 
were randomly assigned to one of three groups (a) 
alprazolam plus exposure, (b) alprazolam plus 
relaxation, (c) placebo plus exposure, and (d) placebo 
plus relaxation. Patients had eight weeks treatment. 
F/Up Six months 
Outcome (ALP+EXP)=(ALP+REL)=(PLC +EXP)=(PLC+REL) 
Beck et al. 
(1994) 
Participants Sixty-four PD patients 
Condition A pre-post test design comparing cognitive therapy and 
relaxation training for PD. Patients were assigned 
randomly to one of groups (a) relaxation training (RT) 
(b) cognitive therapy and exposure-based components 
(CT+EXP) and (c) a minimal-contact control (MCC) 
condition. The patients received 10 sessions once a week. 
F/Up 6 months 
Outcome RT=CT+ EXP 
CT> RT+ EXP in reduction of agoraphobic avoidance 
Kiliç, 
Noshirvani, 
Başoğlu, 
Mark 
(1997) 
Participants Sixty-nine PDA patients 
Condition A long-term study of PDA patients after alprazolam 
and/or exposure. 8-week controlled study. 
F/Up 3.5-years 
Outcome EXP=Alprazolam  
Craske, 
Rowe 
Lewin, 
Noriega-
Dimitri 
(1997) 
  
Participants Thirty-eight PDA patients  
Condition A pre-post design to examine Interoceptive exposure vs 
breathing retraining within CBT for PDA: The patients 
were were randomly assigned to (a) cognitive 
restructuring + interoceptive exposure and in vivo 
exposure or (b) cognitive restructuring + breathing 
retraining and in vivo exposure to agoraphobic 
situations. 
F/Up Six months 
Outcome IEXP+ vivo EXP+CR > vivo EXP+BR+CR 
Ito, 
de Araujo, 
Tess, 
de Barros- 
Asbahr, 
Marks 
(2001) 
  
Participants Eighty PDA patients 
Condition A pre-post design to examine self-exposure therapy for 
PDA. Randomized controlled study of external vs. 
interoceptive self-exposure. Patients were divided to a 
(a) external exposure (b) interoceptive exposure (c) 
combined exposure (d) control group. Each group 
included seven sessions over 10 weeks and daily self-
exposure homework. 
 
Chapter I - Theoritical Background  43 
 
 
 
F/Up One year  
Outcome EXP > Control group  
IEXP=EEXP=Combined EX (Introceptive+External) 
Arntz 
(2002)  
Participants Sixty-nine patients with PD 
Condition A pre-post design to examine cognitive therapy versus 
interoceptive exposure. Patients randomly allocated to 
two treatment conditions. A 12-session treatment in each 
group. 
F/Up Six months 
Outcome CT=IEXP 
Öst,Thulin, 
Ramnerö 
(2004)  
Participants Seventy-three PDA patients 
Condition A pre-post design to examine CBT vs exposure in vivo in 
the treatment of PDA. The patients were randomly 
assigned to three groups (a) Exposure, (b) CBT or (c) WL 
control and received 12-16 individual therapy sessions, 
once a week. 
F/Up One year 
Outcome EXP=CBT 
Uhle 
(2006)  
 
Participants Three hundred seventy-nine inpatients with PDA 
Condition To examine the short and long term effectveness of vivo 
exposure for PDA in an inpatient setting: A 7 year 
follow-up. The patients received an individual treatment 
program with "high density" cognitive behavioral in 
vivo exposure (HDE) averaging 3-4 weeks, 8 hours total. 
F/Up Six weeks, one year, seven years. 
Outcome High significant reduction in anxiety cognition, anxiety 
sensation, agoraphobia avoidance and depressive 
symptoms. 
Marchand 
Coutu, 
Dupuis, 
Fleet, 
Borgeat, 
Todorov, 
Mainguy 
(2008) 
 
Participants One hundred thirty-seven PDA patients 
Condition A randomized double-blind, placebo-controlled trial for 
treatment of PDA in four psychosocial treatments: (a) 
cognitive and graded in vivo exposure treatments, (b) 
graded in vivo exposure, cognitive treatment, and 
supportive therapy. These treatments were combined 
with imipramine or placebo. All patients completed a 14-
session protocol. 
F/Up 3-, 6-, and 12-months 
Outcome (EXP+CT+IMI)=(EXP+CT+ PLC) 
Peter, 
Bruckner, 
Hand, 
Rohr, 
Rufer 
(2008) 
Participants Forty-two female participants with PD/PDA 
Condition A pre-post design to examine treatment outcome of 
female agoraphobics 3–9 years after exposure in vivo: In 
comparison with 42 healthy controls that were matched 
according to gender, age, marital and occupational 
status. All patients received exposure in vivo either in 
group or individual therapy. 
F/Up 3–9 years 
Outcome 40% of the patients had no further agoraphobic 
symptoms at all. 36% patients still had mild-to-moderate 
agoraphobic symptoms 24% were non-responders and 
suffered from severe goraphobia. 
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Note*: ALP: Alprazolam; BR: Breathing Retraining; CBT: Cognitive Behavior Therapy; CR: 
Cognitive Restructuring; CT: Cognitive Therapy; EXP: Exposure; EEXP: External Exposure; 
IEXP: Introceptive Exposure; vivo EXP: vivo Exposure; IMI: Imipramine; PLC: Placebo; REL: 
Relaxation Therapy; WL: Waiting List; FU: Follow-Up. 
In summary, all these studies indicated Exposure therapy was effective in reducing 
anxiety cognition, anxiety sensation, agoraphobia avoidance and depressive 
symptoms compared to the control group and relaxation treatment immediately after 
treatment and follow-up, but not compared to Cognitive Behavior Therapy. 
1.3.2.2 Anxiety Management Training (AMT) 
Panic Management Training is a general approach to treating panic attacks and 
involves teaching the client how to control severity of panic attacks and maladaptive 
responses in panic situations by using some specific behavioral skills such as 
Progressive Muscle Relaxation (PMR), Diaphragmatic Breathing training (BT) as 
means to reduce anxiety responses or eliminate agoraphobia. 
Relaxation Therapy  
Relaxation training as a form of anxiety management strategies is characterized by its 
focus on self-regulation strategies for reducing physiological arousal and anxiety, 
particularly the central nervous system-mediated symptoms most often associated 
with panic disorder (Barlow & Craske 2007).  
In stressful situations or panic attacks, there is increased activity of the sympathetic 
nervous system (SNS) which leads to physiological arousal or the "fight or flight" 
response (Conrad & Roth, 2007; Klerman et al., 1993). The most remarkable physical 
change that occurs during the fight-or-flight response is the increased heart rate, 
blood pressure, rate of breathing, dilation of the pupils, blood supply to the muscles 
and increased muscle tension experienced in the large muscles of the arms, legs, 
back, shoulders, neck and jaw (Conrad & Roth, 2007). Hence, in contrast to the stress 
response, relaxation is characterized by reduced sympathetic nervous system tone 
and increased parasympathetic activity. This may include decreased metabolism, 
blood pressure, oxygen consumption, and heart rate, as well as a feeling of calmness 
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(Wilson, 2009). On the other hand when the body is in a relaxed state there is little 
muscle tension, leading to decreased anxious feelings (Jacobson, 1938). According to 
Jacobson if one’s body is relaxed, one’s mind cannot be in a state of fear. 
Relaxation as an anxiety management technique can have various forms. A form of 
relaxation known as applied relaxation has shown good result as a treatment for 
panic attack. This technique induces relaxation in order to diminish the physiological 
symptoms of panic (Ruhmland & Margraf, 2001). 
Applied relaxation entails training patients in progressive muscle relaxation (PMR) 
until they are skilled in cue control relaxation, at which point relaxation is used as a 
coping skill for practicing exposure to items from a hierarchy of anxiety-provoking 
tasks (Öst, 1987; Manzoni, et al. 2008; Craske, Maidenberg & Bystritsky, 1995; 
Salkovskis, Clark & Hackmann, 1991). 
Progressive or active muscle relaxation is a systematic technique for achieving a deep 
state of relaxation and was described by Edmund Jacobson in the 1920s. Jacobson 
noted that because anxiety accompanies muscle tension one can reduce anxiety by 
learning to relax the muscular tension. According to Jacobson, induction of a deep 
state of relaxation does in fact attenuate various reflexive responses as well as 
improve mental activities and reduce emotional reactions, including reactions to 
sudden pain (Calloway, 2007). Later studies have proved Jacobson's early work and 
have shown that patients who display chronic anxiety and/or other forms of anxiety 
disorders have higher levels of resting baseline muscle tension and autonomic 
activity than do non patient controls (Barlow 1988, p. 96). 
Progressive Muscle Relaxation (PMR) involves the active tensing and relaxing of 
sixteen different muscle groups of the body, focusing attention on the sensation of 
tension and relaxation. 
A theoretical basis for relaxation as a treatment for panic attacks has not been 
elaborated beyond the provision of a somatic counter response to the muscular 
tension that is likely to occur during anxiety and panic (Barlow, 2008, p. 25). 
However evidence does not lend support to this theory (Rupert, Dobbins & Mathew, 
1981). As found in breathing retraining, fear and anxiety are reduced to the extent 
that the relaxation provides a sense of control (Barlow, 2008). Therapeutic gains are 
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more difficult to identify in instances of applied forms of relaxation which involve 
exposure based procedures as anxiety- provoking situations are faced. 
Öst (1987) developed an applied relaxation (AR) technique which was used as the 
relaxation treatment. His technique includes: explaining the rationale for the 
treatment specific to each patient, increasing the patient's awareness to their anxiety 
reactions, progressive relaxation, breathing until the patient feels physically relaxed, 
generalizing the relaxation techniques outside of the therapist's office, and learning 
to rapidly reach the relaxation state. Although Öst's technique includes a breathing 
component, it does not teach the patient to breathe diaphragmatically. Instead, the 
participant is instructed to focus on inhaling and relaxing as they exhale. 
Öst (1988) investigated the efficacy of applied relaxation (AR) vs. Progressive Muscle 
Relaxation (PMR) in treatments of PD. Eighteen PD outpatients were randomly 
assigned to AR and PMR. The patients were treated individually for 14 weekly 
sessions and were followed up 6-29 months later. The results showed that both 
treatments yielded very large improvements, which were maintained or furthered at 
follow-up (approximately 19 months after treatment completion). All members of the 
AR group were significantly better than those in PMR at follow-up. The proportion 
of clinically improved patients (according to stringent criteria) was 38% for PMR and 
75% for AR at post-treatment, and 25% vs 100% at follow-up. 
Öst, Westling & Hellström (1993) evaluated the effects of three different behavioral 
methods: Applied Relaxation (AR), exposure in vivo and cognitive methods in the 
treatment of PD with agoraphobia (PDA). Forty-five PDA patients were assessed 
with a battery of self-report, behavioral and cognitive measures before and after 
therapy, and at a 1-year follow-up. They were randomly assigned to Applied 
Relaxation (AR), Exposure in vivo or Cognitive Treatment (CT) and received 12 
individual therapy sessions, once a week. All patients also had self-exposure 
instructions. The three treatments yielded significant improvements that were 
maintained at follow-up. One criterion of clinically significant improvement was 
fulfilled by 87% of the AR group, 80% of the exposure group and 60% of the CT-
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patients at the end of treatment, and 85, 79 and 67%, respectively, at follow-up. 
Between-group differences were observed on two measures only, both showing 
better results for AR than for CT.  
Öst & Westling (1995) investigated the efficacy of a coping technique, Applied 
Relaxation (AR) and cognitive therapy, in the treatment of PD. The PD patients were 
randomly divided PD patients into applied relaxation and cognitive therapy 
treatment groups. In post-treatment, there were no significant differences between 
panic patients and normal controls when interpreting internal events. Therefore, both 
cognitive therapy and applied relaxation therapy were equally successful in 
normalizing cognitions, and there were no significant differences between the 
treatment groups. Thus they concluded that the two different treatments, one aimed 
at generating cognitive changes, and one aimed at creating physiological changes, 
both produced the same results. 
Clark, Salkovskis et al., (1994) also used a modified version of Öst's Applied 
Relaxation technique and compared its effects to those of cognitive therapy and 
imipramine in the treatment of PD. The study group consisted of 64 PD patients who 
were treated over 12 sessions once a week. They found the three treatments were 
effective, with cognitive therapy being initially more effective than either 
pharmachotherapy or AR as measured by a panic/anxiety composite score 
comprised of 17 panic/anxiety measures. Comparisons between treatments showed 
that at 3 months cognitive therapy was superior to both AR and imipramine on most 
measures. At 6 months cognitive therapy did not differ from imipramine and both 
were superior to AR on several measures. At 15 months cognitive therapy was again 
superior to both AR and imipramine but on fewer measures than at 3 months. 
Carlbring et al., (2002) examined the efficacy of CBT vs. Applied Relaxation (AR) for 
PD on the Internet. For this purpose participant were randomized to either AR or a 
multi-modal treatment package based on cognitive behavioral therapy (CBT). In the 
Öst's Applied Relaxation (AR) group was adapted for self-help with three relaxation 
instructions. The treatment was divided into: (1) psychoeducation, (2) rational, (3) 
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PMR: long version, (4) PMR: short version, (5) conditioned relaxation, (6) differential 
relaxation, (7) quick relaxation, (8) AR, and (9) relapse prevention. The results 
indicated that two groups did not have significant difference in any of the 
measurements at pre-treatment. Although not statistically significant, the AR 
condition had a better overall effect compared to the CBT program. 
Arntz & van Hout (1996) compared cognitive therapy to Öst’s (1987) applied 
relaxation (AR) protocol. Thirty-six outpatients with the DSM-III-R diagnosis of PD 
with no or mild agoraphobia were randomly assigned to cognitive therapy (CT) or 
applied relaxation (AR). Eighteen similar patients constituted a waiting list group. 
Treatment consisted of 12 weekly sessions. Patients self-monitored panic attacks 
during the whole treatment period, and the following 4 weeks, and during 1 week at 
a half-year follow-up. Results of this study indicated that cognitive therapy group 
was significantly superior to relaxation therapy in reducing panic frequency, and 
somewhat less strongly superior to relaxation therapy group in reducing the 
questionnaire scores. At the end of treatment 77.8-83.3% of the cognitive therapy 
patients were panic-free, compared to 50% of the patients who received relaxation 
therapy and 27.7% of the waiting-list patients. 
An extensive review on relaxation treatment in panic disorder is presented below 
(Table 1.4). 
 
Table 1.4: Overview of Relaxation treatment studies in panic disorder 
Öst 
(1988) 
 
Participants Eighteen patients: 14 PD patients and 4 Generalized 
Anxiety Disorder (GAD) 
Condition A pre-post test design comparing of Applied relaxation 
(AR) vs Progressive muscle relaxation (PMR) in 
treating PD, the patients were randomly assigned to 
into two treatments groups, AR and PMR. The patients 
treated individually for 14 weekly sessions. 
F/Up 6-29 months 
Outcome AR >PMR 
Öst, Westling, 
Hellström 
(1993) 
 
Participants Forty-five PDA patients 
Condition A pre-post test design to examine applied relaxation 
(AR), exposure in vivo and cognitive methods in 
treaing PDA. Patients received 12 individual therapy 
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sessions, once a week.  
F/Up One year  
Outcome AR=CT=EXP 
Clark, 
Salkovskis, 
Hackmann 
Middleton, 
Anastasiades,  
Gelder 
(1994) 
Participants Sixty-four PD patients 
Condition A pre-post test design comparing cognitive therapy 
(CT), applied relaxation (AR) and imipramine (IMI) in 
the treatment of PD: patients were initially assigned to 
CT, AR, IMI or WL group. During treatment patients 
had up to 12 sessions in the first 3 months and up to 
three booster sessions in the next 3 months. CT and 
applied relaxation sessions lasted one hour. 
F/Up 3, 6, and 15 months.  
Outcome At 3 months: CT > AR , IMI 
At 6 months: CT, IMI > AR 
At 15 months: CT > AR, IMI 
Öst & 
Westling 
(1995) 
Participants Thirty-eight participants with PD 
Condition A pre-post test design to examining the Applied 
Relaxation (AR) vs cognitive therapy (CT) in the 
treatment of PD, the patients randomly assigned into 
two treatment groups, AR and CT. The patients were 
treated individually for 12 weekly sessions. 
F/Up One year  
Outcome AR= CT 
Arntz & Van 
Hout 
(1996) 
Participants  Fifty-four patients with PD with or without 
agoraphobia 
Condition A pre-post test design to examining cognitive therapy 
(CT) vs applied relaxation (AR) in PD. The patients 
were randomly assigned to CT or AR, and WL group. 
Treatment consisted of 12 weekly sessions. Patients 
self-monitored panic attacks during the whole 
treatment period. 
F/Up a half-year 
Outcome CT > AR > WL group 
Carlbring, 
Ekseliusb, 
Anderssona, 
(2002)  
Participants Twenty-two PD /PDA 
Condition A randomized trial of CBT vs. applied relaxation (AR).  
Participants were randomized to either (AR) or (CBT). 
CBT group had a self-help manual consisting of 
psychoeducation, BR, CR, exposure, relapse prevention 
and assertiveness training. In the AR group Ost’s 
applied relaxation book was adapted for self help use 
with three relaxation instructions was sent to the 
participants. The treatment was divided into 
psychoeducation, rational, PMR long version, PMR 
short version, conditioned relaxation, differential 
relaxation, and quick relaxation, AR, and relapse 
prevention. 
F/Up Not reported  
Outcome AR=CBT 
Note*: AR: Applied Relaxation; BR: Breathing Retraining; CBT: Cognitive Behavior Therapy; 
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CR: Cognitive Restructuring; CT: Cognitive Therapy; EXP: Exposure; IMI: Imipramine; 
MCC: Minimal-Contact Control; PMR: Progressive Muscle Relaxation; RT: Relaxation 
Training; WL: Waiting List; FU: Follow-Up. 
In summary, each of these studies shows that relaxation training was effective in 
panic management and reduction of anxiety and physiological arousal symptoms in 
panic situations both immediately after treatment and follow-up. Relaxation therapy 
was effective compared to the control group but not compared to CBT alone or 
exposure treatment. 
Breathing retraining and Respiratory Control 
Breathing Training (BT) is a central component early on in the development of panic 
treatment and consists of diaphragmatic breathing techniques (Meuret, Ritz, Wilhelm 
& Roth, 2008). A high percentage of patients with PD tend to hyperventilate during a 
panic attack (Sullivan, Kent & Kleber, et al., 2004). As mentioned earlier, during 
panic attacks, the respiration rate often increases and patients experience 
uncomfortable physical symptoms that are similar to those produced by 
hyperventilation such as dizziness, tachycardia, palpitations, nausea and 
breathlessness. The patients who experience chronic hyperventilation often report 
being “short of breath” (Leahy, Holland & McGinn, 2011). 
The general goal of BT is to decrease the patient's respiratory rate (Beamish et al., 
2002), reduce the probability of hyperventilation, and make it less likely for patients 
to catastrophize physiological symptoms (Meuret, Ritz, Wilhelm & Roth, 2008). 
Breathing Training assists individuals in proper breathing, which regulates the 
balance of oxygen and CO2 and increases the threshold for hyperventilation 
(Courtney, 2011; Meuret, Ritz, Wilhelm & Roth, 2008). BT shows the patient that 
many of the sensations they experience during a panic attack are the result of over 
breathing, rather than the actual manifestations of feared conditions (Taylor, 2001). 
Studies have shown that individuals who are able to identify and control internal 
somatic symptoms of anxiety that trigger panic attacks are successful in reducing 
panic (Meuret, Ritz, Wilhelm & Roth, 2008; Beamish, et al., 2002).  
In this regard, diaphragmatic breathing exercises designed to “normalize” breathing, 
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are easily learned and can be quickly applied in anxious situations (Barlow & Craske 
2007; Rapee & Barlow, 1991). Diaphragmatic breathing promotes slow, deep and 
rhythmic breathing with emphasis on the diaphragm muscle moving downward on 
inhalation and upward on exhalation (Hazlett-Stevens & Craske, 2009). The 
respiration rate is 5 to 8 respirations per minute and is associated with a return of a 
normal respiratory sinus arrhythmia. As the patient slows their respiration rate, the 
tidal volume tends increase while the minute volume decreases. The tidal volume in 
diaphragmatic breathing ranges from 750 to 2000 ml of air per inhalation (Kajander 
& Peper, 1998). The exhalation phase is longer than the inhalation phase. While 
breathing diaphragmatically, people are encouraged to relax and give their breathing 
“passive attention.” Therefore this breathing pattern promotes relaxation as well as 
other physical effects that are contrary to hyperventilation and autonomic nervous 
system arousal (Nezo, Lombardo & Netzo, 2004). 
In addition to diaphragmatic or abdominal breathing, a relatively new technique, the 
Valsalva maneuver, is specific breathing training to lower fast heart beat 
(tachycardia) that can be taught to enable patients to avert attack.  
As mentioned earlier, the onset of tachycardia is the most frequently reported 
symptom of panic attacks. Over 80% of those experiencing panic list a rapid or 
irregular heart rate as a symptom (DSM-IV, American Psychiatric Association, 
2000). Margraf, Taylor, Ehlers, Roth and Agras (1987) reported that the incidence of 
heart palpitations during panic attacks was as high as 73%. 
Vagal maneuvers are physical techniques that stimulate the vagus nerve to induce a 
slower heart rate. The two common vagal maneuvers are carotid massage and 
Valsalva maneuvers. In carotid massage, trained individuals apply external pressure 
to the carotid artery in the neck to stimulate the nerve, which raises blood pressure 
there and slows heart rate. The Valsalva maneuver can be performed by moderately 
forcing attempted exhalation against a closed airway, usually done by holding one's 
breath and bearing down as if having a bowel movement, or pinching one's nose 
shut while inhaling as if one were trying to block a sneeze (Luster, Baumgartner, 
Adams, Convertino, 1996; Lim et al.,1998). This will cause a quick spike in heart rate, 
followed by a slowing of the heart rate. 
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Sartory & Olajide (1988) examined the efficacy of vagal innervation techniques to 
terminate tachycardia in treatment of panic disorder patients. In their study nine 
participants were randomly assigned to either experimental or control groups. 
Patients in both groups were seen on four occasions, twice during the first week and 
then at weekly intervals. The patients in the experimental group were taught to slow 
their heart rates by vagal innervation, slower abdominal breathing, and relaxation 
techniques and the control group was trained in breathing and relaxation techniques. 
The result showed both groups had improved after four treatment sessions but 
patients in the experimental group experienced a 50% reduction in the number of 
symptoms occurring during panic attacks and also reported less generalized 
cognitive anxiety. 
However, research indicates that BT is effective in treating panic disorder (Meuret et 
al., 2010a; Meuret, et al., 2008) but combining BT with cognitive intervention has 
better effect than BT alone (de Ruiter, Rijken, Garssen, & Kraaimaat, 1989). Some 
research shows that when BT is used alone, it is no more effective than a placebo 
treatment (Klosko, Barlow, Tassinari & Cerny, 1990; Garssen et al., 1992; Meuret et 
al., 2008). 
Rapee (1985) examined the effectiveness of breathing training on panic attacks in a 
case study with panic disorder. In this study the patient received three sessions of 
diaphragmatic breathing training program, and reduction of her respiratory rate to 
seven breaths per minute. The result showed that a significant decrease in number of 
symptoms of panic and panic frequency from 22 to only 2 attacks at 3 weeks post-
treatment. 
Clark, Salkovskis, & Challey (1985) showed that brief respiratory control training 
alone would produce substantial reductions in panic attack frequency and anxiety 
symptoms. In their study, eighteen patients who experienced frequent panic attacks 
and responded positively to an initial hyperventilation challenge were taught to 
reattribute the cause of their panic attacks to stress-induced hyperventilation. 
Therapy was conducted in the following sequence: (1) brief, voluntary 
hyperventilation to reproduce a mild panic attack (2) reattribution of the cause of the 
symptoms to hyperventilation: (3) training in a respiratory control technique by 
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pacing audiotape (12 breaths per minute). The results of study showed significant 
improvements in reduction of panic attack frequency and self-reported anxiety and 
depression. Further reductions in panic attack frequency were maintained at 6-
month and 2-year follow-ups. 
Salkovskis et al., (1986) replicated and extended the treatment introduced by Clark et 
al., (1985) by concurrent measurement of behavior and pCO2 in nine patients who 
experienced phobic and/or non-phobic panic attacks. They tested whether patients 
suffering from panic attacks had lower resting pCO2 levels before treatment and 
whether these levels increased during treatment. The results showed a significant 
reduction in panic attack frequency and questionnaire report of fear. Patients' resting 
pCO2 was significantly lower than controls’ and rose to normal levels during 
treatment. In fact, PCO, values at the end of treatment were similar to those found in 
non- patient samples. 
Hibbert and Chan (1989) compared the effectiveness of five sessions of BT with a 
placebo treatment in PD and PDA patients. They divided forty PD patients into 
hyperventilators and non hyperventilators on the basis of a conventional provocation 
test. All patients were treated for two weeks with either training in controlled 
breathing or a placebo treatment. They found both treatments were effective; 
respiratory control did not differ significantly from placebo treatment on any of the 
self-report measures. The only difference that emerged was with regard to observer 
ratings of anxiety, which showed more improvement in the respiratory control 
group. 
Bonn et al., (1984) investigated the effect of diaphragmatic breathing in combination 
with exposure in agoraphobic patients. Twelve agoraphobic patients received 
respiratory control plus exposure in vivo or exposure in vivo alone. At one month 
follow-up, the two groups of patients showed similar degrees of improvement in 
frequency of panic attacks and other psychophysiological scores. At a six month 
follow-up the patients treated with in vivo exposure alone were beginning to show a 
fall-off in relearned adaptive behavior (learning decrement), whereas those given 
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breathing retraining showed further improvement. This suggests that patients 
pretreated with BT are less likely to need further treatment. 
Meuret, Wilhelm, & Roth (2001) developed a respiratory biofeedback-assisted 
therapy for panic disorder in 4 participants that were trained to raise their end-tidal 
pCO2 by slow, diaphragmatic breathing. Results showed a lower basal pCO2 before 
treatment and an increase to normal levels after BT, along with improvement in 
clinical measures such as panic attack frequency and severity, trait anxiety, anxiety 
sensitivity, and depression. 
Franklin (1989) evaluated the effectiveness of BT compared to relaxation therapy, 
cognitive modification, and a placebo in treatment of PDA. Four of eight patients in 
this study were treated with four different sequences of these interventions, and 4 
control patients were treated with the same sequences after a 4-week waiting period. 
The results showed the BT group yielded highly significant reductions in panic 
attack frequency and intensity, and it was the only component that produced 
significant improvements in the behavioral measures of agoraphobia. Relaxation 
produced significant reductions only in frequency of panic attacks. Cognitive 
modification reduced cognitive distress significantly, but it affected no other 
measure. 
Wollburg (2007) studied the psychophysiological effects of respiratory challenges 
before and after BT in PD and patients with Episodic Anxiety (EA) attacks. This 
study included 45 PD patients and 39 EA patients who suffered from subclinical 
panic attacks, and 20 non-anxious controls (NAC). Patients were randomized to one 
of two versions of a 4-week therapy with BT, either lower or raise end tidal pCO2, or 
a waiting list. Before and after treatment, participants underwent in randomized 
order a Voluntary Hypoventilation (VHO) test and a Voluntary Hyperventilation 
(VHT) test in which they were asked to either lower or raise their pCO2 while 
psychophysiological measures were recorded. At pre- treatment, PD and EA patients 
were more anxious, distressed, tense, and worried than NAC, and reported more 
dizziness chest pain and nausea during the laboratory assessment. 
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After treatment, the results showed that both therapies improved the main outcome 
measure and BT was also equally effective for the lower and raise Breathing Training 
(BT). Furthermore, BT affected baseline pCO2, resulting in lower levels in the 
hypocapnic groups and higher levels in the hypercapnic groups without affecting 
any other measures. 
Berger (2001) conducted a comparative study between breathing training BT and 
CBT on the treatment PD. Ten people with PD were randomly assigned to CBT 
without BT and eleven were randomly assigned to a BT group. The BT group 
included six 30 to 60 minute sessions of breathing training. The CBT group followed 
a modified version of Craske, Barlow & Meadows’ protocol (1994) which consisted of 
ten 45 to 90 minute sessions. Results showed that BT appears to be as effective as 
CBT in treating PD. There were no significant pre to post differences in the severity 
or frequency of panic attacks between the two groups.  
Although there are not many studies that demonstrate the effectiveness of breathing 
retraining for panic disorder, there are some that demonstrate its effectiveness for 
hyperventilation (DeGuire et al. 1992; Tweeddale, Rowbottom, & McHardy, 1994). 
DeGuire et al. (1992) established that breathing retraining increased end-tidal CO2 
and decreased respiratory rate in participants with signs of hyperventilation 
syndrome and who complained of cardiac symptoms such as chest pain, heart 
palpitations, and shortness of breath. The physiological changes that occurred as a 
result of breathing retraining resulted in a decrease in the frequency of cardiac 
symptoms experienced by the participants. Because the somatic symptoms 
associated with PD are likely to result from hyperventilation, the results of the 
DeGuire, Gevirtz, Hawkinson & Dixon study, (1996) suggested that breathing 
retraining may therefore also be effective as a treatment for PD. They also 
investigated the long-term effects of paced diaphragmatic breathing on subjects who 
reported functional cardiac symptoms and who also demonstrated associated signs 
of hyperventilation syndrome. Participants were a representative sample composed 
of 10 out of the original 41 subjects who had participated three years previously in 
the study designed to evaluate the short-term effects of breathing retraining on 
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functional cardiac symptoms and respiratory parameters (respiratory rate and end-
tidal carbon dioxide). The results of this follow-up study showed that breathing 
retraining had lasting effects on both respiratory parameters measured. Participants 
evidenced significantly higher end-tidal carbon dioxide levels and lower respiratory 
rates when compared to pre-treatment levels measured three years earlier. Subjects 
also continued to report a decrease in the frequency of functional cardiac symptoms 
when compared to pre-treatment levels. 
De Ruiter, Rijken, Garssen & Kraaimaat (1989) compared (a) Breathing Retraining 
plus Cognitive Restructuring (BRCR), (b) in vivo graded self exposure, and a (c) 
combined BRCR plus exposure, in the treatment of PD. Outcome measures consisted 
of a battery of self- report measures of phobic anxiety and avoidance, panic, fear of 
somatic symptoms, general anxiety, somatic complaints, and depression. All 
measures were administered 4 weeks prior to treatment, immediately prior to 
treatment and post-treatment. They found that the three treatments produced 
improvement on all the self-report measures between pre and post-treatment, except 
frequency of panic/day. There were no significant differences between treatments. 
Craske et al., (1997) compared interoceptive exposure and breathing retraining in 
treatment of panic disorder. Thirty-eight participants with PD A were randomly 
assigned to (a) cognitive restructuring plus interoceptive exposure and in vivo 
exposure to agoraphobic situations; or (b) cognitive restructuring plus breathing 
retraining and in vivo exposure to agoraphobic situations. Assessments were 
conducted at pre intervention, post-treatment and six months later. They found that 
both post-treatment and 6-month follow-up, participants receiving interoceptive 
exposure reported fewer panic attacks and less overall severity, general anxiety, 
overall severity and functioning and distress than did those receiving breathing 
retraining.  
An extensive review on Breathing Retraining in panic disorder is presented below 
(Table 1.5). 
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Table 1.5: Overview of Breathing Retraining studies panic disorder 
Bonn, 
Readhead, 
Timmons 
(1984) 
Participants Twelve PD patients 
Condition A pre-post test design to examine enhanced adaptive 
behavioral response in agoraphobic patients with BT. 
The patients were alternately allocated to two treatment 
groups: (a) breathing training and exposure therapy 
(BT+EXP) and (b) only exposure (EXP). 
F/Up 6 month 
Outcome (BT+ EXP)=(EXP) at post-treatment,  
(BT + EXP) > (EXP) at FU 
 Clark, 
Salkovskis,  
Chalkley, 
(1985) 
Participants Eighteen PD patients 
Condition Longitudinal pretest-posttest designs to assess 
respiratory control as a treatment for panic attacks. 
Treatment consisted of (a) brief, voluntary 
hyperventilation (b) explanation of the effects of 
overbreathing and reattribution of the cause of a 
patient's attacks to hyperventilation; (c) training in a 
respiratory control technique. 
F/Up 6-month and 2-year 
Outcome Reduction in panic attack frequency, self-reported 
anxiety and depression. 
Rapee 
(1985) 
Participants One PD patient 
Condition 3 breathing training sessions/4 weeks. 
F/Up Not reported 
Outcome Decrease in panic attack frequency and severity of 
symptoms and anxiety. 
Salkovskis, 
Jones & 
Clark (1986) 
Participants Nine PD patients 
Condition 4 sessions/4 weeks, replication of respiratory control in 
the treatment of panic attacks by concurrent 
measurement of behavior and pCO2 based on the 
supposition that catastrophic interpretations of 
sensations produced by hyperventilation. 
F/Up Not reported 
Outcome Reduction in panic attack frequency, self-reported 
anxiety and depression; increase of pCO2 to normal 
levels. 
Sartory & 
Olajide 
(1988) 
Participants Eight patients with generalized anxiety disorder with the 
distinct, spontaneous panic attacks and one patient with 
epileptic 
Condition Examine the efficacy of Vagal Innervation techniques in 
the treatment of PD; the subjects allocated randomly to 
(a) Relaxation+ Vagal Innervation (REL+V. I) group and 
(b) Relaxation control group (REL). Patients were seen 
on four sessions individually treatment. 
F/Up Not reported 
Outcome REL+ V.I=REL 
But reducing of number of panic symptoms and anxiety: 
REL+V.I >REL 
de Ruiter, Participants Forty-six PD patients 
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Garssen, 
Rijken, 
Kraaimaat 
(1989) 
Condition Examine hyperventilation syndrome in PDA and 
generalized anxiety disorder, the patients were 
randomly assigned to (a) BT plus Cognitive 
Restructuring (BT+CR) (b) in vivo exposure, (c) 
combined BT+CR plus exposure. Treatments consisted 
of 8 sessions. 
F/Up Not reported 
Outcome BT+CR=EXP=BT+CR+EXP 
Hibbert & 
Chan (1989) 
Participants Forty PD patients with with or without avoidance 
Condition Examine the efficacy of respiratory control in PD. All 
patients were divided into (a) BT or (b) a placebo 
treatment. The patients in each group were treated for 
two week and both groups received conventional 
anxiety treatments, most commonly, in vivo exposure. 
F/Up Nor reported 
Outcome BT+ EXP > Placebo +EXP on observer-rated anxiety 
BT+EX=Placebo+EX on self- report measures 
Franklin 
(1989) 
Participants Eight patients with PD/A 
Condition To evaluate the short-term effectiveness of BT compared 
to relaxation (REL) and cognitive modification (CM), 
and a placebo treatment (PLC), 4 patients were treated 
with four different sequences of these interventions 1 
session/4 weeks and 4 patients were assigned to waiting 
list group. 
F/Up Not reported 
Outcome BT > REl, CM and PLC 
Craske, 
Rowe, 
Lewin & 
Noriega-
Dimitiri 
(1997) 
Participants Thirty-eight participants with PD/A 
Condition To examine the short and long term effectveness of BT 
and exposure for PDA, the patiants were randomly 
assigned to (a) cognitive restructuring plus introceptive 
exposure and in vivo exposure (CR+IEXP+in vivo EXP) 
or (b) cognitive restructuring plus BT and in vivo EXP 
(CR+BT+in vivo EXP).  
F/Up 6 months 
Outcome (CR+IEXP+in vivo EXP) > (CR+BT+in vivo EXP) 
Schmidt, 
Woolaway-
Bickel et al., 
(2000) 
Participants Seventy-seven PD/PDA patients 
Condition Longitudinal pretest-posttest designs to assess BT in the 
context of CBT protocol. Patients were assigned to 
receive (a) two sessions/two weeks (CBT + BT), (b) 
twelve sessions only CBT (c) WL. 
F/Up One year 
Outcome CBT>CBT+BT 
Meuret, 
Wilhelm, 
Roth 
(2001) 
Participants Four PD patients 
Condition A pre-post test design to examine respiratory 
biofeedback assisted therapy in PD. Patients assigned to 
one of two conditions: (a) an immediate treatment group 
or (b) WL group. Patients assigned to the immediate 
treatment group received five individual treatments. 
Duration of treatment: 5 sessions/4 weeks. 
 
Chapter I - Theoritical Background  59 
 
F/Up 8 weeks 
Outcome Respiratory group: Reduction of PDSS, ASI, BDI, and 
STAI-T and increase of pCO2 to normal levels through 
FU. 
Berger 
(2001) 
Participants Twenty-one PD/PDA patients 
Condition A pre-post test design to compare BT and CBT on the 
treatment of PD. Patients randomly assigned to (a) CBT 
without BT and (b) BT group. The BT group included six 
sessions of BT. The CBT group consisted of ten sessions.  
F/Up 4 weeks 
Outcome BT=CBT 
Meuret, 
Wilhelm, 
Ritz, Roth 
(2006) 
Participants Thirty-seven PD patients with or without Agoraphobia 
Condition A pre-post test and FU design to test capnometry-
assisted BT as a therapeutic approach for PD. Patients 
randomly assigned to BT or a WL group. Patients 
underwent a four-week BT consisting of ﬁve-weekly/ 1 
h treatment sessions. 
F/Up 2 and 12-month 
Outcome BT > WL 
Wollburg 
(2007) 
Participants Forty-five PD patients, 39 Episodic Anxiety (EA) patients 
who suffered from subclinical panic attacks and 20 non-
anxious controls (NAC) 
Condition Psychophysiological effects of respiratory challenges 
before and after BT in PD patients and patients with 
episodic anxiety attacks. Therapy consisted of five 
weekly sessions of biofeedback-assisted breathing 
training and practice of breathing exercises at home on a 
daily basis. 
F/Up 4 weeks 
Outcome Hypercapnic (Raise-CO2) = Hypocapnic (Lower-CO2) 
breathing. 
Meuret, 
Rosenfield 
Hofmann, 
Suvak Roth 
(2009) 
Participants Thirty-ﬁve PD/A 
Condition A pre-post test design to examine whether changes in 
pCO2 mediate changes in fear of bodily sensation in a 
bio-behavioral treatment for PD that targets changes in 
end-tidal pCO2. Patients underwent 4 weeks of 
capnometry-assisted breathing training targeting 
respiratory dysregulation. 
F/Up 2-month 
Outcome BT targeting pCO2 reduced fear of bodily sensations. 
Note*: BT: Breathing Training; BTCR: Breathing Training & Cognitive Restructuring; CBT: 
Cognitive Behavioral Therapy; CM: Cognitive Modification; CR: Cognitive Restructuring; 
EXP: Exposure; IEXP: interoceptive exposure; in vivo EXP: in vivo exposure; WL: Waiting 
List; FU: Follow-Up; REL: Relaxation; VI: Vagal Innervation; ASI: Anxiety Sensitivity Index; 
BDI: Beck Depression Inventory; PDSS: Panic Disorder Severity Scale; STAI-T: State-Trait 
Anxiety Inventory, trait version.  
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In summary, each of these studies found Breathing Training was effective in panic 
management and reduction of anxiety, physiological arousal symptoms and 
hyperventilation rate in panic situations both immediately after treatment and 
follow-up. Berathing Training was effective compared to the control group, 
relaxation therapy alone or exposure therapy alone, but not compared to CBT alone. 
1.3.2.3 Cognitive interventions 
The aim of cognitive interventions in PD is to change irrational or disturbing belief 
patterns such as catastrophic misinterpretation of bodily sensations or experiences by 
revealing to patients the way they evaluate upsetting situations. In cognitive therapy 
of PD, the person examines his feelings and teaches that fearing the way their body 
feels at a particular moment is not necessarily dangerous. In fact, the patients learn 
how to separate unrealistic thoughts from realistic ones and develop techniques to 
change the way they respond to panic situations (Clark & Beck, 2009; Sargent, 1990). 
Panic Education 
Psychoeducation is designed to provide patients with accurate information about 
panic attacks and panic disorder, particularly the symptomatology of panic attacks 
and some explanatory mechanism such as catastrophic misinterpretation of bodily 
signals. 
Psychoeducation may also involve asking the client to register symptoms in line with 
a model such as the panic circle developed by Clark (1986). 
It is thought that by the time a person with PD finally encounters a mental health 
professional she/he is often convinced that she/he has a life threatening physical 
condition that has eluded diagnosis. 
A primary goal of the psychoeducational components is to allay these fears by 
explaining the physiology of a panic attack and also tailored information to help the 
patient understand maintaining factors (Anderson & Carlbring, 2010). 
Panic education commonly occurs during the first few sessions and is based upon the 
postulate that patients need to know the relationship between cognitions and 
sensations and the development of panic attacks before they can participate in 
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specific therapeutic interventions. The purpose of panic education is to allay the fears 
experienced and introduce a new view on the panic experience. Thus, panic 
education is not planned as a stand-alone treatment, but as a supplement to other 
interventions. 
Patients are informed about symptoms of PD. Some of the information includes an 
explanation of panic attacks, and the cause of the symptoms, common myths about 
the dangers of panic attacks, and a clear definition of the fight-or-flight response 
(Houghton, & Saxon, 2007; McNally, 1994). Commonly, it is explained that PD is a 
reaction to stress and anticipatory anxiety a way to ward off a repetition of a panic 
attack (Sanderson & Wetzler, 1995). Sometimes group sharing of personal 
experiences of panic attack is used to help the individual realize that they are not 
alone in the experience of panic disorder. Sometimes group sharing of personal 
experiences of panic attack is used to dispel the individual’s perception that they are 
alone in the experience of panic disorder. Individuals are provided with success 
experiences about the treatment of panic attacks. Therefore, panic education presents 
information about PD, and provides support, and encouragement as the first stage in 
treat panic disorder (Anderson & Calbring, 2010). 
Therapists may also examine with their patients some of the assumptions and beliefs 
about the meaning attributed to the panic experiences (McNally, 1994). This may 
provide a base for later changes in beliefs. 
There may be initial effects of psychoeducation that facilitate further progress in 
treatment. For instance Shear et al., (1994) found that by starting treatment with 
psychoeducation the subsequent treatment, which was either based on CBT or a non- 
prescriptive supportive therapy, did not differ. 
Hu, Choi & Park (2003) in a study examined which treatment component was most 
helpful in treatment group behavioral therapy for panic disorder. In their study 161 
patients with panic disorder, after treatment, were asked to rank for five components 
of panic control treatment (PCT). The results showed that most helpful component of 
PCT was psychoeducation that was constructed to provide the corrective information 
for PD. 
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Dannon, Iancu & Grunhaus, (2002) examined the effects of a self-information booklet 
(SIB) program in decreasing frequency and severity of panic attacks in PD patients. 
In this study Eighty-four patients were randomly assigned to receive either 
paroxetine with self-information booklet (Group A) or paroxetine alone (Group B). 
Follow-up was done after 1, 3, and 12 weeks. After 3 weeks of therapy, the outcome 
of study showed that Group A had significantly greater improvement than patients 
in group B in reduction of anxiety and panic attack symptoms. After 12 weeks of 
treatment intervention, two groups were not statistically significantly different from 
each other. The authors concluded that administration of a psychoeducational 
brochure to PD patients at the initiation of therapy had beneficial effects during the 
first weeks of treatment. 
Cognitive Restructuring 
The cognitive restructuring is based on Beck's work on how dysfunctional 
information processing may underlie affective disturbances and the resulting 
dysfunctional behaviors (Beck & Emery, 1985; Sanderson & Wetzler, 1995). The goal 
of cognitive restructuring is to alter the relationship between physiological arousal 
and the meaning of the arousal (McCarter, 1996; Choy, 2008).  
Cognitive models of PD suggest that change in catastrophic misinterpretations of 
bodily sensations will predict symptom reduction and is a central mechanism of 
change in cognitive therapy of PD (Teachman, Marker, Clerkin, 2010; Casey, et al., 
2004b). Hence, the therapeutic effects of cognitive restructuring emphasized that 
targeting the catastrophie misinterpretation of bodily sensation is a central 
mechanism of change in cognitive therapy of PD (Casey, et al., 2004a). 
Through therapy faulty cognitions and processes are identified, challenged through 
reality-testing and then restructured in more realistic form (Clark, 1986; Barlow, 
Craske, Cerny & Klosko 1989). It is important to note that in order for the therapy to 
be genuinely effective it is the patient who must ultimately conclude that certain 
cognitions or cognitive processes are distorted or incorrect.  
Cognitive restructuring includes four components: (a) description of the cognitive 
model of panic and educating patients about exacerbating panic symptoms through 
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catastrophic thoughts (vicious cycle) (b) identifying negative and anxious thought 
cognitions associated with physical sensation triggers of recent panic attacks 
(Sanderson & Rego, 2002; Gabbard, 2004; McCarter, 1996), (c) practicing replacement 
of maladaptive cognitions with noncatastrophic explanations, and providing 
information about the individual panic sequence and the panic inducing and 
maintaining cognitions, (d) instructing patients in between session exercises.  
Patients were asked to describe examples of recent panic attacks and to identify 
maladaptive thoughts and consequences associated with them (Meuert et al., 2010b).  
Catastrophic misinterpretations of panic related to somatic cues are specially 
targeted (Wells, 1997; Clark, 1986). Interruption of catastrophic interpretations such 
as fear of having a heart attack, losing control or going insane are challenged and 
changed with more positive internal conversations, such as “This has happened 
before, but I can stand this. This is anxiety and this will go away” other common 
misinterpretations also may be targeted such as over-valuating the consequences of a 
panic attack,i.e., public humiliation, losing one's job or interpersonal rejection 
(Sanderson & Wetzler, 1995). 
Sanderson & Wetzler (1995) employed logs which targeted certain areas with 
patients who had learned how to restructure their cognitions to facilitate the self-
monitoring process. In the logs clients were asked to: (a) report the status in which 
the panic attacks happened; (b) determine the feelings at the time of the attack and 
rate their severity; (c) in three columns, log the negative automatic thoughts, the kind 
of cognitive distortion for example Catastrophizing, Overgeneralizations, All-or-
nothing thinking, Jumping to conclusions, Disqualifying the positive), and a rational 
(i.e., realistic) response; and (d) describe the feeling after they completed the log. 
Often patients continued to keep these logs throughout the course of treatment. 
Cognitive restructuring, in combination with other techniques, has been used 
successfully to modify dysfunctional thoughts and catastrophic misinterpretation of 
bodily sensations. It is commonly combined with exposure especially when 
agoraphobic avoidance is prominent (Marchand et al, 2008; Ost, Thulin, Ramnero 
2004; Arntz &Van Hout, 1996; Bouchard et al., 1996). 
In this regard, Foa & Kozak, (1986) postulated that combining exposure with 
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cognitive restructuring provided the patient with corrective information about the 
dangerousness of feared situations.  
The problem is that exercises called 'behavioral experiments' or 'hypothesis testing' 
play an important role in cognitive restructuring (Bouchard et al, 1996). They are 
used to test the validity of the subject’s beliefs and to induce reappraisal of the 
threatening stimulus by allowing the client to confront the anxiety provoking 
stimulus. Without them, cognitive restructuring would not be clinically valid (Beck & 
Emery, 1985). This means that the patient is exposed to somatic and cognitive 
impulses related with panic attacks in order to learn to reattribute the 
misinterpretations (Beamish et al., 2002). In this regard, exposure usually focuses on 
interoceptive phobic stimuli and agoraphobic situations. In the case of exposure to 
interoceptive cues, hyperventilation, aerobic exercises or inhalation of CO2 are 
generally used to elicit feared stimuli (Barlow, Craske, 2007; Watkins, Sturgis, & 
Clum, 1988; Nazemi, et al., 2003b). Within the context of experiencing bodily and 
cognitive symptoms similar to those experienced during a panic attack, the patient 
learns a series of cognitive restructuring procedures for dealing with these symptoms 
(Barlow, Craske, 2007; Bystritsky et al., 2000; Beamish et al., 2002). As already 
mentioned, exposure therapy is typically programmed to move more or less 
progressively from the least to the most fearful stimuli and, at each step, contact with 
the panicogenic stimulus is maintained until the anxiety has subsided. The amount of 
exposure in exposure therapy of course will always exceed what is found in 
cognitive restructuring and behavioral experiments.  
However, Margraf and Schneider (1991), Salkovskis, Clark and Hackman (1991), 
Bouchard, et al., (1996), Clark et al. (1994), Williams and Falbo (1996), Ost, Thulin, & 
Ramnero (2004), Beck et al., (1992), Brown et al., (1998), Wenzel et al., (2006), Arntz 
(2002), Arntz &Van Hout (1996) have demonstrated that cognitive restructuring can 
be effective even in the absence of any exposure intervention, including behavioral 
experiments. However, outcome studies have also shown that it is not necessary to 
directly challenge dysfunctional beliefs with cognitive restructuring to obtain effects 
that are comparable to those of cognitive restructuring (Marchand et al., 2008; Beck et 
al., 1994; Margraf & Schneider, 1991; Ost, 1987; Ost, Westling & Hellström, 1993). 
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Margraf and Schneider (1991) in a study with eighty PDA patients found cognitive 
restructuring to be as successful as interoceptive exposure alone, or a combination of 
cognitive and interoceptive exposure. Up to 93% of their participants were panic-free 
at 3 month follow-up. The short interval of the follow-up may explain why no 
differences were found between experimental groups.  
Margraf et al., (1993) reported in their meta-analysis of PD treatment that the 
cognitive component of assisting patients to reattribute their bodily sensations was 
found to be more important to recovery than simply habituating participants 
through exposure. 
Salkovskis et al., (1991) proposed that cognitive restructuring therapy focusing on 
changing the misinterpretation of bodily sensations (focal therapy) would be more 
effective in reducing the frequency of panic attacks than cognitive therapy which did 
not focus on misinterpretations of bodily sensations (non-focal therapy). Five 
participants were in the first group and two in the second group. They found that 
treatment consisting of reattribution of the physical symptoms associated with panic, 
without implementing any breathing retraining or exposure techniques, was more 
effective at reducing the frequency of panic attacks in PD patients than non-focal 
therapy. 
Brown, Beck, Newman, Beck, Tran (1998) examined the efficacy of focused cognitive 
therapy (FCT) and standard cognitive therapy (SCT) in PD patients. In their study, 
FCT focused specifically on the “catastrophic misinterpretation” of physical and 
psychological sensations experienced during panic attacks induced in the office or 
occurring spontaneously between sessions. SCT focused primarily on the cognitions 
and beliefs relevant to interpersonal concerns involved in generalized anxiety. The 
result showed that both groups had significant decreases in the severity of the 
clinical measures after treatment. Moreover, 89.5% of the SCT group and 84.2% of the 
FCT group were free of panic attacks at 1-year follow-up. 
Bouchard, et al., (1996) compared cognitive restructuring versus exposure in the 
treatment of PDA. A total of 28 subjects with PDA were randomly assigned to either 
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of two treatment conditions: exposure therapy or cognitive restructuring. Both 
conditions comprised 15 therapy sessions lasting 90 min each. The exposure therapy 
(interoceptive and exteroceptive) was conducted according to a written treatment 
manual based on descriptions from Barlow and Cerny (1988) and Wolpe (1990). The 
cognitive restructuring group received at each weekly session. The results showed no 
significant difference among the groups and both treatment groups were statistically 
and clinically effective in reducing panic and agoraphobic symptoms. 
Arntz & van Hout (1996) compared cognitive therapy versus applied relaxation in 
PD treatment in thirty- six patients. Each group received 12 treatment sessions. The 
results showed the cognitive therapy group achieved superior outcomes in reducing 
panic frequency compared to the relaxation therapy group at post treatments and 
follow-up. 
Williams and Falbo (1996) investigated the effectiveness of cognitive therapy and 
exposure treatment on panic symptoms. They found that both treatments did not 
differ from one another in effectiveness. 94% of the low agoraphobia patients were 
free of panic after treatment and 52% of the high agoraphobia patients became panic 
free. 
Wenzel et al., (2006) evaluated the effectiveness of cognitive therapy in dysfunctional 
beliefs in PD. The results indicated that patients who received cognitive therapy 
achieved significant reductions in level of panic belief or dysfunctional cognitions 
across treatment, with the largest decline occurring between intake and 4 weeks into 
treatment. 
Clark et al., (1994) compared cognitive restructuring with drug therapy and 
relaxation in treatment of PD. They found that cognitive restructuring was more 
effective in reducing panic and panic-related conditions then applied relaxation or 
imipramine. At a12 month follow-up, the same pattern of results emerged. 
An extensive review on cognitive treatment in panic disorder is presented below 
(Table 1.6). 
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Table 1.6: Overview of cognitive therapy versus other treatment modalities 
Margraf & 
Schneider 
(1991) 
Participants Eighty PDA patients 
Condition Evaluated outcome and components of CBT for PD. The 
participants were randomly assigned to either of four 
conditions: (a) CT (b) Ex (c) CT+EX (d) WL. 
F/Up One month 
Outcome CT=EX=CT+EX 
Salkovskis, 
Clark, 
Hackmann 
(1991) 
Participants Seven PD patients 
Condition Assessment of Cognitive Restructuring alone in treating 
of PD. 5 patients allocated in focus cognitive therapy for 
changing the misinterpretation of bodily sensations 
(focal therapy) and 2 patients were allocated in non-
focus on misinterpretations of bodily sensations (non-
focal therapy). 
F/Up Not reported 
Outcome FCT>NFCT 
Clark et al. 
(1994) 
Participants Sixty-four PD patients 
Condition A comparison of cognitive therapy, applied relaxation 
and imipramine in the treatment of PD. Participants 
were assigned to (CT), (AR), (IM) or (WL).  
F/Up 3, 6, 15 months 
Outcome At 3 months:CT>AR+IM 
At 6 months :CT=AR=IM 
At 15 months:CT>AR+IM 
Williams 
and Falbo 
(1996) 
Participants Forty-eight PDA patients 
Condition A comparison of the efficacy of cognitive therapy and 
performance-based exposure in panic attacks.  
Participants were assigned to (a) cognitive therapy, (b)  
exposure therapy, (c) combined cognitive/performance 
treatment and (d) WL. 8 weekly individual 1 hour 
treatment sessions. 
F/Up 6 weeks, 1-2 years 
Outcome CT=EX=COM > WL 
Bouchard, 
et al., (1996) 
Participants Twenty-eight PDA patients 
Condition A comparison of the efficacy of cognitive restructuring 
vs exposure therapy. Patients were randomly assigned 
to (a) exposure therapy or (b) cognitive restructuring for 
15 weekly sessions. 
F/Up 4 weeks, 6 months 
Outcome CR=EX 
Arntz & 
Van Hout 
(1996) 
Participants Fifty-four PD/PDA patients 
Condition A pre-post test design to examine cognitive therapy vs 
applied relaxation in PD. The patients were randomly 
assigned to (a) cognitive therapy or (b) relaxation, (c) WL 
group. Treatment consisted of 12 weekly sessions.  
F/Up Six months 
Outcome CT > AR 
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Brown, 
Beck, 
Newman, 
Beck, 
Tran 
(1998) 
Participants Forty PD patients 
Condition A comparison of efficacy of focus cognitive therapy and 
standard cognitive therapy for PD. The patients were 
randomly assigned to the (a) standard cognitive therapy 
(SCT) and (b) focused cognitive therapy (FCT) groups 
for 12 to 18 sessions of treatment. 
F/Up One year 
Outcome FCT=SCT 
Dannon, 
Iancu, 
Grunhaus 
(2002) 
Participants Fifty-four PD/PDA patients 
Condition A pre-post test design to examine effectiveness of 
Psychoeducation by a self-information booklet (SIB) in 
PD. The patients were randomly assigned to receive (a) 
paroxetine with brochure (b) paroxetine without a 
brochure. Treatment consisted of 12 weekly sessions. 
Patients self-monitored panic attacks during the whole 
treatment period. 
F/Up 1, 3, and 12 weeks 
Outcome After 3 week: SIB+Parox> Parox 
After 12 weeks: SIB+Parox= Parox 
Arntz 
(2002) 
 
Participants Sixty-nine PD patients 
Condition A pre-post design to examine cognitive therapy vs 
interoceptive exposure. Patients randomly allocated to 
(a) cognitive therapy (b) interoceptive exposure group, 
12-session treatments in each group. 
F/Up Six months 
Outcome CT=IEX 
Wenzel, 
Sharp, 
Brown, 
Greenber & 
Beck, (2006) 
Participants 197 PD patients 
Condition A longitudinal pre test-posttest design study to assess 
dysfunctional beliefs in PD. Patients received 8 weeks 
cognitive therapy. 
F/Up 3, 6, 12, and 24-months 
Outcome CT produced a significant reduction in panic belief (PBI) 
at posttreatment and FU. 
Note*: AR: Applied Relaxation; CR: Cognitive Resructuring; CT: Cognitive Therapy; COM: 
Combination of Cognitive and Behavioural Interventions; EX: Exposure; IEX= Introceptive 
Exposure BT: Breathing Training; Relaxation; FCT: Focused Cognitive Therapy; NFCT: Non 
Focal Cognitive Therapy; SCT: Standard Cognitive Therapy; SIB: Self-Information Booklet; 
IMI: Imipramine therapy; Parox: Paraoxtine therapy; WL: Waiting List; FU: Follow-Up; PBI: 
Panic Believe Inventory. 
In summary, each of these studies showed cognitive restructuring and 
psycoeducation were effective in changing irrational or disturbing belief patterns 
such as catastrophic misinterpretation of bodily sensations. Cognitive therapy was 
effective compared to the waiting list control group, relaxation therapy alone and 
supportive therapy, immediately after treatment and follow-up but not compared to 
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exposure treatment. 
1.3.2.4 Combination Treatments 
Cognitive behavioral therapy in treating panic disorder focuses on targeting the fear 
of bodily sensations, apprehension of panic and agoraphobic avoidance through a 
combination of cognitive and behavioral techniques (Rayburn & Otto, 2003; Otte, 
2011). 
Recent evidence supports combining CBT techniques for PD treatment (Pincus et al., 
2010; Gallo et al., 2012; Butler et al., 2006; Barlow, et al., 2000). There are a number of 
different multi-model treatment approaches to treating PD, each using some 
combination of the treatment strategies (Barlow, 1990; Carlbring et al., 2006; Sánchez-
Meca et al., 2010). CBT approaches have been found to produce total cessation of 
panic attacks in over 80% of PD patients according to Beck et al., (1988a). 
Across studies, there is some variation in the emphasis placed on cognitive and 
behavioral elements, and the extent to which all elements are included. Panic control 
treatment (PCT) includes all these elements, whereas Clark's cognitive therapy for 
panic largely focuses on cognitive restructuring (Roth & Fonagy, 2005). 
Panic Control Therapy (PCT), or panic inoculation, is a well validated CBT approach 
(Barlow & Craske, 2007; Craske et al., 2003). The main goal of PCT is to better control 
anxiety and panic symptoms and promote a greater sense of mastery over panic 
attacks (Barlow & Craske 2007). PCT is a widely used form of CBT, with combination 
of behavioral and cognitive components for managing anxious sensations and 
breaking the association between these sensations and catastrophic interpretations in 
panic disorder (Barlow, Craske, 2007). PCT combines psychoeducation, cognitive 
restructuring, breathing retraining and progressive muscle relaxation, and exposure-
based procedures designed to reduce fear of somatic sensations and agoraphobic 
situations (Barlow & Craske 2007). In fact PCT is an amalgam of techniques drawn 
from a variety of cognitive and behavioral methods and based largely on the 
interactions of three systems affecting the human experience in panic and anxiety: 
physiological (e.g., palpitation, sweating, dizziness, nausea), cognitive (fears of losing 
control or going crazy), and behavioral (avoidance, pacing) (Barlow & Craske 2007; 
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Hofmann & Spiegel, 1999). PCT techniques are thus directed towards each of these 
systems and based on a 12-to 15 session manualized treatment protocol (Barlow & 
Craske 2007). 
PCT first uses psycho education focusing on the etiology, prevalence, and 
hypothesized maintenance of panic and cognitive restructuring to identify and 
monitor negative thoughts that contribute to panic.  
Second, somatic control exercises, such as breathing retraining and progressive 
muscle relaxation, are included to reduce or eliminate physical symptoms that often 
trigger panic attacks and improve the patient’s ability to lessen somatic arousal and 
to change misappraisals of somatic cues (Barlow, 1990).  
Third, interoceptive exposure, which refers to gradually exposing the patient to the 
feared somatic sensations in a systematic manner, is added to increase tolerance to 
the sensations and to demonstrate that they are harmless. Finally, the patient is 
exposed to previously avoided situations in which panic attacks are likely to occur, 
thus decreasing future avoidance of these situations and feared catastrophes 
associated with them (Levitt & Karekla, 2005). 
Numerous research studies have been conducted to investigate the efficacy of PCT 
including dismantling studies investigating the mechanisms of action of the overall 
treatment package and the efficacy of its component parts (e.g, Barlow, et al., 2000; 
Barlow et al.,1989; Craske, Brown, & Barlow, 1991; Gallo et al., 2012; Addis, Hatgis, et 
al.,2006). Studies evaluating the effectiveness and efficacy of PCT and its components 
have consistently shown that the overall PCT package results in significant reduction 
in frequency of severity of panic attacks in approximately 80% of individuals treated 
(Barlow, et al., 2000; Barlow, Craske, Cerny & Klosko, 1989; Hofmann and Spiegel, 
1999).  
Based on the results of follow-up studies of patients who receive PCT demonstrated 
that most of them remain better after at least 2 years (Craske & Barlow, 2008)  
Barlow et al., (1989) randomly assigned patients with panic disorder to receive (a) 
PCT alone, (b) relaxation alone, (c) relaxation and PCT in combination, or (d) wait-list 
control group. They found that all three treatment groups were successful and 
superior to the wait list control, but PCT and PCT in combination with relaxation 
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were superior to relaxation alone in reducing panic frequency but not generalized 
anxiety. At post treatment, 87% of the PCT group and 85% of the PCT plus relaxation 
group, and 60% of the relaxation group were panic free, compared with only 6% of 
the control group; however, relaxation training led to a higher dropout rate, both 
when used alone and in combination.  
PCT has also been delivered and tested in group formats. In a study, Craske et al., 
(2003) examined the effectiveness of group PCT delivered in decreasing panic attacks 
in PD patients. Patients were randomly assigned to receive 16 weekly, 90-min 
sessions PCT with/without the addition of in vivo exposure. The results of study 
showed that both treatment conditions were effective in the reduction of frequency 
and severity of panic attacks. At post-treatment, 79% of the sample reported no panic 
attacks. The majority of this sample was categorized as having moderate to severe 
agoraphobia at pre-treatment (82%), compared to 29% in the moderate to severe 
range at post-treatment. 
Support for PCT also comes from a study by Klosko et al., (1990). They compared the 
efficacy of PCT and Alprozolam to a drug placebo condition and a wait list control 
condition. They found that 87% of the patients in the PCT condition had achieved 
panic free status compared with 50% of the patients in the Alprazolam condition, 
36% of the patients in the placebo drug condition, and 33% of the patients in the wait 
list control condition. The PCT was found to be significantly more effective than the 
other three conditions. 
Barlow, et al., (2000) in a study compared PCT to imipramine, a placebo, and 
combinations of PCT with imipramine or a placebo. Results indicated that after 
treatment all active treatments were equivalent and all were better than placebo. 
However at the 6 month follow-up, individuals who received PCT alone had 
significantly more durable effects and significantly less intent to treat. Analysis of the 
clinical Global Impression Scale were 31.9% for PCT alone vs 19.7% for imipramine 
alone and 26.3% for PCT combined with imipramine. Moreover, more than one-third 
of subjects refused participation in the study because they were unwilling to take 
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imipramine. Only, 1 out of 308 potential participants refused the study because of the 
possibility of receiving psychotherapy. 
Addis et al., (2006) examined the effectiveness of CBT for panic disorder versus 
treatment as usual in a managed care setting with a 2-year follow up. Eighty 
outpatients with PD received either PCT or treatment as usual (TAU). The results 
showed no significant differences between the treatments across the follow-up 
period. However when treatment completer status was added as a moderator, those 
receiving PCT showed lower levels of panic severity and phobic avoidance and a 
greater likelihood of achieving and maintaining clinically significant change. 
Pincus et al., (2010) evaluated the efficacy of PCT in thirteen adolescent case with PD. 
Participants were 26 adolescent subjects that were randomly assigned to receive 
either 12 weeks of PCT or a self-monitoring control group. The results showed that 
adolescents receiving PCT showed a significant reduction in clinician-rated severity 
of panic disorder and in self-reported anxiety, anxiety sensitivity, and depression, in 
comparison to control group participants. These treatment gains were maintained at 
3- and 6-month follow-ups. 
Öst, Thulin & Ramnero (2004) examined a combination of CBT packages for 
treatment of panic disorder. They used a range of cognitive and behavioral coping 
strategies to identify the misinterpretation of bodily sensations and generate an 
alternative, non-catastrophic interpretation of the sensations. The results showed 
79% of the patients at post-treatment were panic free. They had significant 
improvements, both on panic/agoraphobia measures and on measures of general 
anxiety, depression, social adjustment and quality of life, which were maintained at a 
one year follow-up. 
Combined CBT and pharmacological therapy in treatment PD is common in clinical 
practice and numerous studies using a variety of medications and CBT packages 
(McCabe & Gifford, 2009). This compares favorably with any of the pharmacological 
treatments in the acute phase of the treatment and may in fact be more effective in 
the long run. 
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The results of a comprehensive review of the literature on the efficacy of 
psychotherapy and pharmacotherapy in PD/PDA showed that of 124 studies 
included, CBT was more effective than a non-treatment control and a placebo control 
(Mitte, 2005). 
Furukawa, Watanabe & Churchill (2006) examined 23 studies (involving 1,709 
patients) comparing a combination of psychotherapy and pharmachotherapy vs 
treatment alone for patients with PDA. The results showed of twenty- three studies, 
twenty-two studies used CBT as the psychotherapy intervention. The author found 
that in the acute-phase treatment combined CBT and medication was superior to 
pharmacotherapy or psychotherapy, although at follow up (6 to 24 months) 
combined treatment was superior to medication but equivalent to CBT alone. 
Roy-Byrne et al., (2005b) in a randomized controlled trial examined the effectiveness 
of a combined pharmacotherapy and cognitive-behavioral intervention on PD. The 
patients randomly received either treatment as usual or an intervention consisting of 
a combination of up to 6 sessions of CBT. They found combined cognitive-behavioral 
and pharmacotherapy resulted in sustained and gradually increased improvement 
relative to treatment as usual.  
An extensive review on Panic Control Treatment (PCT) in panic disorder is 
presented below (Table 1.7). 
 
Table 1.7: Overview of Panic Control Treatment (PCT) studies in Panic Disorder (PD) 
Klosko, 
Barlow, 
Tassinari & 
Cerny 
(1990) 
Participants Forty-seven patients with PD  
Condition Compared PCT vs Alprazolam. Subjects were randomly 
assigned to PCT or Alprazolam treatment. These 
conditions were compared with a medication placebo 
and a waiting-list control group. 
F/Up Not reported 
Outcome PCT > ALP 
Telch, 
Lucas, 
Schmidt, et 
al.,(1993) 
Participants Sixty-seven patients with PD/PDA 
Condition Comparative effectiveness of CBT for PD. Subjects was 
randomly assigned to treatment CBT or waiting list 
group. 12 PCT sessions over 8 weeks consisted of: (a) 
psychoeducation (b) cognitive therapy, (c) breathing 
training and (d) interoceptive exposure. 
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F/Up 6 months 
Outcome PCT > WL 
Barlow, 
Gorman 
Shear & 
Woods 
(2000) 
Participants Three hundred twelve PD patients 
Condition A randomized controlled trial to compare CBT, 
imipramine, or their combination for PD. Patients 
randomly assigned to receive: (a) CBT (b) Imipramine (c) 
CBT + imipramine (d) Placebo (e) CBT + placebo.  
F/Up 6 months 
Outcome (CBT), (IMI) > PLC in reduction of PDSS  
(CBT), (IMI) =PLC in reduction of CGI. 
At FU: (IMI), (CBT) > PLC in reduction of PDSS, CGI 
(IMI+CBT) = (CBT+PLC) in reduction of PDSS 
(CBT+PLC) > (IMI+CBT) in reduction of CGI 
Roy-Byrne 
et al., (2005) 
Participants Two hundred thirty two PD patients 
Condition A pre-test, post-test, FU design to test the effectiveness 
of a combined pharmacotherapy + CBT versus TAU 
(typically pharmacotherapy) for PD. Subjects in 
combination group received 6 CBT sessions (across 12 
weeks). 
F/Up One year 
Outcome CBT +PHMT>TAU 
Addis, 
Hatgis 
Cardemil, 
et al., (2006) 
Participants eighteen patients with PD 
Condition A long-term outcome study to compare PCT vs 
Treatment as Usual (TAU). Subjects randomly assigned 
to one of the two groups. 
F/Up 2 years 
Outcome PCT=TAU 
Furukawa, 
Watanabe 
& 
CHurchill 
(2006) 
Participants 1,709 PD patients 
Condition A Meta-analysis for Psychotherapy plus antidepressant 
for PD/A. 
F/Up Not reported 
Outcome In the acute-phase treatment: 
CBT+PHMT > PHMT 
After termination of the acute-phase treatment: 
CBT+PHMT=CBT 
Marcus, 
Gorman, 
Shear, 
et al., (2007) 
Participants One hundred seventy two PD patients 
Condition A Comparison of medication side effect reports by PD 
Patients With and Without Concomitant CBT. Subjects 
randomly assigned to one of three conditions (a) CBT 
plus imipramine, (b) imipramine and (c) placebo. 
F/Up 2 years 
Outcome (CBT+IMI)>(IMI) and (PLC) 
Pincus, 
May et al., 
(2010) 
Participants Twenty-six adolescents with PD 
Condition A randomized controlled trial to evaluate the efficacy of 
PCT for PD. Subjects assigned to receive (a) CBT or (b) a 
self monitoring control group. 
F/Up 3- and 6-months 
Outcome PCT> control group 
Gallo, Participants Fifty-five adolescents with PD/PDA 
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Chan, 
Buzzella, 
Whitton & 
Pincus 
(2012) 
Condition Assessed the impact of an intensive CBT vs Wait-list 
group. The treatment entailed 8 days of 2 to 6 hours of 
treatment for a total of 20 hours of treatment. 
F/Up Not reported 
Outcome CBT> WL 
Note*: ALP: Alprazolam therapy group; CR: Cognitive Restructuring; EXP: Exposure 
therapy; IMI: Imipramine; PCT: Panic Control Therapy; PHMT: Pharmacotherapy; PLC: 
Placebo; REL: Relaxation Therapy; TAU: Treatment As Usual; WL: Waiting List group; FU: 
Follow-Up; CGI: Clinical Global Impressions; PDSS: Panic Disorder Severity Scale. 
In summary, each of these studies found that a combination of cognitive and 
behavioral techniques was effective in managing anxious sensations and breaking 
the association between these sensations and catastrophic interpretations in panic 
disorder. Panic Control Therapy (PCT) or combination of cognitive behavior therapy 
was effective compared to the control group or relaxation alone, pharmachotherapy 
alone and placebo. 
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1.4 Group Therapy for panic Disorder: An Overview 
Cognitive behavioral therapy for panic disorder and agoraphobia may be conducted 
in individual or group formats (Barlow, 2008). Although psychotherapy has been 
demonstrated in a large body of research to be an effective treatment for anxiety 
disorders, the individual format has been the norm, both in CBT and other therapies. 
So that even when given choice, patients will likely choose individual treatment over 
group treatment. In one study, 95% of the sample chose individual treatment over 
group when asked for their preference (Sharp, Power & Swanson, 2004).  
Group psychotherapy is a form of psychotherapy during which one or several 
therapists treat a group of clients usually between eight and twelve individuals 
(although it is possible to have more participants) together as a group (Andersson & 
Calbring, 2010). The length of every session can be from an hour and a half to three 
hours and can be conducted, once to twice a week (Rutan et al., 2007). 
The most prominent theories on the influence of groups upon individuals came from 
Gustav LeBon in 1895, when he identified the phenomenon of the “group mind”. 
LeBon hypothesized that when an individual is in a crowd, his level of human 
functioning declines, (Rutan et al., 2007). LeBon proposed that large groups by nature 
regress to a more uncivilized, even primitive level of behavior. He attributed this 
decline to three factors:  
First, he linked the theory of strength in number, as impacting the individual to feel 
stronger, even invincible, when among the group, thus increasing their likelihood to 
behave differently.  
Secondly, LeBon stated that the mind set of the group develops to the point of a 
hypnotic state, or as he termed it, a contagion, which overcomes and directs its 
members.  
The last, but most important in LeBon’s opinion was that due to this contagion, the 
level of suggestibility increases, making it easier to influence an individual (Rutan et 
al., 2007).  
Group psychotherapy was further developed by Moreno, Slavson, Spotnit, Yalom 
and Ormont (Yalom & Leszcz, 2005). Yalom's approach to group therapy has been 
very influential throughout the world (Corey, 2009).  
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Prior to the mid 1980s, groups were seldom focused on a homogeneous treatment 
population, but were usually comprised of clients suffering from various complaints. 
Conventional wisdom began to change with the increasing research evidence for the 
efficacy of psychotherapies such as CBT which at first specifically targeted 
depression (Niemeyer, 1985). 
Luby (1995) noted that CBT could be easily adapted to diagnostically homogeneous 
group formats. Because of its established research efficacy, specific focus, and 
manualized treatments protocols, CBT is well suited to group applications. 
GCBT may be defined as therapy that uses the dynamics of the group format, in 
addition to common CBT techniques, to change distorted, maladaptive, and 
dysfunctional beliefs, interpretations, behaviors, and attitudes (Bieling, McCabe & 
Antony, 2009; Petrocelli 2002; Van Dam-Baggen & Kraaimaat, 2000).  
The format of GCBT could be psycho-educative in nature, being open-ended or 
manualized. The frequency and duration of session in CBT-groups can vary 
considerably, depending on the choice of format and other patient-dependent 
variables (Morrison, 2001). 
White & Freeman (2000) suggested that clients' understanding of the cognitive model 
is fundamental to the CBT approach in both group and individual formats.  
In early sessions, members learn the principles of cognitive behavioral theory. This 
learning does not require that the group therapist lecture to members while they 
remain passive. The term that characteristizes the relationship between group 
therapist and members is collaborative empiricism (Brabender, Fallon & Smolar, 
2004). 
Group CBT is often practiced in more linear fashion however, with emphasis on the 
thought=>feeling=>behavior causal chain. In this regard, the GCBT therapist 
employs a clear understanding of the interaction between thoughts, feelings, and 
behaviors (White, 2000).  
Member and therapist function as co-investigators joined in the effort to understand 
the interrelationships of each member's cognitions, affects, and behaviors (Bieling, 
McCabe, Antony, 2009). Establishing this type of relationship encourages 
 
 Chapter I - Theoritical Background  78 
 
responsibility-taking rather than answer-seeking on the part of the member (White, 
2000).  
In the early phase of treatment, the therapist launches the collaboration using a 
socratic method wherein a line of questioning enables the member to discover how 
systems of meaning influence feeling and behavior in the problems emerging in his 
or her life. The systematic exploration of members' experiences shows them that 
some reactions in situations are preceded by barely discernable and fleeting 
automatic thoughts that give rise to the painful feelings (Bieling, McCabe, Antony, 
2009). For Instance, heightened stress and arousal increase the flow of adrenaline, 
which may result in hyperventilation, shortness of breath, and dizziness. The patient 
misinterprets these sensations ("I'm dying; I'm going crazy"), thus creating a vicious 
cycle. To combat this the therapist explains the benign nature of the panic attack to 
group members and then offers instruction on how to induce a mild attack and then 
control it using proper breathing techniques and progressive muscular relaxation. 
Members become skilled through the use of thought records in analyzing their 
experience into thoughts, feelings, and behaviors. As a result, clients learn new skills 
to manage distressing feelings (Brabender, Fallon & Smolar, 2004). Clients also 
receive feedback from other group members regarding the evidence for and against 
their automatic thoughts. This corrective feedback within a peer group is an 
important component of the group process (Bieling, McCabe, Antony, 2009). A core 
principle that separates GCBT from individual CBT is the social force of cohesiveness 
(the degree to which group members find themselves personally interested in 
relating to each other) (Petrocelli, 2002). However group cohesiveness can only be 
arranged by the group, GCBT is like most cognitive-behavioral approaches in that it 
is task oriented and designed to seek problem resolution (Petrocelli, 2002, White, 
2000).  
It is thought that as people join together to form an effective therapy group, they also 
form a positive alliance whose purpose is to reduce the panic attacks of all team 
members. Although this positive working alliance is related to the working alliance 
and relationship that is essential to individual treatment (Horvath et al., 2011). There 
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appears to be a higher order of allegiance that develops in a successful group 
atmosphere. 
Senge (1990) attributed these higher group goals to an atmosphere where “people 
continually expand their capacity to create the results they truly desire, where new 
and expansive patterns of thinking are nurtured, where collective aspiration is set 
free, and where people are continually learning to learn together” (p.3).  
In CBT, learning is a central component. But learning for the benefit of the group is a 
unique characteristic of the group format (Yalom & Leszcz, 2005). 
According to Stein, et al., (2009) in a group, clients can share their experience and 
problems and learn that they are not alone or 'different'. Furthermore, they will feel 
less isolated and begin to realize that they have a specific, understandable syndrome 
and not a unique bizarre condition. 
According to, Zal, (2001) “in group therapy they can experience a decrease of anxiety 
and obtain relief of guilt feelings. They can also achieve an increase in self- esteem, as 
they are taken seriously, perhaps for the first time. Group therapy can foster self- 
expression and ventilation, as well as better interpersonal relationships and 
communication. A supportive group can do much too foster risk taking and 
assertiveness and encourage the growth and maturity of the personality. Initially, the 
more adventurous patients will take risks and be more active. They can serve as 
significant role models, encouraging others to follow. Groups can utilize each other 
for support for some of the exposure and behavioral exercises and continue to act as 
a support system to help maintain improvement'' (p. 69). 
1.4.1 Benefits of the Group CBT Format 
In light of the market driven demands for cost-effectiveness, there has been an 
increased interest in the application of the cognitive therapy principle in group 
context (Segal & Shaw, 1996). From an economic standpoint the charge for 90 
minutes of group psychotherapy is generally one-half to one - third the cost of 50 
minutes of individual therapy (Vos, Corry, Haby, Carter, Andrews, 2005). 
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Some authors estimate that individual therapy is 64% more expensive than group 
therapy (McCrone et al., 2005). An additional advantage of CBT over 
pharmachotherapy appears to be greater cost-effectiveness. In a study examining the 
cost and outcomes of CBT and pharmachotherapy, Otto, Pollack, and Maki (2000) 
found that group CBT was a more cost-effective treatment than pharmachotherapy, 
with equivalent acute treatment efficacy and greater maintenance of treatment gain, 
without requiring ongoing treatment. In addition, group treatment was more cost-
effective than individual treatment, with a total annual cost of $523 per person for 
group treatment compared to $1,357 per person for individual treatment. In contrast, 
the annual cost for pharmacotherapy was $2,305 (Bieling, McCabe & Antony, 2009). 
In addition due to limited resources most treatment programs, especially those 
supported by public funds, are unable to make individual therapy routinely 
available to their patients. As compared to individual therapy, group therapy allows 
a larger number of patients to be treated by fewer clinicians on a given work day 
(Washton, 2011).  
Aside from the obvious practical advantages of treating several patients at the same 
time, cost effectiveness and reducing waiting lists, there are some unique benefits to 
the group CBT format (Morrison, 2001). In comparison with individual cognitive 
behavioral therapy, cognitive behavioral groups have the opportunity to 
demonstrate the relationship between thoughts and feelings through the negative 
thoughts of the group members, and recognize the cognitive distortions of others, 
which could help the reattribution of their own cognitions (Bieling, McCabe & 
Antony, 2009). 
According to Yalom and Leszcz (2005), the gathering together of people who share a 
common problem often creates a bond between them, stemming from a sense of 
mutual identification and an expectation of being intuitively understood. This is 
critically important in counteracting the intense feeling of isolation, alienation and 
shame that patients with panic disorder often experience. 
More specific advantages of group treatment include reassurance by learning that 
others have similar problems, vicarious learning, learning through helping others, 
observing others’ success thus reinforcing the patient to continue treatement, 
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committing to a group of peers to change oneself, the availability of multiple role 
play partners, and being challenged by peers counter distorted thinking (Heimberg 
& Becker, 2002). A main advantage in group treatment of panic disorder with 
agoraphobia is that the group provides the phobic stimulus that causes anxiety or 
panic attack which creates an in vivo exposure, thus providing a perfect opportunity 
to learn adaptive coping skills.  
The advantages of group treatment would not be complete without mentioning those 
identified by Yalom in his book, “The Theory and Practice of Group Psychotherapy”, 
a highly popular group psychotherapy text published in 1995. He identifies eleven 
primary therapeutic factors of group treatment: instillation of hope, universality, 
imparting information, altruism, the corrective recapitulation of the family group, 
development of social techniques, imitative behavior, interpersonal learning, group 
cohesiveness, catharsis (opportunity to express feelings) and existential factors 
(recognizing one’s mortality, to learning to take responsibility for one’s own life, no 
matter how much support others give).  
Yalom, Tinklenberg, and Gilula (1968) were among the first to develop a method for 
assessing therapeutic factors. Twenty group therapy clients placed 60 therapeutic 
factor Q-sort items into categories ranging from “Least helpful to me in group” to 
“Most helpful to me in group.” Using these categories, Yalom et al., (1968) derived a 
ranking of the relative client-perceived importance of therapeutic factors. 
Specifically, the clients in Yalom et al.'s study ranked the factors from most to least 
important as follows: (1) interpersonal learning, (2) catharsis, (3) cohesiveness, (4) 
self-understanding, (5) existential factors, (6) universality, (7) instillation of hope, (8) 
altruism, (9) family re-enactment, (10) guidance and, (11) identification (Kivlighan & 
Holmes, 2004). 
MacKenzie (1983) developed a questionnaire that was intended to assess the climate 
of a group. The Group Climate Questionnaire – Short Form (GCQ-S: MacKenzie, 
1983) includes a subscale that measures the construct engagement. This subscale is 
thought to relate to Yalom's (2005) concept of group cohesion. A factor analysis of 
this questionnaire showed that engagement included both support (group cohesion 
as a precondition for change) and work (group cohesion as a therapeutic factor) 
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dimensions of the group. This instrument provides evidence that group cohesion 
serves in both of these capacities.  
There have been many studies on therapeutic factors influencing the outcome of 
group psychotherapy (Bloch, & Crouch, 1986; Yalom, 1995). Which factors are more 
important for the therapeutic outcome may differ with various dimensions such as 
the therapeutic approach, the type of disorders, and so on.  
Huh, Choi & Park (2003) aimed to identify which therapeutic factors have crucial 
influence on treatment outcome in group behavioral therapy with patients with 
panic disorder. They examined therapeutic factors of group behavioral therapy for 
panic disorder in 161 patients with panic disorder. After treatment, patients were 
assessed by Yalom’s Curative Factor Questionnaire. The results showed patients with 
the greatest improvement from treatment rated significantly higher in guidance, 
group cohesiveness, altruism, identification, and family reenactment factors.  
Choi and Park (2006) further investigated which therapeutic factors had the most 
positive influence on the outcome of cognitive behavioral group treatment for social 
phobia. Fifty patients with social phobia were asked to complete the Yalom’s 
Curative Factors Questionnaire and Therapeutic Components Evaluation Form at the 
end of their Cognitive Behavioral Group Treatment (CBGT). Among the 12 
therapeutic factors, existential factor, interpersonal learning-output, guidance, and 
self-understanding showed higher mean scores among all the patients. The patients 
who showed more improvement rated significantly higher in therapeutic factors 
such as interpersonal learning-output, guidance, universality and group 
cohesiveness. 
García-Cabeza et al. (2011) also evaluated these therapeutic factors in five studies 
focused on patients diagnosed with severe mental disorder. All factors were 
measured with the Yalom Q-sort questionnaire that defines factors based on the 
value given by the patients. They found that the instillation of hope was most 
important in patients with severe mental disorders. 
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According to Yalom & Leszcz (2005), while some beneficial aspects of the group 
approach also apply to the individual paradigm (e.g., modeling), the phenomen of 
social support, social pressure and vicarious learning remain unique to group 
intervention, thus lending support to the contention that group treatment is the more 
effective approach. 
It seems that group therapy may also offer additional benefits that may not be found 
in individual therapy because of the unique interactional experiences that take place 
between those participating in the group. Yalom articulates these therapeutic factors 
in several sources (e.g., Yalom & Leszcz, 2005; Yalom, Cox & Vinogradov 2008), most 
notably group cohesion and universality, which collectively describe the 
connectedness group members experience with each other. These are perhaps the 
most important benefits of group therapy, being described by numerous authors 
(e.g., Leszcz & Kobos 2008).  
Eidelson (1985) described several potential advantages of group versus individual 
CBT as follows: 
First, group CBT encourages and offers opportunities for vicarious learning or 
learn from observing other members: members see other group members' attempts to 
challenge and restructure their thinking and consequently learn how to challenge 
their own thought processes. Modeling and observational learning can be very 
powerful and occur readily in groups. The members of group are often learning and 
may exhibit common traits after a few weeks together. 
Second, group CBT provides greater resources or a diversity of viewpoints and 
maximum resources because all of the other group members that may be harnessed 
during the process of helping people develop new alternatives. In addition to the 
therapist(s), contribute to the process; members can draw on more points of view to 
help challenge their beliefs. 
Third, the group format provides a form of strong feelings of belongings, trust, and 
social connection so that the tendency of the panic disordered person to withdraw 
from social interaction is offset; the interpersonal support and encouragement that 
often occurs in successful groups provides a safe environment where individual can 
share their innermost thoughts and ideas without the fear of being rejected or 
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ridiculed for them. Furthermore group provides a motivation for the group member 
to stimulate more interpersonal interactions outside the group setting. 
Fourth, group CBT can allow beyond individual therapy in providing direct for 
more experiential disputation of irrational or dysfunctional beliefs; group members 
help one another to overcome such typical beliefs as: catastrophic thoughts about 
normal or anxious physical sensations, i.e.,”If I have a panic attack in public I will go 
crazy and have to be committed.” “My heart skipped a beat, I must be having a 
heart attack.” In fact, in the group setting it is the norm that the members do 
contribute to one another's improvement; just by being there, each member expert 
when it comes to panic attack, the members are able to make suggestions that 
contribute to others' progress. 
Fifth, one of the main principals behind group CBT is the feedback one gives 
oneself. Because it becomes obvious throughout the group that other members are 
distorting reality, members can identify when others in group are making these 
cognitive distortions, then they are probably doing likewise. Therefore, this factor 
provides an opportunity to develop a new perspective on oneself and her or his 
relationships with others. 
Sixth, when group members help other group members to correct their distorted, 
negative thinking, all group members’ gain practice rehearsing more positive or 
adaptive thoughts. In fact, group CBT provide an opportunity to demonstrate the 
relationship between thought and feelings. In addition, some group members 
become more aware of their own maladaptive thought patterns and become ready 
through group practice, to challenge their own beliefs. 
Finally, in group CBT format some “loaded” issues such as compliance with 
homework assignments in psychotherapy, can be handled without engendering 
extreme defensiveness. It is often the case that more than one member is reporting 
difficulty with homework or some other problem. These issues can be treated as 
general problems that everyone can benefit from discussing. In this way, no one 
member feels singled out. Cognitive tools such as thought records can be used to 
help members understand and solve their problems. 
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1.4.2 Previous Research on effect of Group CBT in Panic Disorder 
Otto et al., (1999) examined the efficacy of group CBT therapy for patients who fail to 
respond to pharmacotherapy for PD. They selected samples of patients who were 
refractory to an adequate dose of medication ('adequately-treated' nonresponders) 
and patients who had not responded to an inadequate dose of medications 
(inadequately-treated' nonresponders). They examined outcome in response to group 
CBT. The adequately-treated sample consisted of 10 patients and the inadequately-
treated sample consisted of 14 patients, CBT was provided in 12 sessions with group 
format. CBT for the adequately-treated patients resulted in significant decreases in 
both outcome measures. CGI-severity (clinician global impression of severity) scores 
decreased from a pretreatment mean of 4.7 to a week-12 score of 2.5. PDSS scores 
(Panic Disorder Severity Scale) decreased from a composite score mean of 2.1 to a 
mean of 1.1. Patients in the inadequately-treated sample also improved significantly 
with treatment. CGI-severity scores decreased from a mean of 5.0 at baseline to a 
mean of 2.8 at week 12 and PDSS scores decreased from a mean of 2.3 to a mean of 
1.2. Forty-three percent of the sample had a CGI-severity score of 1 or 2 at week 12. 
Heldt et al., (2006) studied the impact of brief group CBT (GCBT) for PD on QoL 
(Quality of Life) and to identify the clinical features associated with these changes. In 
their study thirty-six patients with PD refractory to pharmacological treatment took 
part in a treatment protocol consisting of 12 sessions of GCBT. To evaluate the 
changes in QoL, the results showed significant improvement in all domains of QoL 
was observed, which was associated with reductions in general and anticipatory 
anxiety and agoraphobic avoidance. They concluded GCBT was efficacious in the 
treatment of PD. 
Rufer et al., (2010) conducted a study designed to assess the association of different 
aspects of panic disorder with quality of life (QoL) and to examine the relationship 
between QoL and symptomatic outcome following brief group CBT (GCBT). The 
sample consisted of 55 outpatients with PD who underwent GCBT. QoL was 
assessed at baseline, posttreatment and six months follow-up. Baseline scores were 
compared with normative data obtained from a large population sample. They 
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concluded that treatment responders showed significantly better QoL than non-
responders. PD symptom reduction following GCBT was associated with 
considerable improvement in emotional and physical aspects of QoL. 
Rosenburg and Hougaard (2005) evaluated the effectiveness of group CBT for PD 
with agoraphobia in a clinical setting. The patients randomly divided to group CBT 
(GCBT) or waiting list group (WL). The applied treatment programme consisted of 
14 weekly 1½-h sessions of group CBT with groups of six patients. The results 
showed, investigation group achieved better outcome on most analyses, (42.2%) 
found to be panic-free after treatment compared with 12.5% in the control group. 
Treatment gains were durable with 66.7% without panic attacks at follow-up at 1.5-2 
years. 
Galassi et al., (2007) studied about the efficacy of group treatment. Seventy-six PD 
patients were included in the study. The treatment consisted of 14 weekly 2-hr group 
sessions and included: (a) an educational component, (b) interoceptive exposure, (c) 
cognitive restructuring, (d) problem solving, and (e) in vivo exposure. The patients 
achieved significant treatment gains on all dimensions assessed with a high rate of 
panic remission and significant improvement in the associated symptoms. 
Furthermore, these gains were maintained at 6-months' follow-up. Notably, there 
was no control group in this study.  
Dannon et al., (2004), evaluated the effectiveness of group CBT in the treatment of PD 
and to compare the treatment outcome of group CBT versus Paroxetine 
pharmacotherapy. Fifty seven PD patients were randomly allocated to receive either 
GCBT or Paroxetine. Follow up was done after four and twelve weeks of treatment in 
order to compare the efficacy of GCBT versus Paroxetine. Group CBT and Paroxetine 
were both effective in the short term treatment of PD. Assessments at weeks four and 
twelve of treatment showed no statistically significant differences between the two 
groups in terms of treatment outcome. Treatment with group CBT alone for the acute 
phase of PD appears to be equally efficacious to treatment with Paroxetine alone. 
Also the study showed that GCBT produced beneficial results, for it was associated 
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with a reduction in the number and frequency of panic attacks and with an improved 
feeling of well-being. 
Erickson, Janeck & Tallman, (2007) in a study demonstrated that group CBT format is 
effective in various anxiety disorders, particularly panic disorder. In their study 152 
patients were randomly assigned to receive 11-week group CBT or a wait-list control 
group. Follow-up was done after six months. The result showed reductions in 
anxiety scores for participants in the group CBT were greater than those for the 
control group participants. Patients with PD in particular appeared to benefit. 
Outcomes for the group CBT were superior in terms of clinically significant changes, 
defined as a 20% or 40% improvement. Reductions in anxiety scores continued to be 
present six months later. 
In another study Lidren et al., (1994) compared bibliotherapy and group CBT in 
treatment of PD. Thirty-six patients were randomly assigned to 1 of 3 conditions 
group therapy, bibilotherapy or a waiting list control condition. Interventions lasted 
8 weeks and were followed by a posttest, along with 3- and 6- month follow-up 
assessments. They found that both the bibliotherapy and group treatments were 
more effective than the waiting list condition in reducing frequency of panic attacks. 
Both interventions maintained their effects throughout the follow -up periods. 
An extensive review on group psychotherapy format studies in panic disorder is 
presented below (Table 1.8). 
 
Table 1.8: Overview group psychotherapy format studies in panic disorder 
Lidren, 
Watkins 
Gould, 
Clum, 
Asterino, 
Tulloch 
(1994) 
Participants Thirty-six patients with PD 
Condition A comparative study design to evaluate efficacy of 
GCBT versus bibliotherapy using a Self Help book (SH) 
in the treatment of PD. Patients randomly assigned to 
one of three conditions: (a) GCBT, (b) SH) and (c) WL, 8 
session weekly/1/5 h. 
F/Up 3- and 6- month 
Outcome GCBT= SH >WL 
Otto, 
Mark, 
Pollack, 
Participants Twenty-four PD patients 
Condition Assessed group CBT for patients failing to respond to 
pharmacotherapy. Subjects received 12 GCBT sessions. 
Two groups: (a) the patients inadequately treated that 
 
 Chapter I - Theoritical Background  88 
 
Susan, 
Penava, 
Bonnie & 
Zucker 
(1999) 
had been treated for a 2 month minimum with a dosage 
of medication and (b) patients who had not responded to 
an inadequate dose of medications. 
F/Up Not reported 
Outcome GCBT=PHMT 
Dannon, 
Gon-
Usishkin, 
Gelbert, 
Grunhaus 
(2004) 
Participants Fifty-seven PD/A patients 
Condition A comparative study of the efficacy of GCBT versus 
drug treatment. The patients were randomly allocated to 
receive either GCBT or Paroxetine (PHMT). 
F/Up 4 week, 6 months 
Outcome GCBT=PHMT 
Rosenburg 
& 
Hougaard 
(2005) 
Participants Forty PD/A patients 
Condition A longitudinal study designed to investigate the 
influence of group CBT for PD/A. The patients were 
randomly divided to group CBT or WL. Treatment 
program consisted of 14 weekly 1½-h sessions of group 
CBT with groups of six patients. 
F/Up 4 months 1.5 – 2 years 
Outcome GCBT>WL 
Heldt, 
Blava, 
Isolan, 
Kipper, 
Teruchkin, 
et al., (2006) 
Participants Thirty-six PD patients 
Condition Examined effectiveness of Group CBT on QoL and 
identified the clinical features associated with these 
changes in patient’s refractory to medication treatment. 
The treatment protocol consisted of 12 sessions of CBGT. 
Lack of control group. 
F/Up Not reported 
Outcome Significant improvement in all domains of QoL. 
Reductions in general and anticipatory anxiety and 
agoraphobic avoidance. 
Galassi, 
Quercioli, 
Charismas, 
Niccolai & 
Barciulli 
(2007) 
Participants Seventy-eight PD/A patients 
Condition A randomized, controlled trial to examine efficacy of 
GCBT for PDA. Consisted of six GCBT groups with 14 
weekly 2-hour. Lack of a control group. 
F/Up 6-months 
Outcome Significant improvement on all dimensions assessed 
(MIA, STAI, BDI, CGI) with a high rate of panic 
remission and significant in the associated symptoms. 
Erickson, 
Janeck & 
Tallman 
(2007  
 
Participants One hundred fifty two patients with anxiety disorders  
Condition Assessed a GCBT format to treat patients who have 
different anxiety disorders in the same group. Patients 
were randomly assigned to treatment in the 11-week 
GCBT or to a wait-list control group (WL). 
F/Up 6 months 
Outcome GCBT>WL 
Rufer, et al., 
(2010) 
Participants Fifty-five PD patients 
Condition A pretest post design to assess the changes in quality of 
life (QoL) following group CBT for PD. Nine groups 
 
Chapter I - Theoritical Background  89 
 
  
  
 
were conducted; five to seven patients participated in 
each group, GCBT protocol consisted of five weekly 
sessions of 150 minutes each. Results of QoL in patients 
with PD compared to healthy subjects. 
F/Up Six months 
Outcome Emotional and physical aspects of QoL improved 
following CBGT. This improvement was ssociated with a 
decrease of PD symptoms. 
Note*: GCBT: Group Cognitive Behavior Therapy; PCT: Panic Control Treatment; PHMT: 
Pharmacotherapy; SH: Self Help bibliotherapy; WL: Waiting List; FU: Follow-Up; BDI: Beck 
Depression Inventory; CGI: Clinical Global Impression Scale; PDSS: Panic Disorder Severity 
Symptoms; MIA: Mobility Inventory for Agoraphobia; STAI: State-Trait Anxiety Inventory; 
QOL: Quality Of Life.  
In summary, these studies showed CBT delivered in group format effective in 
reducing PD symptomatology and catastrophic interpretations in PD. Group CBT 
and pharmachochotherapy had comparable treatment efficacy. Both treatments had 
similar effects in reducing PD symptoms and were more efficacious than placebo and 
control group immediately after treatment and follow-up.  
1.4.3 Individual Therapy versus Group Therapy 
A review of the literature has shown that many studies have been done comparing 
individual therapy versus group therapy for subjects such as therapeutic factors, 
process variables, depression, social phobia and OCD, eating disorder, obesity, 
childhood aggression or other problems, sexually abused women, borderline 
personality disorder. There is a gap in the literature comparing treatment of panic 
disorder in an individual therapy modality versus group therapy modality. Only a 
few studies have examined whether individual and group treatments are equally 
effective in the treatment of panic disorder (Sharp, Power & Swanson, 2004; Neron, 
Sylvain, Lacroix, Denis, Chaput & Yves, 1995). 
The question whether individual and group treatments are equally effective is 
important for several reasons, the foremost perhaps being economical. If group 
therapies are as effective as individual therapies, this could decrease the costs of 
treatment substantially, since group therapy is considerably less expensive than 
individual therapy (Vos et al., 2005).  
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From a clinical and scientific perspective, if these treatments are equally effective, 
this suggests that the presence of other patients during the treatment does not hinder 
the treatment of the individual patient. On the other hand, it may also be possible 
that the treatments result in comparable effects but through different mechanisms 
(Yalom & Leszcz 2005). For example, in individual treatment the relationship 
between client and therapist may be stronger, while in group therapy other 
mechanisms, such as cohesion and social support play the greater role (Yalom & 
Leszcz 2005). If individual and group treatments are not equally effective, this would 
suggest that one is not as good as the other in teaching the patient techniques that 
help reduce panic disorder. Or it could be possible that group processes interfere 
with the therapeutic process (Yalom & Leszcz 2005). But before these questions can 
be answered, it first has to be known whether group and individual treatments are 
indeed equally effective. 
There has been a gradual accumulation of research comparing group to individual 
treatments over the past five decades, and what has been shown is that there are no 
significant differences between the two treatments format (McRoberts et al, 1998).  
Research has also shown there are different therapeutic processes in the two 
modalities (Holmes & Kivlighan, 2000). At the same time however, little is 
understood about the similarities or difference between the processes in these two 
treatment modalities (McRoberts et al., 1998), and few studies have examined them 
(Holmes & Kivlighan, 2000).  
Outcomes of empirical studies comparing the effectiveness of individual and group 
therapy interventions demonstrate that both treatment modalities according to 
various theoretical orientations are substantially more effective than no treatment or 
minimal treatments for a variety of psychological disorders and problems (Bednar & 
Kaul, 1994; Fuhriman & Burlingame, 1994). 
Burlingame, MacKenzie, & Strauss (2004), examined 107 studies and 14 meta-
analyses published between 1990 and 2002 across six disorders: mood disorder, 
anxiety, eating disorder, substance abuse, personality disorder and psychosis. They 
reported that there was adequate evidence to conclude that group therapy is as 
effective as individual therapy either as the primary treatment or as a part of a 
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treatment program. 
Toseland & Siporin (1986), conducted a meta-analysis of 74 empirical studies which 
participants were randomly allocated to receive individual or group treatment (for 
various diagnosis). The same modality and technique were used with all subjects in 
both the group and individual formats. The results obtained in 75% of the studies 
two treatment format were equally effective and in 25% of studies group therapy was 
more effective than individual therapy. 
In a meta-analysis of 700 group therapy studies, Fuhriman and Burlingame (1994), 
concluded that group psychotherapy is as effective as individual therapy in treating 
a range of psychological problems and across treatment models. 
McRoberts et al (1998) conducted a meta-analysis of 23 empirical studies which 
individual and group therapies were compared directly. Results of this review 
demonstrated that no treatment outcome differences were found for group versus 
individual therapy formats; a finding that supports earlier reviews (Berman, & 
Niemeyer, 1990; Tillitski, 1990).  
Other meta-analytic studies demonstrate group therapy's effectiveness with a variety 
of populations in different treatment settings (e.g., Burlingame, et al., 2003; Kösters, 
Burlingame, Nachtigall, & Strauss, 2006; McDermut, et al., 2001; Payne & Marcus, 
2008). These studies implie that mode of therapy does not appear to affect outcome, 
with individual and group therapy demonstrating comparable effectiveness 
(McRoberts et al., 1998). This finding holds true across a number of variables, 
including "the chronicity of the disorder, gender, or age of the client" (McRoberts et 
al, 1998, p. 108). Additionally, no significant differences in effectiveness have been 
observed between theoretical orientations or treatment settings when comparing 
individual and group therapy (McRoberts et al., 1998). Individuals who participate in 
group therapy are better off than those on wait lists, with 72-85% of participants 
demonstrating treatment gains (Burlingame et al., 2003; McDermut et al., 2001). 
A conclusion based on Morrison’s review (2001), and Petrocelli’s meta-analysis 
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(2002), showed that for the most part there was little difference in results between 
CBGT and individual CBT treatment studies.  
The research shows, although group therapy may be a viable and cost-effective 
alternative to traditional individual therapy services, nevertheless, what has been 
shown is that most patients have a strong preference for individual over group 
treatment (Cuijpers, van Straten & Warmerdam, 2008). Additionally most of the 
treatment experiences of mental health professionals, about 80%, tend to be in 
individual therapy, with other modalities being significantly underutilized (Norcross 
et al., 1988). For example, the numbers of psychotherapists using group therapy as a 
form of personal therapy are significantly lower than those engaging in individual 
therapy (Guy et al., 1988). Group therapy is only undertaken by about 4% to 30% of 
professionals (Norcross et al., 1988). 
However, these authors also assert that in some situations individual therapy might 
represent the more effective treatment setting. For instance, a client may feel more 
comfortable discussing emotional topics with an individual therapist. This may be 
especially true when the client is shy, or dislikes talking in front of many people. The 
individual format may also facilitate discussions related to more intimate issues that 
may be serving as impediments to treatment progress (Cuijpers, van Straten & 
Warmerdam, 2008). 
Lazarus (1971) proposed that individual treatment may lead clients to experience a 
greater feeling of involvement, higher motivation, and better adherence. Findings by 
Subich and Coursal (1985), support these assertions. These authors found that 
compared to subjects assigned to group therapy, clients in individual treatment 
expected to be both more open and responsible in therapy. But on the other side, 
group therapy may also offer additional benefits that may not be found in individual 
therapy because of the unique interactional experiences that take place between those 
participating in the group. As compared with individual therapy, in group therapy 
participants can learn effective social skills and try out new styles of relating with 
other members of the group (Corey, 2008). In addition, the phenomen of social 
support, social pressure and vicarious learning remain unique to a group 
intervention. As already mentioned Yalom articulates therapeutic factors in several 
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sources (e.g., Yalom & Leszcz, 2005; Yalom, Cox & Vinogradov 2008), most notably 
group cohesion and universality, which collectively describe the connectedness 
group members experience with each other. These are perhaps the most important 
benefits of group therapy, being described by numerous authors. While some 
beneficial aspects of the group approach also apply to the individual paradigm (e.g., 
modeling), the phenomen of social support, social pressure and vicarious learning 
remain unique to a group intervention. The added benefits of these variables seem to 
lend support to the contention that group treatment is an effective approach (Yalom 
& Leszcz, 2005). 
1.4.4 Previous Research on Individual Therapy versus Group Therapy 
in Panic Disorder 
There are a few studies which have evaluated the efficacy of group versus individual 
therapy in treatment of panic disorder: 
Néron, Lacroix and Chaput (1995), compared the efficacy of group CBT versus 
individual cognitive behavior therapy in the treatment of PD and PDA. Twenty 
patients with PD or PDA were randomly assigned to group CBT (GCBT) or 
individual CBT (ICBT) with weekly sessions for 12 or 14 weeks. Sessions (GCBT= 2 
hours, ICBT=1 hour) were administered weekly for 12 (GCBT) or 14 weeks (ICBT). In 
addition GCBT patients were given two individual one hour sessions during their 12-
week treatment. The CBT protocol was identical for both treatment modalities. 
The results showed that both treatment formats significantly reduced panic 
frequency at treatment end. However, a differential effect favoring individual CBT 
(ICBT) over group CBT (GCBT) was observed at the end of the follow-up phase with 
regards to generalized anxiety symptoms. 
Sharp & colleagues (2004) studied the efficacy of group CBT versus individual 
cognitive behavior therapy in the treatment of PD and PDA. Ninety-Seven PD or 
PDA was randomly assigned to group CBT (GCBT), individual CBT (ICBT) or 
waiting List control group. Treatment consisted of 1-hour sessions held once a week 
for 8 weeks. All patients were seen by the same therapist and all received an identical 
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treatment manual. Meanwhile, all participants took either anxiolytic or 
antidepressant medication or a combination of both or were required to continue 
taking these medications as prescribed throughout the study period. They found that 
both group and individual CBT were superior to a wait list control group in 
reduction of anxiety and depression symptoms and agoraphobic avoidance but did 
not differ significantly from each other. However individual CBT was associated 
with greater clinical significance (i.e., outcome score at least two standard deviations 
below the pre-treatment mean for the entire sample), than either group CBT or wait-
list control immediately following termination of treatment. However, this 
advantage for individual treatment was not detectable at 3-month follow-up. 
Marchand, et al., (2009) conducted a randomized controlled clinical trial with a wait-
list control group to examine the effectiveness of three modalities (brief, group, and 
standard) of cognitive-behavioral treatment (CBT) for PDA. 100 patients were 
randomly assigned to each treatment condition: a 14-session individual CBT (n=33), 
a 14-session group CBT (n=35) and a 7-session brief CBT (n=32). Participants 
received a self-study manual and were assigned weekly readings and exercises. The 
results indicated that all three-treatment conditions significantly reduced the 
intensity of symptoms, increased participants' quality of life, offered high effect sizes, 
superior maintenance of gains over time, and lower rates of relapse, compared to the 
wait-list control. 
An extensive review on group versus individual psychotherapy format studies in 
panic disorder is presented below (Table 1.9). 
 
Table 1.9: Overview of group versus individual psychotherapy format in panic disorder 
Neron, 
Lacroix, 
Chaput 
(1995) 
Participants twenty patients with PD/A 
Condition A pretest-posttest comparison group design to evaluate 
effect of group vs individual CBT. The subjects 
randomly received either (a) GCBT, (b) ICBT. All 
patients were seen by the same therapist and all received 
an identical treatment manual. Sessions GCBT: 12 
weekly sessions, 2 hours, ICBT=14 weekly session 1 
hour. 
F/Up 3-6 months 
Outcome GCBT=ICBT in reduction of HAMD, ZDI 
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ICBT>GCBT in reduction of BAI, HAMA 
Sharp, 
Power & 
Swanson 
(2004) 
Participants Ninty-seven patients PD/A 
Condition A comparative study design evaluating efficacy of group 
versus individual CBT. The participants were randomly 
allocated to receive (a) GCBT, (b) ICBT, and (c) WL. 8 
sessions 1hour. All patients were seen by the same 
therapist and all received an identical treatment manual. 
F/Up 3 months 
Outcome GCBT and ICBT=WL in reduction of SRT 
GCBT = ICBT in reduction of HAMA, MADRS & FQ 
Marchand, 
Roberge, 
Primiano & 
Germain 
(2009)  
 
Participants One hunderd patients PD/A 
Condition A long-term clinical outcome study of standard, group 
and brief CBT for PDA: The participants were randomly 
allocated to receive (a) 14 session GCBT, (b) 14 sessions 
ICBT, and (c) 7 sessions brief CBT or (d) WL.  
F/Up Two year 
Outcome GCBT, ICBT and BCBT >WL 
GCBT = ICBT 
Note*: BCBT: Brief Cognitive Behavior Therapy; GCBT: Group Cognitive Behavior Therapy; 
ICBT: Individual Cognitive Behavior Therapy; WL: Waiting List group; BAI: Beck Anxiety 
Inventory; FQ: Fear Questionnaire; HAMA: Hamilton Anxiety Scale; HAMD: Hamilton 
Depression Scale; MADRS: Montgomery-Asberg Depression Scale; SRT: Symptom Rating 
Test; ZDI: Zung Depression Inventory. 
In summary, each of these studies found CBT delivered in group format as 
comparable to those of individual CBT in reducing PD symptomatology and treating 
PD immediately after treatment and at follow-up. Group therapy is a feasible 
arrangement and can provide a cost-effective alternative to individual therapy, as the 
studies by Sharp et al (2004) and Marchand et al (2009) showed.  
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1.5 Aim of the Study 
The primary goals of this research is (a) to evaluate the effectiveness of an fourteen 
week program of Cognitive Behavioral therapy in two format of group and 
individual therapy in reducing the cognitive, affective and panic disorder severity, 
(b) comparison of efficacy of group versus individual CBT in treatment of panic 
disorder.Therefore, the results of this study provide additional support, along with 
new insight, to the field of panic disorder and agoraphobia.  
Panic disorder with or without agoraphobia is a prevalent clinical disorder which 
places heavy demands on treatment resources in primary care (Power, Sharp, 
Swanson, Simpson, 2000). Patients with panic disorder suffer from recurrent panic 
attacks, anticipatory anxiety, abnormal sensitivity to anxiety and a wide range of 
alarming symptoms accompanied by catastrophic cognitions, considerable 
impairment in functioning and depression (Coryell, Pine, Fyer & Klein 2006; Perna, 
et al. 2004; van Beek &, Griez, 2000). Since people with panic disorder focus 
increasing attention toward monitoring their body and the outside world for sign of 
panic, they often develop deficits in multiple life domains. Work, social relationship 
and quality of life are all negatively affected (Telch et al., 1995).  
Clinical evidence suggests that CBT is an effective treatment for PD/A. In particular 
CBT leads to reductions in anxiety symptoms, anxious cognition, agoraphobic 
avoidance, and depressive symptoms (Barlow, 2011; Deacon and Abramowitz, 2004; 
Teachman et al., 2010; Wenzel et al., 2006). There is evidence of Group-based CBT 
studies that shows the positive effects in reduction of anticipatory anxiety, secondary 
depression, number and severity of panic attacks and dysfunctional cognitions in PD 
(Sharp, Power, Swanson, 2004; Marchand et al., 2009; Rufer, Albercht, Schmidt et al, 
2010; Rosenburg & Hougaard; 2005., Dannon et al., 2004. To the best of my 
knowledge there are few reported studies comparing individual versus group 
therapy in patients with PD. Although, as mentioned previously, Sharp et al., 2004 
and Neron et al., (1995) revealed individual and group CBT were equally in 
reduction of depression in patients with panic disorder in post intervention and 
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follow-up. But on the other side, Neron et al., (1995) study showed that individual 
CBT was superior to group CBT in reduction of overall anxiety in patients with panic 
disorder in post intervention and a six month follow-up, while the study by Sharp et 
al., (2004) indicated that two treatment format did not differ significantly from each 
other in reduction of overall anxiety and other panic symptoms after treatment. It 
must be noted that in both studies all participants took either anxiolytic or anti-
depressant medication or combination of both, which may have obscured group 
differences. In contrast, the present study excluded individuals on psychotropic 
medication including benzodiazepine or concurrent psychotropic medications, from 
participation. In addition the current study will measured more specific symptoms 
related to PD compared with study by Neron et al., and Sharp et al., that a few 
dependent variables were measured in their study. Hence this study is an attempt to 
examine and compare the effectiveness of two formats: cognitive behavioral group 
therapy and individual cognitive behavior therapy without combination with 
pharmacotherapy in the treatment of panic disorder after 14 sessions of CBT and a 4-
month follow-up. This study is a response to changes in format policy in treating 
panic disorder that have occurred in recent years. It also serves as a prototype 
intervention for future policy direction. By evaluating the effectiveness of GCBT and 
ICBT to treat panic disorder this current study offers a model for replication in future 
interventions not only for panic disorder but other anxiety disorders as well. In 
addition this treatments format offers a cost-effective intervention which will reduce 
costs, save money, and thereby allow the allocation of financial resources to address 
other pressing health concerns. 
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1.6 Hypotheses and Research questions 
1.6.1 Hypotheses 
Based on previous empirical studies (Neron et al., 1995; Sharp et al., 2004 & 
Marchand et al., 2009) that found that was no significant difference between 
individual and group formats in reduction of some panic symptoms. Therefore, it is 
expected no differences in effectiveness of CBT for panic disorder with or without 
agoraphobia delivered in either the individual or group treatment formats. The 
following hypotheses were formulated: 
The following hypotheses were formulated: 
Ha 1: Group therapy is affective as individual therapy in reduction of overall 
negative affect (Depression and Anxiety) 
 Ha 2: Group therapy is affective as individual therapy in reduction of 
catastrophizing cognition (agoraphobic cognition and anxiety sensitivity) 
Ha 3:  Group therapy is affective as individual therapy in reduction of agoraphobic 
avoidance and panic disorder severity  
Ha 4:  Greater improvement of group therapy and Individual CBT compared to 
Wait-list group. 
Ha 5: Therapeutic outcomes in group CBT and individual CBT at post-test will be 
maintained at four months follow-up. 
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1.6.2 Research Questions 
a) Is there any difference between the outcomes of individual CBT, group CBT 
groups and waiting list control group in terms of severity of panic attack, anxiety, 
depression, agoraphobic cognition, anxiety sensitivity, and agoraphobic 
avoidance at post -treatment? 
b) What are the differences between Individual CBT and Group CBT groups 
regarding their effects on different panic disorder criterion post-treatment? 
c) What are the differences between Individual CBT and Group CBT in terms of 
severity of symptoms over the follow-up period (4 month post-treatment)? 
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Chapter II - Methodology 
2.1 Design and procedure 
2.1.1 Participants 
Participants in this study were 45 outpatients (25 men and 20 women) with a 
DSM_IV diagnosis of panic disorder with or without agoraphobia. Participants in 
this study were between the ages of 18 and 65 years old who were residents of the 
Bandarabbas city, in Iran and applied for treatment of panic disorder. Participants 
were referred from local emergency room physicians, mental health clinics and 
private psychiatric offices. The study has been conducted in Ebne-Sina´s psychiatric 
government clinic and five offices in Bandarabbas city. 
Of those accepted into the study, four patients had entered treatment but had failed 
to complete the trial. Four people failed to show up for the first session and could not 
be reached by phone, and one became ineligible after beginning antidepressants after 
session 5 of the group cognitive behavior therapy.  
The confidentiality of participants was protected by storing all data based on an 
assigned number rather than the name or other identifying information. The 
participant was made aware that involvement in the study was voluntary and 
withdrawal from the study at any time was acceptable without repercussions.  
To be included in the study, the participants had to meet the following criteria: 
• The participant must be between 18- 65 years old, and either male or female. 
• The participants must give informed consent. 
• The participant must fulfill DSM-IV criteria for panic disorder with or without 
agoraphobia 
• The participant must have suffered panic disorder for at least 1 month 
• The participant must have panic disorder as the primary problem 
 
Individuals were excluded from participation for any of the following reasons: 
1) A lifetime diagnosis of psychosis, bipolar disorder, organic mental disorder or 
other psychiatric disorder and current diagnosis of substance abuse or 
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dependence, a current co-principal diagnosis of a depressive disorder, or any 
medical condition that might compromise their health or influence their abilities 
to benefit from the protocol. Such medical conditions included: cardiovascular 
(heart or circulation) condition, respiratory disease, (such as asthma), seizure 
disorders, diabetes, hypertension, hyperthyroid, head injury or surgeries, and 
evidence of organic brain syndrome or mental retardation. 
2) Psychotropic medication (for a psychiatric or psychological condition) including 
benzodiazepine. 
3) A history of previous same treatments. 
4) The unwillingness or inability to give informed consent. 
The inclusion and exclusion criteria were reviewed with each participant prior to his 
or her enrollment and 8 people were excluded after the initial screening based on the 
excluding criteria.  
The flowchart of participants in the study is presented in Figure 2.1: 
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Figure 2.1: Flowchart of study participants, point of random assignment and dropouts 
Assessed for 
eligibility N=61 
Randomly assigned 
N=56 
N=3 met exclusion 
criteria 
N=2 unwilling to 
participate 
 
18 assigned to 
Group CBT 
 
20 assigned to 
Individual CBT 
18 assigned to 
Waiting List 
 
Drop out N=1 Drop out N=2 Drop out N=1 
      
Received pre-test 
and at least one 
GCBT N=17 
Received pre-test 
and at least one 
ICBT N=18 
Received pre-test 
N=17 
      
Drop out N=2 
Completed trial=15 
Drop out N=3 
Completed trial=15 
Drop out N=2 
Completed trial=15 
      
4 month Follow–Up 
N=15 
4 month Follow–Up 
N=15 
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2.1.2 Study Design and Procedure 
This study uses a Quasi-experimental design with a non-equivalent control group 
design with pre-post post-test samples. This design is used whenever the true 
experimental design is not feasible and availability permits subject's selection.  
Prior to entering the study, all prospective participants were privately interviewed 
by the primary investigator of the study who administered the general overview and 
panic disorder section of the Structured Clinical Interview for DSM-IV Disorders 
(SCID) (Spitzer et al., 1997). A demographic questionnaire was also used to obtain 
relevant information pertaining to their panic history and other medical history. 
At the first encounter participants were told that the purpose of the study was to test 
the efficacy of a non-medication treatment for panic disorder. If they were interested 
to partake they would be randomly placed into one of two treatment groups or 
waiting list group. 
The prospective participants were told that participation was voluntary and that they 
could withdraw at any time. The time commitment for the study was also explained. 
If the participant was interested, an appointment was then scheduled for the 
participant to be seen by the primary investigator of the study. 
Eligible candidates were randomly assigned to three groups: Group Cognitive-
Behavioral Therapy (N=15), Individual Cognitive-Behavioral Therapy (N=15) or a 
waiting -list group (as control group) (N=15).  
In the two treatment conditions (Group CBT and Individual CBT), patients met with 
a therapist and received 14 weekly sessions of treatment. 
Control group participants were regularly checked once a week to make sure that 
none of them had received any kind of psychological, psychiatric or counseling 
intervention. 
Treatment effectiveness of individual and group CBT was compared with each other 
and the untreated wait-list control group with a pretest post-test design on the same 
measures. Follow-up testing to evaluate long term benefit was conducted at 4 month 
post treatment. It was carried out by both a telephone call and a letter that was 
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mailed to all participants following the completion of the study. It is diagrammed as 
below: 
 
 N  Treatments week  FU 
4 months 
QI 15 Assessment pre 
14 week 
group CBT 
Assessment post 
Telephone and 
E-mail 
QII 15 Assessment pre 
14 week individual 
CBT 
Assessment post 
Telephone and 
E-mail 
QIII 15 Assessment pre TAU Assessment post - 
 
There is one independent variable, the treatment condition (Group CBT, Individual 
CBT, and wait-list control) and two measurement occasions (pre-treatment, post-
treatment) with an additional follow-up, or in other words, a 3 (group) x 2 
assessment phase (pre, post assessment) and a 2 (group) x 3 (pre, post and follow-up 
assessment phase) design. The dependent variables are panic disorder severity score, 
frequency of catastrophic cognitions score, anxiety sensitivity score, avoidance of 
situation related to fear score, anxiety score and depression score. Additional 
information including age, gender, marital status, occupational status, level of 
education, age of onset and duration of illness were also collected as descriptive 
independent variables. 
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2.1.3 Treatment Protocol 
Individual CBT group (ICBT) received a maximum of fourteen, one hour sessions 
and group CBT (GCBT) received a maximum of fourteen, 1.5 hour sessions and 
Waiting List group (WL) waited 3 months, and then also received a maximum of 
fourteen, one hour sessions of ICBT.  
The therapy was conceptualized as a program of individual and group therapy based 
upon Cognitive-Behavioral therapy. The treatment package included: 
(a) education about the nature and causes of panic, 
(b) self-monitoring and awareness of cues, 
(c) identification of different response components, understanding the 
physiology of panic and learning physical control such as breathing retraining 
or progressive muscle relaxation training (PMR), 
(d) self statement analysis and cognitive restructuring, 
(e) prediction testing, 
(f) interoceptive and naturalistic exposure to feared physical sensations, and 
(g) how to maintain progress. 
  
The present study followed Barlow's treatment protocol. The treatment program 
completed 1 session per week and consisted of 14 one hour sessions of individual 
and group cognitive behavioral therapy. The patients in both individual and group 
formats were seen by the same therapist and all received an identical treatment 
manual. The main treatment components during each of the fourteen sessions are 
listed below: 
 Session 1: 
1. Introduction  
2. Psychoeducation (fear and anxiety and causes, physiological aspects of anxiety 
and symptoms of panic attacks, review of the function of the central nervous 
system and profile of a person with panic disorder). 
3. Brief description of the treatment program (cognitive techniques, relaxation, 
exposure therapy, retraining breathing).  
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4. Treatment schedule (once a week for the next 14 weeks). 
5. Distribution of Weekly Record sheet. The weekly sheet contains of record of 
Panic Situation, Physical symptoms Situation, Physical symptoms, Emotion/s, 
(Rate intensity of emotion (0-100%), Unhelpful Thoughts or Images, (Rate 
intensity of belief (0-100%) Response to Thought, (Rate of intensity believe to 
this different perspective 0-100%) Outcome: Describe of emotion, (Re-rate 
intensity of emotion 0-100%). 
Session 2:  
1. Review weekly record.  
2. Introduce cognitive restructuring (automatic thoughts and techniques for 
monitoring cognitions).  
3. Introduce progressive muscle relaxation (PMR) exercise – 16 muscle groups. 
Session 3:  
1. Review weekly record.  
2. Explore alternative explanations for cognitive self-statements.  
3. PMR (16 muscle groups) with discrimination training.  
Session 4:  
1. Review weekly record. 
2. Identify logical errors in thinking and introduce analysis of faulty logic 
(Evidence, Overgeneralizing, Certainties versus Possibilities, All-or-Nothing 
Thinking, and Absolutistic Thinking).  
3. PMR (8 muscle groups) with discrimination training.  
 Session 5:  
1. Review weekly records and discuss progress/problems. 
2. Repetition of PMR (8-muscle groups). 
3. Presentation of didactic instructions on: 
a) Decatastrophizing 
b) Rescue factors 
c) Reattribution 
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d) Hypothesis testing  
Session 6:  
1. Review weekly records.  
2. Introduce PMR (4 muscle groups) procedures. 
3. Present the rationale for exposure therapy.  
4. Develop of an exposure hierarchy.  
5. Begin imaginary practice for covert rehearsal and application of cognitive 
strategies during graded visualization of anxiety. 
Session 7:  
1. Review weekly records.  
2. Repetition of PMR (4 muscle-groups).  
3. Introduction and rationale of breathing exercise: hyperventilation example 
and training of diaphragmatic breathing.  
4. Imaginal exposure and panic symptom induction; breathing retraining. 
5. Hypothesis testing and cognitive coping strategy practice (assigns a behavioral 
experiment in a low-level anxiety-provoking situation and use self -
instruction to mange the situation).  
Session 8:  
1. Review weekly records.  
2. Imaginal exposure and self-exposure homework (assign a behavioral 
experiment in a low-level anxiety-provoking situation and use self -
instruction to manage the situation). 
3. Introduce 4-muscle group procedure with recall relaxation. 
4. Hypothesis testing, thought stopping and diversionary techniques for anxiety 
management.  
 Session 9:  
1. Review weekly records.  
2. Relaxation by recall (attention to breathing and vocalizing “relax” with 
exhalations and released the tension from particular muscle group). 
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3. Continue imaginal exposure and self-exposure practice (spend approximately 
30 minutes practicing visualizing moderate-anxiety items with the client).  
4. Hypothesis testing and cognitive management practice.  
 Session 10:  
1. Review weekly records.  
2. Imaginal exposure and self-exposure practice (spend approximately 30 
minutes practicing the visualization procedures with items from the anxiety 
hierarchy).  
3. Introduce and practice cue-controlled relaxation (Attention to breathing, then 
take a deep breath and think the word “relax” with exhalation). 
4. Hypothesis testing and cognitive management practice (application of 
cognitive coping strategies and cue- controlled relaxation during exercise).  
Session 11:  
1. Review weekly records.  
2. Imaginal exposure and self-exposure homework (with high anxiety hierarchy 
items). 
3. Repetition of cue- controlled relaxation. 
4. Hypothesis testing and cognitive management practice. 
Session 12:  
1. Review weekly records.  
2. Imaginal exposure and self-exposure homework (with high anxiety hierarchy 
items).  
3. Hypothesis testing and cognitive management practice. 
Session 13:  
1. Review the weekly record and treatment progress. 
2. Begin generalization practice to help the client generalize coping strategies to a 
great variety of life situations and integrate the cognitive coping strategies 
with the in vivo exposure treatments.  
3. Encourage the client to verbalize his/her understanding of the importance of 
 
Chapter II - Methodology  109 
 
practice in various situations. 
Session 14:  
1. Review the weekly record and the client's progress in the previous weeks. 
2. Continue generalization practice and relapse prophylaxis issues (practicing 
what client has learned in confrontation with new situations).  
3. Briefly review the cognitive procedures and rationales used during this 
treatment program, focusing most on those procedures that have been most 
useful to the client. Include comments on the following: 
• The three response model of anxiety and the role of "false alarms" in 
panic symptoms 
• The importance of using coping procedures to facilitate continuing 
exposure to fearsome situations 
• Relaxation procedures (16 muscle groups,8 muscle groups, 4 muscle 
groups, Discrimination training, Recall relaxation, Cue-controlled 
relaxation) 
• Diaphragmatic breathing 
• Automatic thinking 
• Analysis of faulty logic 
• Decatastrophizing 
• Exploring alternatives 
• Reattribution 
• Rescue factors 
• Hypothesis testing 
• Self-statements 
4. Schedule the post-treatment assessments. 
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2.2 Measures 
1. Demographic questionnaire: The demographic questionnaire was used in this 
study to obtain information about personal characteristics of participants, 
including age, gender, marital status, occupational status and education level. In 
addition, the patient's history of panic disorder including number of months or 
years of the disorder and panic attack frequency including how many panic 
attacks the person has per week were also requested. 
2. Panic Disorder Severity Scale (PDSS) (Shear et al., 2001): The PDDS was 
administered to assess severity of diagnosis in participants. The Panic Disorder 
Severity Scale (Shear et al., 2001b) is a brief, clinician-rated, 7-item scale that 
assesses seven specific dimensions that comprise the key features of PDA, which 
are rated on a 4 point scale (0, none;4, extreme). The seven items include 
frequency of panic, anxiety focused on future panic, distress during panic, 
interoceptive avoidance, situational avoidance, interference in social functioning, 
and interference in work functioning. The PDSS was found to have excellent 
interrater reliability (kappa =.87). It has fair internal consistency, with a 
Cronbach's alpha of .65, in view of the fact that the key features of PDA vary 
considerably from patient to patient. The total score on the PDSS was significantly 
correlated with the clinical severity ratings for PD on the ADIS-IV (r=.55; Shear et 
al., 1997). This measure has demonstrated both convergent and discriminant 
validity with other panic and anxiety assessment tools (Shear, Masser, 1994). 
Shear, et al., (2001b) evaluated the internal consistency of PDSS in 198 patients 
according to DSM-III-R panic disorder. The internal consistency yielded a 
Cronbach’s alpha of 0.64. Joint reliability ranged from 0.84 to 0.88 for trained 
raters. The validity of PDSS total score showed moderate correlations with both 
panic disorder severity ratings of the Anxiety Disorders Interview Schedule—
Revised (ADIS-R) (r = 0.54) (DiNardo & Barlow, 1988) and severity ratings of the 
Clinical Global Impression (CGI) Scale (r = 0.66). Individual PDSS item scores 
were strongly associated (r = 0.60-0.78) with ADIS-R items of similar content and 
less strongly associated (r = 0.35-0.47) with CGI Scale and ADIS-R severity 
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ratings. The PDSS items most highly correlated with similar ADIS-R items were 
panic frequency (r = 0.71), anticipatory anxiety (r = 0.78), agoraphobic fear and 
avoidance (r = 0.73), and sensation fear and avoidance (r = 0.69). The PDSS has 
proved to be sensitive to change with treatment. 
3. The Beck Anxiety Inventory (BAI) (Beck et al., 1988): The BAI was administered 
to assess general anxiety symptoms in participants. The BAI is a standard 21 item 
measure of emotional and somatic symptoms and has scores from 0 to 63 (Beck et 
al., 1988b). Participants are asked to assess their level of intensity on a four-point 
scale (not at all, mildly, moderately, and severely) during the past week for each 
of the symptoms. The BAI is considered to have high internal consistency. The 
BAI holds high internal consistency (α=.92) and test retest reliability over one 
week (r=.75). These data indicate that the BAI is highly effective for determining 
the presence of anxiety disorders (Fydrich, Dowdall & Chambless, 1992). In Iran, 
Kaviani & Mousavi (2008) investigated anxiety levels in clinical and non-clinical 
populations. They examined the validity and reliability of the BAI in the Iranian 
normal population as well as in clinically anxious patients. In their study 1,513 
non-clinical respondents were randomly recruited and completed the Beck 
Anxiety Inventory (BAI). Of this population, 112 respondents were randomly 
selected and re-tested in order to measure test-retest reliability with a one-month 
interval time between first and second tests. Furthermore, 261 clinically anxious 
patients were tested. In order to measure validity, 150 patients were interviewed. 
Results showed that the Persian version of the BAI had a good reliability (r=0.72, 
p<0.001), a very good validity (r=0.83, p<0.001), and an excellent internal 
consistency (Alpha=0.92). Steer, Ranieri, Beck & Clark (1993) provided further 
information about the psychometric characteristics of the Beck Anxiety Inventory 
(BAI). The BAI was administered to 470 outpatients with mixed psychiatric 
disorders along with the revised Beck Depression Inventory (BDI) and the SCL-
90-R. The BAI's internal consistency was high (alpha=.92). The BAI was 
significantly correlated with the SCL-90-R Anxiety subscale (r=.81) and less with 
the SCL-90-R Depression subscale (r=62) and the BDI (r=.61). The mean BAI 
scores of the 141 (30.0%) outpatients with mood disorders and the 86 (18.3%) 
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outpatients with anxiety disorders were comparable, but higher than the mean 
BAI score of the 243 (51.7%) outpatients with other disorders. Fydrich, Dowdall & 
Chambless (1992) and Hoyer et al., (2002) carried out further psychometric 
research. In these two studies the test-retest reliability and internal consistency of 
the scale were examined with a sample of 40 outpatients having anxiety 
disorders. The BAI proved highly internally consistent (cronbach's alpha=.94) and 
acceptably reliable over an average time lapse of 11 days (r=.67). 
4. Fear Questionnaire-Agoraphobia subscale (FQ-AG) (Marks & Mathew, 1979): 
This test was administered to assess avoidance of situations related to 
agoraphobia and social phobia in participants. The FQ (Marks & Mathew, 1979) is 
a standard measure of fear and avoidance. The FQ contains three item subscales: 
Agoraphobia, Blood Injury, and Social phobia. Marks & Mathew (1979), reported 
good psychometric properties for each subscale. Scores of 12 on each subscale are 
considered subclinical. The total score on this measure can range between zero 
and 100. The test-retest reliability is reported to be r =.89. Cox, Swinson & Shaw, 
(1991) examined the usefulness of the FQ in differentiating and social phobia in 68 
patients suffering from PDA, 50 social phobics, 75 subjects with 'non-clinical' 
panic attacks and 188 non-panicking controls. The FQ agoraphobia and social 
subscales had satisfactory internal consistency and were accurate (82%) in 
correctly differentiating the patients. The highest level of social fear was reported 
by social phobics and the highest level of agoraphobic fear was reported by 
patients with panic disorder and agoraphobia. Five items from these two 
subscales significantly differentiated social phobia from panic disorder with 
agoraphobia. The results support the reliability and validity of the FQ. 
5. Beck Depression Inventory Second Edition (BDI-II) (Beck, Steer, & Brown, 
1996): The BDI was administered to assess depressive symptoms in participants. 
The BDI is a widely used self-report method for assessing depressive 
symptomatology. It consists of 21 self-report questions with four possible 
responses for each. Each item is a list of four statements arranged in increasing 
severity about a particular symptom of depression. According to Kendall and 
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Watson (1989) the internal consistency of the BDI has an averaged of α =.86 across 
numerous studies. Test-retest reliability for one to three months is r= .74 and the 
scale has an internal consistency between α = .76 to .95 (Riskind, Steer, Beck, & 
Brown, 1987). Kühner et al., (2007), examined the content validity of the BDI-II 
that has improved by meeting DSM-IV symptom criteria. Internal consistency 
was satisfactorily high (alpha>or=0.84), and retest reliability exceeded r > = 0.75 
in nonclinical samples. Associations with construct-related scales (depression, 
dysfunctional cognitive constructs) were high; The BDI-II differentiated well 
between different grades of depression and was sensitive to change. 
6. Anxiety Sensitivity Index (ASI) (Peterson & Reiss, 1993): The ASI test assesses 
anxiety aroused by symptoms of fear in participants (Peterson & Reiss, 1993). It is 
a 16-item scale and includes such questions as: ''It scares me when I feel shaky'', 
and "It scares me when I'm nervous". Participants rate their agreement with each 
anxiety-related symptom using a five point Likert scale (0-Very Little, 4-Very 
Much). The ASI measures sensitivity to sensations of anxiety distinct from state or 
trait anxiety (McNally, 1989; Reiss, Peterson, Gursky, & McNally, 1986). The ASI 
has shown adequate internal consistency (alpha=.82, Telch, et al., 1989c) and good 
split-half reliability (r=.85, Peterson & Heilbronner, 1987). Retest reliability has 
been found to be within the r =. 71-75 range and the ASI total score has 
demonstrated validity (Reiss et al, 1986). Mantar, Yemez & Alkın (2010), 
investigated the validity and reliability of the ASI in 150 healthy individuals 
without any psychiatric disorder and 300 patients with an anxiety disorder 
and/or major depressive disorder according to DSM-IV criteria. All subjects 
included in the study were evaluated by the ASI, State-Trait Anxiety Inventory-
Trait form (STAI-T), BDI and Somatosensory Amplification Scale (SAS). The 
results showed that the scale differentiated the healthy group from all patient 
subgroups. ASI was found to be moderately correlated to STAI-T (r=0.68), BDI 
(r=0.57) and SAS (r=0.47). In fact analysis, ASI was found to be compared of 3 
factors: physical, cognitive and social. The Cronbach alpha value for these sub 
items was calculated to be 0.89 for physical symptoms; 0.88 for cognitive 
symptoms and 0.82 for the social symptoms. It was also found that ASI had a 
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high internal consistency (Cronbach alpha=0.93) and the scale had a fairly good 
test-retest reliability (r=0.64, p<0.001). 
7. Agoraphobic Cognition Questionnaire (ACQ) (Chambless & Gillis., 1993): The 
ACQ was administered to measure catastrophic cognition and fear of fear in 
participants (Chambless & Gillis, 1993). ACQ is a 14-item self-administered 
questionnaire concerning maladaptive thoughts regarding negative consequences 
associated with anxiety. The items are rated on a five point (1-5) scale ranging 
from the "thought never occurs" to the "thought always occurs when I am 
nervous. According to Chambless, et al. (1985), the ACQ has good internal 
consistency with alpha = .80. The scale is stable over time. A test-retest correlation 
of .75 was found with a one month interval between pre and post-test 
administration. The ACQ scale has good discriminant validity as it is able to 
distinguish between groups (i.e., agoraphobics, "normals”, and clients with other 
depression and anxiety disorders). The ACQ is sensitive to behavioral and 
cognitive changes with treatment. Thirty-five clients not partaking in the 
reliability study took the ACQ before and after treatment. Scores on the ACQ 
showed a change in avoidance and panic [t (34) =4.08, p < .001] (Chambless et al., 
1985). The reliability and validity of the ACQ was also addressed in a study by 
Rapee, Craske, Brown, and Barlow (1996), who explored the lack of perceived 
control over internal emotional responses and externally threatening events in 
anxious individuals. Participants included 250 individuals seeking treatment for a 
variety of anxiety disorders in an outpatient clinic. Results indicated that the ACQ 
can be conceptualized as a unitary measure, and test-retest reliability was high for 
a one month period over three times. The following correlations over time were 
reported: Time 1-2 (r=.88), Time 1-3 (r=.82) and Time 2-3 (r=.84). 
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2.3 Statistical Data Analyses 
All statistical analyses were carried out using the program Statistical Package for the 
Social Sciences (SPSS for Windows, version 20 SPSS Inc). The results were considered 
significant when p<0.05. 
 
Demographic and Clinical Measures  
Differences in categorical variables such as gender, marital status, education, 
occupation status, panic disorder duration and panic attack frequency were tested 
with the chi square test. Continuous variables such as age, BAI, BDI, PDSS, ACQ, ASI 
and FQ-AG were investigated with one-way analyses of variance (ANOVA). 
The assumption of homogeneity of variances is examined through Levene's test of 
equality to make sure that there are no significant differences in the mean scores on 
the dependent variable and confounding variable among the three groups in 
pretreatment. 
Pretreatment, posttreatment scores on the questionnaires were analyzed using 
repeated measures ANOVA with the factors 3 (Group: ICBT, GCBT, WL) x 2 (Time: 
pretreatment, posttreatment) and a 2 (Group: ICBT, GCBT) x 3 (Time: pretreatment, 
posttreatment) repeated measures design. 
Repeated measures analyses were also tested for sphericity (using Mauchly 
sphericity test). Heterogenity of variance was calculated using the Greenhouse-
Geisser correction. 
Bonferroni adjustments of p values were used to correct for multiple comparisons. 
Effect sizes are indicated in terms of η². All effects are reported as significant at p<.05. 
Pearson product-moment correlation coefficients were computed to assess the 
relationship between variables.  
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Chapter III - Results 
3.1 Introduction 
This chapter presents the data analysis, the comparison two treatment formats, 
Individual Cognitive Behavior Therapy (ICBT), Group Cognitive Behavior Therapy 
(GCBT) and the Wait-list control group (WL) before and after the treatment. This 
chapter is divided into two sections. The first section aims to examine sample 
comparability before treatment. In order to ensure the lack of pre-existing differences 
between the groups, and ensure the randomization of participants in groups, Chi-
square tests for six categorical variables (gender, level of education, marital status, 
occupational status, panic duration and frequency of panic) and one-way between 
groups ANOVA for age variable and six dependent variables (Depression, Anxiety, 
Severity of Panic Disorder, Agoraphobic Cognition, Anxiety sensitivity and 
Agoraphobic avoidance) were utilized in this section.  
Then a Univariate Analysis of Variance (ANOVA) with repeated measures was 
performed to test for effects of group x time. In case of significant interaction group x 
time effects, post- hoc analyses were carried out. Participants who were initially in 
the WL group were excluded from the four months follow-up due to initiation of 
treatment at post testing. 
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3.2 Group comparison pre-treatment 
The three groups were compared with regard to demographic characteristics. The 
following demographic variables were included in the analysis: age, gender, marital 
status, occupational status and level of education. Futhermore, the following panic 
disorder related variables were included: panic disorder duration (how long the 
person has experienced panic attacks) and panic attack frequency (how many panic 
attacks the person has per week). These variables were selected to provide a means 
of assessing the severity of the disorder.  
3.2.1 Demographic data  
Age: According to results shown in Table 3.1, the mean age of participants is 
(M=32.98, SD=10.62). The groups did not differ significantly with regard to age. 
 
Table 3.1: Descriptive Statistics and ANOVA results for Age 
Demographic 
Variables Group N Mean SD 
SD 
Error Min Max 
F (df=2, 
42) 
P* 
Age (years) Individual 
Therapy 
15 32.07 11.04 2.85 18 56 
0.16 0.86 Group Therapy 15 34.20 12.30 3.17 19 61 
Waiting List 15 32.67 8.86 2.29 21 48 
Total 45 32.98 10.62 1.58 18 61 
Note*: Sig.p<0.05 
 
Table 3.2 presents a comparison of the three groups according to selected 
demographic characteristics. 
 
Table 3.2: Chi-Square Test of Demographic Variables by group 
Demographic 
Variables 
Values Individual 
Therapy 
Group 
Therapy 
Waiting 
List 
Stat. Test 
N % N % N % χ2 p 
Gender Female 7 47% 5 33% 8 53% 1.260 0.533 Male 8 53% 10 67% 7 47% 
Marital Status Single 9 60% 7 47% 6 40% 
5.54 0.477 Married 4 27% 7 47% 9 60% 
Sep/Divorced 1 7% 1 7% 0 0% 
Widowed 1 7% 0 0% 0 0% 
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Education Less H.S diploma 3 20% 3 20% 3 20% 
3.03 0.932 
H.S diploma 7 47% 9 60% 7 47% 
Undergraduate 2 13% 1 7% 2 13% 
Bachelors 2 13% 2 13% 3 20% 
Masters 1 7% 0 0% 0 0% 
Occupational Status Employee 8 53% 6 40% 4 27% 
4.8 0.904 
Self- employment 2 13% 4 27% 3 20% 
Military 2 13% 1 7% 2 13% 
Student 2 13% 1 7% 3 20% 
Housewife 1 7% 2 13% 2 13% 
Unemployed 0 0% 1 7% 1 7% 
Panic Disorder 
duration 
Less than 6 month 3 20% 2 13% 2 13% 
1.04 0.903 6 months to 1 year 7 47% 8 53% 6 40% 
More than 1 year 5 33% 5 33% 7 47% 
Panic Attack 
Frequency 
≤ 2 per week 10 67% 9 60% 10 67% 
0.194 0.908 
≥ 3 per week  5 33% 6 40% 5 33% 
 
Table 3.2 illustrates that the three groups are not significantly different with regard to 
key demographic variables.  
Gender: As depicted in Table 3.2, of 45 participants, 20 (44%) are female and 25 (56%) 
are male. The Chi-Square test revealed no significant group differences. 
Marital Status: As depicted in Table 3.2, 22 (49%) of participants were single, 20 
(44%) were married, 2 (4%) were separated or divorced and 1 (2%) was widowed. 
The Chi- Square test revealed no significant group differences. 
Education: As shown in Table 3.2, 9 (20%) of 45 participants had less than a high 
school education, 23 (51%) had a high school diploma, 5 (11%) were undergraduates, 
7 (16%) had a Bachelors degree and 1 (2%) had a Masters degree. The Chi- Square 
test revealed no significant group differences. 
Occupational Status: According to Table 3.2, of 45 participants 18 (40%) were 
employees, 9 (20%) were self-employed, 5 (11%) were military, 6 (13%) were 
students, 5 (11%) were housewives and 2 (4%) were unemployed. The Chi- Square 
test showed no significant group difference. 
Panic Disorder Duration: As shown in Table 3.2, of 45 participants 7 (16%) had a 
history of panic disorder of less than 6 months and 21 (47%) had a history of panic 
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disorder of 6 months to 1 year, and 17 (38%) had a history of panic disorder of more 
than 1 year. The Chi –square analysis revealed no significant group difference. 
Panic attack frequency: As shown in Table 3.2, of 45 participants 29 (64%) had 2 
panic attacks or less, per week and 16 (36%) had 3 panic attacks or more per week. 
Chi–square analysis revealed no significant group difference. 
Summary 
The results showed that the three groups did not differ significantly with regard to 
demographic variables or history of disorder at pre-treatment. 
3.2.2 Pre-treatment comparison of questionnaire data 
The three groups were compared with regard to pre-treatment scores of the 
following dependent variables: Beck Anxiety Inventory (BAI) score, Beck Depression 
Inventory (BDI), Panic Disorder Severity Scale (PDSS), Agoraphobic Cognition 
Questionnaire (ACQ), Anxiety Sensitivity Index (ASI), Fear Questionnaire –
agoraphobia scale (FQ-AG) Means and SDs are presented in Table 3.3. 
Table 3.3: Means and SDs of variables (BAI, BDI, PDSS, ACQ, ASI, and FQ-AG) in pre-
treatment 
Variable Group N Mean SD SD Error Min Max 
BAI  
Individual Therapy 15 33.07 8.08 2.09 22 53 
Group Therapy 15 30.20 5.36 1.38 22 41 
Waiting List 15 31.33 5.73 1.48 24 48 
Total 45 31.53 6.46 0.96 22 53 
BDI  
Individual Therapy 15 23.73 4.71 1.22 18 32 
Group Therapy 15 22.67 4.53 1.17 17 30 
Waiting List 15 22.53 5.30 1.37 16 32 
Total 45 22.98 4.78 0.71 16 32 
PDSS  
Individual Therapy 15 20.27 2.63 0.68 16 24 
Group Therapy 15 19.20 2.14 0.55 15 22 
Waiting List 15 21.27 2.22 0.57 17 25 
Total 45 20.24 2.44 0.36 15 25 
ACQ  
Individual Therapy 15 40.53 5.83 1.50 28 48 
Group Therapy 15 41.40 4.81 1.24 34 52 
Waiting List 15 39.33 7.06 1.82 29 54 
Total 45 40.42 5.89 0.88 28 54 
ASI  Individual Therapy 15 39.07 5.36 1.39 32 47 Group Therapy 15 37.80 3.53 0.91 32 43 
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Waiting List 15 41.13 6.32 1.63 28 51 
Total 45 39.33 5.27 0.79 28 51 
FQ-AG  
Individual Therapy 15 17.67 4.56 1.18 11 26 
Group Therapy 15 17.47 3.91 1.01 10 24 
Waiting List 15 18.20 4.21 1.09 12 25 
Total 45 17.78 4.15 0.62 10 26 
 
Since one-way ANOVA relies on the test of homogeneity of variance, the underlying 
assumption of homogeneity of variance was examined with the Levene’s test for 
homogeneity of variances. Table 3.4, represents the results of Levene’s test of 
Equality of Variance of the three groups in pre-test. 
Table 3.4: Levene’s Test of Equality of Variance for all variables at pretest 
Variable Levene’s statistic df1 df2 p* 
BAI 1.407 2 42 0.256 
BDI 0.249 2 42 0.781 
PDSS 0.481 2 42 0.622 
ACQ 0.948 2 42 0.396 
ASI 2.522 2 42 0.092 
FQ-AG .360 2 42 0.700 
Note*: Sig.p<0.05 
The data were sumitted to ANOVA comparing the three groups. None of the 
variables showed significant results. The ANOVA results are shown in table 3.5. 
Table 3.5: One-way ANOVA for all variables in pre-test 
Variable Source Sum of Squares df Mean 
Square 
F p* 
BAI 
Between Groups 62.533 2 31.267 
0.740 0.483 Within Group 1774.667 42 42.254 
Total 1837.200 44  
BDI 
Between Groups 12.978 2 6.489 
0.275 0.761 Within Group 992 42 23.619 
Total 1004.978 44  
PDSS 
Between Groups 32.044 2 16.022 
2.922 0.065 Within Group 230.267 42 5.483 
Total 262.311 44  
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ACQ 
Between Groups 32.311 2 16.156 
0.453 0.639 Within Group 1496.667 42 35.635 
Total 1528.978 44  
ASI 
Between Groups 84.933 2 42.467 
1.569 0.220 Within Group 1137.067 42 27.073 
Total 1222 44  
FQ-AG 
Between Groups 4.311 2 2.156 
0.120 0.887 Within Group 753.467 42 17.940 
Total 757.778 44  
Note*: Sig.p<0.05 
BAI: As shown in Table 3.3, there was no significant group difference pre-treatment 
with regard to Anxiety scores as measured with the Beck Anxiety Inventory (BAI). 
The mean score indicated a severe level of anxiety (scores ranging from 26 to 63 
represent severe anxiety).  
As shown in Table 3.4 the homogeneity of variance assumption was met.  
BDI: As shown in Table 3.3, there was no significant group difference pre-treatment 
with regard to Beck Depression Inventory (BDI). The scores indicated a moderate 
level of depression (scores ranging from 20 to 28 represent moderate depression). 
As shown in Table 3.4, the homogeneity of variance assumption was met.  
PDSS: As shown in Table 3.3, there was no significant group difference pre-
treatment with regard to Panic Disorder Severity Scale (PDSS). The mean score 
indicated a severe level of Panic Disorder Severity (scores ranging from 14 and above 
represent severe panic disorder).  
As shown in Table 3.4, the homogeneity of variance assumption was met. 
ACQ: As shown in Table 3.3, there was no significant group difference pre-treatment 
with regard to Agoraphobic Cognition (ACQ).  
As shown in Table 3.4 the homogeneity of variance assumption was met. 
ASI: As shown in Table 3.3, there was no significant group difference pre-treatment 
with regard to Anxiety Sensitivity Index (ASI). The scores indicated a high level of 
anxiety sensitivity severity. Donnell and McNally (1990) defined high Anxiety 
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Sensitivity as an ASI score of 27 or higher. 
According to Table 3.4, the homogeneity of variance assumption was met. 
FQ-AG: As shown in Table 3.3, there was no significant group difference pre-
treatment with regard to agoraphobic avoidance (FQ-AG). Marks and Mathews 
(1979) defined scores of less than 12 on FQ-AG subscale are considered normative.  
As shown in Table 3.4, the homogeneity of variance assumption was met.  
Summary 
The results indicate that there are no significant group differences with regard to 
demographic data and clinical variables at pre-treatment. 
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3.3 Effect of treatments pre-post and pre-post-follow-up 
Questionnaire data were submitted to ANOVA with a 3 (groups: ICBT, GCBT, WL) x 
2 (time: pretest, posttest) and a 2 (groups: ICBT, GCBT) x 3 (time: pretest, posttest, 4 
month follow-up) repeated measures design. Partial Eta² was used to evaluate effect 
size.  
3.3.1 Beck Anxiety Inventory (BAI) 
3.3.1.1 Treatment (ICBT/GCBT/WL) by time (pre/posttest) 
Data were submitted to repeated measures ANOVA with a design of 3 (group: ICBT, 
GCBT, WL) x 2 (time: pretest, posttest). In addition to the F ratio partial eta² was 
extracted to assess the effect size.  
The BAI means and standard deviations of the BAI are presented in Table 3.6. 
 
Table 3.6: Mean and SDs of BAI in Pre-treatment and Post-treatment 
Group  pre-test post-test 
 N M SD M SD 
ICBT 15 33.07 8.07 12.13 2.92 
GCBT 15 30.20 5.36 17.33 3.35 
Waiting list 15 31.33 5.73 29.80 5.98 
Total 45 31.53 6.46 19.76 8.59 
 
The results of analysis of variance of the BAI are shown in Table 3.7.  
Table 3.7: Results of the ANOVA of Group, Time and Time by Group of BAI from Pre-
treatment to Post-treatment 
Source 
Sum of 
Squares 
df 
Middle of 
Squares 
F p 
η² 
 
Group 1110.689 2 555.344 10.920 0.001 .342 
Time 3121.111 1 3121.111 314.961 0.001 .882 
Time x Group 1424.689 2 712.344 71.885 0.001 .774 
Error 416.200 42 9.910    
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There was a significant main effect for group and time and a significant interaction 
effect of time x group. Partial eta² indicates a large effect size for time and a medium 
effect size for time x group interaction. 
Post - hoc tests were used to compare groups with respect to the mean difference 
between pre-post BAI scores (Table 3.8).  
Table 3.8: Pairwise comparisons among Three Groups for BAI Scores 
Group I Group J Mean Differences  Std. Error p 
ICBT GCBT -5.200 1.571 0.006 
ICBT Waiting List -17.667 1.571 0.001 
GCBT Waiting List -12.467 1.571 0.001 
  
As shown in Table 3.8, patients who participated in both treatment groups showed 
significantly more reduction in BAI severity scores between pretest and posttest than 
the Wait-list group, while the significant difference between two treatments 
modalities indicated that ICBT is more efficacious in reducing anxiety severity. The 
findings are shown in Figure 3.1. 
 
Beck Anxiety Inventory 
 
Figure 3.1: Means and standard errors for the Beck Anxiety Inventory (BAI) of groups at 
pre and post-test 
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Summary 
Both treatment groups (Individual CBT, Group CBT) showed significantly more 
improvement with regard to the Beck Anxiety Inventory (BAI) compared to the wait-
list control group from pretest to posttest. In addition, Individual CBT was more 
effective than Group CBT in reduction of anxiety severity. 
3.3.1.2 Treatment (ICBT/GCBT) by time (pre/post/four-month follow-
up)  
Data were submitted to repeated measures ANOVA with a design of 2 (Group: ICBT, 
GCBT) x 3 (Time: pretest, posttest, follow-up). In addition to the F ratio partial eta² 
was extracted to assess the effect size.  
The group means and standard standard deviations of the BAI are presented in Table 
3.9. 
Table 3.9: Mean and SDs of BAI in Pre-treatment, Post-treatment and Follow-up in ICBT 
and GCBT 
Group  pre-test post-test Follow-up 
 N M SD M SD M SD 
ICBT 15 33.07 8.07 12.13 2.92 9.00 2.90 
GCBT 15 30.20 5.36 17.33 3.35 12.80 2.73 
Total 30 31.63 6.89 14.73 4.07 10.90 3.38 
 
The results of the ANOVA for BAI scores are shown in Table 3.10. 
 
Table 3.10: Results of the ANOVA of Group, Time and Time by Group of BAI from Pre-
treatment, Post-treatment to Follow-up 
Source Sum of 
Squares 
df Middle of 
Squares 
F p η² 
 
Group 94.044 1 94.044 2.335 .138 .077 
Time 7301.756 2 3650.876 297.645 0.001 .914 
Time x Group 278.689 2 139.344 11.360 0.001 .289 
Error 686.889 56 12.266    
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There was a significant main effect for time and a significant interaction effect of 
group x time. Partial eta² indicates a large effect size for time. Furthermore the 
significant difference between two treatments modalities indicated that ICBT is more 
efficacious in reducing anxiety severity. The findings are shown in Figure 3.2.  
 
Beck Anxiety Inventory 
 
Figure 3.2: Means and standard errors for the Beck Anxiety Inventory (BAI) of treatment 
groups at pretest, posttest and follow-up  
Summary 
Participants in both treatment groups (Individual CBT, Group CBT) showed 
significantly more improvement with regard to Beck Anxiety Inventory (BAI) from 
pre to posttest than the waiting list control group. Furthermore, individual CBT led 
to greater improvement than group CBT from pretest, postpost to follow-up. 
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3.3.2 Beck Depression Inventory (BDI) 
3.3.2.1 Treatment (ICBT/GCBT, WL) by time (pre/posttest) 
Data were submitted to repeated measures ANOVA with a design of 3 (group: ICBT, 
GCBT, WL) x 2 (time: pretest, posttest). In addition to the F ratio partial eta² was 
extracted to assess the effect size.  
The BDI means and standard deviations of three groups are presented in Table 3.11. 
Table 3.11: Mean and SDs of BDI in Pre-treatment and Post-treatment 
Group  pre-test post-test 
 N M SD M SD 
ICBT 15 23.73 4.71 11.27 2.66 
GCBT 15 22.67 4.53 13.27 2.46 
Waiting list 15 22.53 5.30 22.93 4.21 
Total 45 22.98 4.78 15.82 6.03 
 
The results of analysis of variance of the BDI are shown in Table 3.12. 
Table 3.12: Results of the ANOVA of Group, Time and Time by Group of BDI from Pre-
treatment to Post-treatment 
Source Sum of 
Squares 
df Middle of 
Squares 
F p η² 
 
Group 503.267 2 251.633 8.864 .001 .297 
Time 1152.044 1 1152.044 208.141 .001 .832 
Time x Group  677.489 2 338.744 61.201 .001 .745 
Error 232.467 42 5.535    
 
There was a significant main effect for group, time and a significant interaction effect 
of time x group. Partial eta² indicates a large effect size for time and a medium effect 
size for time x group interaction. 
Post - hoc tests were used to compare groups with respect to the mean difference 
between pre- post BDI scores (Table 3.13).  
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Table 3.13: Pairwise comparisons among Three Groups for BDI Severity Scores 
Group I Group J Mean Differences  Std. Error p 
ICBT GCBT -2.000 1.172 0.095 
ICBT Wait-list -11.667 1.172 0.001 
GCBT Waiting list -9.667 1.172 0.001 
 
As shown in Table 3.13 patients who participated in the both treatment groups 
showed significantly more reduction in BDI severity scores between pretest and 
posttest compared to the Wait-list group, while not significantly differing from each 
other. The findings are shown in Figure 3.3. 
 
Beck Depression Inventory 
 
Figure 3.3: Means and standard errors for the Beck Depression Inventory (BDI) of groups 
at pretest, posttest 
Summary 
Both treatment groups (Individual CBT, Group CBT) showed significantly more 
improvement with regard to the Beck Depression Inventory (BDI) compared to the 
wait-list control group, while not significantly differing from each other. 
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3.3.2.2 Treatment (ICBT/GCBT) by time (pre/post/four-month follow-
up) 
Data were submitted to repeated measures ANOVA with a design of 2 (Group: ICBT, 
GCBT) x 3 (Time: pretest, posttest, follow-up) to evaluate the change in depression 
symptoms (BDI) in two groups. In addition to the F- ratio, partial eta² was extracted 
to assess the effect size.  
The group means and standard deviations of the BDI are presented in Table 3.14. 
 
Table 3.14: Mean and SDs of BDI in Pre-treatment, Post-treatment and Follow-up in ICBT 
and GCBT 
Group  pre-test post-test Follow-up 
 N M SD M SD M SD 
ICBT 15 23. 73 4.71 11.27 2.66 9.80 3.59 
GCBT 15 22.67 4.53 13.27 2.46 11.93 2.712 
Total 30 23.20 4.57 12.27 2.72 10.87 3.31 
 
The results of analysis of variance of the BDI are shown in Table 3.15. 
Table 3.15: Results of the ANOVA of Group, Time and Time by Group of BDI from Pre-
treatment, Post-treatment to follow-up 
Source Sum of 
Squares 
df Middle of 
Squares 
F p η² 
 
Group 23.511 1 23.511 .822 .372 .029 
Time 2736.089 2 1368.044 289.363 .001 .912 
Time x Group 49.156 2 24.578 5.199 .008 .157 
Error 264.756 56 4.728    
 
There was a significant main effect for time and a significant interaction effect of 
group x time. Partial eta² indicates large effect size for time. Furthermore the 
significant difference between two treatment modalities indicated that ICBT is more 
efficacious in reducing depression. The findings are shown in Figure 3.4. 
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Beck Depression Inventory 
 
Figure 3.4: Means and standard errors for the Beck Depression Inventory (BDI) of 
treatment groups at pretest, posttest and follow-up 
Summary 
Participants in both treatment groups (Individual CBT, Group CBT) showed 
significantly more improvement with regard to Beck Depression Inventory (BDI) 
from pretest, posttest to 4 months follow-up. Furthermore, individual CBT led to 
greater improvement than group CBT. 
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3.3.3 Panic Disorder Severity Scale (PDSS) 
3.3.3.1 Treatment (ICBT/GCBT, WL) by time (pre/posttest) 
Data were submitted to repeated measures ANOVA with a design of 3 (group: ICBT, 
GCBT, WL) x 2 (time: pretest, posttest). In addition to the F ratio partial eta² was 
extracted to assess the effect size.  
The PDSS means and standard deviations of three groups are presented in Table 
3.16. 
Table 3.16: Mean and SDs of PDSS in Pre-treatment and Post-treatment 
Group  pre-test post-test 
 N M SD M SD 
ICBT 15 20.27 2.63 9.20 1.93 
GCBT 15 19.20 2.14 11.47 1.60 
Waiting list 15 21.27 2.22 20.40 2.59 
Total 45 20.24 2.44 13.69 5.30 
 
The results of analysis of variance of the PDSS are shown in Table 3.17. 
Table 3.17: Results of the ANOVA of Group, Time and Time by Group of PDSS from Pre-
treatment to Post-treatment 
Source Sum of 
Squares 
df Middle of 
Squares 
F p η² 
 
Group 678.200 2 339.100 40.323 0.001 .658 
Time 966.944 1 966.944 690.675 0.001 .943 
Time x Group 405.756 2 202.878 144.913 0.001 .873 
Error 58.800 42 1.400    
 
There was a significant main effect for group, time and a significant interaction effect 
of time x group. Partial eta² indicates a medium effect size for group and a large 
effect size for time and time x group interaction. 
Post - hoc tests were used to compare groups with respect to the mean difference 
between pre- post PDSS scores in Table 3.18.  
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Table 3.18: Pairwise comparisons among Three Groups for PDSS Scores 
Group I Group J Mean Differences  Std. Error p 
ICBT GCBT -2.27 0.760 0.014 
ICBT Wait-list -11.20 0.760 0.001 
GCBT Waiting list -8.93 0.760 0.001 
 
As shown in Table 3.18 patients who participated in the ICBT and GCBT groups 
showed significantly more reduction in PDSS severity scores between pretest and 
posttest compared to the Wait-list group, while the significant difference between 
two treatments modalities indicated that ICBT is more efficacious in reducing 
severity of panic disorder. The findings are shown in Figure 3.5. 
 
Panic Disorder Severity Scale (PDSS) 
 
Figure 3.5: Means and standard errors for the Panic Disorder Severity Scale (PDSS) of 
groups at pretest, posttest 
Summary   
Both treatment groups (Individual CBT, Group CBT) showed significantly more 
improvement with regard to the panic disorder severity (PDSS) compared to the 
wait-list control group from pre to posttest. Furthermore individual CBT led to 
greater improvement than group CBT. 
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3.3.3.2 Treatment (ICBT/GCBT) by time (pre/post/four-month follow-
up) 
Data were submitted to repeated measures ANOVA with a design of 2 (Group: ICBT, 
GCBT) x 3 (Time: pretest, posttest, follow-up)  
The group means and standard deviations of the PDSS are presented in Table 3.19. 
Table 3.19: Mean and SDs of PDSS in Pre-treatment, Post-treatment and Follow-up in 
ICBT and GCBT 
Group  pre-test post-test Follow-up 
 N M SD M SD M SD 
ICBT 15 20. 27 2.63 9.20 1.93 6.80 1.32 
GCBT 15 19.20 2.14 11.47 1.60 8.80 1.21 
Total 30 19.73 2.42 10.33 2.09 7.80 1.61 
 
The results of analysis of variance of the PDSS are shown in Table 3.20. 
Table 3.20: Results of the ANOVA of Group, Time and Time by Group of PDSS from Pre-
treatment, Post-treatment to Follow-up 
Source Sum of 
Squares 
df Middle of 
Squares 
F p η² 
 
Group 25.600 1 25.600 3.388 0.076 .108 
Time 2371.822 2 1185.911 802.927 0.001 .966 
Time x Group 51.467 2 25.733 17.423 0.001 .384 
Error 82.711 56 1.477    
 
There was a significant effect for time and a significant interaction effect of group x 
time. Partial eta² indicates a large effect size for time. Furthermore individual CBT 
led to greater improvement than group CBT. The findings are shown in Figure 3.6. 
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Panic Disorder Severity Scale 
 
Figure 3.6: Means and standard errors for the Panic Disorder Severity Scale (PDSS) of 
treatment group at pretest, posttest, and follow-up 
Summary   
Participants in both treatment groups (Individual CBT, Group CBT) showed 
significantly more improvement with regard to Panic Disorder Severity Scale (PDSS) 
from pretest, posttest to 4 months follow-up. Furthermore, individual CBT led to 
greater improvement than group CBT. 
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3.3.4 Agoraphobic Cognition (ACQ) 
3.3.4.1 Treatment (ICBT/GCBT, WL) by time (pre/posttest) 
Data were submitted to repeated measures ANOVA with a design of 3 (group: ICBT, 
GCBT, WL) x 2 (time: pretest, posttest). In addition to the F ratio partial eta² was 
extracted to assess the effect size.  
The ACQ means and standard deviations of the PDSS are presented in Table 3.21. 
Table 3.21: Mean and SDs of ACQ in Pre-treatment and Post-treatment 
Group  pre-test post-test 
 N M SD M SD 
ICBT 15 40.53 5.83 19.80 5.29 
GCBT 15 41.40 4.81 22.67 5.31 
Waiting list 15 39.33 7.06 39.00 7.37 
Total 45 40.42 5.89 27.16 10.41 
 
The results of analysis of variance of the ACQ are shown in Table 3.22. 
Table 3.22: Results of the ANOVA of Group, Time and Time by Group of ACQ from Pre-
treatment to Post-treatment 
Source Sum of 
Squares 
df Middle of 
Squares 
F p η² 
 
Group 1353.689 2 676.844 9.847 .001 .319 
Time 3960.100 1 3960.100 1055.357 .001 .962 
Time x Group 1896.800 2 948.400 252.746 .001 .923 
Error 157.600 42 3.752    
 
There was a significant main effect for group, time and a significant interaction effect 
of time x group. Partial eta² indicates a large effect size for time and time x group 
interaction. 
Post - hoc tests were used to compare groups with respect to the mean difference 
between pre- post ACQ scores in Table 3.23.  
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Table 3.23: Pairwise comparisons among Three Groups for ACQ Scores 
Group I Group J Mean Differences  Std. Error p 
ICBT GCBT -2.87 2.217 0.609 
ICBT Wait-list -19.20 2.217 0.001 
GCBT Waiting list -16.33 2.217 0.001 
 
As shown in Table 3.23 patients who participated in the ICBT and GCBT groups 
showed significantly more reduction in ACQ severity scores between pretest and 
posttest compared to the Wait-list group, while not significantly different from each 
other. The results of pairwise comparison show that there is no significant difference 
between treatment groups in reducing ACQ.  
The findings are shown in Figure 3.7. 
 
Agoraphobic Cognition (ACQ) 
 
Figure 3.7: Means and standard errors for the Agoraphobic Cognition (ACQ) of groups at 
pretest, posttest 
Summary 
Both treatment groups (Individual CBT, Group CBT) showed significantly more 
improvement with regard to the Agoraphobic Cognition (ACQ) compared to the 
wait-list control group from pre to posttest, while not significantly differing from 
each other. 
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3.3.4.2 Treatment (ICBT/GCBT) by time (pre/post/four-month follow-
up) 
Data were submitted to repeated measures ANOVA with a design of 2 (Group: ICBT, 
GCBT) x 3 (Time: pretest, posttest, follow-up). In addition to the F ratio partial eta² 
was extracted to assess the effect size.  
The group means and standard deviations of the ACQ are presented in Table 3.24. 
Table 3.24: Mean and SDs of ACQ in Pre-treatment, Post-treatment and Follow-up in 
ICBT and GCBT 
Group  pre-test post-test Follow-up 
 N M SD M SD M SD 
ICBT 15 40.53 5.83 19.80 5.29 15.73 4.77 
GCBT 15 41.40 4.81 22.67 5.31 17.67 4.89 
Total 30 40.97 5.27 21.23 5.41 16.70 4.85 
 
The results of analysis of variance of the ACQ are shown in Table 3.25. 
Table 3.25: Results of the ANOVA of Group, Time and Time by Group of ACQ from Pre-
treatment, Post-treatment to Follow-up 
Source Sum of 
Squares 
df Middle of 
Squares 
F p η² 
 
Group 80.278 1 80.278 1.122 .299 .039 
Time 9988.267 2 4994.133 1174.871 .001 .977 
Time x Group 15.022 2 7.511 1.767 .180 .059 
Error 238.044 56 4.251    
 
There was only a significant effect for time and partial eta² indicates a large effect size 
for time. Furthermore there is no significant difference between treatment groups in 
reducing ACQ. The findings are shown in Figure 3.8.  
 
 Chapter III - Results  138 
 
Agoraphobic Cognition (ACQ) 
 
Figure 3.8: Means and standard errors for the Agoraphobic Cognition (ACQ) of treatment 
groups at pretest, posttest, and follow-up 
Summary 
Participants in both treatment groups (Individual CBT, Group CBT) showed 
significant improvement with regard to Agoraphobic Cognition (ACQ) from pretest, 
posttest to 4 months follow-up, while not significantly differing from each other. 
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3.3.5 Anxiety Sensitivity Severity (ASI) 
3.3.5.1 Treatment (ICBT/GCBT, WL) by time (pre/posttest) 
Data were submitted to repeated measures ANOVA with a design of 3 (group: ICBT, 
GCBT, WL) x 2 (time: pretest, posttest). In addition to the F ratio partial eta² was 
extracted to assess the effect size.  
The ASI means and standard deviations are presented in Table 3.26. 
Table 3.26: Mean and SDs of ASI in Pre-treatment and Post-treatment 
Group  pre-test post-test 
 N M SD M SD 
ICBT 15 39.07 5.36 20.67 6.00 
GCBT 15 37.80 3.53 22.47 3.94 
Waiting list 15 41.13 6.32 40.80 7.12 
Total 45 39.33 5.30 27.93 10.82 
 
The results of analysis of variance of the ASI are shown in Table 3.27. 
Table 3.27: Results of the ANOVA of Group, Time and Time by Group of ASI from Pre-
treatment to Post-treatment 
Source Sum of 
Squares 
df Middle of 
Squares 
F p η² 
 
Group 2406.422 2 1203.211 21.491 .001 .506 
Time 2901.344 1 2901.344 561.206 .001 .930 
Time x Group 1402.022 2 701.011 135.596 .001 .866 
Error 217.133 42 5.170    
 
There was a significant main effect for group, time and a significant interaction effect 
of time x group. Partial eta² indicates a large effect size for time and time x group 
interaction. 
Post - hoc tests were used to compare groups with respect to the mean difference 
between pre- post ASI scores in Table 3.28.  
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Table 3.28: Pairwise comparisons among Three Groups for ASI Scores 
Group I Group J Mean Differences  Std. Error p 
ICBT GCBT -1.800 2.132 .403 
ICBT Wait-list -20.133 2.132 .001 
GCBT Waiting list -18.333 2.132 .001 
 
As shown in Table 3.28 patients who participated in the ICBT and GCBT groups 
showed significantly more reduction in ASI severity scores between pretest and 
posttest compared to the Wait-list group, while not significantly differing from each 
other. The findings are shown in Figure 3.9. 
 
Anxiety Sensitivity Index (ASI) 
 
Figure 3.9: Means and standard errors for the Anxiety Sensitivity (ASI) of groups at pretest 
and posttest 
Summary 
Both treatment groups (Individual CBT, Group CBT) showed significantly more 
improvement with regard to the Anxiety Sensitivity Index (ASI) compared to the 
wait-list control group from pre to posttest, while not significantly differing from 
each other.  
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3.3.5.2 Treatment (ICBT/GCBT) by time (pre/post/four-month follow-
up) 
Data were submitted to repeated measures ANOVA with a design of 2 (Group: ICBT, 
GCBT) x 3 (Time: pretest, posttest, follow-up). In addition to the F ratio partial eta² 
was extracted to assess the effect size.  
The group means and standard deviations of the ASI are presented in Table 3.29. 
Table 3.29: Mean and SDs of ASI in Pre-treatment, Post-treatment and Follow-up 
Group  pre-test post-test Follow-up 
 N M SD M SD M SD 
ICBT 15 39.07 5.36 20.67 6.00 16.27 3.30 
GCBT 15 37.80 3.53 22.47 3.94 18.80 2.68 
Total 30 38.43 4.51 21.57 5.07 17.53 3.22 
 
The results of analysis of variance of the ASI are shown in Table 3.30. 
Table 3.30: Results of the ANOVA of Group, Time and Time by Group of ASI from Pre-
treatment, Post-treatment to Follow-up 
Source Sum of 
Squares 
df Middle of 
Squares 
F p  η² 
 
Group 23.511 1 23.511 .533 .463 .019 
Time 7375.622 2 3687.811 572.458 .001 .953 
Time x Group  60.956 2 30.478 4.731 .013 .145 
Error 360.756 56 6.442    
 
There was a significant effect for time and a significant interaction effect of time x 
group. Partial eta² indicates a large effect size for time. Furthermore individual CBT 
led to greater improvement than group CBT in reducing ASI. The findings are shown 
in Figure 3.10. 
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Anxiety Sensitivity Index (ASI) 
 
Figure 3.10: Means and standard errors for the Anxiety Sensitivity (ASI) of treatment 
groups at pretest, posttest, and follow-up 
Summary 
Participants in both treatment groups (Individual CBT, Group CBT) showed 
significant improvement with regard to Anxiety Sensitivity (ASI) from pretest, 
posttest to 4 months follow-up. Furthermore, individual CBT led to greater 
improvement than group CBT. 
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3.3.6 Agoraphobic Avoidance Severity (FQ-AG) 
3.3.6.1 Treatment (ICBT/GCBT, WL) by time (pre/posttest) 
Data were submitted to repeated measures ANOVA with a design of 3 (group: ICBT, 
GCBT, WL) x 2 (time: pretest, posttest). In addition to the F ratio partial eta² was 
extracted to assess the effect size.  
The FQ-AG means and standard deviations of the FQ-AG are presented in Table 
3.31.  
Table 3.31: Mean and SDs of FQ-AG in Pre-treatment and Post-treatment 
Group  pre-test post-test 
 N M SD M SD 
ICBT 15 17.67 4.56 11.60 3.54 
GCBT 15 17.47 3.91 12.60 3.04 
Waiting list 15 18.20 4.21 17.93 4.30 
Total 45 17.78 4.15 14.04 4.55 
 
The results of analysis of variance for severity of agoraphobic avoidance are shown 
in Table 3.32.  
Table 3.32: Results of the ANOVA of Group, Time and Time by Group of FQ-AG from 
Pre-treatment to Post-treatment 
Source Sum of 
Squares 
df Middle of 
Squares 
F p  η² 
 
Group 211.489 2 105.744 3.559 .036 .145 
Time 313.600 1 313.600 188.699 .001 .818 
Time x Group 140.600 2 70.300 42.301 .001 .668 
Error 69.800 42 1.662    
 
There was a significant main effect for group, time and a significant interaction effect 
of time x group. Partial eta² indicates a large effect size for time and a medium effect 
size for time x group interaction. 
Post - hoc tests were used to compare groups with respect to the mean difference 
between pre- post FQ-AG scores in Table 3.33.  
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Table 3.33: Pairwise comparisons among Three Groups for FQ-AG Scores 
Group I Group J Mean Differences  Std. Error p 
ICBT GCBT -1.00 1.34 .459 
ICBT Wait-list -6.33 1.34 0.001 
GCBT Waiting list -5.33 1.34 0.001 
 
As shown in Table 3.33 patients who participated in the ICBT and GCBT groups 
showed significantly more reduction in FQ-AG severity scores between pretest and 
posttest compared to the Wait-list group, while not significantly differing from each 
other. The findings are shown in Figure 3.11. 
 
Agoraphobic Avoidance (FQ-AG) 
 
Figure 3.11: Means and standard errors for the agoraphobic avoidance (FQ-AG) of groups 
at pretest and posttest 
Summary 
Both treatment groups (Individual CBT, Group CBT) showed significant 
improvement with regard to the agoraphobic avoidance (FQ-AG) compared to the 
wait-list control group from pre to posttest, while not significantly differing from 
each other.  
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3.3.6.2 Treatment (ICBT/GCBT) by time (pre/post/four-month follow-
up) 
Data were submitted to repeated measures ANOVA with a design of 2 (Group: ICBT, 
GCBT) x 3 (Time: pretest, posttest, follow-up). 
The group means and standard deviations of the FQ-AG are presented in Table 3.34. 
Table 3.34: Mean and SDs of FQ-AG in Pre-treatment, Post-treatment, Follow-up in ICBT 
and GCBT 
Group  pre-test post-test Follow-up 
 N M SD M SD M SD 
ICBT 15 17.67 4.56 11.60 3.54 9.33 2.66 
GCBT 15 17.47 3.91 12.60 3.04 10.87 2.61 
Total 30 17.57 4.17 12.10 3.28 10.10 2.71 
 
The results of analysis of variance of the FQ-AG are shown in Table 3.35. 
Table 3.35: Results of the ANOVA of Group, Time and Time by Group of FQ-AG from 
Pre-treatment, Post-treatment to Follow-up 
Source Sum of 
Squares 
df Middle of 
Squares 
F p η² 
 
Group 13.611 1 13.611 .427 .519 .015 
Time 896.356 2 448.178 220.501 .001 .887 
Time x Group  11.822 2 5.911 2.908 .063 .094 
Error 113.822 56 2.033    
 
There was only a significant effect for time and partial eta² indicates a large effect size 
for time. Furthermore there is no significant difference between treatment groups in 
reducing FQ-AG.The findings are shown in Figure 3.12.  
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Agoraphobia Avoidance (FQ-AG) 
 
Figure 3.12: Means and standard errors for the Agoraphobic avoidance (FQ-AG) of 
treatment groups at pretest, posttest, and follow-up 
Summary 
Participants in both treatment groups (Individual CBT, Group CBT) showed 
significant improvement with regard to Agoraohobic avoidance (FQ-AG) from 
pretest, posttest to 4 months follow-up, while not significantly differing from each 
other.  
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3.4 Correlations among pretest measures 
In order to determine the relationship among variables, a Pearson product-moment 
correlation coefficient matrix was computed with regard to pretest measures. The 
correlation coefficients are presented below in Table 3.36. 
Table 3.36: Pearson product-moment correlation between dependent variables at pretest N 
= 45 
variable BDI PDSS ACQ ASI FQ-AG 
BAI 
r 0.555** 0.620** 0.618** 0.414** 0.446** 
p 0.001 0.001 0.001 0.005 0.002 
BDI 
r  0.328* 0.536** 0.309* 0.272 
p  0.028 0.001 0.039 0.070 
PDSS 
r   0.397** 0.326* 0.367* 
p   0.007 0.029 0.013 
ACQ 
r    0.307* 0.418** 
p    0.040 0.004 
ASI 
r     0.343* 
p     0.021 
* Correlation is significant at the 0.05 level (2-tailed) 
** Correlation is significant at the 0.01 level (2-tailed) 
 
Results the correlational analysis between pretest measures indicated that there was 
a significantly positive correlation between the BAI and all other measures. The 
following scatterplots show that the significant correlations are not due to outliers. 
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Figure 3.13: Scatterplot between BAI and BDI 
There is a high significant positive correlation between anxiety (BAI) and depression 
(BDI), (r = 0.55, p = .001). This correlation indicates that increases in BAI were 
correlated with increases in BDI. 
 
 
Figure 3.14: Scatterplot between BAI and PDSS 
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There is a high significant positive correlation between anxiety (BAI) and panic 
disorder severity (PDSS), (r = 0.62, p = .001). This correlation indicates that increases 
in BAI were correlated with increases in PDSS. 
 
 
Figure 3.15: Scatterplot between BAI and ACQ 
There is a high significant positive correlation between anxiety (BAI) and 
agoraphobic cognition (ACQ), (r = 0.62, p = .001). This correlation indicates that 
increases in BAI were correlated with increases in ACQ. 
 
 
 Chapter III - Results  150 
 
 
Figure 3.16: Scatterplot between BAI and ASI 
There is a high significant positive correlation between anxiety (BAI) and anxiety 
sensitivity (ASI), (r = 0.41, p = .005). This correlation indicates that increases in BAI 
were correlated with increases in ASI. 
 
 
Figure 3.17: Scatterplot between BAI and FQ-AG 
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There is a high significant positive correlation between anxiety (BAI) and 
agoraphobic fear (FQ-AG), (r = 0.45, p = .002). This correlation indicates that 
increases in BAI were correlated with increases in FQ-AG. 
 
The BDI was also significantly positively correlated with all measures apart from the 
FQ-AG. The following scatterplots illustrate the correlations.  
 
 
Figure 3.18: Scatterplot between BDI and PDSS 
There is a significant positive correlation between depression (BDI) and panic 
disorder severity (PDSS), (r = 0.33, p = .028). This correlation indicates that increases 
in BDI were correlated with increases in PDSS. 
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Figure 3.19: Scatterplot between BDI and ACQ 
There is a high significant positive correlation between depression (BDI) and panic 
agoraphobic cognition (ACQ), (r = 0.54, p = .001). This correlation indicates that 
increases in BDI were correlated with increases in ACQ. 
 
 
Figure 3.20: Scatterplot between BDI and ASI 
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There is a significant positive correlation between depression (BDI) and panic 
agoraphobic cognition (ACQ), (r = 0.31, p = .039). This correlation indicates that 
increases in BDI were correlated with increases in ASI. 
 
 
Figure 3.21: Scatterplot between BDI and FQ-AG 
 
There was a significantly positive correlation between the PDSS and all other 
measures. The following scatterplots show that the significant correlations are not 
due to outliers. 
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Figure 3.22: Scatterplot between PDSS and ACQ 
There is a high significant positive correlation between panic disorder severity 
(PDSS) and agoraphobic cognition (ACQ), (r = 0.40, p = .007). This correlation 
indicates that increases in PDSS were correlated with increases in ACQ. 
 
 
Figure 3.23: Scatterplot between PDSS and ASI 
There is a significant positive correlation between panic disorder severity (PDSS) and 
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anxiety sensitivity (ASI), (r = 0.33, p = .029). This correlation indicates that increases 
in PDSS were correlated with increases in ASI. 
 
 
Figure 3.24: Scatterplot between PDSS and FQ-AG 
There is a significant positive correlation between panic disorder severity (PDSS) and 
agoraphobic fear (FQ-AG), (r = 0.37, p = .013). This correlation indicates that 
increases in PDSS were correlated with increases in FQ-AG. 
 
There was a significantly positive correlation between the ACQ and all other 
measures. The following scatterplots show that the significant correlations are not 
due to outliers. 
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Figure 3.25: Scatterplot between ACQ and ASI 
There is a significant positive correlation between agoraphobic cognition (ACQ) and 
anxiety sensitivity (ASI), (r = 0.31, p = .040). This correlation indicates that increases 
in ACQ were correlated with increases in ASI. 
 
 
Figure 3.26: Scatterplot between ACQ and FQ-AG 
There is a high significant positive correlation between agoraphobic cognition (ACQ) 
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and agoraphobic fear (FQ-AG), (r = 0.42, p = .004). This correlation indicates that 
increases in ACQ were correlated with increases in FQ-AG. 
 
There was a significantly positive correlation between the ASI and all other 
measures. The following scatterplots show that the significant correlations are not 
due to outliers. 
 
Figure 3.27: Scatterplot between ASI and FQ-AG 
There is a significant positive correlation between anxiety sensitivity (ASI) and 
agoraphobic fear (FQ-AG), (r = 0.34, p = .021). This correlation indicates that 
increases in ASI were correlated with increases in FQ-AG. 
 
Summary 
The results of correlational analysis indicated that the there were a significant 
positive correlation between all measures apart from BDI and the Fear-Agoraphobia 
Questionnaire (FQ-AG).  
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Chapter IV - Discussion 
Although a growing literature supports the effectiveness of cognitive-behavioral 
therapies for patients with panic disorders in general, less is known about the 
efﬁcacy of individual compared to group CBT programs for patients with PD. In 
addition there have been no previous studies comparing the effectiveness of these 
formats with this type of psychotherapy in an Iranian population. Hence the present 
study investigated the comparative efficacy and difference between CBT 
implemented in an individual /group format in a sample of patients with panic 
disorder with or without agoraphobia. These two formats of treatments were 
compared with a waiting list control group.  
The principal findings of the current investigation are the following: Compared with 
the waiting list group, both of the active treatment conditions (group CBT and 
individual CBT) resulted in a significant greater decrease from pre to post treatment 
in Depression, Anxiety, Agoraphobic Cognitions, Agoraphobic avoidance, Panic 
Disorder Severity Scale, and Sensitivity to Anxiety.  
There was a significant difference between the two treatment groups from pre to post 
treatment, and 4 month follow-up. Data analysis revealed that, compared with the 
waiting list control group, the participants in both CBT formats showed significant 
improvement after treatment, while, participants in both treatment formats were 
equally effective in the reduction of, depression (BDI), agoraphobic cognition (ACQ), 
sensitivity of anxiety (ASI) and agoraphobia (FQ-AG), but individual CBT led to 
greater improvement than group CBT in relation to the reduction of overall anxiety 
(BAI), and panic disorder severity (PDSS) in post treatment. Furthermore 
participants in both treatment groups is maintained their improvement at 4 months 
follow-up phase, while, individual CBT group led to greater improvement than 
group CBT in relation the reduction of overall anxiety (BAI), depression (BDI), panic 
disorder severity (PDSS) and sensitivity to anxiety (ASI) at 4 months follow-up.  
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4.1 Severity of PD 
The results of the present study indicated that all participants in the three conditions 
exhibited sever levels of anxiety (cut-off score: of 26 and above) and moderate 
depression (cut-off score: of 28 and above) in baseline assessments, while the BAI 
and BDI baseline scores of the three groups did not differ significantly.  
Patients with panic disorder suffer from a wide range of anxiety, stress and 
depression and approximately 60% of patients report depressive and anxiety 
symptoms (Cameron, 2007). Anxiety and depressive symptoms are often comorbid 
with each other. The comorbidity of depressive and anxiety symptoms are associated 
with barriers to treatment and worse psychiatric outcomes, including treatment 
resistance, increased risk for suicide, greater chance for recurrence, and greater 
utilization of medical resources, (Aina & Susman, 2006). As Grillon et al. (2008) 
stated, in panic disorder, persistent symptoms of anxiety are caused by anticipation 
of the next uncued (unpredictable) panic attack. Anticipatory anxiety is a strong 
predictor for the "autonomic" subtype, and a reverse predictor for the cognitive 
subtype in panic disorder (Sarp, et al., 2010). Some support for this position is found 
in studies of the BAI where individuals with panic disorder attain signiﬁcantly 
higher scores on the BAI than those with other anxiety disorders (e.g., Leyfer, 
Ruberg, Woodruff-Borden, 2006).  
Grillon et al., (2008) in a study showed patients with panic disorder are overly 
sensitive to unpredictable aversive events and exhibit sever anxiety in the 
unpredictable condition. 
Similar results were found in a study by King et al (2011). They reported patients 
with panic disorder suffer from a sever levels of anxiety. They reported sever mean 
scores (M=34.9) for BAI scale in 50 patients with PD at baseline.  
The findings of the current study are consistent with the findings of Beck & Steer 
(1990). They reported in the manual, the BAI total score means and standard 
deviations for panic disorder is (M= 27.27, SD=13.11). 
The results of this study indicated that the BDI baseline scores of the three groups 
did not differ significantly. The BDI total mean score for three groups indicated 
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moderate depression (cut-off score 20 and above).  
Individuals diagnosed with panic disorder tended to yield lower quality of life and 
depression scores than anxiety disorders expect PTSD (Pollock & Kuo, 2004).  
Analysis of depression in PD can be explained by a reduction in positively reinforced 
behaviors and in an increase in negatively reinforced escape and avoidance 
behaviors, including also verbal behaviors like complaining (Bergström, et al., 2010).  
The results of study by Salkovskis, Hackmann, et al., (2006) and Chambless (1985) 
also showed a moderate rate of depression as is assessed with BDI in patients with 
PDA. The authors stated that avoidance behaviors may also act as risk factors in the 
onset of depression. 
The unpredictability of panic attacks and the ongoing symptomatology often lead to 
feelings of helplessness and maladaptive coping strategies and as a result patients 
show elevated levels of depression (Lepöla, Koponen & Leinonen, 1996). 
Gregor, et al. (2005) in a study of 39 PD patients found increased impairment in both 
family/home responsibilities, social functioning and less participation in life 
activities led to incidences of depression and reduction of quality of life. This 
correlation may exist because panic attacks can be so debilitating that they interfere 
with life functioning and can subsequently result in a decreased sense of worth and 
symptoms of depression. Hence, depression is likely to be secondary to agoraphobic 
anxieties, anticipatory anxiety or other symptoms related to panic disorder. 
Therefore when panic symptoms begin to decrease, life functioning and social 
integration may improve and result in a decrease in depressive symptoms as well. 
The results of this study indicated that the PDSS baseline scores of the three groups 
did not differ significantly. The PDSS total mean score for the three groups indicated 
severe level of panic disorder severity (cut-off score 14 and above). 
The Panic Disorder Severity Scale (PDSS) assesses the severity of seven dimensions 
of PD symptoms and functional impairment: 1) frequency of panic attacks, 2) distress 
during panic attacks, 3) anticipatory anxiety, 4) agoraphobic fear ⁄ avoidance, 5) 
interoceptive fear ⁄ avoidance, 6) impairment ⁄ interference in work function and 7) 
impairment ⁄ interference in social functioning.  
Similar results were found in a study by Choi et al (2012). They reported patients 
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with panic disorder suffer from a sever levels of panic disorder (PDSS) scale. They 
reported sever mean scores for PDSS scale in 119 patients with PD at baseline.  
The results of this study indicated that the ACQ baseline scores of the three groups 
did not differ significantly. The ACQ total mean score for the three groups indicated 
severe level of agoraphobic cognition severity. 
According to Clark & Beck (2009), the mean ACQ total score for panic disorder is 
approximately 28, with post-treatment scores dropping to 19. 
Similar levels of ACQ were reported by Hoffart et al., (2008), Salkovskis, Hackmann, 
et al., (2006), Michelson, et al., (1990), Manjula et al., (2009). They reported patients 
with panic disorder suffer from a sever levels of Agoraphobic Cognition (AC) before 
beginning treatment. 
The agoraphobic cognition questionnaire (ACQ) assessed "fear of fear", and the 
frequency of maladaptive thought and catastrophic consequence about both the 
physical and social consequences (e.g., fainting, choking, heart attack, loss of self-
control) when experiencing panic attack. 
The findings of the current study are consistent with, various clinical studies that 
indicated that most individuals with panic disorder report thoughts or images of 
physical or mental catastrophe in response to internal stimuli during panic episodes. 
According to Hofmann et al., (2007) catastrophic appraisals play a key role in the 
pathogenesis of panic attacks and PD. The catastrophic misinterpretation of bodily 
sensations and symptoms was postulated as the main cognitive mechanism in panic 
disorder. Goldstein and Chambless (1978) labeled this fear of experiencing anxiety or 
panic attacks as “fear of fear”. This leads to hypervigilance about bodily sensations, 
increased arousal of the sympathetic nervous system, more physical sensations and 
heightened anxiety, which then spiral into a panic attack and as a result of these 
catastrophic cognitions the symptoms are maintained. 
The results of this study indicated that the patients in three groups exhibited high 
anxiety sensitivity on ASI (cut-off score: of 27 and above) and there was no 
significant difference between groups in the pretreatment.  
Prospective studies have demonstrated that elevated AS is a risk factor for the 
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subsequent development of panic attacks (Hayward, et al., 2000; Plehn & Peterson, 
2002). The results of a study by Dixon et al., (2013) also indicated that ASI scores 
often predict panic symptoms in response to biological challenges (e.g., carbon 
dioxide inhalation) that provoke feared bodily sensations. Prospective longitudinal 
studies indicate that scores on the ASI predict subsequent spontaneous attacks, 
indicating that elevated anxiety sensitivity is a risk factor for panic disorder. 
The results of a meta-analysis Olatunji, Wolitzky-Taylor (2009), that included 38 
studies, revealed panic disorder associated with greater AS compared to other 
anxiety disorders except for posttraumatic stress disorder. These findings suggest 
that AS is central to the phenomenology of panic disorder. 
Similar levels of ASI were reported by Manjula et al., (2009), Hecker et al., (2004) and 
Teachman et al. (2008). They reported patients with panic disorder suffer from a 
sever levels of Anxiety Sensitivity (AS) scale before beginning intervention. 
Research on the psychopathalogy of panic disorder suggests that patients with panic 
disorder have a psychological predisposition to respond fearfully to physiological 
cues of arousal and various reviews also support that individuals with panic 
disorder are significantly more likely to misinterpret bodily sensations in terms of a 
serious impending threat or danger than non-panic comparison groups (see Casey et 
al., 2004b). Moreover, there is considerable empirical evidence that panic disorder is 
characterized by elevated scores on the ASI fear of somatic sensations subscale (e.g 
Deacon & Abramowitz, 2006, Rector et al., 2007, Taylor, Zvolensky, et al., 2007).  
Schneider and Schulte (2008) found that individuals with panic disorder exhibited a 
significantly higher automatic priming effect for ideographically selected anxiety 
symptom primes followed by catastrophic interpretations than nonclinical controls. 
The authors interpret this automatic priming effect as a consequence of strong 
idiographic associations produced by the relation of catastrophic thoughts to bodily 
symptoms during panic attacks. 
According to Peterson and Reiss (1993), high levels of anxiety sensitivity should 
increase the frequency of panic attacks by contributing to the tendency to interpret 
bodily sensations in a catastrophic manner, thus increasing the chances that a panic 
attack will occur. They further argued that anxiety sensitivity should increase the 
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intensity of panic attacks, since individuals with high anxiety sensitivity should be 
especially frightened by panic sensations. They stated that anxiety sensitivity would 
reduce a person’s capacity to cope with panic attacks, as people with low anxiety 
sensitivity would be able to dismiss panic attacks as temporary events while those 
with high anxiety sensitivity would interpret panic attacks as a sign of possible 
mental or physical illness.  
According to Beck, anxiety conditions are created and maintained by faulty cognitive 
processes that exaggerate physical and psychosocial dangers. In other terms, patients 
with panic disorder have signiﬁcant negative perceptions of their physical health and 
increased fear of autonomic arousal. Hence they display more negative health 
perceptions and higher levels of anxiety sensitivity (Markowitz et al., 1989; Schmidt, 
Telch, & Joiner, 1996). 
The results of this study indicated that the patients in the three groups exhibited high 
agoraphobic avoidance on FQ-AG and there was no significant difference between 
groups in the pretreatment.  
The main feature of panic disorder is anxiety about being in a situation or place from 
which escape may be difficult, or in which help may not be easily available should a 
panic attack or panic-like symptoms occur. This anxiety usually leads to safety 
behaviors or avoidance of a variety of feared situations because they are used by 
panic patients to “prevent” a panic attack. Situations which are commonly avoided 
by individuals with PDA include: being alone away from home; being home alone; 
crowded areas; malls, travelling in buses, trains, cars, or planes; going to a new place, 
closed spaces and open spaces. Some individuals are able to face these situations but 
usually do so with reluctance and dread or sometimes the individual feels more 
comfortable about being in these situations if accompanied by someone else. 
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4.2 Effectiveness of treatment (pretest to posttest) 
The results from this study indicated that compared with the waiting list control 
group, patients who participated in the individual CBT and group CBT showed a 
significant improvement in reducing overall anxiety severity from pretest to post 
treatment, however further improvement with ICBT showing better gains in 
reducing of the anticipatory anxiety (BAI). As anticipatory anxiety scores moved 
from severe anxiety in pretreatment to mild anxiety in ICBT and moderate anxiety in 
GCBT after treatment. 
Many studies have found the positive effects of CBT treatment in reductions of 
depression and anxiety scores when panic severity and frequency decreased (i.e., 
Sharp, Power, Swanson, 2004., Soares et al., 2013., Deacon & Abramowitz, 2006).  
In a group consisting of 454 patients with panic disorder, Allen et al., (2010) 
examined the relationship of between depression and anxiety to treatment outcome 
cognitive-behavior therapy for panic disorder. They found CBT responders showed 
greater reductions on measures of anxiety and depressive symptoms. These data 
suggest that successful treatment of panic disorder is associated with reductions of 
comorbid anxiety and depressive symptoms.  
Bohni et al., (2009) have substantiated that group CBT produced significant decreases 
in overall anxiety (BAI) scores in thirty-nine patients with panic disorder. The 
improvements correspond to a large effect size. 
In agreement with results of this study Neron, Lacroix, Chaput, (1995) also found 
ICBT and GCBT significantly effective in reducing anxiety symptoms in total BAI 
and HAMA (Hamilton Anxiety) scores in post treatment. However, a differential 
effect favouring individual CBT over group CBT was observed with regards to 
symptoms other than panic, such as generalized anxiety and depressive symptoms. 
Thus our study replicated the finding of by Néron, Lacroix & Chaput (1995). 
The present finding is consistent with Sharp, Power & Swanson (2004) who obtained 
a substantial improvement in reduction of anxiety symptoms in a similar study 
comparing individual therapy and group therapy over 8 sessions with waiting list 
control group. At treatment end-point, in terms of statistical significance, both 
formats of treatment were significantly superior to waiting list control but on the 
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other hand, this result is not consistent with their results who obtained improvement 
in reduction of anxiety symptoms in individual therapy and group therapy with no 
significant difference between each other. At treatment end-point, in terms of 
statistical significance, both the formats of treatment were significantly superior to 
waiting list control but did not differ significantly from each other, but when clinical 
significance of outcome at treatment end-point was considered, individual CBT 
showed a significant advantage over both group CBT and waiting list control.  
It must be noted that their study had some methodological limitations, such as 
patients taking concurrent psychotropic medications were not excluded from the 
study, but were required to continue taking these medications as prescribed 
throughout the study period. In contrast the present study excluded individuals on 
psychotropic medication including benzodiazepine or concurrent psychotropic 
medications, from participation. It is likely that this difference in samples accounted 
for the differing results. In addition, it must be noted that measures of anxiety and 
depression (Hamilton Anxiety Scale and the Montgomery Asberg Depression) in 
their study were rated by the psychologist rather than self-report measures. This 
might also account for the differences. 
These results also are not consistent with a study conducted by Marchand, et al., 
(2009). They compared 14-session standard CBT, 14-session group CBT and 7-session 
brief CBT in the treatment of patients with moderate to severe PDA taking either 
anxiolytic or antidepressant medication or a combination of both. They reported all 
three-treatment formats significantly reduced the anticipatory anxiety (BAI) 
symptoms with high effect sizes, and there were no statistical differences between 
them after treatment. It must be noted that in their study all participants took either 
anxiolytic or antidepressant medication or a combination of both. Again, the use of 
patients on medications may account for the results of their study. As previously 
mentioned the present study excluded individuals from participation for use of 
psychotropic medication.  
The results of a study by King et al., (2011), Beck, Sokol, Clark, Berchick, Wright 
(1992) and Sokol, Beck, Greenberg, et al., (1989) on group of patients with PD 
reported that individual CBT produced significant decreases in overall anxiety (BAI) 
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scores in the CBT group compared with control group by the end of treatment. 
Similar results were found for CBT interventions delivered in group format. 
The results of a study by Kim et al., (2010) and Telch, et al., (1993) on group of 
patients with PD also reported that group CBT produced more significant decreases 
in overall anxiety scores (BAI) compared with control groups.  
The results from this study also indicated that patients who participated in the ICBT 
and GCBT groups demonstrated significantly greater reduction in the severity of 
depression symptoms compared to the Wait-list control group from pretest to post 
treatment, while there was no significant difference between each other. Most 
notably, participants in two treatment formats moved from moderate levels of 
depression at pre-treatment to mild range of depression at end of treatment.  
Consistent with this study’s results, Sharp, Power, Swanson (2004) and Marchand, et 
al., (2009) and Neron, Lacroix, Chaput, (1995) also showed the effectiveness of ICBT 
and GCBT in treating PD symptoms related to depression and concluded that ICBT 
and GCBT were significantly effective in reducing total depression scores in post 
treatment with no significant difference between each other.  
Consistent with this study’s results, a meta-analysis (in 23 studies) conducted by Oei, 
Llamas & Devilly (1999) showed the effectiveness of CBT in treating fear symptoms 
related to depression and avoidance in panic disorder patients and suggested that 
both group and individual format of CBT can be regarded as the established 
treatment of PD to reduce depression and avoidance compare with no-treatment 
control groups at post-treatment. 
The effect of CBT on depression symptoms has been shown by Emmrich et al., (2012), 
Clark et al., (1999), Teachman, Marker & Smith-Janik (2008) and Tsao, Mystkowski, 
Zucker, and Craske (2002). They found individual CBT is more effective in treating 
depressive symptoms comorbid with panic disorder in patients with PDA compared 
with waiting list control group. The results suggested that CBT can be regarded as an 
established treatment of depression or depressive symptomatology in panic disorder. 
A study conducted by Carter, Sbrocco, Gore, et al., (2003) reported group CBT 
program had a more positive impact in reducing depression levels after termination 
of treatment in 25 patients with panic disorder than waiting list control group. 
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The results of this study indicated that both treatment formats demonstrated 
significantly greater reduction in the severity of panic attacks compared to the wait-
list control group in posttreatment, however, participants in ICBT group showed 
significantly greater improvement than GCBT in post treatment. The results showed 
that severity of panic disorder (PDSS) scores moved from severe range in 
pretreatment to non-clinical range in ICBT and moderate range in GCBT in 
posttreatment. 
Results from some studies suggested that reduction of panic severity was associated 
with both decreases in danger related cognitions and increases in sense of self-
efficacy or effectiveness in dealing with such panic situations (Clark et al., 1999; 
Teachman, et al., 2008). However, studies that report post-treatment changes in both 
factors leave open the possibility that changes in one factor may be simply a co-effect 
of changes in the other factor (Bandura, 1988). 
These results also are not consistent with a study conducted by Marchand et al., 
(2009). They found ICBT and GCBT were equally effective in reducing severity of 
panic disorder (PDSS) scores at post treatment. Thus our study did not replicate the 
finding of Marchand et al. As previously mentioned, the differing results might be 
due to use of a medicated sample group.  
In agreement with results of this study, similar findings have been reported by 
Nakano et al., (2008), Manjula, et al., (2009), Meulenbeek, et al., (2010) and Bergström 
et al., (2010) who showed a significant reduction in panic disorder severity (PDSS) 
among group of patients with PD. They found that participants in group CBT 
condition improved more in reduction of PDSS than control condition in post 
treatment. 
The findings of the current study are consistent with the findings of Beck, Sokol, 
Clark, Berchick & Wright (1992) and Hofmann, et al., (2007) they examined changes 
in panic disorder severity among group of patients with panic disorder. They have 
demonstrated that individual CBT led to a significant impact on reduction of severity 
of panic disorder (PDSS) compared with control group.  
The results from this study indicated that patients who participated in the ICBT and 
GCBT groups demonstrated significantly greater reduction in the severity of 
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agoraphobic cognition (AC) scores compared to the Wait-list control group, while 
there was no significant difference between each other. 
Reduction in catastrophic agoraphobic cognition or behavioral avoidance could 
result from a generalization of anxiety coping skills learnt during CBT. Therefore, 
patients might use these skills in the posttest period to reduce behavioral avoidance 
and fears.  
These results also are consistent with a study conducted by Marchand et al., (2009). 
They found ICBT and GCBT were equally effective in reducing agoraphobic 
cognition (ACQ) scores at post treatment and maintained at two years follow-up. 
Thus our study replicated the finding of Marchand et al.  
Many studies suggest that successful treatment was associated with a reduction in 
catastrophic cognitions (AC) (Noda et al., 2007; Taylor, 2000; Hofmann et al., 2007). 
These studies reported that numerous variants of CBT intervention for PDA 
successfully reduced catastrophic cognitions and symptomatic improvement in the 
majority of cases and therefore regarded as a first-line treatment. 
 Taylor (2000) reported that modifying patients' catastrophic misinterpretations of 
bodily sensations resulted in significant reductions in panic disorder.  
Recent works (e.g. Hofmann et al., 2007; Smits, Powers, Cho & Telch, 2004) discuss 
the role of CBT in changes of catastrophic cognitions (AC) during treatment of PDA. 
Production of the catastrophic misinterpretation will increase panic symptoms in 
panic disorder individuals, whereas correction of the misinterpretation will prevent 
panic attacks.  
Hofmann et al., (2007) suggest that catastrophic cognitons relating to physical, 
mental, and social concern were mediators of treatment change for individuals with 
PDA who received CBT as a component of their treatment while, Smits et al., (2004) 
showed that CBT effects on PDA were partially mediated by the reduction of fear of 
fear that led to reduction of agoraphobia. The results of their study indicated that 
CBT improved the adjustment level in patients with PDA in overt behaviors, 
cognitions, and somatic sensations.  
Casey, et al., 2004b) investigated the role of both negative and positive cognitions in 
predicting panic severity in an international sample of 149 PD patients. They found 
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that catastrophic misinterpretation of bodily sensations predicted high panic severity 
while positive cognitions led to better management of panic attacks.  
Exposure is considered the essential element of CBT for anxiety disorders especially 
reducing agoraphobic cognition in patients with PD (Moscovitch, Antony, & 
Swinson, 2009, Malbos et al., 2013). Beck and Shipherd (1997) found that fear 
sensitization and habituation of fear-anxiety are important in the success of CBT in 
reducing the frequency and severity of fear of bodily sensations and agoraphobic 
cognitions in treatment of PD patients.  
The findings of the current study are also consistent with the findings of Noda, 
Nakano et al., (2007). They examined changes in agoraphobic cognition severity 
among 95 patients with PD. They demonstrated that group CBT led to significant 
impact on reduction of severity of Agoraphobic cognition, panic-related fear and 
avoidance and reduced their functional impairment in posttreatment. 
Gloster, Wittchen, Einsle et al., (2011), Hendriks et al., (2010) King et al., (2011) found 
that individual CBT formats was more effective than a wait-list control group in the 
improvement and reduction of agoraphobic avoidance to modify catastrophic 
cognition among groups of PD patients. 
The results from this study indicated that patients who participated in the ICBT and 
GCBT groups demonstrated significantly greater reduction in anxiety sensitivity 
(ASI) compared to the Wait-list control group in posttest, while there was no 
significant difference between each other. As the participants in two treatment 
formats moved from severe levels of sensitivity to anxiety at pre-treatment to 
moderate range at end of treatment. 
The current study provides support for the effectiveness of CBT intervention at 
lowering anxiety sensitivity and extends the work of previous studies. Some studies 
suggest that the reduction in anxiety sensitivity is specific for CBT treatment (Deacon 
& Abramowitz, 2006; Hofmann et al., 2007; Smit et al., 2008a).  
These results also are consistent with a study conducted by Marchand et al., 2009). 
They found ICBT and GCBT were equally effective in reducing anxiety sensitivity 
(ASI) scores at post treatment. Thus our study replicated the finding of Marchand et 
al.  
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A meta-analysis (Smits, et al., 2008b), that included 16 studies, revealed a large AS 
reduction effect size (d = 1.40) for CBT interventions in individuals with PD and 
other Axis I pathology. Additional analyses revealed that the average participant 
receiving CBT improved more than 92% of control group participants. These results 
suggest that CBT treatments aimed at ameliorating panic and other related disorders 
also lead to reductions in AS levels. 
The results of study by McNally and Lorenz (1987), Taylor & Cox, (1998), Smits, et 
al., (2004), Smits et al., (2008a) and Hofmann et al. (2007) also indicated an overall 
reduction of anxiety sensitivity in those who had successfully completed individual 
cognitive-behavioral treatment for panic disorder. As expected, treatment 
participants experienced a reduction in AS levels from the clinical to non-clinical 
range, compared with the non-treatment control group at posttreatment. 
Additionally, the current results regarding the effectiveness of group CBT on 
reducing ASI support findings from previous studies. Bohni et al., (2009) Penava et 
al., (1998) , Carter et al., (2003) and Schmidt, Trakowski, and Staab (1997), found a 
reduction in anxiety sensitivity among group of PD patients with high AS following 
group CBT interventions compared with the waiting list control group at 
posttreatment. These results showed that group CBT can reduce AS levels from the 
clinical range for panic disorder with or without agoraphobia into the normal range. 
The results from this study indicated that patients who participated in the ICBT and 
GCBT groups demonstrated significantly greater reduction in agoraphobic avoidance 
severity (FQ-AG) compared to the Wait-list control group in posttest.  
These results also are consistent with a study conducted by Sharp, Power & Swanson 
(2004) and Marchand et al., (2009). They found ICBT and GCBT were equally 
effective in of avoidance and agoraphobia (FQ-AG) scores at post treatment.  
Consistent with the prediction, some studies suggest that the reduction in 
agoraphobic avoidance and fear severity is specific for CBT intervention in treatment 
of PD (Bandelow et al., 2007; Roy-Byrne et al., 2005b; Shear, et al., 2001a; Vincelli et 
al., 2003).  
Consistent with the results of this study, a meta-analysis conducted by Oei, Llamas & 
Devilly (1999) showed the effectiveness of CBT in treating fear symptoms related to 
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phobic anxiety and avoidance in PD patients and suggested that CBT can be 
regarded as the established treatment of PD in reducing fear and avoidance. This 
study showed that fear and avoidance measures (in 27 studies) improved at post-
treatment and/or follow-up. 
The results of a study by Vincelli et al., (2003) and Gloster, Wittchen, Einsle et al., 
(2011) Pelissolo et al., (2012) also showed the effectiveness of individual CBT in 
patients with PDA in significantly reducing fear (FQ-AG) response criterion. They 
found that individual CBT was more effective than a wait-list control group in the 
improvement and reduction of agoraphobic avoidance to modify catastrophic 
cognition in PD patients.  
Additionally, the current results regarding the effectiveness of group CBT on 
reducing FQ-AG support findings from previous studies. The results of a study by 
Ross et al. (2005) and Carter et al., (2003) revealed that PD participants in group CBT 
condition improved more in reduction of agoraphobic avoidance compared with 
waiting list control group immediately post treatment. 
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4.3 Effectiveness of treatment (Pretest-Posttest-Follow-up) 
The participants in ICBT and GCBT treatments not only maintained their therapeutic 
gains on six dependent variables (anxiety, depression, panic disorder severity, 
agoraphobic cognition, anxiety sensitivity and fear) but also continued to improve 
during the four month follow-up. However the results from this study showed 
significantly greater improvements in ICBT than GCBT in some measures in post 
treatment to four months follow up.  
The results showed that anticipatory anxiety scores moved from severe anxiety in 
pretreatment to mild anxiety in ICBT and moderate anxiety in GCBT in 
posttreatment. In addition, these two treatment formats showed continued 
significant reduction in rate of anxiety, to mild anxiety, at the 4 month post 
intervention; however, ICBT group was likewise significantly more effective 
compared with GCBT in reducing of the anticipatory anxiety (BAI) at the end of the 
follow-up phase. 
In agreement with results of this study Neron, Lacroix, Chaput, (1995) also found 
ICBT and GCBT significantly effective in reducing anxiety symptoms in total BAI 
and HAMA (Hamilton Anxiety) scores in post treatment and at a 6 month follow-up. 
However, a differential effect favouring individual CBT over group CBT was 
observed with regards to generalized anxiety and depressive symptoms. This 
differential effect favouring individual therapy was also observed at the end of the 
follow-up phase. Thus our study replicated the finding of by Néron, Lacroix & 
Chaput (1995). 
This result is not consistent with results from a study conducted by Sharp, Power & 
Swanson (2004) and Marchand, Roberge, Primiano, Germain (2009) who obtained 
improvement in reduction of anxiety symptoms in individual therapy and group 
therapy which were maintained at a three month and 2 years follow-up, respectively, 
with no significant difference between each other. The previously mentioned 
limitations of these two studies. 
This outcome parallels the findings from and Erickson, Janeck, Tallman, (2007), 
Clerkin, et al., (2008), Telch et al., (1993), Sokol, et al., (1989) Heldt, et al., (2010) and 
Moller & Hegna (2001). They found participants with PD in CBT group were more 
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effective in treatment and maintained their improvement in reduction of anxiety 
(BAI) scores, with a continued reduction after end of treatment to respectively to six 
months, 1-year, 2- years and three years follow-up and majority of the treated 
patients met criteria for recovery. 
The results from this study also indicated that the participants in both treatment 
groups moved from moderate depression levels at pretreatment to minimal range in 
post treatment. In addition, the two treatment formats showed a continued 
significant reduction in rate of depression at 4 months post intervention, however 
further improvement with ICBT showing better gain in reducing of depression.  
This indicates that even at the four month follow-up, CBT programs had effectively 
helped patients deal with anxiety, and moreover, reduced factors such as sensitivity 
to autonomic arousal, catastrophic thoughts, and intensity of symptoms associated 
with panic thus preventing negative emotion of panic disorder. In other words, both 
groups showed increased self-efficacy and were effectively able to deal and cope 
with new stressors following treatment termination. 
This result is not consistent with results from a study conducted by Sharp, Power & 
Swanson (2004), Marchand et al., (2009) and Neron, Lacroix, Chaput, (1995) who 
obtained improvement in reduction of depression symptoms in individual therapy 
and group therapy which were maintained at a three month, 2 years and a 6 month 
follow-up respectively, with no significant difference between each other.The 
previously mentioned limitations of these two studies. 
The results of studies by Telch et al., (1993) Sokol et al., (1989) and Ruwaard et al., 
(2010) also reported reductions in depression (BDI) scores in group CBT were 
maintained at a 6 month, 1-year and three year follow-up respectively.  
The results showed that severity of panic disorder (PDSS) scores moved from severe 
range in pretreatment to mild range in ICBT and moderate range in GCBT in 
posttreatment. In addition, these two treatment formats showed continued 
significant reduction in rate of severity of panic disorder (PDSS), to mild range at the 
4 month post intervention; however, ICBT group was likewise significantly more 
effective compared with GCBT in reducing severity of panic disorder at the end of 
 
 Chapter IV - Discussion  174 
 
the follow-up phase. 
These results also are not consistent with a study conducted by Marchand et al., 
(2009). They found ICBT and GCBT were equally effective in reducing severity of 
panic disorder (PDSS) scores at two year follow-up. Thus our study did not replicate 
the finding of Marchand, Roberge, Primiano and Germain. As previously mentioned, 
the differing results might be due to use of a medicated sample group.  
This is consistent with previous findings Otto, Deveney, (2005), Taylor, (2000), , Smit 
et al., (2004), that panic patients through the CBT program could significantly reduce 
severity of panic disorder (PDSS) at the end of treatment and maintain this 
improvement at long term follow-up.  
The study Noda et al., (2007), Meulenbeek et al., (2010) and Heldt et al., (2006) and 
Nakano et al., (2008) also concluded that the improvement in reduction severity of 
panic disorder (PDSS) in group CBT was maintained at 3 months, 6 months and one 
year follow-up, respectively. 
Hofmann et al., (2007), Clerkin et al., (2008) also reported that individual CBT 
produced significant improvement in reduction of severity of panic disorder in post 
treatment and maintenance over 24 weeks and 6 months follow-up, respectively. 
The results from this study also indicated that patients in the ICBT and GCBT groups 
not only demonstrated significantly reduction in catastrophic misinterpretation 
(ACQ) from pretest to posttest but also continued to improve during the four month 
follow-up with no significant difference between each other.  
It is likely that participants in both CBT interventions continued to use the strategies 
learned in sessions after they finished treatment and therefore the treatment effect 
persisted and became greater over time. 
These results also are consistent with a study conducted by Marchand, Roberge, 
Primiano, Germain (2009). They found subjects in two treatment groups maintained 
their gains in reducing agoraphobic avoidance (ACQ) scores at two years follow-up, 
while not differing significantly from each other. Thus our study replicated the 
finding of Marchand, Roberge, Primiano, and Germain. 
The study Craske, Farchione, Allen (2007) also concluded that the improvement in 
reduction agoraphobic cognition (ACQ) in CBT groups was maintained and even 
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improved at 6 and 12 months later (follow-up). 
This result is consistent with results from study by Hofmann et al., (2007), who 
obtained improvement in reduction of agoraphobic cognition in individual CBT 
group which maintained at a six month follow-up. 
Agoraphobic cognition was found to improve with group CBT and the improvement 
was maintained at 3 months (Noda et al., 2007) up to a 6 months follow-up (Hecker, 
Melinda, Losee1, et al., 2004). 
Nakano et al (2008) reported that group CBT program was successful in reducing 
catastrophic misinterpretation and agoraphobic cognition in posttreatment. The 
result showed the average agoraphobic cognition (ACQ) score fell from 13.3 at 
baseline to 5.3 post-treatment (47% reduction). This effectiveness was sustained for 1 
year.  
The results of this study also found a significant reduction in anxiety sensitivity from 
pretest to posttest which was maintained at four months follow-up. The results of 
this study also revealed that the improvement in reduction of Anxiety Sensitivity 
(AS) in the two treatment formats maintained the rate of severity to mild at the four 
month follow up, but ICBT showed greater improvement than GCBT in at four 
months follow up.  
Participants in both groups learned to conceptualize panic as an extreme end of a 
continuum of the body’s natural response to threat. It follows that they were less 
likely to view panic as a “weakness”or permanent problem, but rather as a 
hypersensitive alarm mechanism that was capable of being readjusted. As a result, 
CBT participants in both formats as a whole probably felt fewer stigmas with the 
experience of panic and consequently may have been more comfortable admitting 
that they had experienced a panic attack at the four month follow-up assessment. 
In a study by Antony (2001), panic cognition measures mean scores (e.g., ASI, ACQ) 
and fear and avoidance (FQ) at pretreatment were consistent with clinical samples 
diagnosed with severe panic disorder and avoidance. However in posttreatment and 
follow-up, with improved functionality after progressively reduced catastrophic 
misinterpretation of arousal-related body sensations and reduced agoraphobic fear 
and avoidance, scores were similar to non-clinical samples at the four month follow-
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up with no significant differences between treatment conditions.  
Several clinical trials of CBT for panic disorder have shown the expected lowering of 
anxiety sensitivity among patients successfully treated with CBT at follow-up 
(McNally & Lorenz, 1987; Smit et al., 2008a; Smits et al., 2008b., Deacon, Lickel, 
Possis, Abramowitz, Taylor, 2012). 
These results also are not consistent with a study conducted by Marchand, Roberge, 
Primiano, Germain (2009) where improvements in reduction of anxiety sensitivity in 
individual therapy and group therapy were maintained at 2 years follow-up, with no 
statistically significant difference from each other. 
Consistent with this study’s results, a meta-analysis (in 31 studies targeted PD) 
conducted by Öst (2008) showed the effectiveness of group or individual format of 
CBT in treating maladaptive cognitions and behaviors (i.e., catastrophic 
misinterpretations of physical symptoms) in the end of treatment and maintain this 
improvement at follow-up.  
The study by, Smits, et al., (2008a) and Arch., Eifert., Davies., (2012) also concluded 
that the improvement in reduction anxiety and bodily sensations (ASI) in individual 
CBT format was maintained at the 3-week and 6 – and one year follow-ups 
respectively. 
Anxiety sensitivity and anxiety cognitions were found to improve with group CBT 
and the improvement were maintained at a six weeks (Bergström et al., 2010), 4 
months (Hecker, et al., 2004), six months (Clerkin, 2008) up to a 12 months follow-up 
(Martinsen, Olsen, Tonset, Nyland, Aarre, 1998). 
The results from this study also indicated that patients in the ICBT and GCBT groups 
not only demonstrated significantly reduction in agoraphobia, and situational 
avoidance (FQ-AG) from pretest to posttest but also continued to improve during the 
four month follow-up with no significant difference between each other.  
These results also are consistent with a study conducted by Sharp, Power & Swanson 
(2004) and Marchand, Roberge, Primiano, Germain (2009) where improvements in 
reduction of avoidance and agoraphobia in individual therapy and group therapy 
were maintained at, 3 months and 2 years follow-up respectively, with no 
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statistically significant difference from each other. 
This is consistent with previous findings Addis et al., (2006) and Nakano et al., (2008) 
Craske, Farchione, Allen (2007) who obtained improvement in reduction of severity 
of fear and agoraphobia (FQ-AG) in group CBT program were maintained at 5 
months and one year follow-up, respectively. 
Similar results have also been reported by Evans, Holt, Oei (1991) that panic patients 
through the individual CBT program could significantly reduce severity of fear and 
agoraphobia (FQ-AG) at 1 year after the treatment. 
In general, these findings appear to substantiate the conceptualization of panic 
proposed in the study and lend support to the argument that the intervention was 
successful in reducing anxiety sensitivity and consequently reducing the tendency to 
attribute threatening meaning to anxiety or panic. 
These follow-up results can be contrasted to results from alternative 
pharmachological treatment studies for PD. More than 30 percent of panic sufferers 
who stop taking tricylic antidepressants experience a relapse that requires additional 
treatment (Clum, 1990). The average relapse rate across all studies is approximately 
40% (Barlow, 1988). Although the current study did not directly compare ICBT or 
GCBT to pharmachological intervention, it seems clear from the literature cited, that 
one of the most important findings for this study involves the virtual lack of relapse 
across a number of variables relevant to PD. Increase in confidence in one’s personal 
ability to mange PD may be the key factor in maintaining treatment effects across 
time. This confidence may be lacking in persons who undergo pharmacological 
interventions and attribute improvements in their condition to the medication versus 
acquired cognitive behavioral skills. 
Summary 
Results of this study demonstrated signiﬁcant improvements in reduction of severity 
of panic disorder, negative affects (depression, anxiety), agoraphobic avoidance, 
negative automatic thoughts and sensitivity to anxiety in patients that participate in 
two treatment formats (individual and group CBT) interventions, while individual 
CBT group led to greater improvement than group CBT in reducing of anxiety 
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anticipatory anxiety (BAI) and severity of panic disorder (PDSS) after treatment 
interventions. These improvements were maintained at 4 months follow-up, while 
patients in individual CBT led to greater improvement than group CBT in relation to 
reduction of anticipatory anxiety (BAI), depression (BDI), severity of panic disorder 
(PDSS) and sensitivity to anxiety (ASI), but two treatment formats were equally 
effective in the reduction of agoraphobic cognition (ACQ) and agoraphobia (FQ-AG) 
in post treatment and at the 4 months follow-up. The improvements indicate that 
these programs are a promising intervention for patients with PD. 
4.4 Conclusions  
This study examined the efficacy of CBT in individual and group formats for the 
treatment of panic disorder in Iranian participants. The results obtained suggest that 
CBT produced significantly greater decreases than waiting list control group in panic 
disorder symptoms as measured by the BAI; BDI; PDSS; ACQ; ASI and FQ-AG.  
From the experience and insights gained through all the hypotheses of this study, it 
can be concluded that cognitive behavioral therapy is an effective treatment for 
reducing a wide range of symptoms, including depression, anxiety, panic disorder 
severity, agoraphobic cognition, anxiety sensitivity and fear in patients with PD. 
Compared to the waiting list control group, two treatment formats also were found 
to be effective in significantly reducing symptoms of panic disorder in post treatment 
and at 4 months follow-up. These findings were consistent with the analysis of 
statistical significance, in which the proportion of participants who moved from a 
dysfunctional or clinical range to a non-clinical range was greatest for the CBT 
treatment condition (ICBT or GCBT). Hence cognitive behavioral therapy (CBT) 
should be the treatment of choice for PD.  
Cognitive behavioral therapy (CBT) is close to Iranian culture and therapists can 
educate their clients on the logics of techniques and assumptions underlying them 
more easily. Thus, the clients can accept them with no trouble (Khoshbooii, 2012). 
Health professionals and policy makers may notice the effectiveness of cognitive 
behavior therapy and its adaptation to Iranian culture in the treatment of PD. 
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The second conclusion of this study is that individual CBT showed a stronger 
therapeutic response in reduction of anticipatory anxiety, depression, severity of 
panic disorder, sensitivity to anxiety than group CBT format. While, two treatment 
modalities were equally effective in reducing agoraphobic cognition and 
agoraphobia avoidance from pretest to posttest and maintained these levels at 4 
month follow-up. 
Although all sessions of treatment in this study were delivered by the same therapist 
and same manual, but what should be considered is that essentially CBT treatment in 
this study was an educational and instructional type and has been designed mainly 
for individual treatment format. Therefore, caution should be exercised in 
generalizing our results to other types of group therapy such as groups with a other 
approach and more psychotherapeutic focus. 
The most common format in traditional cognitive-behavioral therapy is the 
individual format (Sharp, Power & Swanson, 2004) but individual CBT is 
undoubtedly the most costly of the treatment delivery modalities and also has 
implications for service delivery, particularly in terms of availability of qualified 
therapists. It is clear that financial concerns are predominant in patients’ reasons for 
choosing to not engage in therapy (Marchand, et al., 2004, Sharp, Power & Swanson, 
2004) even when they see a need to do so. 
However, the results of this study suggests that there were some differences in 
relation to effectiveness between the group and individual modalities but the group 
treatment is as effective as individual treatment in reduction of symptoms of panic., 
hence the group format may be chosen to be the standard kind of therapy to be 
offered in a service and a good option to reduce costs. This is particularly beneficial 
for low-income families who struggle to pay the cost of mental health care. For 
example in Iran, there are a large number of patients in need of treatment and limited 
budgets to provide it. However, the option of individual treatment should also be 
maintained in order to address specific needs and to respect patients’ preferences. 
Cost-effectiveness of group therapy encourages and increases the number of patients 
willing to seek treatment for panic disorder. The mental health community should 
recognize this population as significantly underserved and work to make therapy 
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services not only more available, but also more affordable to therapists-in-training. It 
seems, increasing the availability of group therapy may be one option, as it is just as 
effective as individual therapy and even offers some unique benefits (Frankel, 2002; 
Leszcz, 2008), usually at a much cheaper cost (McCrone et al., 2005).  
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4.5 Limitations of the Present Study 
Although the present study contributes to an understanding of the treatment of panic 
disorder, it is not without limitations. The main limitations are expressed as follows: 
First, although it appears that the individual and group treatment are effective, it 
must be noted that nearly all dependent measures were self-report measures rather 
than behavioral observations or physiological indices, so there were potential 
confounds such as social desirability effects. 
Second, in the present study, a structured clinical interview was not conducted at 
post-treatment as well as at follow-up. Therefore, the researcher could not confirm 
the rate of recovery of the participants. The researcher could only report the 
reduction of PD symptoms criteria based on the questionnaire. 
Third, the therapist and researcher was the same person, which may have biased the 
results. However, group differences emerged only at follow-up when the therapist 
was no longer in attendance. 
Fourth, in the present research the final evaluation of PD symptoms criteria was 
conducted 4 months after post-treatment, which is a relatively short duration. 
Other limitations of this study include (a) This study was conducted on small size (b) 
many people with panic symptoms are comorbid with other mental health problems, 
especially depression, another anxiety disorder, substance abuse, but the present 
study excluded individuals with this comorbid disorders. These factors may affect 
the generalizable of results.  
Fifth, panic disorder patients seem to be more sensitive to hyperventilation than 
normal volunteers. But the present study lacked of psychophysiological tests to 
assess sensitive to hyperventilation and physiologically abnormal responses to 
respiratory function in participants.  
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4.6 Future Directions of Research 
This study was conducted on a small sample, therefore, similar studies with larger 
sample size should be conducted to examine whether these findings can be 
confirmed.  
In the present study, a structured clinical interview was not conducted at post-
treatment as well as at follow-up. Therefore, the researcher could not confirm the rate 
of recovery of the participants. The researcher could only report the reduction of PD 
symptoms criteria based on the questionnaire. Therefore, future research should 
employ a diagnostic clinical interview in order to evaluate the rate of recovery of 
participants in each treatment modality.  
Additionally, future research should have long term follow-up evaluation in order to 
determine the long term effects of the therapies. In the present research the final 
evaluation of PD symptoms criteria was conducted 4 months after post-treatment, 
which is a relatively short duration.  
Casey et al., (2004b) concluded in their study that is necessary to include measures of 
positive cognition (e.g. self efficacy in dealing with anxiety thought) in assessing the 
impact of catastrophic cognitions. In this study didn’t address the positive 
cognitions. Further research will be needed to investigated how self efficacy changes.  
In the present study, one of the exclusive criteria was that only patients with PD 
diagnosis were involved as participants. However, in clinical situations, many people 
who suffer from panic symptoms have comorbid with other behavioral mental health 
problems, especially depression, another anxiety disorder, substance abuse or 
suicidality (Nock, Hwang, Sampson, Kessler, 2010). Therefore, future studies should 
evaluate and compare the effectiveness of ICBT and GCBT in PD with comorbidity. 
A replication of this study with a combination of individual and group cognitive 
behavioral intervention, preferably with the same therapist, may be particularly 
effective for many panic disorder patients. Thus the group would provide a 
laboratory where the patient can test out maladaptive beliefs about fear-evoking 
stimuli in relative safety.  
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Summary 
There is an evidence to support the effectiveness and cost effectiveness of group 
cognitive behavioral therapy in the treatment of panic disorder. The main objective 
of the present study was to compare the effectiveness of individual and group 
formats of cognitive-behavioral therapy in panic disorder patients. 
45 outpatients with panic disorder with or without agoraphobia were randomly 
assigned to three groups: Group Therapy, Individual Therapy or a waiting -list 
group. In the two treatment conditions, patients received 14 weekly sessions of 
treatment based upon Cognitive-Behavioral therapy. Assessments were carried out 
pre and post treatment and in the two treatment groups at a 4-month follow-up. 
Treatment effectiveness of individual and group CBT was compared with each other 
and the untreated wait-list control group with regard to Beck Anxiety Inventory 
(BAI), Beck Depression Inventory (BDI), Panic Disorder Severity Scale (PDSS), 
Agoraphobic Cognition Questionnaire (ACQ), Anxiety Sensitivity Index (ASI) and 
agoraphobic avoidance (FQ-AG). 
Data analysis revealed that the three groups were not significantly different from 
each other at pre-treatment. Compared with the waiting list control group, the 
participants in both CBT formats showed significant improvement after treatment 
with reduction of panic disorder symptoms, while, two treatment formats were 
equally effective in the reduction of, depression (BDI), agoraphobic cognition (ACQ), 
sensitivity of anxiety (ASI) and agoraphobic avoidance (FQ-AG), but individual CBT 
led to greater improvement than group CBT in relation to the reduction of overall 
anxiety, and panic disorder severity in post treatment. Furthermore participants in 
both treatment groups is maintained their improvement at 4 months follow-up 
phase, while, individual CBT group led to greater improvement than group CBT in 
relation the reduction of overall anxiety (BAI), depression symptoms (BDI), panic 
disorder severity (PDSS) and sensitivity to anxiety (ASI) at 4 months follow-up.  
  
 
 Reference  184 
 
Reference 
Abramowitz, J. S., Deacon, B. J., Whiteside, S. P. H. (2011). How well does Exposure 
Therapy work? Exposure therapy for anxiety: Principles and practic, (pp. 17-32). 
New York: Guilford Press.  
Addis, M. E., Hatgis, C. E., Cardemil, E., Jacob, K., Krasnow, A. D. & Mansfield, A. 
(2006). Effectiveness of cognitive behavioral treatment for panic disorder versus 
treatment as usual in a managed care setting: Two year follow-up. Journal of 
Consulting and Clinical Psychology, 74, 377-385.  
Agras, W. S. (1993). The diagnosis and treatment of panic disorder. Annual Review 
of Medicine, 44, 39-51.  
Ahmadvand, A., Sepehrmanesh, Z., Ghoreishi, F. S, Afshinmajd, S. (2012). Prevalence 
of psychiatric disorders in the general population of Kashan, Iran. Archives of 
Iranian medicine, 15, 205-509. 
Aina, Y., & Susman, J.L. (2006). Understanding comorbidity with depression and 
anxiety disorders. Journal of the American Osteopathic Association. 106, 9–14. 
Allen, L. B., White, K. S., Barlow, D. H., Shear, K. J., Gorman, J. M. and Woods, S. W. 
(2010). Cognitive-Behavior Therapy for Panic Disorder: Relationship of Anxiety 
and Depression Comorbidity with Treatment Outcome. Journal of 
Psychopathology Behavior Assessment, 32, 185–192. 
Alkin, T., Tural, U., Onur, E., Oztürk, V., Monkul, E. S. & Kürşad, K. (2007). Basilar 
artery blood flow velocity changes in patients with panic disorder following 35% 
carbon dioxide challenge. Journal of Progress in Neuro-Psychopharmacology and 
Biological Psychiatry, 31, 115-122.  
American Psychiatric Association (2000). Diagnostic and Statistical Manual of mental 
disorder (text revision). Washington, D. C: Author.  
American Psychiatric Association. (2007). Practice Guideline for the treatment of 
patients with panic disorder. Washington, DC: American Psychiatric Association. 
Anderson, G., & Carlbring, P. (2010). Panic disorder. In W. T. O'Donohue., C. Draper 
(Eds.), Stepped Care and E-Health: Practical Applications to Behavioral disorder 
(pp. 61-77). New York Dordrecht Heidelberg London: Springer.  
Antony, M. M. (2001). Measures for panic disorder and agoraphobia. In M. M. 
Antony, & S. M. Orsillo (Eds.), Practitioner’s guide to empirically based measures 
of anxiety. AABT clinical assessment series (pp. 95–125). Dordrecht, Netherlands: 
Kluwer Academic Publishers 
Antony, M. M., Brown, T. A., & Barlow, D. H. (1992). Current perspective on panic 
and panic disorder (Current Direction) in psychological science. Journal of the 
 
Reference  185 
 
American psychological society, 1, 79-82.  
Apfeldorf, W. J., Shear, M. K., Leon, A. C., & Portera, L. (1994). A brief screen for 
panic disorder. Journal of Anxiety Disorders, 8, 71-78.  
Arch, J. J., Eifert, G. H., Davies, C., Vilardaga, J. C. P., Rose, R. D., & Craske, M. G. 
(2012). Randomized clinical trial of cognitive behavioural therapy (CBT) versus 
acceptance and commitment therapy (ACT) for mixed anxiety disorders. Journal 
of Consulting and Clinical Psychology, 80, 750-765.  
Argyropoulos, S. V., Sandford, J. J., & Nutt, D. J. (2000). The psychobiology of 
anxiolytic drugs Part 2: pharmacological treatments of anxiety, Journal of 
Pharmacology & Therapeutics, 88, 213-227.  
Arntz, A. (2002). Cognitive therapy versus interoceptive exposure as treatment of 
panic disorder without agoraphobia. Journal of Behavior Research Therapy, 40, 
325-341.  
Arntz, A. & van den Hout, M. (1996). Psychological treatments of panic disorder 
without agoraphobia: Cognitive therapy versus applied relaxation. Journal of 
Behavior Research and Therapy, 34, 113-121.  
Austin, D. W. & Richards J. C. (2001). The catastrophic misinterpretation model of 
panic disorder. Journal of Behavior Research Therapy, 39, 1277-1291.  
Baldwin, D. S., Anderson, I. M., & Nutt, D. J. (2005). Evidence-based guidelines for 
the parmacological treatment of anxiety disorders: recommendations from the 
British Association of Psychopharmacology. Journal of Psychopharmacology, 19, 
567-596.  
Bandelow, B., Seidler-Brandler, U., Becker, A., Wedekind, D., & Rüther, E. (2007). 
Meta-analysis of randomized controlled comparisons of psychopharmacological 
and psychological treatments for anxiety disorders. World Journal of Biological 
Psychiatry, 8, 175–187.  
Bandura, A. (1988). Self-efficacy conception of anxiety. Journal of Anxiety Research, 
1, 77 – 98. 
Barker, R. (Ed), (1989). Introduction: Where does panic disorder come from? Panic 
disorder: theory research and therapy (pp. 1-16). New York: John Wiley and sons. 
Barlow, D. H. (1988). Diagnosis and assessment of panic disorder and agoraphobia. 
In anxiety and its disorders: The nature and treatment of anxiety and panic. New 
York: The Guilford press.  
Barlow, D. H. (1990). Long-term outcome for patients with panic disorder treated 
with cognitive-behavioral therapy. Journal of Clinical Psychiatry, 51, 17-24.  
Barlow, D. H. (1994). Effectiveness of behavior treatment for panic disorder with and 
 
 Reference  186 
 
without agoraphobia. In B. E. Wolfe & J. D. Maser (Eds.), Treatment of panic 
disorder (pp. 105-120). Washington, DC: American Psychiatric Press.  
Barlow, D. H. (2002). Experience of anxiety. Anxiety and its disorders: The nature 
and treatment of anxiety and panic (pp. 1-36) (2th ed.). New York: Guilford Press. 
Barlow, D. H. (2008). Panic disorder and Agoraphobia. Clinical handbook of 
psychological disorders: A step by step treatment manual (pp. 24-28) (4th ed). 
New York, NY: Guilford press. 
Barlow, D. H. (2011). The development and evaluation of psychological treatments 
for panic disorder. In M. Gernsbacher, D. Pew & L. Hough (Eds.), Psychology 
and the real world: Essays illustrating fundamental contributors to society (pp. 
198-204). New York: Worth Publishers. 
Barlow, D. H., Brown, T. A., & Antony, M. M. (1995). Diagnostic Comorbidity in 
Panic Disorder: Effect on Treatment Outcome and Course of Comorbid 
Diagnoses Following Treatment. Journal of Consulting and Clinical Psychology, 
63, 408-418. 
Barlow, D. H. & Cerny, J. A. (1988). The nature and consequences of panic, 
Psychological treatment of panic. The psychological treatment of panic (pp. 1-28). 
New York: Guilford Press.  
Barlow, D. H., Chorpita, B. F., & Turousky, J. (1996). Fear, panic, anxiety and 
disorders of emotion. In D. A. Hope, (Ed), Annual Nebraska Symposium on 
motivation, (pp. 251-328). Lincoln: Nebraska university press. 
Barlow, D. H. & Craske, M. G. (2007). Master your anxiety and panic: Client 
workbook for anxiety and panic (4th ed). New York: Oxford university press.  
Barlow, D. H., Craske, M. G., Cerny, J. A. & Klosko, J. S. (1989). Behavioral treatment 
of panic disorder. Journal of Behavior Therapy, 20, 261-282.  
Barlow, D. H., Gorman, J. M., Shear, M. K., & Woods, S. W. (2000). Cognitive-
behavioral therapy, imipramine, or their combination for panic disorder: A 
randomized controlled trial. Journal of American Medical Association, 283, 2529-
2536. 
Battaglia, M., Bernardeschi, L., Politi, E., Bertella, S., & Bellodi, L. (1995). Comorbidity 
of panic and somatization disorder: A genetic-epidemiological approach. Journal 
of Comprehensive Psychiatry, 36, 411-420.  
Beamish, P. M., Granello, P. E, Granello, D. H., McSteen, P. B., Bender, B. A., & 
Hermon, D. (1996). Outcome studies in the treatment of panic disorder: A review. 
Journal of Counseling and Development, 74, 460-467.  
Beamish, P. M., Granello, D. H., & Belcastro, A. L. (2002). Treatment of panic 
disorder: Practical guidelines. Journal of Mental Health Counseling, 24, 224-246.  
 
Reference  187 
 
Beck, A. T., & Emery, G. (1985). Anxiety disorders and phobias: A cognitive 
perspective. New York: basic Books. 
Beck, J. G., & Shipherd, J. (1997). Repeated exposure to interoceptive cues: Does 
habituation of fear occur in panic disorder patients? Journal of Behavior Research 
and Therapy, 35, 551–557.  
Beck, A. T., Sokol, L., Clark, D. A., Berchick, B., & Wright, F. (1992). Focused 
cognitive therapy for panic disorder: a crossover design and one year follow-up. 
American Journal of Psychiatry, 147, 778-783.  
Beck, A. T., Epstein, N., Brown, G., & Steer, R. A. (1988a). An inventory for 
measuring clinical anxiety: psychometric properties. Journal of Consulting and 
Clinical Psychology, 56, 893-897. 
Beck, A. T., Steer, R. A., & Garbin, M. G. (1988b). Psychometric properties of the Beck 
Depression Inventory: Twenty-five years of evaluation. Journal of Clinical 
Psychology Review, 8, 77-100.  
Beck, A. T., & Steer, R. A. (1990). Manual for the Beck Anxiety Inventory. San 
Antonio, TX: Psychological Corporation.  
Beck, A.T., Steer, R.A., & Brown, G.K. (1996). Manual for the Beck Depression 
Inventory-II. San Antonio, TX: Psychological Corporation. 
 Beck, J. G., Stanley, M. A., Baldwin, L. E., Deagle, E. A., & Averill, P. M. (1994). 
Comparison of cognitive therapy and relaxation training for panic disorder. 
Journal of Consulting and Clinical Psychology, 62, 818-826. 
Bednar, R. L. & Kaul, T. J. (1994). Experiential group research: Can the cannon ﬁre? In 
A. E. Bergin, & S. L. Garﬁeld (Eds.), Handbook of psychotherapy and behavior 
change (pp. 631-663) (4th ed.). New York: Wiley.  
Bieling, P.J., McCabe, R.E., Antony, M.M. (2009). Group process in CBT. Cognitive-
Behavioral Therapy in Groups, (pp. 22-45). New York: Gillford Press. 
Bennett, B. (2004). Mental illness: A Guide to Recovery (pp. 40-42). Trafford 
publishing.  
Berger, B. G. (2001). The treatment of panic disorder: A comparative study between 
breathing retraining and cognitive behavioral therapy: Dissertation Abstracts 
International:-Section-B:-The Sciences-and-Engineering. 61, 43-90. 
Bergström, J., Andersson, G., Ljótsson, B., Rück, C., Andréewitch, S., Karlsson, A., 
Carlbring, P., Andersson, E., & Lindefors, N. (2010). Internet-versus Group 
administered Cognitive Behavior Therapy for Panic Disorder in a Psychiatric 
Setting: A Randomized Trial. Unpublished manuscript. BMC Psychiatry, 10-54.  
Bernstein, D. A., & Borkovec, T. D. (1973). Progressive relaxation training. 
 
 Reference  188 
 
Champaign, I. L: Research Press.  
Bernstein, A., Zvolensky, M. J., Sachs-Ericsson, N., Schmidt, N. B., & Bonn-Miller, M. 
O. (2006). Associations between age of onset and lifetime history of panic attacks 
Panic in the Military 60 and alcohol use, abuse, and dependence in a 
representative sample. Journal of Comprehensive Psychiatry, 47, 342-349.  
Berzak, E., Reznik, M., Narsia, O., Benjamin, J. (2004). Sensitivity to carbon dioxide in 
subjects with a single lifetime panic attack: possible clinical "bedside" predictive 
test for panic disorder after a first attack. Journal of Depression and Anxiety, 20, 
48-50.  
Bloch, S., & Crouch, E. (1986). Therapeutic Factors in Group Psychotherapy. Oxford 
University Press. 
Bohni, M. K., Spindler, H., Arendt, M., Hougaard, E, & Rosenberg, N.K. (2009). A 
randomized study of massed three-week cognitive behavioral therapy schedule 
for panic disorder. Journal Acta Psychiatrica Scandinavica, 120, 187-95. 
Bonn, J. A., Readhead, C. P. A., & Timmons, B. H. (1984). Enhanced behavioral 
response in agoraphobic patients pretreated with breathing retraining. Lancet, 2, 
665-669. 
Botella, C., García-Palacios, A., Villa, H., Banos, R.M., S, Alcaniz, M. (2007). Virtual 
Reality Exposure in the Treatment of Panic Disorder and Agoraphobia: A 
Controlled Study. Journal of Clinical Psychology and Psychotherapy, 14, 164-175. 
Bouchard, S., Gauthier, J., Laberge, B., & French, D. (1996). Exposure versus cognitive 
restructuring in the treatment of panic disorder with agoraphobia. Journal of 
Behaviour Research and Therapy, 34, 213 – 224. 
Bouton, M.E., Mineka, S., & Barlow, D.H. (2001). A modern learning theory 
perspective on the etiology of panic disorder. Journal Psychological Review, 108, 
4-32. 
Brabender,V., Fallon, A.E., & Smolar, A.I. (2004). Essentials of Group Therapy. (p.36). 
John Wiley & Sons, Inc. 
Breier, A., Charney D.S., & Heninger, G.R. (1986). Agoraphobia with panic attacks. 
Development, diagnostic stability, and course of illness, Arch General Psychiatry, 
43, 1029-1036. 
Bremner, J.D. (2004). Brain imaging in anxiety disorders. Expert Review of 
Neurotherapeutics, 4, 275-284. 
Breslau, N., & Davis, G.C. (1993). Migraine, Physical Health and Psychiatric 
Disorder: A Prospective Epidemiological Study in Young Adults. Journal of 
Psychiatric Research, 27, 211-221. 
 
Reference  189 
 
Brown, G.K., Beck, A.T., Newman, C.F., Beck, J.S., & Tran, G.Q. (1998). A 
Comparison of Focused and Standard Cognitive Therapy for Panic Disorder. 
Journal of Anxiety Disorders, 11, 329-345. 
Brown, T.A., & Cash, T.F. (1989). The phenomenon of panic in nonclinical 
populations: Further evidence and methodological considerations: Journal of 
Anxiety Disorders, 3, 139-148. 
Burlingame, G.M., Fuhriman, A., & Mosier. (2003). The differential effectiveness of 
group psychotherapy : A meta-analytic perspective. Group Dynamics: Theory, 
Research and practice, 7, 3-12. 
Burlingame, G.M., MacKenzie, K.R., & Strauss, B. (2004). Small group treatment: 
Evidence for effectiveness and mechanism of change. In M.J. Lambert (5th ed.). 
Bergin & Garfield's Handbooks of psychotherapy and behavior change (pp. 647-
696). New York: Wiley & Sons. 
Burns, L.E., Thorpe, G.L., & Cavallaro, L.A. (1986). Agoraphobia 8 years after 
behavioral treatment: A follow-up study with interview, self-report, and 
behavioral data. Journal Behavioral Therapy, 17, 580-591. 
Butler, A. C., Chapman, J. E., Forman, E. M., Beck, A. T. (2006). The empirical status 
of cognitive-behavioral therapy: a review of meta-analyses. Journal of Clinical 
Psychology Review, 26, 17–31.  
Bystritsky, A., Craske, M., Maidenberg, E., Vapnik, T., & Shapiro, D. (2000). 
Autonomic reactivity of panic patients during a CO2 inhalation procedure. 
Journal Depression and Anxiety, 11, 15-26. 
Cabill, S. P. & Foa, E. B. (2003). Anxiety disorders. In Nutt, D. J. & Ballenger, J. C, 
(Eds), Exposure therapy in treatment of anxiety disorders, pp. 445-463. Blackwell 
publishing company.  
Caldirola, D., Bellodi, L., Caumo, A., Giovanni, M., & Giampaolo, P. (2004). 
Approximate Entropy of Respiratory Patterns in Panic Disorder. American 
Journal of Psychiatry, 161, 79-87.  
Calloway, N. J. (2007). A comparative study of the effects of photostimulation and 
Autogenic training in reducing stress, Anxiety, and depression. A comparative 
study.  
Cameron, O.G. (2007). Understanding Comorbid Depression and Anxiety. 
Psychiatric Times Magazine, 14, 24. 
Carlbring P, Ekselius L, Andersson G. (2002). Treatment of panic disorder via the 
Internet: a randomized trial of CBT vs. applied relaxation. Journal of behavior 
therapy and experimental Psychiatry.  
Carlbring, P., Bohman, S., Brunt, S., Buhrman, M., Westling, B. E., Ekselius, L., & 
 
 Reference  190 
 
Anderson, G. (2006). Remote treatment of panic disorder: A randomized trial of 
Internet based cognitive behavior therapy supplemented with telephone calls. 
American Journal of Psychiatry, 163, 2119-2125.  
Carter, M. M., Sbrocco, T., Gore, K. L., Watt Marin, N. W., & Lewis, E. L. (2003). 
Cognitive-behavioral group therapy versus a wait-list control in the treatment of 
African-American women with panic disorder. Journal of Cognitive Therapy and 
Research, 27, 505–518. 
Cartner, M. M., & Barlow, D. H. (1995). Learned alarms: The origins of panic. In W. L. 
O'Donohue & L. Krasner. (Eds), Theories of behavior therapy: Exploring 
behavior change, (pp. 209-228). New York: Guilford press.  
Casey, L. M., Oei, T. P. S., Newcombe, P. A., & Kenardy, J. (2004a). The role of 
catastrophic misinterpretation of bodily sensations and panic self-efﬁcacy in 
predicting panic severity. Journal of Anxiety Disorders, 18, 325-340.  
Casey, L. M., Oei, T. P. S., & Newcombe, P. A. (2004b). An integrative cognitive 
model of panic disorder: The role of positive and negative cognitions. Journal of 
Clinical Psychology Review, 24, 529-555.  
Chambless, D. L. (1985). The relationship of severity of agoraphobia to associated 
psychopathology. Journal of Behavior Research Therapy, 23, 305-310.  
Chambless, D. L., Caputo, G., Bright, P. & Gallagher, R. (1985). Assessment of fear 
among agoraphobics: The body sensation questionnaire and the Agoraphobic 
cognition questionnaire. Journal of consulting and clinical psychology, 6, 1090-
1097.  
Chambless, D., & Gillis, M. (1993). Cognitive therapy of Anxiety disorders. Journal of 
consulting and clinical psychology, 61, 248-260.  
Choi, K.W., Woo, J. M., Kim, Y. R., Lee, S. H., Lee, S.Y., Kim, E. J., Chung, S. K., Kang, 
E. H., Lee, J. H., & Yu, B. H. (2012). Long-term escitalopram treatment in Korean 
patients with Panic Disorder: A Prospective, Naturalistic, Open-label, Multicenter 
Trial. Journal Clinical Psychopharmacol Neuroscience.10, 1-44. 
Choi, Y. H., Park, K. H. (2006). Therapeutic factors of cognitive behavioral group 
treatment for social phobia. Journal of the Korean Medical Society, 21, 333-336.  
Chouinard, G. (2004). Issues in the clinical use of benzodiazepines: potency, 
withdrawal, and rebound. Journal of clinical psychiatry, 65, 7-12.  
Choy, Y. (2008). Treatment Planning for Panic Disorder. Psychiatric Times magazine, 
Vol. 25 No. 2.  
Clark, D. M. (1986). A cognitive approach to panic. Journal of Behavior Research and 
Therapy, 24, 461-470.  
 
Reference  191 
 
Clark, D. M. (1988). A cognitive model of panic attacks. In S. Rachman & J. D. Maser, 
(Eds), Panic: Psychological perspectives (pp. 71–90). New Jersey: Lawrence 
Erlbaum Associations. 
Clark, D. M. (1996). Panic disorder: From theory to therapy. In P. M. Salkovskis (Ed.), 
Frontiers of cognitive therapy, (pp. 318-344). New York: Guilford Press.  
Clark, D. A., & Beck, A. T. (2009). Cognitive Therapy of Anxiety Disorders: Science 
and Practice. Cognitive therapy of panic disorder, (pp. 275-332): Guilford Press. 
Clark, D. M., Salkovskis, P. M., & Challey, A. J. (1985). Respiratory control as a 
treatment for panic attacks. Journal of Behavioral Therapy and Experimental 
Psychiatry, 16, 23-30.  
Clark, D. M., Salkovskis, P. M., Hackman, A., Middleton, H., Anastasiades, P., & 
Gelder, M. (1994). A comparison of cognitive therapy, applied relaxation and 
imipramine in the treatment of panic disorder. British Journal of Psychiatry, 164, 
759-769.  
Clark, D. M., Salkovskis, P. M., Hackmann, A., Wells, A., Ludgate, J., & Gelder, M. 
(1999). Brief cognitive therapy for panic disorder: A randomized controlled trial. 
Journal of Consulting and Clinical Psychology, 67, 583–589. 
Clark, D. M., Steer, R. A., & Beck, A. T. (1994). Common and speciﬁc dimensions of 
self-reported anxiety and depression: Implications for the cognitive and tripartite 
models. Journal of Abnormal Psychology, 103, 645–654. 
Clerkin, E.M., Teachman, B.A., Smith Janik, S.B. (2008). Sudden gains in group 
cognitive-behavioral therapy for panic disorder. Journal of Behavior Research 
and Therapy, 46, 1244–1250. 
Clum, G. A. (1989). Psychological interventions vs. drug in the treatment of panic. 
Journal of Behavior therapy, 20, 429-457.  
Clum, G. A. (1990). Coping with panic: A drug free approach to dealing with anxiety 
attack. California: Brooks/Cole Publishing Co.  
Compton, W., Thomas, Y., Stinson, F., & Grant, B. (2007). Prevalence, Correlates, 
Disability, and Comorbidity of DSM-IV Drug Abuse and Dependence in the 
United States: Results From the menbereich the National Epidemiological Survey 
on Alcohol and Related Conditions. Archives of General Psychiatry 64, 566-576.  
Conrad, A. & Roth W. T. (2007). Muscle relaxation therapy for anxiety disorders: It 
works but how? Journal of Anxiety Disorders, 21, 243-264.  
Corey, G. (2008). Ethical and professional issues in group practice, (8 th ed). Theory 
and practice of group counseling, (pp. 47-67). Belmont, CA: Brooks/Cole. 
Corey, G. (2009). Existential Therapy, (9 th ed.). Theory and Practice of Counseling 
 
 Reference  192 
 
and Psychotherapy (pp. 136-157). Brooks/Cole.  
Coryell, W., Pine. D., Fyer. A., Klein, D. (2006). Anxiety responses to CO2 inhalation 
in subjects at high-risk for panic disorder. Journal Affective disorder 92, 63-70.  
Cosci, F., Knuts, I. J., Abrams, K., Griez, E. J., Schruers, K. R. (2010). Cigarette 
smoking and panic: a critical review of the literature. Journal of Clinical 
Psychiatry, 71, 606-615. 
Courtney, R. D. O. (2011). Dysfunctional Breathing and Relevance: Its parameters, 
measurement and relevance, (pp. 31-32). RMIT University. 
Cox, B. J. 1999. The role of anxiety sensitivity in panic and other disorders. Program 
abstracts of the 19th National Conference of the Anxiety Disorders Association of 
America (ADAA) 24:86. 
Cox, B. J., Endler, N. S., & Swinson, R. P. (1995). An examination of levels of 
agoraphobic severity in panic disorder. Journal of Behavior Research & Therapy, 
33, 57–62. 
Cox, B. J., Swinson, R. P., & Shaw, B. F. (1991). Value of the Fear Questionnaire in 
differentiating agoraphobia and social phobia. The British Journal of Psychiatry, 
159, 842-845.  
Cramer, V., Torgersen, S., & Kringlen, E. (2005). Quality of life and anxiety disorders: 
a population study. Journal of Nervous and Mental Disease, 193, 196-202.  
Craske, M. G. (1999). Anxiety disorder: psychological approaches to theory and 
treatment. Boulder, Co: West view press. 
Craske, M. G., DeCola J. P., Sachs A. D., & Pontillo, D. C. (2003). Panic control 
treatment for agoraphobia. Journal Anxiety Disorder, 17, 321-333.  
Craske, M.G., Farchione, T.J., Allen, L.B., (2007). Cognitive behavioural therapy for 
panic disorder and comorbidity: More of the same or less of more? Journal of 
Behavior Research Therapy, 45, 1095–109. 
Craske, M. G., Barlow, D. H., & Meadows, E. A. (1994). Therapist guide for the 
mastery of your anxiety and panic II and agoraphobia supplement. Albany, New 
York: Graywind Publications Incorporated.  
Craske, M. G., & Barlow, D. H. (2008). Panic disorder and agoraphobia. In D. H. 
Barlow (Ed). Clinical handbook of psychological disorders (pp. 1-64) (4th ed.). 
New York: Guilford Press.  
Craske, M. G., Brown, T. A., & Barlow, D. H. (1991). Behavioral treatment of panic 
disorder: A two-year follow-up. Journal Behavior Therapy, 22, 289-304. 
Craske, M. G., Maidenberg, E. & Bystritsky, A. (1995). Brief cognitive behavioral 
 
Reference  193 
 
versus nondirective therapy for panic disorder. Journal of behavior therapy and 
experimental psychology, 26, 113-120.  
Craske, M. G., Miller, P. P., Rotunda, R., & Barlow, D. H. (1990). A descriptive report 
of features of initial unexpected panic attacks in minimal and extensive avoiders. 
Journal of Behavior Research and therapy, 28, 395-400.  
Craske, M. G., Rowe, M., Lewin, M., & Noriega-Dimitri, R. (1997). Interoceptive 
exposure versus breathing retraining within cognitive-behavioural therapy for 
panic disorder with agoraphobia. British Journal of Clinical psychology 36, 85-99. 
Crowe, R. R. (1985). The genetics of panic disorder and agoraphobia. Journal of 
Psychiatric Development, 2, 171-186.  
Crowe, R. R., Noyes R., Pauls, D. L., & Slymen, D. (1983). A family study of panic 
disorder. Archive General Psychiatry, 40, 1065-1069.  
Cuijpers, P., van Straten, A., & Warmerdam, L. (2008). Are individual and group 
treatments equally effective in the treatment of depression in adults? A meta-
analysis. Journal of European Psychiatry, 22, 38-51. 
Dannon, P. N., Gon-Usishkin, M., Gelbert, A., Lowengrub, K., & Grunhaus, L. (2004). 
Cognitive behavioral group therapy in panic disorder patients: the efficacy of 
CBGT versus drug treatment. Annals of Clinical Psychiatry, 16, 41-46.  
Dannon, P. N., Iancu I., & Grunhaus, L. (2002). Psychoeducation in panic disorder 
patients: effect of a self-information booklet in a randomized, masked-rater 
study. Journal of Depression and Anxiety, 16, 71-76.  
Deacon, B., Lickel, J., Possis, E., Abramowitz, B. M., & Taylor. K. W. (2012). Do 
Cognitive Reappraisal and Diaphragmatic Breathing Augment Interoceptive 
Exposure for Anxiety Sensitivity? Journal of Cognitive Psychotherapy: An 
International Quarterly, 26, 257-269. 
Deacon, B., & Abramowitz, J. (2006). A pilot study of two-day cognitive-behavioral 
therapy for panic disorder. Journal of Behavior Research and Therapy, 44, 807– 
817.  
Deacon, B., & Abramowitz, (2004). Cognitive and behavioural treatments for Anxiety 
Disorders: A review of meta-analytic findings. Journal of Clinical Psychology, 60, 
429-441. 
DeGuire, S., Gevirtz, R., Hawkinson, D., & Dixon, K. (1996). Breathing retraining: a 
three-year follow-up study of treatment for hyperventilation syndrome and 
associated functional cardiac symptoms. Journal of biofeedback and self-
regulation, 21, 191-198.  
DeGuire, S., Gevirtz, R., Kawahara, Y., & Maguire, W. (1992). Hyperventilation 
syndrome and the assessment of treatment for functional cardiac symptoms. 
 
 Reference  194 
 
American Journal of Cardiology 70, 673-677.  
De Ruiter, C., Rijken, H., Garssen, B., & Kraaimatt, F. (1989). Breathing retraining, 
exposure and a combination of both, in the treatment of panic disorder with 
agoraphobia. Journal of Behavior Research and Therapy, 27, 647-655. 
DiNardo, P. A., & Barlow, D. H. (1988). Anxiety Disorders Interview Schedule-
Revised (AD1S-R). Albany, NY: Graywind Publications.  
Dixon, L. J., Sy, J.T., Kemp, J. J., & Deacon, B. J. (2013). Does Anxiety Sensitivity 
Cause Panic Symptoms? An Experimental Investigation, Journal of Experimental 
Psychopathology, 4, 208-223. 
Donnel, C. D., & McNally, R. J. (1990). Anxiety sensitivity and panic attacks in a 
nonclinical population. Journal of Behavior Research and Therapy, 28, 83-85.  
Dorland's pocket medical Dictionary (1982). (23 th ed). WB Saunders Co 
Philadelphia.  
Eaton, W. W., Kessler, R. C., Wittchen, H. U., & Magee, W. J. (1994). Panic and panic 
disorder in the United States. American Journal Psychiatry 151, 413 - 420.  
Ehlers, A. (1993). Somatic symptoms and panic attacks: A retrospective study of 
learning experiences. Journal of Behavior Research and Therapy, 31, 269-278.  
Ehlers, A. (1995). A one-year prospective study of panic attacks: Clinical course and 
factors associated with maintenance. Journal of Abnormal psychology, 104, 164–
172. 
Eidelson, J. I. (1985). Cognitive group therapy for depression: Why and What. 
International journal of Mental Health, 13, 54-66.  
Eifert, G. H., & Forsyth, J. P. (2005). Acceptance and commitment therapy for anxiety 
disorders: A practitioner’s guide to using mindfulness, acceptance, and value-
based behavior change strategies. Oakland, CA: New Harbinger.  
Emmrich, A., Beesdo-Baum, K., Gloster, A. T., Knappe, S., Höfler, M., Arolt, V., 
Deckert, J., Gerlach, A. L., Hamm, A. O., Kircher, T., Lang, T., Richter, J., Ströhle, 
A., Zwanzger, P., & Wittchen, H. U. (2012). Depression does not affect the 
treatment outcome of CBT for panic and agoraphobia: results from a multicenter 
randomized trial. Journal of Psychotherapy and Psychosomatics, 8, 161-172.  
Erickson, D. H., Janeck, A. S., & Tallman, K. (2007). A cognitive-behavioral group for 
patients with various anxiety disorders. Journal of Psychiatry Service, 58, 1205-
1211.  
Evans, L., Holt, C., & Oei, T.P. (1991). Long term follow-up of agoraphobics treated 
by brief intensive group cognitive behavioural therapy. Australian and New 
Zealand Journal of Psychiatry 25, 343-349. 
 
Reference  195 
 
Fava, G. A., Rafanelli, C., & Grandi, S. (2001). Long-term outcome of panic disorder 
with agoraphobia treated by exposure. Journal of Psychological Medicine, 5, 891-
898.  
Foa, E., & Kozak, M. J. (1986). Emotional processing of fear: Exposure to correcting 
information. PsychologicalBulletin, 99, 20-35. 
Forsyth, J. P., & Eiferta, J. H. (1996). Systemic alarms in fear conditioning I: A 
reappraisal of what is being conditioned. Journal of Behavior Therapy, 27, 441-
462.  
Forsyth, J. P., Acheson, D. A., & Fusé, T. M. (2009). General principles and 
empirically supported. In W. O'Donohue., J. Fisher & S. C. Hayes (Eds), 
Interoceptive exposure for panic disorder. John Willey & Sons.  
Frankel, B. (2002). Existential issues in group psychotherapy. International Journal of 
Group Psychotherapy, 52, 115–131.  
Franklin, J. A. (1989). A 6-years follow-up of the effectiveness of respiratory 
retraining in-situ isometric relaxation and cognitive modification in the treatment 
of agoraphobia. Journal of Behavior modification 13, 139-167. 
Franklin, J. A., & Andrews, G. (1989). Stress and the onset of agoraphobia. Australian 
psychologist journal, 24, 203-219.  
Fuhriman, A., & Burlingame, G. M. (1994). Group psychotherapy: Research and 
practice. In A. Fuhriman & G. M. Burlingame (Eds.). Handbook of group 
psychotherapy (pp. 3-40). New York: Wiley. 
Furer, P., Walker, J. R., Chartier, M. J., Stein, M. B.(1997). Hypochondriacal concerns 
and somatization in panic disorder. Journal of Depression & Anxiety. 6, 78-85. 
Furukawa, T. A., Watanabe, N., & Churchill, R. (2006). Psychotherapy plus 
antidepressant for panic disorder with or without agoraphobia: systematic 
review. British Journal of Psychiatry, 188, 305-312.  
Fydrich, T., Dowdall, D., & Chambless, D. L. (1992). Reliability and validity of the 
Beck Anxiety Inventory. Journal of Anxiety Disorders, 6, 55-61.  
Fyer, M. R., Uy, J., Martinez, J., Goetz, R., Klein, D. F., Fyer, A., Liebowitz, M. R., & 
Gorman, J. (1987). CO2 challenge of patients with panic disorder. American 
Journal of psychiatry, 144, 1080-1082.  
Fyer, A. J., Mannuzza, S., Chapman, T. F., Lipsitz, J., Martin, L. Y., & Klein, D. F. 
(1996). Panic disorder and social phobia: effects of comorbidity on familial 
transmission. Journal of Anxiety 2, 173–178.  
Gabbard, G. O. (2004). Panic Disorder. Gabbard's treatments of psychiatric disorders 
(pp. 485-487) (4 th ed). American Psychiatric Publishing.  
 
 Reference  196 
 
Galassi, F., Quercioli, S., Charismas, D., Niccolai, V., & Barciulli, E. (2007). Cognitive-
behavioral group treatment for panic disorder with agoraphobia. Journal Clinical 
Psychology, 63, 409-416.  
Gallo K. P., Chan P. T., Buzzella, B. A., Whitton, S. W., & Pincus, D. B. (2012). The 
impact of an 8-day intensive treatment for adolescent panic disorder and 
agoraphobia on comorbid diagnoses. Journal of Behavior therapy, 43, 153-159.  
Garakani, A., Mathew, S. J., & Charney, D. S. (2006). Neurobiology of anxiety 
disorders and implications for treatment. Mount Sinai Journal Medicine, 73, 941-
949.  
García-Cabeza, I., Ducajú, M., Chapela, E., & González de Chávez, M (2011). Group 
Analysis. American psychological association (APA), 44, 421-438. 
Garssen, B., De Ruiter, C., & Van Dyck, R. (1992). Breathing retraining: A rational 
placebo? Clinical Psychology Review, 12, 141-153.  
Gibbs, D. M. (1992). Hyperventilation-Induced Cerebral Ischemia in Panic Disorder 
and Effect of Nimodipine. American Journal of Psychiatry, 49, 1589-1591.  
Gloster, A. T.,Wittchen, H. U., Einsle, F., Lang, T., Helbig- Lang, S., Fydrich, T., Fehm, 
L., Hamm, A. O., Richter, J., Alpers, G. W., Gerlach, A. L., Ströhle, A., Kircher, T., 
Deckert, J., Zwanzger, P., Höfler, M., & Arolt, V. (2011). Psychological Treatment 
for Panic Disorder with Agoraphobia: A Randomized Controlled Trial to 
Examine the Role of Therapist-Guided Exposure in-situ in CBT. Journal of 
Consulting and Clinical Psychology, 79, 406-420.  
Goldstein, A. J., & Chambless, D. L. (1978). A reanalysis of agoraphobia. Journal of 
Behavior Therapy, 9, 47–59. 
Goldstein, R. B., Wickramaratne, P. J., Horwath, E., & Weissman, M. (1997). Familial 
aggregation and phenomenology of 'early'-onset (at or before age 20 years) panic 
disorder. Archives of General Psychiatry, 54, 271-278.  
Goldstein, R. B.,Weissman, M. M., Adams, P. B., Howath, E., Lish, J.D., Charney, D., 
Woods, S.W., Sobin, C., & Wickramaratne, P.j. (1994). Psyciatric disorders in 
relatives of probands with panic disorders and or major depression. Archive 
genetic psychiatry, 51, 383-394.  
Goodwin, R. D. (2002). Self-report hay fever and panic attacks in the community. 
Annuals of Allergy, Asthma, and Immunology, 88, 556-559. 
Goodwin, R. D., Pine, D. S., & Hoven, C. W. (2003). Asthma and panic attacks among 
youth in the community. Journal of Asthma, 40, 139-145.  
Goodwin, R. D., & Roy-Birne, P. (2006). Panic and suicidal ideation and suicide 
Attempt: Result from the National Comorbidity Survey. Journal of Depression 
and Anxiety, 23, 124-132.  
 
Reference  197 
 
Gorman, J. M., Askanazi, J., Liebowitz, M. R., Fyer, A. J., Stein, J., Kinney, J. M., & 
Klein, D. F. (1984). Response to hyperventilation in a group of patients with panic 
disorder. American Journal Psychiatry, 141, 857-861. 
Gorman, J. M., Fyer, M. R, Goetz, R., Askanazi, J., Liebowitz, M. R., Fyer, A. J., 
Kenny, J., & Klein, D. F. (1988). Ventilatory physiology of patients with panic 
disorder. Archives of General Psychiatry, 45, 31-39. 
Gorman, J. M., Kent, J. M., Sullivan, G. M., & Coplan, J. D. (2000). Neuroanatomical 
hypothesis of panic disorder, revised. American Journal of Psychiatry, 157, 493-
505.  
Gorman, J. M., Martinez, J., Browne, S., Coplan, J., & Papp, L. A. (2001). Physiological 
Changes during Carbon Dioxide Inhalation in Patients with Panic Disorder, 
Major Depression, and Premenstrual Dysphoric Disorder: Evidence for a Central 
Fear Mechanism. Journal Archive of General Psychiatry, 58, 125-131.  
Gorman, J. M., Papp, L. A., Coplan, J. D., Martinez, J, M., Lennon, S., Goetz, R. R., 
Ross, D., & Klein, D. (1994). Anxiogenic Effects of CO2 and Hyperventilation in 
patients with Panic Disorder, American Journal of psychiatry, 151, 547-553.  
Gould, R. A., Otto, M. W., & Pollack, M. H. (1995). A meta-analysis of treatment 
outcome for panic disorder. Clinical Psychology Review, 15, 819–844.  
Grant, B. F., Hasin, D. S., Stinson, F. S., Dawson, D. A., Goldstein, R. B., Smith, S., 
Huang, B., & Saha, T. D. (2006). The epidemiology of DSM-IV panic disorder and 
agoraphobia in the United States: results from the National Epidemiologic 
Survey on Alcohol and Related Conditions. The journal of clinical psychiatry, 67, 
363-374.  
Gratacòs, M., Sahún, I., Gallego, X., Amador-Arjona, A., & Dierssen, M. (2007). 
Candidate genes for panic disorder: insight from human and mouse genetic 
studies. Journal of Genes, Brain and Behavior, 6, 2-23.  
Greenberg, P. E., Sisitsky, T., Kessler, R. C., Finkelstein, S. N., Berndt, E. R, Davidson, 
J. R., Ballenger. J. C., & Fyer, A. J. (1999). The economic burden of anxiety 
disorders in the 1990s. Journal of Clinical Psychiatry 60, 427–435.  
Gregor, K. L., Zvolensky, M. J., & Yartz, A. R. (2005). Perceived health among 
individuals with panic disorder: associations with affective vulnerability and 
psychiatric disability. The journal of nervous and mental disease, 193, 697-699.  
Griez, E., de Loof, C, Pols, H., Zandbergen J., & Lousberg, H. (1990a). Specific 
sensitivity of patients with panic attacks to carbon dioxide inhalation. Psychiatry 
Research, 31, 193-199.  
Griez, E., Zandlbergen, J., Pols, H., & de Loof, C. (1990b). Responses to 35% CO2 as a 
marker of panic in sever anxiety. American Journal of psychiatry, 145, 796-797.  
 
 Reference  198 
 
Grillon, C. H., Lissek, S., Rabin, S., McDowell, D., Dvir, S., & Pine, D. S (2008). 
Increased Anxiety During Anticipation of Unpredictable But Not Predictable 
Aversive Stimuli as a Psychophysiologic Marker of Panic Disorder. American 
Journal Psychiatry, 165, 898–904.  
Guy, J. D., Stark, M. J., & Polestra, P. L. (1988). Personal therapy for psychotherapists 
before and after entering professional practice. Professional Psychology: Research 
and Practice, 19, 474-476.  
Hafner, R. J., & Milton, F. (1977). The influence of propranolol on the exposure in 
vivo of agoraphobics. Journal of Psychological Medicine, 7, 419-425.  
Hayward, C., Killen, J. D., Kraemer, H. C., & Taylor, C. B. (2000). Prospective 
predictors of panic in adolescents. Journal of the Academy of Child Psychiatry, 
39, 1-8. 
Hazlett-Stevens, H., & Craske, M. G. (2004). Brief Cognitive-Behavioral Therapy: 
Definition and Scientiﬁc Foundations. In F. W. Bond & W. Dryden (Eds.), 
Handbook of Brief Cognitive Behavior Therapy (pp. 1-21). John Wiley & Sons 
Ltd.  
Hazlett-Stevens, H. & Craske, M. G. (2009). Breathing retraining and diaphragmatic 
breathing techniques. In W. T, O’Donohue & J. E, Fisher (Eds.). General 
Principles and Empirically Supported Techniques of Cognitive behavior therapy 
(pp. 166-172). John Wiley & Sons, Inc., Hoboken, New Jersy. 
Hecker, J. E., Losee, M. C., Roxann, R. N., & Maki, K. (2004). Mastery of your anxiety 
and panic and brief therapies. Journal of anxiety disorders, 18, 111-126. 
Heimberg, R. G., & Becker, R. E. (2002). Cognitive behavioral group therapy for 
social phobia: A treatment manual. Cognitive-behavioral group therapy for social 
phobia: Basic mechanisms and clinical strategies (pp. 129-132). New York: 
Guilford Press.  
Heldt, E., Blava, C., Isolan, L., Kipper, L., Teruchkin, B., Otto, M. W., Fleck, M., & 
Manfro, G. G. (2006). Quality of life and treatment outcome in panic disorder: 
cognitive behavior group therapy effects in patients refractory to medication 
treatment. Journal of Psychotherapy Psychosomatics, 75, 183-186.  
Heldt, E., Kipper, L., Blaya, C., Salum, G. A., Hirakata, V. N., Otto, M. W., & et al. 
(2010). Predictors of relapse in the second follow-up year post cognitive-behavior 
therapy for panic disorder. Revista Brasileira de Psiquiatria, 33, 23-29. 
Hendriks, G. J., Keijsers, G. P. J., Kampman, M., Oufr Voshaar. R. C., Verbraak, M. J. 
P. M., Broekman, T. G., & Hoogduin, C. A. L. (2010). A randomized controlled study 
of paroxetine and cognitive-behavioral therapy for late-life panic disorder. ACTA 
Psychiatr Scand, 122, 11-19. 
 
 
Reference  199 
 
Hibbert, G. A., & Chan, M. (1989). Respiratory control: its contribution to the 
treatment of panic attacks. A controlled study. Journal Psychiatry, 6, 154-232.  
Hiller, W., Leibbrand, R., Rief, W., & Fichter, M. M. (2005). Differentiating 
hypochondriasis from panic disorder. Journal of Anxiety Disorders, 19, 29-49.  
Hocaoglu, C., Gulec, M. Y., & Durmus, I. (2008). Psychiatric comorbidity in patients 
with chest pain without a cardiac etiology. Israel Journal of Psychiatry & Related 
Sciences, 45, 49-54. 
Hoffart, A., Sexton, H., Hedley, L. M., & Martinsen, E.W. (2008). Therapy 
Mechanisms of change in cognitive therapy for panic disorder with agoraphobia, 
Journal of Behavior Therapy and Experimental Psychiatry, 39, 262-272. 
Hofmann, S. G., Barlow, D. H., Papp, L. A., Detweiler, M. F., Ray, S. E., Shear, M. K., 
Woods, S. W., & Gorman, J. M. (1998). Pretreatment attrition in a comparative 
treatment outcome study on panic disorder. American Journal of Psychiatry, 155, 
43-47.  
Hofmann, S. G., Meuret, A. E., Rosenfield, D., Suvak, M. K., Barlow, D. H., Gorman, 
J. M., Shear, M. K., & Woods, S. W. (2007). Preliminary evidence for cognitive 
mediation during cognitive behavioral therapy for panic disorder. Journal of 
Consulting and Clinical Psychology, 75, 374-379. 
Hofmann, S. G., & Smits, J. A. (2008). Cognitive-behavioral therapy for adult anxiety 
disorders: a meta-analysis of randomized placebo-controlled trials. Journal of 
Clinical Psychiatry, 69, 621–632.  
Hofmann, S. G., & Spiegel, D. A. (1999). Panic Control Treatment and its 
Applications. Journal Psychotherapy Practice and Research, 8, 3-11. 
Hollander, E., Liebowitz, M. R., & Gorman, J. M. (1988). Anxiety. In J. A. Talbott, R. 
E. Hale & S. C. Yudolsky (Eds.). The American Psychiatric press textbook of 
psychiatry. Washington DC: American Psychiatric.  
Hollander, E., & Simeon, D. (2010). Anxiety disorders. In R. E. Hales., S. C. Yudofsky, 
G. O. Gabbard (Eds). Essentials of Psychiatry, (pp. 185-229) (3th ed). Amercian 
Psychiatric Publishing, Inc. 
Holmes, S. E., & Kivlighan D. M. (2000). Comparison of Therapeutic factors in Group 
and individual treatments processes. Journal of counseling psychology, 47, 478-
484.  
Hopper, J. L., Judd, F. K., Derrick, P. L., & Burrows, G. D (1987). A family study of 
panic disorder, "Genetic epidemiology, 4, 33-41.  
Horvath, A. O., Del Re, A. C., Flückiger, C., & Symonds, D. (2011). Alliance in 
individual psychotherapy. Psychotherapy: Theory, Research, Practice, Training, 
48, 9-16.  
 
 Reference  200 
 
Houghton, S., & Saxon, D. (2007). An evaluation of large group CBT psycho-
education for anxiety disorders delivered in routine practice. Patient Education 
and Counseling journal, 68, 107-110.  
Hoyer, J., Becker, E. S., Neumer, S., Soeder, U., & Margraf, J. (2002). Screening for 
anxiety in an epidemiological sample: Predictive accuracy of questionnaires. 
Journal of Anxiety Disorders, 16, 113-134.  
Huh, Y. J., Choi, Y. H., & Park, K. H. (2003). Therapeutic factors of group cognitive 
behavioral therapy for panic disorder. Journal of Cognitive Behavior Therapy in 
Korea, 3, 57-67.  
Iketani, T., Nagao, K., Minamikawa, N., Shidao, A., et al. (2002). Anxiety sensitivity 
and catastrophic cognition in panic disorder: Association with agoraphobia. 
Journal Clinical Psychiatry, 44, 977-983.  
Ito, L. M., de Araujo, L. A., Tess, V. L., de Barros-Neto, T. P., Asbahr, F. R., & Marks, 
I. (2001). Self-exposure therapy for panic disorder with agoraphobia: randomized 
controlled study of external v. interoceptive self-exposure. British Journal of 
Psychiatry, 178, 331-336.  
Jacob, R. G., & Rapport, M. D. (1984). Panic disorder: Medical and Psychological 
Parameters. In S. M. Turner (Ed), Behavioral theories and treatment of anxiety 
(pp. 321-365). New York: Plenum Press.  
Jacobson, E. (1938). Progressive relaxation. Chicago: University of Chicago Press.  
Jette, N., Patten, S., Williams, J., Becker, W., Wiebe, S. (2008). Comorbidity of 
migraine and psychiatric disorders —a national popula tion-based study. 
Headache. 48, 501-516. 
Kajander, R., & Peper, E. (1998). Teaching diaphragmatic breathing to children. 
Biofeedback, 26, 14-17. 
Jang, K. L. (2005). The behavioral genetics of psychopathology: a clinical guide, 
Lawrence Erlbaum Associations., publishers. 
Jansson. L., Jerremalm. A., & Öst, L. G. (1986). Follow-up of agoraphobic patients 
treated with exposure in vivo or applied relaxation. British Journal of Psychiatry, 
149, 486-490.  
Kashdan, T. B., Zvolensky, M. J., & McLeish, A. C. (2008). Anxiety sensitivity and 
affect regulatory strategies: Individual and interactive risk factors for anxiety-
related symptoms. Journal of Anxiety Disorders, 22, 429-440.  
Katerndahl, D. A. (1988). The sequence of panic symptoms. Journal of family 
practice, 26, 49-52. 
Katerndahl, D. A., & Realini, J. P. (1997). Quality of life and panic-related work 
 
Reference  201 
 
disability in subjects with infrequent panic and panic disorder. Journal of Clinical 
Psychiatry, 58, 153-158.  
Katon, W. (1986). Panic disorder; Epidemiology, diagnostic, and treatment in 
primary care. Journal of clinical psychology, 47, 21-27.  
Katon, W. (1994). Panic disorder in the medical setting. Washington, DC: National 
Institute of Mental Health.  
Katon, W., Hollified, M., Chapman, T., Mannuzza, S., Ballenger, J., & Fyer, A. (1995). 
In frequent panic attack: Psychiatric comorbidity, personality characteristic and 
functional disability. Journal of psychiatric research, 29, 121-131.  
Katon, W., Lin, E., Von Korff, M., Russo, J., Lipscomb, P., & Bush, T. (1991). 
Somatization: a spectrum of severity. American Journal of Psychiatry, 148, 34-40.  
Kaviani, H., & Mousavi, A. (2008). Psychometric properties of the Persian version of 
Beck Anxiety Inventory (BAI). Tehran University Medical Journal, 2, 136-140.  
Kenardy, J. A., Dow, M. G., Johnston, D. W., Newman, D. G., Thomson, A., & Taylor, 
C. B. (2003). A multicenter comparison of delivery methods of cognitive-
behavioral therapy for panic disorder: an international multicenter trial. Journal 
of Consulting and Clinical Psychology, 71, 1068-1075. 
Kenardy, J., Oei, T. P. S., & Evans, L. (1990). Hyperventilation and Panic Attack 
Australian and New Zealand Journal of Psychiatry, 24, 261-267. 
Kenardy, J., & Taylor, C. B. (1999). Expected versus unexpected panic attacks: a 
naturalistic prospective study. Journal Anxiety Disorder, 13, 435-45.  
Kendall, P. C., & Watson, D. (Eds.) (1989). Anxiety and depression: Distinctive and 
overlapping features. Academic Press, San Diego, CA.  
Kessler, R. C., Berglund, P., Demler, O., Jin, R., Merikangas, K. R., & Walters, E. E. 
(2005a). Lifetime prevalence and age-of-onset distributions of DSM-IV disorders 
in the National Comorbidity Survey Replication. Archives of general psychiatry, 
62, 593-602. 
Kessler, R. C., Chiu, W. T, Demler, O., Merikangas, K. R., & Walters, E. E. (2005b). 
Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the 
National Comorbidity Survey Replication. Archives of General Psychiatry, 62, 
617-27.  
Kessler, R. C., Chiu, W. T., Jin, R., Ruscio, A. M., Shear, K., & Walters, E. E. (2006). 
The epidemiology of panic attacks, panic disorder, and agoraphobia in the 
National Comorbidity Survey Replication. Archives of general psychiatry, 63, 
415-424.  
Kessler, R.C., Stang, P.E., Wittchen, H.U., Ustun, T.B., Roy-Burne, P.P., & Walters, 
 
 Reference  202 
 
E.E. (1998). Lifetime panic-depression comorbidity in the National Comorbidity 
Survey. Arch General Psychiatry, 55, 801-808. 
Khawaja, N. G., & Oei, T. P. S. (1998). Catastrophic cognitions in panic disorder with 
and without agoraphobia. Clinical Psychology Review, 18, 341-365.  
Khoshbooii, R. (2012). Comparison Group and Individual Cognitive Behavioral 
Therapy in Treatment of Depression among Iranian Women around Menopause. 
International Journal of Psychological Studies, 4, 174-181.  
Kiliç, C., Noshirvani, H., Basoglu, M., & Marks, I. (1997). Agoraphobia and panic 
disorder: 3. 5 years after alprazolam and/or exposure treatment. Journal of 
Psychotherapy Psychosomatic, 66, 175-178.  
Kim, B., Lee, S. H., Kim, Y. W., Choi, T. K., Yook, K., Suh, S. Y., Cho, S. J., & Yook, K. 
H, (2010). Effectiveness of a mindfulness-based cognitive therapy program as an 
adjunct to pharmacotherapy in patients with panic disorder. Journal Anxiety 
Disorder, 24, 590-595.  
King, A. L. S., Valença, A. M., de Melo-Neto, V. L., Freire, R. C. H., Mezzasalma, M. 
A., de Oliveira e Silva, A. C., & Nardi, A. E. (2011). Efficacy of a specific model for 
ognitive-behavioral therapy among panic disorder patients with agoraphobia: a 
randomized clinical trial. Sao Paulo Medical Journal, 129, 325-334. 
Kinley, D. J., Cox, B. J., Clara, I., Goodwin, R. D., & Sareen, J. (2009). Panic attacks and 
their relationship to psychological and physical functioning in Canadians: results 
from a nationally representative sample. Canadian Journal of Psychiatry, 54, 113-
122.  
Kivlighan, D. M., & Holmes, S. E. (2004). The importance of therapeutic factors: A 
typology of therapeutic factors studies. In J. L. DeLucia-Waack, D. A. Gerrity, C. 
R. Kalonder, & M. T. Riva (Eds.) Handbook of group counseling and 
psychotherapy (pp. 23-36). Sage Publications, Inc., Thousand Oaks, CA. 
Klein D. F. (1984). Introduction to the Anxiety Disorders Program. In: L. Grinspoon, 
(Ed). Psychiatry Update American Psychiatric Association Annual Review, 
Washington, DC: American Psychiatric Press, Inc., 3, 390-392.  
Klein, D. F. (1993). False suffocation alarms, spontaneous panics, and related 
conditions: an integrative hypothesis. Archives of General Psychiatry, 50, 306-
317.  
Klerman, G. L., Weissman, M. M., Ouellette, R., Johnson, J., & Greenwald, S. (1991). 
Panic attacks in the community. Social morbidity and health care utilization. 
Journal of the American Medical Association (JAMA), 265, 742-74. 
Klerman, G. L., Hirschfeld, R. M. A., & Weissman, M. M. (1993). Panic Anxiety and 
its treatments: Report of the World Psychiatric Association Presidential 
Educational Program Task Force, (pp. 44). American Psychiatric Association.  
 
Reference  203 
 
Klosko, J. S., Barlow, D. H., Tassinari, R., & Cerny, J. A. (1990). A comparison of 
alprazolam and behavior therapy in the treatment of panic disorder. Journal of 
Consulting Clinical Psychology, 58, 77-84.  
Kösters, M., Burlingame, G., Nachtigall, C., & Strauss, B. (2006). A meta-analytic 
review of the effectiveness of inpatient group psychotherapy. Group Dynamics: 
Theory, Research & Practice. 10, 143-163.  
Kühner, C., Burger, C., Keller, F., & Hautzinger, M. (2007). Reliability and validity of 
the Revised Beck Depression Inventory (BDI-II): Results from German samples. 
Journal of Nervenarzt, 78, 651-656.  
Lau, J. J., Calamari, J. E., & Waraczynski M. (1996). Panic attack symptomatology and 
anxiety sensitivity in adolescents. Journal of Anxiety Disorders, 10, 355-364.  
Lazarus, A. A. (1971). Behavior therapy and beyond. New York:Mc Craw-Hill. 
Lazarus, A. A. (2006). The Utility and Futility of Combining Treatments in 
Psychotherapy. Clinical Psychology: Science and Practice, 3, 59-68.  
Leahy, R. L., Holland, S. J. F., & McGinn. L. K. (2011). Treatment Plans and 
Interventions for Depression and Anxiety Disorders, (2 th ed).  
Lepöla, U., Koponen, H., Leinonen, E. (1996). A naturalistic 6-year follow-up study of 
patients with panic disorder. Journal of Acta Psychiatrica Scandinavica, 93, 181-
183.  
Leszcz, M. (2008). The interpersonal approach to group psychotherapy. In G. M. 
Saiger., S. Rubenfeld & M. D, Dluhy. (Eds.), Windows into today's group therapy 
(pp. 129-149). New York: Rutledge. 
Leszcz, M., & Kobos, J. C. (2008). Evidence-based group psychotherapy: Using 
AGPA's practice guidelines to enhance clinical effectiveness. Journal of Clinical 
Psychology, 64, 1238-1260.  
Levitt, J. T., & Karekl. M. (2005). Acceptance and mindfulness-based approaches to 
anxiety conceptualization and treatment. In S. M, Orsillo (Ed.), Integrating 
Acceptance and Mindfulness with Cognitive Behavioral Treatment for Panic 
Disorder, (pp. 165-173). Springer Link.  
Leyfer, O.T., Ruberg J.L, Woodruff-Borden, J. (2006). Examination of the utility of the 
Beck Anxiety Inventory and its factors as a screener for anxiety disorders. Journal 
of Anxiety Disorder, 20, 444-458. 
Ley, R. (1987). Panic disorder: A hyperventilation interpretation, In L. Michelson & l. 
M, Ascher (Eds.). Anxiety and stress disorders: Cognitive-behavior assessment 
and treatment; (pp. 191-212). New York. Guilford press.  
Lidren, D. M., Watkins, P. L., Gould, R. A., Clum, G. A., Asterino, M., & Tulloch, H. 
 
 Reference  204 
 
L. (1994). A comparison of bibliotherapy and group therapy in the treatment of 
panic disorder. Journal of Consulting & Clinical Psychology, 62, 865-869.  
Li, X., Sundquist, J., & Sundquist, K. (2011). Sibling risk of anxiety disorders based on 
hospitalizations in Sweden. Journal of Psychiatry and Clinical Neuroscience, 65, 
233-238.  
Lilienfeld, S. O. (1997). The relation of anxiety sensitivity to higher and lower order 
personality dimensions: Implications for the etiology of panic attacks. Journal of 
Abnormal Psychology, 106, 539-544.  
Lim, S. H., Anantharaman, V., Teo, W. S., Goh, P. P., & Tan, A. T. (1998). Comparison 
of treatment of supra ventricular tachycardia by Valsalva maneuver and carotid 
sinus massage. Annals of Emergency Medicine, 31, 30-35.  
Loughlin, K., & Generali, J. (2006). The guide to off-label prescription drugs: new 
uses for FDA-approved. Mental health (pp. 402-411). New York: free press.  
Lousberg, H., Griez, E., & Van den Hout, M. A. (1988). Carbon dioxide 
chemosensitivity in panic disorder. Journal of Acta Psychiatrica Scandinavica, 77, 
214-218.  
Luby, j. L. (1995). Group therapy. In Glick, I. D. (Ed.): Treating depression (pp. 123-
151). San Francisco: Jossey-Bass.  
Luster, E. A., Baumgartner, N., Adams, W. C., & Convertino, V. A. (1996). Effects of 
hypovolemia and posture on responses to the Valsalva maneuver. Aviation, 
space, and environmental medicine, 67, 308-13.  
Lydiard, R. B., Otto, M. W., & Milrod, B. (2001). Panic disorder. In Go. Gabbard (Ed). 
Treatments of psychiatric Disorders, (pp. 247–282) (3th ed). American psychiatric 
press: Washington, D. C.  
MacKenzie K. R. (1983). The clinical application of a group climate measure. In: Dies, 
R. R, MacKenzie K. R, (Eds), Advances in group psychotherapy: Integrating 
research and practice, (pp. 159-170). Madison, CT: International Universities 
Press.  
Maier, W., Lichtermann, D., Meyer, A., et al. (1993). A controlled family study in 
panic disorder. Journal of psychiatric research, 27, 79-87.  
Mailer, R. G., & Reiss, S. (1992). Anxiety sensitivity in 1984 and panic attacks in 1987. 
Journal of Anxiety Disorders, 6, 241-247.  
Manjula, M., Kumariah, V., Prasadarao, P. S. D. V., & Raguram, R. (2009). Cognitive 
behavior therapy in the treatment of panic disorder. Indian Journal Psychiatry, 
51, 108-116.  
Mantar, A., Yemez, B., & Alkin, T. (2010). The validity and reliability of the Turkish 
 
Reference  205 
 
version of the anxiety sensitivity. Turkish Journal of Psychiatry, 21, 225-234.  
Manzoni, G. M., Pagnini, F., Castelnuovo, G., & Molinari, E. (2008). Relaxation 
training for anxiety: a ten-year systematic review with meta-analysis. Journal 
BMC Psychiatry, 2, 8- 41.  
Marchand, A., Coutu, M. F., Dupuis, G., Fleet, R., Borgeat, F., Todorov, C., & 
Mainguy, N. (2008). Treatment of panic disorder with agoraphobia: randomized 
placebo-controlled trial of four psychosocial treatments combined with 
imipramine or placebo. Journal of Cognitive Behavior Therapy, 37, 146-159. 
Marchand, A., Germain, V., Reinharz D, Mainguy, N., & Landry, P. (2004). Analysis 
of the cost and the effectiveness of a psychotherapy for panic disorder with 
agoraphobia (PDA) versus a treatment combining pharmacotherapy and 
psychotherapy. Journal mental health Quebec, 29, 201-220.  
Marchand, A., Roberge, P., Primiano, S., & Germain, V. (2009). A randomized, 
controlled clinical trial of standard, group and brief cognitive-behavioral therapy 
for panic disorder with agoraphobia: A two-year follow-up. Journal of anxiety 
disorders, 23, 1139-1147.  
Marcus, S. M., Gorman, J., Shear, M. K., Lewin, D., Martinez, J., Ray, S., Goetz, R., 
Mosovich, S., Gorman, L., Barlow, D., & Woods, S. (2007). A Comparison of 
Medication Side Effect Reports by Panic Disorder Patients with and without 
Concomitant Cognitive Behavior Therapy. American Journal Psychiatry, 164, 
273-275.  
Margraf, J., Barlow, D. H., Clark, D. M., & Telch, M. J. (1993). Psychological treatment 
of panic: Work in Progress on outcome, active ingredients, and follow-up. 
Journal of Behavior Research and Therapy, 31, 1-8.  
Margraf, J., & Schneider, S. (1991). Outcome and active ingredients of cognitive 
behavioral treatment for panic disorder. Paper presented at the 25th Annual 
meeting of the association for the Advancement behavior therapy, New York.  
Margraf, J., Taylor, B., Ehlers, A., Roth, W. T., & Agras, W. S. (1987). Panic attacks in 
the natural environment. Journal of nervous and mental disease, 175, 558-565.  
Markowitz, J.S., Weissman, M. M., Ouellette, R., Lish, J., & Klerman, G.L. (1989). 
Quality of life in panic disorder. Archives of General Psychiafry, 46, 984-992. 
 
Marks, I. M., Grey, S., Cohen, S. D., Hill, R., Mawson, D., Ramm, E. M., & Stern, R.S. 
(1983). Imipramine and brief therapist aided exposure in agoraphobics having 
self exposure homework: A controlled trial. Archives of General psychiatry, 40, 
153-162.  
Marks, I. M., & Mathews, A. M. (1979). Brief standard self-rating for phobic patients. 
Journal of Behavior Research and Therapy, 17, 263-267.  
 
 Reference  206 
 
Marks, I. M., Swinson, R. P., Basoglu, M., Kuch, K., Noshirvani, H., O'Sullivan, G., 
Lelliott, P. T., Kirby, M., McNamee, G., & Sengun S. (1993). Alprazolam and 
exposure alone and combined in panic disorder with agoraphobia. A controlled 
study in London and Toronto. British Journal of Psychiatry, 162, 776-787. 
Maron, E., Hettema J. M., & Shlik. (2010). Advances in molecular genetics of panic 
disorder. Molecular Psychiatry, 15, 681-701. 
Marshall, E. C., Zvolensky, M. J., Sachs-Ericsson, N., Schmidt, N. B., & Bernstein, A. 
(2008). Panic attacks and physical health problems in a representative sample: 
singular and interactive associations with psychological problems, and 
interpersonal and physical disability. Journal of Anxiety Disorders, 22, 78-87.  
Martinsen, E. W., Olsen, T., Tønset, E., Nyland, K. E., & Aarre, T. F. (1998). Cognitive-
behavioral group therapy for panic disorder in the general clinical setting: a 
naturalistic study with 1-year follow-up. Journal Clinical Psychiatry, 59, 437-442. 
Mavissakalian, M. R., & Guo, S. (2002). Predictors of entering a long-term drug 
treatment study of panic disorder. Journal of Comprehensive Psychiatry, 43, 88-
94.  
Mavissakalian, M. R., & Michelson, L. (1986). Agoraphobia: Relative and combined 
effectiveness of therapist-assisted in vivo exposure and imipramine. Journal of 
psychiatry, 47, 117-122.  
McCabe, R. E., Chudzik, S. M., Antony, M. M., Young, L., Swinson, R. P., & 
Zvolensky, M. J. (2004). Smoking behaviors across anxiety disorders. Journal of 
Anxiety Disorders, 18, 7-18.  
McCabe, R. E., & Gifford, S. M. (2009). Handbook of anxiety and related disorders. In 
M. M, Antony, and M. B, Stein (Eds.). Psychological treatment of panic disorder 
and agoraphobia (pp. 308-320). Oxford University Press.  
McCarter, R. H. G. (1996). Panic disorder: Cognitive-behavioral treatment integration 
with pharmacotherapy. In Ellison, J. M (Ed.), Integrative treatment of anxiety 
disorders (pp. 77-112). Washington, DC: American Psychiatric Press.  
McCrone, P., Weeramanthri, T., Knapp, M., Rushton. A., Trowell, J., Miles, G., & 
Kolvin, I. (2005). Cost-effectiveness of individual versus group psychotherapy for 
sexually abused girls. Journal of Child and Adolescent Mental Health, 10, 26-31.  
McDermut, W., Miller, I., & Brown, R. A. (2001). The efficacy of group psychotherapy 
for depression : A meta analysis and review of the empirical research. Clinical 
psychology: Science and practice 8, 98-116.  
McNally, R. J., & Foa, E. B. (1996). The limitations of self efficacy theory in explaining 
therapeutic changes in phobic behavior. In R. M Rapee (Ed.), Current 
controversies in the anxiety disorders (pp. 369-372). New York: Guilford Press. 
 
Reference  207 
 
McNally, R. J., & Lorenz, M. (1987). Anxiety sensitivity in agoraphobics. Journal of 
Behavior Therapy and Experimental Psychiatry, 18, 3-11. 
Mc Nally, R. J. (1990). Psychological approaches to panic disorder: A review. 
Psychological Bulletin, 34, 403-419.  
Mc Nally, R. J. (2002). Anxiety Sensitivity and panic disorder. Journal of Biological 
psychiatry, 52, 938-946.  
McNally, R. J. (1989). Is anxiety sensitivity distinguishable from trait anxiety? Reply 
to Lilienfield, Jacob and Turner. Journal of Abnormal Psychology, 98, 193-194.  
McNally, R. J. (1994). Panic disorder: A critical analysis. Psychological aspects (pp. 
139-151). NewYork: Guilford Press.  
McRoberts, C., Burlingame, G. M., & Hoag, M. J. (1998). Comparative efficacy of 
individual and group psychotherapy: A meta-analytic perspective. Group 
Dynamic: Theory, Research, and practice, 2, 101-117.  
Malbos, E., Rapee, R. M., & Kavakli, M. (2013). A controlled study of agoraphobia 
and the independent effect of virtual reality exposure therapy. Australian & New 
Zealand Journal of Psychiatry, 47, 160-168. 
Merikangas, K. R., Angst, J., Eaton. W., Canino, G., Rubio-Stipec, M. Walker, H., 
Wittchen, H. U., Andrade, L., Essau, C., Whitaker, A., Kraemer, H., Robins, L. N., 
& Kupfer, D. J. (1996). Comorbidity and boundaries of affective disorders with 
anxiety disorders and substance misuse: results of an international task force. 
British Journal of Psychiatry, 168, 58-67.  
Meulenbeek, P., Willemse, G., Smit, F., van Balkom, A., Spinhoven, P., & Cuijpers P. 
(2008). Early intervention in panic: randomized controlled trial and cost-
effectiveness analysis. British Journal of Psychiatry, 196, 326-331. 
Meuret, A. E, Rosenfield, D., & Seidel A. (2010a). Respiratory and cognitive 
mediators of treatment change in panic disorder: evidence for intervention 
specificity. Journal Consult Clinical Psychology, 78, 691-704.  
 
Meuret, A. E., Hofmann, S. G., & Rosenfield, D. (2010b). Catastrophic appraisal and 
perceived control as moderators of treatment response in panic disorder. 
International Journal of Cognitive Therapy, 3, 262-277. 
Meuret, A. E., Rosenfield, D., Hoffman, S. G., Roth, W. T., & Suvak, M. K. (2009). 
Changes in respiration mediate changes in fear of body sensations in panic 
disorder. Journal of Psychiatric Research, 43, 634-641. 
Meuret, A. E., Wilhelm, F. H., & Roth, W. T. (2001). Respiratory Biofeedback-Assisted 
Therapy in Panic Disorder. Journal of Behavior Modification, 25, 584-605.  
 
 Reference  208 
 
Meuret, A. E., Wilhelm, F. H., & Roth, W. T. (2006). Effect of capnometry assisted 
breathing therapy on symptoms and respiration in panic disorder. Archieve of 
General Psychiatry. In revision. 
Meuret, A. E., Wilhelm, F. H., Ritz, T., & Roth, W. T. (2008). Feedback of end-tidal 
pCO2 as a therapeutic approach for panic disorder. Journal of Psychiatric 
Research, 42, 560-568. 
Michelson, L., Marchione, K., Greenwald, M., Glanz, L., Testa, S., & Marchione, N. 
(1990). Panic disorder: Cognitive-behavior treatment. Journal of Behavior Research 
and Therapy, 28, 141-151. 
 
Miller, R. C., & Berman, J. S. (1983). The efficacy of cognitive behavior therapies: a 
quantitative review of the research evidence. Psychological Bulletin, 94, 39-53.  
Mitchell, C. G. (1999). Treating anxiety in a manged care setting: A controlled 
comparison of medication alone versus medication plus. Research on social work 
practice, 9, 188-200. 
Mitte, K. (2005). A meta-analysis of the efficacy of psycho and pharmachotherapy in 
panic disorder with and without agoraphobia. Journal of Affective Disorders, 66, 
27-45.  
Mohammadi, M. R., Davidian, H., Noorbala, A. A., Malekafzali, H., Naghavi, H. R., 
Pouretemad, H. R., Bagheri Yazdi, S. A., Rahgozar, M., Alaghebandrad, J., Amini, 
H., Razzaghi, E. M., Mesgarpour, B., Soori, H., Mohammadi, M., & Ghanizadeh, 
A. (2005). An epidemiological survey of psychiatric disorders in Iran. Clinical 
Practice and Epidemiology in Mental Health. Published online.  
Mohammadi, M. R., Rahgozar, M., Bagheri Yazdi, S. A., Mesgarpour, B., Zandi, A., & 
Vosough, F. (2001). Epidemiology of psychiatric disorders in Hormozgan 
province. 
Moller T, Hegna EA. (2001). Group therapy of anxiety benefits and profits, Abstact, 
Pubmed. 
Morrison, N. (2001). Group cognitive therapy: treatment of choice or suboptimal 
option? Journal of Behavioral and Cognitive Psychotherapy, 29, 311-332.  
Moscovitch, D. A., Antony, M. M., & Swinson, R. P. (2009). Exposure based 
treatments for anxiety disorders: Theory and process. In M. M. Antony. & M. B. 
Stein (Eds.), Handbook of anxiety and anxiety disorders (pp. 461−475). New 
York: Oxford University Press.  
Nakano, Y., Lee, K., Noda, Y., Ogawa, S., Kinoshita, Y., Funayama, T., Watanabe, N., 
Chen J., Noguchi, Y., & Furukawa, T. A. (2008). Cognitive-behavior therapy for 
Japanese patients with panic disorder: acute phase and one-year follow-up 
results. Journal of Psychiatry and Clinical Neuroscience, 62, 313-321.  
 
Reference  209 
 
Nardi, A. E. (2006). Some notes on a historical perspective of panic disorder. Brazilian 
Journal of Psychiatry, 55, 154-160. 
Nardi, A. E., Nascimento, I., Valença, A. M., Lopes, F. L., Mezzasalma, M. A., & Zin, 
W. A. (2003). Panic disorder in a breath-holding challenge test: A simple tool for a 
better diagnosis. Archives of Nerero Psychiatry, 61, 718-722.  
Nardi, A. E., Valença, A. M., Nascimento, I., Mezzasalma, M. A., & Zin, W. (1999). 
Panic disorder and hyperventilation. Archives of Nerero Psychiatry, 57, 932-936.  
National Institute of Mental Health. (2007). "Panic Disorder http://www. pueblo. 
gsa. gov/cictext/health/panic/panfly. htm. 
Nauert, R. (2011). Twin Studies Suggest Genetic Risk for Panic Disorder. Journal of 
Psych Central. Retrieved on October.  
Nazemi, H., Ronald A. Kleinknecht, Dale L. Dinnel, Walter J. Lonner Nazemi,S., 
Shamlo, S., & Sobhan, A. (2003a). A Study of Panic Attacks in University Students 
of Iran. Journal of Psychopathology and Behavioral Assessment, 25, 191-201. 
Nazemi, H., & Dager, S. R. (2003b). Coping strategies of panic and control subjects 
undergoing lactate infusion during MRI confinement. Comprehensive 
Psychiatry, 44, 190-197. 
Neimeyer, R. A. (1985). Group psychotherapies for depression: An overview: 
international journal of mental helth, 13, 3-7. 
Neron, S., Lacroix, D., & Chaput, Y. (1995). Group vs. individual cognitive behavior 
therapy in panic disorder: An open clinical trial with a six month follow-up. 
Canadian Journal of Behavioral Science, 27, 379-392.  
Nezu, A. M., Nezu, C. M., & Lombardo, E. (2004). Cognitive behavioral case 
formulation and treatment Design. Springer publishing company.  
Ninan, P. T., & Dunlop, B. W. (2005). Neurobiology and etiology of panic disorder. 
Journal of Clinical Psychiatry, 66, 3-7.  
Nixon, P. G. (1993). The grey area of effort syndrome and hyperventilation from 
Thomas Lewis to today. Journal of the Royal College of Physicians of London, 27, 
377-383.  
Nock, M. K., Hwang, I., Sampson, N., & Kessler, R. C. (2010). Mental disorders, 
comorbidity and suicidal behaviors: results from the national comorbidity survey 
replication. Journal of Molecular Psychiatry, 15, 868-876.  
Noda, Y., Nakano, K., Lee, S. Ogawa, Y. Kinoshita, T. Funayama, N. Watanabe, J. 
Chen, Y., Noguchi, M., Kataoka, M., Suzuki., & Furukawa, T. A. (2007). 
Sensitization of catastrophic cognition in cognitive-behavioral therapy for panic 
disorder. Journal of BMC Psychiatry, 10, 7- 70.  
 
 Reference  210 
 
Norcross, J. C., Strausser, D., & Missar, C. D. (1988). The process and outcomes of 
psychotherapists’ personal treatment experiences. Journal of Psychotherapy, 25, 
36-43.  
Norton, G. R., Cox, B. J., & Malan, J. (1992). Nonclinical panickers: A critical review. 
Clinical Psychology Review, 12, 121-139.  
Norton, G. R., Harrison, B., Hauch, J., & Rhodes, L. (1985). Characteristics of people 
with infrequent attacks. Abnormal psychiatry, 94, 216-221.  
Noyes, R. Jr., Anderson, D. J. Clancy, J., Crowe. R. R., Slymen, D. J., Choneilm, M. M., 
& Hinrichs, J. V. (1984). Diazepam and propranolol in panic disorder and 
agoraphobia. Archives of General Psychiatry, 41, 287-292.  
Noyes, R. Jr., Crowe, R. R, Harris, E. L, Hamra, B. J.,McChesney, C. M., & Chaudhry, 
D. R. (1986). Relationship between panic disorder and agoraphobia. A family 
study. Archive of Genetic Psychiatry, 43, 227-232.  
Nutt, D., & Ballenger, J. (2003). Generalized anxiety disorder, obsessive-compulsive 
disorder and post-traumatic stress disorder. In Anxiety disorders (pp, 39-51). 
Oxford, Blackwell Publishing.  
Oei, T. P. S., Llamas, M., & Devilly, G. J. (1999). The efficacy and cognitive processes 
of cognitive behavior in the treatment of panic disorder with agoraphobia. 
Journal of Behavioral & Cognitive Psychotherapy, 27, 63-88.  
Olatunji, B. O., Cisler, J. M., & Deacon, B. J. (2010). Efficacy of cognitive behavioral 
therapy for anxiety disorders: a review of meta-analytic findings. Psychiatric 
Clinics of North America, 33, 557–577. 
Olatunji, B.O., & Wolitzky-Taylor, K.B. (2009). Anxiety sensitivity and the anxiety 
disorders: a meta-analytic review and synthesis. Psychological Bulletin, 135, 974-
999. 
Öst, L. G. (1987). Applied relaxation: Description of a coping technique and review of 
controlled studies. Journal of Behavior Research and therapy, 25, 397-409. 
Öst, L. G. (1988). Applied relaxation vs. progressive relaxation in the treatment of 
panic disorder. Journal of Behavior Research and Therapy, 26, 13-22. 
Öst, L. G. (2008). Cognitive behavior therapy for anxiety disorders: 40 years of 
progress. Nord Journal Psychiatry, 62, 5-10. 
Öst, L. G., & Hugdahl, K. (1983). Acquisition of agoraphobia, mode of onset and 
anxiety response patterns. Journal of Behavior Research and Therapy, 21, 623-
631. 
Öst, L. G., Thulin, U., & Ramnerö, J. (2004). Cognitive behavior therapy vs. exposure 
in vivo in the treatment of panic disorder with agoraphobia (corrected from 
 
Reference  211 
 
agoraphobia). Journal Behavior Research Therapy, 42, 1105-1127.  
Öst, L. G., & Westling, B. E., & Hellstrom, K. (1993). Applied relaxation, exposure in 
vivo and cognitive methods in the treatment of panic disorder with agoraphobia. 
Journal of Behavior Research and therapy, 31, 383-394. 
Öst, L. G., & Westling, B. E. (1995). Applied relaxation vs. cognitive behavior therapy 
in the treatment of panic disorder. Journal of Behavior Research Therapy, 33, 145-
158.  
Otto, M., Deveney, D. (2005). Cognitive-behavioral therapy and the treatment of 
panic: Efficacy and strategies. Journal of Clinical Psychiatry, 66, 28–32. 
Otto, M. W., Pollack, M. H., Penava, S. J., & Zucker, B. G. (1999). Group cognitive-
behavior therapy for patients failing to respond to pharmacotherapy for panic 
disorder: a clinical case series. Journal of Behavior Research Therapy, 37, 763-770.  
Otto, M. W., Pollack, M. H., & Maki, K. M. (2000). Empirically-supported treatment 
for panic disorder: Costs, benefits, and stepped care. Journal of Consulting and 
Clinical Psychology, 68, 556-563.  
Otte, C.H. (2011). Cognitive behavioral therapy in anxiety disorders: current state of 
the evidence. Journal of Dialogues Clinical Neuroscience, 13, 413–421. 
Özkan, M. A., & Altindag. (2005). Comorbid personality disorders in subjects with 
panic disorder: do personality disorders increase clinical severity? 
Comprehensive Psychiatry journal, 46, 20-26.  
Papp, L. A., Goetz, R., Cole, R., Klein, D. F., Jordan, F. F., Liebowitz, M. R., Fyer, A. 
L., Hollander, E., & Gorman, J. (1989). Hypersensitivity to carbon dioxide in 
panic disorder: American Journal of psychiatry, 146, 779-781.  
Papp, L. A., Klein, D. F., & Gorman, J. M. (1993). Carbon Dioxide Hypersensitivity, 
hyperventilation, and panic disorder. American Journal of Psychiatry, 150, 1149-
1157.  
Payne, K. T., & Marcus, D. K. (2008). The efficacy of group psychotherapy for older 
adult clients: A meta-analysis. Group Dynamics: Theory, Research, and Practice, 
12, 268-278.  
Pelissolo, A., Zaoui, M., Aguayo, G., Sai Nan Yao, Roche, S., Ecochard, R., Gueyffier, 
F., Pull., CH., Berthoz, A., Jouvent, A., & Cottraux, J. (2012). Virtual reality 
exposure therapy versus cognitive behavior therapy for panic disorder with 
agoraphobia: A randomized comparison study. Journal of Cybertherapy & 
Rehabilitation, 5, 35-43. 
Pérez-Ara, M. A., Quero, S., Botella, C., Baños, R., Andreu-Mateu, S., García-Palacios, 
A., & Bretón-López, J. (2010). Virtual reality interoceptive exposure for the 
treatment of panic disorder and agoraphobia. Study Health Technology 
 
 Reference  212 
 
Information, 154, 77-81. 
Peterson, R. A., & Reiss, S. (1993). Anxiety Sensitivity Index. Worthington, OH: 
International Diagnostic Services Publishing Corporation.  
Peter, H., Bruckner, E., Hand, I., Rohr, W., & Rufer, M. (2008). Treatment outcome of 
female agoraphobics 3-9 years after exposure in vivo: A comparison with healthy 
controls. Journal of Behavior Therapy Expimental Psychiatry, 39, 3–10.  
Perna, G., Barbini, B., Cocchi, S., Bertani, A., & Gasperini, M. (1995). 35% CO2 
challenge in panic and mood disorders. Journal Affective Disorder 33, 189-194. 
Perna, G., Caldirola, D., Arancio, C., & Bellodi, L. (1997). panic attacks: a twin study. 
Journal of Psychiatry research, 66, 69-71. 
Perna, G., Casolari, A., Bussi, R., Cucchi, M., Arancio, C., & Bellodi L. (2004). 
Comparison of 35% carbon dioxide reactivity between panic disorder and eating 
disorder. Journal of Psychiatry research, 125, 277-283.  
Peterson, R. A., & Heilbronner, R. L. (1987). The Anxiety Sensitivity Index: Construct 
validity and factor analytic Structure. Journal of Anxiety Disorders, 3, 25-32.  
Petrocelli, J., (2002). Effectiveness of Group Cognitive Behavioral Therapy for 
General Symptomatology: A Meta-Analysis journal for specialists in group work. 
American Counseling Association (ACA), 27, 92-115.  
Pincus, D. B., Ehrenreich- May, J., Whitton, S. W., Mattis, S. G., & Barlow, D. H. 
(2010). Cognitive-behavioral treatment of panic disorder in adolescence. Journal 
Clinical Child Adolescent Psychology. 39, 638-649.  
Plehn, K., & Peterson, R. A. (2002). Anxiety sensitivity as a predictor of the 
development of panic, symptoms, panic attacks, and panic disorder: A 
prospective study. Journal of Anxiety Disorders, 16, 455–474. 
Pollack, M. H. J. (2005). The pharmacotherapy of panic disorder. Journal of Clinical 
Psychiatry, 66, 23-27.  
Pollock, R., & Kuo, I. (2004). New research in Anxiety Disorders. Poster presented at 
the International Congress of Biological Psychiatry. 
Pollack, M. H., Lepöla, U., & Koponen, H., Simon, N.M, Worthington , J.J, Emilien, 
G., Tzanis, E., Salinas, E., Whitaker, T., & Gao, B. (2006). A double-blind study of 
the efficacy of venlafaxine extended-release, paroxetine, and placebo in the 
treatment of panic disorder. Journal of Depression and Anxiety, 24, 1-14.  
Pollack, M. H., Rapaport, M. H., & Clary, C. M. (2000). Sertraline treatment of panic 
disorder: response in patients at risk for poor outcome. Journal Clinical 
Psychiatry, 61, 922-927.  
 
Reference  213 
 
Power, K. G., Sharp, D. M., Swanson, V., & Simpson, R. J. (2000). Therapist contact in 
cognitive behavior therapy for panic disorder and agoraphobia in primary care. 
Journal of Clinical Psychology and Psychotherapy, 7, 37–46. 
Rachman, S., & Levitt, K. (1985). Panics and their consequences. Journal of Behavior 
Research Therapy, 23, 585-600.  
Rachman, S., Levitt, K., & Lopatka, C. (1987). The links between cognitions and 
bodily symptoms. Journal Behavior Research and Therapy, 5, 411-423.  
Rachman, S., Lopatka, C., & Levitt, K. (1988). Experimental analysis of panic: Panic 
patients. Journal of Behavior Research and Therapy, 26, 33-40. 
Ramage-Morin, P. L. (2004). Panic disorder and coping. Health Reports (Statistics 
Canada, Catalogue), 15, 31-43.  
Rapee, R. M. (1985). A case of panic disorder treated with breathing retraining. 
Journal of Behavior therapy and experimental psychiatry, 16, 63-65. 
Rapee, R. M., & Barlow, D. H. (1991). The cognitive-behavioral treatment of panic 
attacks and agoraphobic avoidance. In Walker, J. R., Norton, G. R. & Ross; C. A. 
(Eds.), Panic disorder and agoraphobia: A comprehensive guide for the 
practitioner, (pp. 252-305). Brooks/Cole Publishing Company.  
Rapee, R. M., Craske, M. G., Brown, T. A., & Barlow, D. H. (1996). Measurement of 
perceived control over anxiety-related events. Journal of Behavior Therapy, 27, 
279-293.  
Rauch, S. L., Shin L. M., & Wright, C. (2003). Neuroimaging studies of amygdala 
function in anxiety disorders. Annual New York Academy of Science, 985, 389-
410.  
Rayburn, N. R., & Otto, M. W. (2003). Cognitive-behavioral therapy for panic 
disorder: a review of treatment elements, strategies, and outcomes, 5, 356-362.  
Razran, G. (1961). The observable unconscious and the in ferable conscious in current 
soviet psychophysiology: Interoceptive conditioning, semantic conditioning, and 
the orienting reflex, psychological Review 68, 81-147.  
Rector, N. A., Szacun-Shimizu, K., & Leybman, M. (2007). Anxiety sensitivity within 
the anxiety disorder: disorder-specific sensitivities and depression comborbidity: 
Behavior Research and Therapy, 45, 1967–1975.  
Reiss, S., Peterson, R. A., Gursky, D. M., & McNally, R. J. (1986). Anxiety sensitivity, 
anxiety frequency and the prediction of fearfulness. Journal of Behavior Research 
& Therapy, 24, 1-8.  
Reiss, S. (1997). Trait anxiety: It's not what you think it is. Journal of Anxiety 
Disorders, 11, 201-214.  
 
 Reference  214 
 
Riskind, J. H., Beck, A. T., Brown, G., & Steer, R. A. (1987). Taking the measure of 
anxiety and depression. Validity of the reconstructed Hamilton scales. The 
Journal of Nervous and Mental Disease, 175, 474-9.  
Robinson, L. A., Berman, J. S., & Neimeyer, R. A. (1990). Psychotherapy for the 
treatment of depression : A comprehensive review of controlled outcome 
research. Psychological Bulletin, 108, 30-49.  
Ronen, T., & Freeman, A. (2007). Cognitive behavior therapy for anxiety disorders. In 
Cognitive Behavior Therapy in Clinical Social Work Practice (pp. 375-395). 
Springer publishing.  
Ross, C.J.M., Davis, T.M.A., Macdonald, G.F. (2005). Cognitive-Behavioral Treatment 
combined with Asthma education for adults with Asthma and coexisting Panic 
Disorder. Clinical Nursing Research, 14, 131-157. 
Rosenberg, N. K., & Hougaard, E. (2005). Cognitive-behavioral group treatment of 
panic disorder and agoraphobia in a psychiatric setting: A naturalistic study of 
effectiveness. Nord Journal Psychiatry, 59, 198-204.  
Roth, A., & Fonagy, P. (2005). What Works for Whom? (2th ed). Anxiety disorder: 
specific phobia, social phobia, generalized anxiety disorder, and panic disorder 
with or without agoraphobia, (pp. 150-198). New York: Guilford press.  
Roy-Byrne, P. P., Wagner, A. W., & Schraufnagel, T. J. (2005a). Understanding and 
treating panic disorder in the primary care setting. Journal Clinical Psychiatry, 
66, 16-22. 
Roy-Byrne, P. P., Craske, M. G., Stein, M. B., Sullivan, G., Bystritsky, A., Katon, W., 
Golinelli, D., & Sherbourne, C. (2005b). A randomized effectiveness trial of 
cognitive-behavioral therapy and medication for primary care panic disorder. 
Archives of General Psychiatry, 62, 290-298. 
Roy-Byrne, P. P., Craske, M. G., & Stein, M. B. (2006). Panic Disorder. Lancet 368, 
1023-1032. 
Roy-Byrne, P. P., Stang, P., Wittchen, H. U., Ustun, B., Walters, E. E., & Kessler, R. C. 
(2000). Lifetime panic-depression comorbidity in the National Comorbidity 
Survey. Association with symptoms, impairment, course and help-seeking. The 
British Journal of Psychiatry, 176, 229-235.  
Rubenstein, A. (2003). Effects of emotional engagement and habituation on exposure 
therapy for PTSD. Yeshiva University.  
Rubin, H. C., Rapaport, M. H., Levine, B., Gladsjo, J. K., Rabin, A., Auerbach, M., 
Judd, L. L., & Kaplan, R. (2000). Quality of well-being in panic disorder: the 
assessment of psychiatric and general disability. Journal of Affective Disorders, 
57, 217-221.  
 
Reference  215 
 
Rufer, M., Alberecht, R., Schmidt, O., Zaum, J., Schnyder, U., Hand, I., & Mueller-
Pfeiffer, C. (2010). Changes in quality of life following cognitive behavioral group 
therapy for panic disorder. Journal of European Psychiatry 25, 8-14.  
Ruhmland, M. & Margraf., J. (2001). Efficacy of psychological treatments for panic 
and agoraphobia. Journal of behavior therapy, 11, 41-53.  
Rupert, P. A., Dobbinns, K., & Mathew, R. J. (1981). EMG biofeedback and relaxation 
instructions in the treatment of chronic anxiety. American journal of clinical 
biofeedback, 4, 52-61.  
Rutan, S. J., Stone, N. W., & Shay, J. (2007). Beginning to group Psychodynamic 
Group Psychotherapy, (pp. 190-212). The Gilford press.  
Ruwaard, J., Broeksteeg, J., Schrieken, B., Emmelkamp, P., & Lange, A. (2010). Web-
based therapist-assisted cognitive behavioral treatment of panic symptoms: A 
randomized controlled trial with a three-year follow-up. Journal of Anxiety 
Disorders, 24, 387-396. 
Sadock, B. J., & Sadock, V. A. (2008). Physical illness and psychiatric disorder. 
Concise textbook of clinical psychiatry (pp, 10-15) (3th ed.). Lippincott Williams 
& Wilkins.  
Salkovkis, P. M., Clark, D. M., & Hackmann, A. (1991). Treatment of panic attacks 
using cognitive therapy without exposure or breathing retraining. Journal of 
Behavior research and therapy, 29, 161-166.  
Salkovskis, P. M., & Clark, D. M. (1990). Affective responses to hyperventilation: a 
test of the cognitive model of panic. Journal of Behavior Research and Therapy, 
28, 51-61.  
Salkovskis, P. M., Jones, D. R., & Clark, D. M. (1986). Respiratory control in the 
treatment of panic attacks: Replication and extension with concurrent 
measurement of behavior and pCO2. British Journal of Psychiatry, 148, 526-532.  
Salkovskis, P. M., Hackmann, A., Wells, A., Gelder, M., & Clark, D. M. (2006). Belief 
disconfirmation versus habituation approaches to situational exposure in panic 
disorder with agoraphobia: A pilot study. Journal of Behavior Research and 
Therapy, 45, 877-885.  
Sánchez-Meca, J., Rosa-Alcázar, A. I., Marín-Martínez, F., & Gómez-Conesa, A. 
(2010). Psychological treatment of panic disorder with or without agoraphobia: a 
meta-analysis. Journal of Clinical Psychology Review, 30, 37-50.  
Sanderson, W. C., & Rego, S. A. (2002). Empirically supported treatment for panic 
disor: research, theory, and application of cognitive behavioral therapy. In R. L. 
Leahy & E. T. Dowd (Eds), Clinical advance in cognitive psychotherapy. Theory 
and Application (pp. 213-216). Springer publishing company. 
 
 Reference  216 
 
Sanderson, W. C., & Wetzler, S. (1995). Cognitive behavioral treatment of panic 
disorder. In G. M. Asnis & H. M. van Praag (Eds.). Panic disorder: Clinical, 
biological, and treatment aspects, (pp. 314-335). New York: Wiley & Sons.  
Sargent, M. (1990). NIMH report: Panic disorder. Journal of Hospital and community 
psychiatry, 41, 621-623.  
Sarp A., Arık, A. C., Guz, H., Şahin, A. R., & Abanoz, Z. (2010). Possible subtypes of 
panic disorders. Turkish Journal of Psychiatry, 21, 269-279. 
Sartory, G., & Olajide, D. (1988). Case histories and shorter communications. Vagal 
innervation techniques in the treatment of panic disorder. Journal Behavior 
Research Therapy, 26, 431-434.  
Schmidt, N. B., Lerew, D. R., & Jackson, R. J. (1997). The role of anxiety sensitivity in 
the pathogenesis of panic: Prospective evaluation of spontaneous panic attacks 
during acute stress. Journal of Abnormal Psychology, 106, 355-364.  
Schmidt, N. B., Telch, M. J., & Joiner, T. E. (1996). Factors influencing health 
perceptions in patients with panic disorder. Journal of Comprehensive 
Psychiatry, 37, 253–260. 
Schmidt, N. B., Trakowski, J. H., & Staab, J. P. (1997). Extinction of panicogenic 
effects of a 35% CO2 challenge in patients with panic disorder. Journal of 
Abnormal Psychology, 106, 630-638. 
Schmidt, N. B., Woolaway-Bickel, K., Trakowski, J., Santiago, H., Storey, J., Koselka, 
M., & Cook., J. (2000). Dismantling cognitive-behavioral treatment for panic 
disorder: questioning the utility of breathing retraining, Journal of consulting 
clinical psychology, 68, 417-24. 
Schmidt, N. B., Zvolensky, M. J., & Maner, J. K. (2006). Anxiety sensitivity: 
prospective prediction of panic attacks and Axis I pathology. Journal of 
Psychiatric Research, 40, 691-699.  
Schneider, R., & Schulte, D. (2008). Catastrophic associations predict level of change 
in anxiety sensitivity in response to cognitive-behavioral treatment for panic. 
Journal of Behavior Research and Therapy 46, 557–572.  
Seddon, K., & Nutt, D. (2007). Pharmacological treatment of panic disorder. 
Psychiatry journal, 6, 198-203.  
Schwartz, D., & Lellouch, J. (1967). Explanatory and pragmatic attitudes in 
therapeutic trials. Journal of Chronic Disorders, 20, 637-648. 
Segal, Z. V., & Shaw. B. F. (1996). Cognitive Therapy. In L. J, Dickstein., M. B, Riba & 
J. M. Oldham (Eds), American Psychiatry Press Review of psychiatry. American 
Psychiatrric Press, Inc. Washington DC. 
 
Reference  217 
 
Senge, P. (1990). The fifth discipline. The art and practice of learning organization, 
New York: Doubleday.  
Sharp, D. M., Power, K. G., & Swanson, V. (2004). A comparison of the efficacy and 
acceptability of group versus individual cognitive behavior therapy in the 
treatment of panic disorder and agoraphobia in primary care. Journal of Clinical 
Psychology and Psychotherapy, 11, 73-82.  
Shear, M. K., Barlow, D. H., Brown, T., Money, R., Sholomskas, D., Woods, S., 
Gorman, J., & Papp, L. (1997). The Multicenter Collaborative Panic Disorder 
Severity Scale (PDSS). American Journal of Psychiatry, 11, 1571-1575. 
Shear, M. K., Houck, P., Greeno, C., & Masters, S. (2001a). Emotion-focused 
psychotherapy for patients with panic disorder. American Journal of Psychiatry, 
158, 1993-1998. 
Shear, M. K., Ricci, P., Williams, J., Frank, E., Grochocinski, V., Vander Bilt, J., Houck, 
P., & Wang, T. 2001b). Reliability and validity of the Panic Disorder Severity 
Scale: Replication and extension. Journal of Psychiatric Research, 35, 293-296. 
Shear, M. K., & Masser, J. M. (1994). Standardized assessment for panic disorder 
research. A conference report. Archives of General Psychiatry, 51, 346-354.  
Shear, M. K., Meuret, A. E., Rosenfield, D., Gorman, J. M., & Woods, S. W. (2007). 
Preliminary Evidence for Cognitive Mediation During Cognitive–Behavioral 
Therapy of Panic Disorder, Journal Consult Clin Psychol. 75, 374–379. 
Sheehan, D. V., Ballenger, J., & Jacobsen, G. (1980). Treatment of endogenous anxiety 
with phobic, hysterical, and hypochondriacal symptoms. Archive General 
Psychiatry, 37, 51-59. 
Sheehan, D. V., & Sheehan, K. H. (1982). The classification of anxiety and hysterical 
states: historical review and empirical delineation. Journal of Clinical 
Psychopharmacology, 2, 235-244.  
Sheikh, J. I., Leskin, G. A., & Klein, D. F. (2002). Gender differences in panic disorder: 
findings from the National Comorbidity Survey. American Journal Psychiatry, 
159, 55-58. 
Shoenberger, D., & Hazlett-Stevens, H. (in press). Interpersonal problems linked to 
panic disorder with agoraphobia. To appear in advances in psychology research 
volume 50. New York: Nova Science Publishers, Inc.  
Skre, I., Onstad, S., Torgersen, S., Lygren, S., & Kringlen, E. (1993). A twin study of 
DSM-III-R anxiety disorders. Acta Psychiatr Scand Journal, 88, 85–92. 
Sokol, L., Beck, A. T., Greenberg, R. L., Wright, F. D., & Berchick, R. J. (1989). 
Cognitive therapy of panic disorder. A nonpharmacological alternative. Journal 
of Nervous and Mental disease 177, 711-716.  
 
 Reference  218 
 
Smits, J. A., Berry, A. C., Rosenfield, D., Powers, M. B., Behar E., & Otto M. W. 
(2008a). Reducing anxiety sensitivity with exercise. Depression and Anxiety, 25, 
689-699.  
Smits, J. A., Berry, A. C., Tart, C. D., & Powers, M. B. (2008b). The efficacy of 
cognitive-behavioral interventions for reducing anxiety sensitivity: A meta-
analytic review. Journal of Behavior Research and Therapy, 46, 1047–1054.  
Smits, J. A., Powers, M. B., Cho, Y., & Telch, M. J. (2004). Mechanism of change in 
cognitive-behavioral treatment of panic disorder: Evidence for the fear of fear 
mediational hypothesis. Journal of Consulting and Clinical Psychology, 72, 646–
652.  
Spitzer, R. L., Williams, J. B. W., Gibbon, M., & First, M. (1997). Structured clinical 
interview for DSM-IV personality disorders, (SCID-II). Washington, D. C: 
American Psychiatric Press.  
Steer, R. A., Ranieri, W. F., Beck, A. T., & Clark, D. A. (1993). Further evidence for the 
validity of the Beck Anxiety Inventory with psychiatric outpatients. Journal of 
Anxiety Disorders, 7, 195-205.  
Stein, M. B., Goin, M. K., Pollack, M. H., Roy-Byrne, P., Sareen, J., Simon, N. M., & 
Campbell-Sills, L. (2009). Practice guideline for the treatment of patients with 
panic disorder, (pp 24-29). Arlington, VA: American Psychiatric Association.  
Stein, M. B., Steckler, T., Lightfoot, J. D., Hay, E., & Goddard, A. W. (2010). 
Pharmacological Treatment of Panic Disorder, Journal of curr top behavioral 
neuroscience, 2, 469-485.  
Stevens, J. C, & Pollack, M. H. (2005). Benzodiazepines in clinical practice: 
consideration of their long-term use and alternative agents. Journal of Clinical 
Psychiatry 66, 21-27.  
Stewart, W., Breslau, N., & Keck, P. E. (1994). Comorbidity of migraine and panic 
disorder. Journal of Neurology, 44, 23-27.  
Stewart, R. E., & Chambless, D.L. (2009). Cognitive-behavioral therapy for adult 
anxiety disorders in clinical practice: a meta-analysis of effectiveness studies. 
Journal of Consulting Clinical Psychology, 77, 595–606.  
Sturges, L. V., Goetsch, V. L., Ridley, J., & Whittal, M. (1998). Anxiety sensitivity and 
response to hyperventilation challenge: Physiologic arousal, interoceptive acuity 
and subjective distress. Journal of Anxiety Disorders, 12, 103-115. 
Struzik, L., Vermani, M., Duffin, J., & Katzman, M. A. (2004). Anxiety sensitivity as a 
predictor of panic attacks. Journal of Psychiatry Research, 129, 273-278.  
Subich, L. M., & Coursol, D. H. (1985). Counseling expectations of nonclients for 
group and individual treatment modes. Journal of Counseling psychology, 32, 
 
Reference  219 
 
245-251.  
Sullivan, G. M., Kent, J. M., Kleber, M., Martinez, J.M., Yeragani, V. K., & Gorman, 
J.M. (2004). Effects of hyperventilation on heart rate and QT variability in panic 
disorder pre-and post-treatment. Psychiatry Research, 125, 29-39.  
Swinson, R. P., Soulios, C., Cox, B. J & Kuch, K. (1992). Brief treatment of emergency 
room patients with panic attacks. American Journal Psychiatry, 149, 944-946. 
Taylor, S. (1999). Anxiety sensitivity: theory, research, and treatment of the fear of 
anxiety. Mahwah, New Jersy: Lawrence Erlbau. 
Taylor, S. (2000). Underastanding and treating panic disorder, cognitive-behavioral 
approaches. Chichester, UK: John Wiley and Sons. 
Taylor, S. (2001). Breathing Retraining in the Treatment of Panic Disorder: Efficacy, 
Caveats and Indications. Scandinavian Journal of Behavior Therapy, 30, 49-56. 
Taylor, S., & Cox, B. J. (1998). An expanded Anxiety Sensitivity Index: evidence for a 
hierarchic structure in a clinical sample. Journal of Anxiety Disorders, 12, 463–
483.  
Taylor, S., Koch, W. J., & McNally, R. J. (1992). How does anxiety sensitivity vary 
across the anxiety disorders? Journal of Anxiety Disorders, 6, 249–259.  
Taylor, S., Zvolensky, M. J., Cox, B. J., Deacon, B., Heimberg, R. G., Ledley, D. R., & 
Cardenas, S. J. (2007). Robust dimensions of anxiety sensitivity: Development and 
initial validation of the Anxiety Sensitivity Index-3. Journal Psychological 
Assessment, 19, 176-188. 
Teachman, B. A., Marker, C. D., & Clerkin, E. M. (2010). Catastrophic 
misinterpretations s a predictor of symptom change during treatment for panic 
disorder. Journal of Consulting and Clinical Psychology, 78, 964-973. 
Teachman, B. A., Marker, C. D., & Smith-Janik, S. B. (2008). Automatic associations 
and panic disorder: Trajectories of change over the course of treatment. Journal of 
Consulting and Clinical Psychology, 76, 988-1002.  
Telch, M. J., Brouillard, M., Telch, C. F., Agras, W. S., & Taylor, C. B. (1989a). Role of 
cognitive appraisal in panic related avoidance. Journal of Behavior Research and 
therapy, 27, 373-383. 
Telch, M. J, Lucas, J. A., & Nelson, P. (1989b). Nonclinical panic in college students: 
an investigation of prevalence and symptomatology. Journal of Abnormal 
Psychology, 98, 300-306. 
Telch, M. J., Shermis, M. D., & Lucas, J. A. (1989c). Anxiety sensitivity: Unitary 
personality trait or domain-specific appraisal? Journal of anxiety Disorder, 3, 25-
32.  
 
 Reference  220 
 
Telch, M. J., Lucas, J. A., Schmidt, N. B., Hanna, H. H., LaNae, Jaimez, T. l., & Lucas 
R. A. (1993). Group cognitive-behavioral treatment of panic disorder. Journal of 
Behavior Research and Therapy 31, 279-287.  
Telch, M. J., Schmidt, N. B., Jaimez, T. L., Jacquin, K. M., & Harrington, P. J. (1995). 
Impact of cognitive-behavioral treatment on quality of life in panic disorder 
patients. Journal of Consulting and Clinical Psychology, 63, 823–830. 
Tillitski, L. (1990). A meta-analysis of estimated effect sizes for group versus 
individual versus control treatments. International Journal of Group 
Psychotherapy, 40, 215-224.  
Tilli, V., Suominen, K., & Karlsson, H. (2012). Panic disorder in primary care: 
Comorbid psychiatric disorders and their persistence. Scandinavian journal of 
primary health care 30, 247-253. 
Tompking, M. A. (2002). Anxiety and panic disorder. In Patterson (Eds.). 
Comprehensive Handbook of Psychotherapy: Cognitive-behavioral approaches, 
2, 273-295.  
Torgersen, S. (1983). Genetic factors in anxiety disorders. Archives of General 
psychiatry, 40, 1085-1089.  
Toseland, R. W., & Siporin, M. (1986). When to recommend group treatment: A 
review of the clinical and the research literature. International journal of group 
psychotherapy, 36, 43-61.  
Tsao, J. C., Mystkowski, J. L., Zucker, B. G., & Craske, M. G. (2002). Effects of 
cognitive-behavioral therapy for panic disorder on comorbid conditions: 
Replication and extension. Journal of Behavior Therapy, 33, 493-509.  
Turner, S., Beidel, D., & Costello, A. (1987). Psychopathology in the offspring of 
anxiety disorder patients. Journal of consulting and clinical psychology, 55, 229-
235.  
Tweeddale, P. M., Rowbottom, I., & McHardy, G. J. (1994). Breathing retraining: 
effect on anxiety and depression scores in behavioral breathlessness. Journal 
Psychosomatic Research, 38, 11-21.  
Uhle, S. (2006). Short-and long-term effectiveness of high density exposure for panic 
disorder with agoraphobia in an inpatient setting: A 7 years follow-up. 
Uhlenhuth, E. H., Warner, T. D., & Matuzas, W. (2002). Interactive model of 
therapeutic response in panic disorder: moclobemide, a case in point. Journal 
Clinical Psychopharmacology, 22, 275-284.  
Van Beek, N., & Griez, E. (2000). Reactivity to a 35% CO2 challenge in healthy first-
degree relatives of patients with panic disorder. Journal of Biological Psychiatry 
47, 830-835.  
 
Reference  221 
 
Van Dam-Baggen, R., & Kraaimaat, F. (2000). Group social skills training or cognitive 
group therapy as the clinical treatment of choice for generalized social phobia? 
Journal of Anxiety Disorders, 14, 437-451.  
Van der Molen., G. M., van den Hout, M. A., Vroemen, J., Lousberg, H., & Griez, E. 
(1986). Cognitive determinants of lactate-induced anxiety. Journal of Behavior 
Research and Therapy, 24, 677-680.  
Vincelli, F., Anolli, L., Bouchard, S., Wiederhold, B. K., Zurloni, V., & Riva, G. (2003). 
Experiential cognitive therapy in the treatment of panic disorders with 
agoraphobia: A controlled study. Journal of Cyberpsychology and Behavior, 6, 
321–328.  
Vos, T., Corry, J., Haby, M. M., Carter, R., & Andrews, G. (2005). Cost-effectiveness of 
CBT and drug interventions for major depression. Australian and New Zealand 
Journal of Psychiatry, 39, 683-692.  
Warren, R., & Zgourides, G. (1988). Panic attacks in high school students: 
Implications for prevention and intervention. Phobia Practice and Research 
Journal, 1, 97-113.  
Washton, A, (2011). Group therapy. In P. Ruiz & E. C. Strain. Substance Abuse: A 
Comprehensive Textbook. (pp. 575-584) (4th ed). Lippincott Williams & Wilkins. 
Watkins, P. L., Sturgis, E. T., & Clum, G. A. (1988). Guided imaginal coping: an 
integrative treatment for panic disorder. Journal Behavior Therapy and 
Experimental Psychiatry. 19, 147-155.  
W. B. Saunders Group. Dorland’s Pocket Medical Dictionary, (26th ed.), US: W. B. 
Saunders Company, 2001.  
Weiner, H. (2008). The Concept of Psychosomatic Medicine. In R. Edwin., I. V. 
Wallace & J. Gach (Eds.). History of psychiatry and medical psychology (pp. 485-
516). Springer Science.  
Weissman, M. M. (1993). Family genetic studies of panic disorder. Journal of 
psychiatric research, 27, 69-78. 
Weissman, M. M., Bland, R. C., Canino, G. J., Faravelli, C., Greenwald, S., Hwu, H. 
G., Joyce, P. R., Karam, E. G., Lee, C. K., Lellouch, J., Lepine, J. P., Newman, S. C., 
Oakley-Browne, M. A., Rubio-Stipec, M., Wells, J. E., Wickramaratne, P. J., 
Wittchen, H. U., & Yeh, E. K. (1997). The Gross national epidemiology of panic 
disorder. Archive General Psychiatry, 54, 305-309.  
Weissman, M. M., Klerman, G., Markowitz, J., & Ouellette, R. (1990). Suicidal 
ideation and suicide attempts in panic disorder and attacks. The New England 
Journal of Medicine, 321, 1209-1214. 
Wells, A. (1997). Cognitive Therapy of Anxiety Disorders. A Practice Manual and 
 
 Reference  222 
 
Conceptual Guide. Chichester: John Wiley. 
Wenzel, A., Sharp, I.R., Brown, G.K., Greenberg, R.K., Beck, A.T. (2006). 
Dysfunctional beliefs in panic attacks: the Panic Belief Inventory. Journal of 
Behavior Research Therapy. In press.  
Westen, D., & Morrison, K. (2001). A multi-dimensional meta-analysis of treatments 
for depression, panic and generalized anxiety disorder: an empirical examination 
of the status of empirically supported therapies. Journal of counseling and 
clinical psychology, 69, 875-899. 
Westling, B. E., & Öst, L. B. (1993). Relationship between panic attacks symptoms and 
cognition in panic disorder patients. Journal of anxiety Disorders, 7, 181-194.  
Whalen, P. J., Rauch S. L., Etcoff, N. L., McInerney, S. C., Lee, M. B., & Jenike, M. A. 
(1998). Masked presentations of emotional facial expressions modulate amygdala 
activity without explicit knowledge. Journal of Neuroscience, 18, 411-418.  
White, K. S., & Barlow, D. H. (2002). Panic disorder and agoraphobia. Anxiety and its 
Disorder: The nature and treatment of anxiety and panic, (pp. 328–379) (2nd ed). 
New York: The Guilford press.  
White, J. R., & Freeman, A. S. (2000). Cognitive behavioral group therapy for specific 
problems and populations. (pp. 29-61). Washington, DC: American psychological 
Association.  
White, J. R. (2000). Introduction. In J. R. White & A. S. Freeman (Eds.). Cognitive 
behavioral group therapy for specific problems and populations, (pp. 3-25). 
Washington, DC: American Psychological Association. 
Wilhelm, F. H., Gevirtz, R., & Roth, W. T. (2001). Respiratory dysregulation in 
anxiety, functional cardiac, and pain disorders: Assessment, phenomenology, 
and treatment. Journal of Behavior Modification, 25, 513-545. 
Williams, S. L., & Falbo, J. (1996). Cognitive and performance-based treatments for 
panic attacks in people with varying degrees of agoraphobic disability. Journal of 
Behavior Research and Therapy 34, 253-64.  
Williams, S. L., Kinney, p., & Falbo. J. (1989). Generalization of therapeutic changes in 
agoraphobia: The role of perceived self-efficacy. Journal of consulting and clinical 
psychology 53, 436-442.  
Wilson, C. H. (2009). Examining the roles of acceptance, suppression and other 
therapeutic strategies in anxiety and relaxation. National University of Ireland 
Maynooth. 
Wittchen, H. U., & Essau, C. A. (1993). Comorbidity and mixed anxiety-depressive 
disorders: Is there epidemiological evidence? Journal of Clinical Psychiatry, 54, 9-
15.  
 
Reference  223 
 
Wittchen, H. U., & Essau, C. A. (1991). The epidemiology of panic attacks, panic 
disorder, and agoraphobia. In Walker, J. R., Norton, G. R. & Ross, C. A. (Eds.). 
Panic Disorder and Agoraphobia. A Comprehensive guide for the Practitioner. 
Belmont: Brooks/Cole. 
Wollburg, E. (2007). Psychophysiological Effects of Respiratory Challenges before 
and after Breathing Training in Panic Disorder and Patients suffering from 
Episodic Anxiety Attacks. University of Dresden. 
Wolpe, J. (1958). Psychotherapy by Reciprocal Inhibition. Stanford, CA: Stanford 
University Press.  
Wolpe, J. (1990). The practice of behavior therapy (4th ed.). New York: Pergamon. 
Woods, S. W., Charney, D. S., Loke, J., Goodman, W. K., Redmond, D. E Jr., & 
Heninger, G. R. (1986). Carbon dioxide sensitivity in panic anxiety. Ventilatory 
and anxiogenic response to carbon dioxide in healthy subjects and patients with 
panic anxiety before and after alprazolam treatment. Archieve General 
Psychiatry, 43, 900-909. 
World Health Organization. (2003). Investing in mental health. Geneva: World 
Health Organization, also available from: URL: http://www. emro. who. 
int/mnh. 
Yalom, I. D. (1995). The Theory and Practice of Group Psychotherapy. New York: 
Basic Books. 
Yalom, I. D., Cox, P. D., & Vinogradov, S. (2008). Group therapy. In R. E. Hales., S. C. 
Yudofsky & G. O Gabbard. (Eds), Textbook of psychiatry, (pp. 1329-1377). 
Washington, DC: American psychiatric publishing.  
Yalom, I. D., & Leszcz, M. (2005). The theory and practice of group psychotherapy 
(pp. 3-105). New York: Basic Books. 
Yalom, I. D. Tinklenberg, j., & Gilula, M (1968) curative factors in group therapy. Un 
published manuscript. 
Yamada, K., Moriwaki, K., Oiso, H., & Ishigooka, J. (2011). High prevalence of 
comorbidity of migraine in outpatients with panic disorder and effectiveness of 
psycho pharmacotherapy for both disorders: a retrospective open label study. 
Journal of Psychiatry Research 185, 145-148.  
Yasamy, M. T., Shahmohammadi, D., Bagheri Yazdi, S. A., Layeghi, H. J, Bolhari, J., 
Razzaghi, E. M; Bina, M., & Mohit, A. (2002). Mental health in the Islamic 
Republic of Iran: achievements and areas of need. Eastern Mediterranean Health 
Journal, 7, 381-391.  
Yates, W. R. (2009). Phenomenology and epidemiology phenomenology and 
epidemiology of panic disorder f panic disorder. Annals of clinical psychiatry 21, 
 
 Reference  224 
 
95-102. 
Yonkers, K., Zlotnick, C., Warshaw, M., Allsworth, J., Shea, M. T, & Keller, M. B. 
(1998). Is the course of panic disorder the same in women and men. American 
Journal of Psychiatry, 5, 596-602. 
Zal, H. M. (2001). Panic disorder (pp. 168-172). New York: Preseus publishing.  
Zeitlin, S. B., & McNally, R. J. (1993). Alexithymia and anxiety sensitivity in panic 
disorder and obsessive-compulsive disorder. 25th Annual Meeting of the 
Association for Advancement of Behavior Therapy. American Journal of 
Psychiatry, 150, 658-660.  
  
 
Appendix A  225 
 
Appendix A 
Criteria for Panic Attacks  
(American Psychiatric Association, DSM-IV-TR, 2000)  
A discrete period of intense fear or discomfort, in which four or  
more of the following symptoms developed abruptly and reached  
a peak within 10 minutes:  
1. palpitations, pounding heart, or accelerated heart rate  
2. sweating  
3. trembling or shaking  
4. sensations of shortness of breath or smothering  
5. feeling of choking  
6. chest pain or discomfort  
7. nausea or abdominal distress  
8. feeling dizzy, unsteady, light-headed, or faint  
9. derealisation (feeling of unreality)  
10. fear of losing control  
11. fear of dying  
12. paresthesias (numbness or tingling sensations)  
13. chills or hot flushes 
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1) The Structured Clinical Interview for DSM-IV (SCID) Axis I disorders clinical 
version (SCID-CV), (Spitzer, Willimas, Gibban & First, 1997): The SCID-CV is a 
clinically administered interview with which to ascertain (DSM-IV). Approximate 
time of administration is one hour. After noting demographic information and 
questions, the interview begins with questions regarding the chief complaint, 
history of present and past psychiatric disorders, treatment history, and current 
functioning. The SCID has a diagnostic module which begins with closed-ended 
questions that invite a "yes" or "no" response. The interviewer then seeks 
elaboration by asking questions such as "tell me about that", or "what was that 
like"? If the interviewer suspects that a particular symptom is present, the 
participant can be further prompted. The reliability and validity of the SCID is 
comparable to other major diagnostic instruments and depends largely on the 
skills and knowledge of the interviewer, when the focus is on one or two 
disorders, reliability is likely to be higher. Spitzer, Williams, Gibbon, First, (1992) 
obtained high reliability rates for a current diagnosis of panic disorder. In this 
panic disorder study, there were 13 international sites and test-retest interviews of 
72 patients which yielded a correlation of r=.87. More recently, the SCID has also 
been used successfully in diagnosing panic disorder in a dissertation regarding 
treatment effects (Rabin, 1996), and diagnosing individuals with panic disorder 
with and without Agoraphobia.  
2) Daily panic record Questionnaire (Clark, 1999): For recording and reporting the 
number of panic attacks and their severity Clark’s record daily panic (1999) was 
used. Clients are noting day and time and the situation when panic attacks 
occurred. They also identify either negative thoughts and physical signs or 
rational responses instead of negative thoughts. Severity of attack is determining 
between 0 to 100. 
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The results of mean scores in figures in a 3 (Status: ICBT, GCBT, WL) x 2 (Time: 
pretest vs. posttest) and a (Status: ICBT, GCBT) x 3 (Time: pretest, posttest, Follow-
up) for BAI, BDI, PDSS, ACQ, ASI, FQ-AG are presented in Figures C1 to C12.  
 
Beck Anxiety Inventory (BAI) 
 
Figure C1: Beck Anxiety means scores of ICBT, GCBT and WL in pretest, posttest (bars 
represent standard errors) 
Beck Anxiety Inventory (BAI) 
 
Figure C2: Beck Anxiety means scores of ICBT, GCBT (bars represent standard errors) in 
Pretest, Posttest, Follow-up 
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Beck Depression Inventory (BDI) 
 
Figure C3: Beck Depression means scores of ICBT, GCBT and WL in Pretest, Posttest (bars 
represent standard errors) 
Beck Depression Inventory (BDI) 
 
Figure C4: Beck Depression means scores of ICBT, GCBT in Pretest, Posttest and Follow-
up (bars represent standard errors)  
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Panic Disorder Severity Scale (PDSS) 
 
Figure C5: Panic Disorder Severity means scores of ICBT, GCBT and WL (bars represent 
standard errors) in Pretest, Posttest 
Panic Disorder Severity Scale (PDSS) 
 
Figure C6: Panic Disorder Severity means scores of ICBT, GCBT (bars represent standard 
errors) in Pretest, Posttest, and Follow-up  
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Agoraphobic Cognition (ACQ) 
 
Figure C7: Agoraphobic Cognition (ACQ) means scores of ICBT, GCBT, WL (bars 
represent standard errors) in Pretest, Posttest 
Acoraphobic Cognition (ACQ) 
 
Figure C8: Agoraphobic Cognition (ACQ) means scores of ICBT, GCBT (bars represent 
standard errors) in Pretest, Posttest, and Follow-up 
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Anxiety Sensitivity Index (ASI) 
 
Figure C9: Anxiety Sensitivity mean scores of ICBT, GCBT and WL (bars represent 
standard errors) in Pretest, Posttest 
Anxiety Sensitivity Index (ASI) 
 
Figure C10: Anxiety Sensitivity means scores of ICBT, GCBT (bars represent standard 
errors) in Pretest, Posttest, and Follow-up   
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Fear Questionnaire-Agoraphobia (FQ-AG) 
 
Figure C11: Fear-Agoraphobia means scores of ICBT, GCBT, WL (bars represent standard 
errors) in Pretest, Posttest 
Fear Questionnaire-Agoraphobia (FQ-AG) 
 
Figure C12: Fear-Agoraphobia means scores of ICBT, GCBT (bars represent standard 
errors) in Pretest, Posttest, and Follow-up 
 
